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ABSTRACT
Modeling Substance Use and Mental Disorder Comorbidity Using Latent Variable
and Network Approaches
By Courtney Taylor Blondino, MPH, Ph.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2021
Director: Elizabeth Prom-Wormley, Ph.D.
Assistant Professor
Division of Epidemiology
Department of Family Medicine and Population Health
Introduction. Substance use disorder (SUD) is a common condition that affects millions
of Americans and represents a substantial burden to the U.S. healthcare system.
Addressing SUD has been complicated by comorbid mental disorders and co-occurring
substance use. Consequently, detailing and addressing SUD and comorbid SUD
represent an important goal to improve the health of Americans.
Objective. The research goal of this dissertation was to characterize the comorbidity
between substance use, including tobacco use, and mental disorder symptoms
measured as negative affect and externalizing symptoms in a population-based sample
using latent variable and network approaches. Specifically, this project aims to:
preliminarily assess comorbidity using multinomial regression between lifetime negative
affect severity, externalizing severity and nicotine dependence, and current use of
tobacco (cigarettes and e-cigarettes) and alcohol (Chapter 2); identify latent classes of
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comorbid substance use as well as negative affect and externalizing symptoms and
their ability to predict SUD severity (Chapter 3); detail substance use, negative affect,
and externalizing symptom networks and test for differences in the network structure
and connectivity by gender (Chapter 4); and use pairwise comparisons from the LCA
and network results to address stability or movement of comorbidity structures over
three waves of data (Chapter 5).
Methods. Waves 1 – 3 from the Population Assessment of Tobacco and Health Study
were used. Various statistical analyses were used to complete each project including
multinomial and ordinal regression, latent class analysis, cumulative ROC curve
analysis, and network analysis.
Results. The associations between psychopathology (negative affect vs. externalizing
severity) varied by different substance use combinations. Results from the latent class
analysis identified a four-class solution as most optimal in characterizing comorbidity:
low symptom (N=23,571, 72.9%), negative affect (N=4,098, 12.7%), externalizing
(N=2,691, 8.3%), and comorbid (N=1,960, 6.1%). Network analysis results showed
similarities between men and women. The strongest substance use/mental health
symptom connections estimated as edge-weights (EW) in the network were between
marijuana with lying (EW = 0.60, 95% CI = 0.49; 0.70), marijuana with engaging in fights
(EW = 0.54, 95% CI = 0.27; 0.81), prescription drugs not prescribed (PDNP) with having
trouble sleeping (EW = 0.53, 95% CI = 0.40; 0.66), and alcohol and impulsivity (EW =
0.48, 95% CI = 0.42; 0.53). Both latent class analysis and network analysis results
identified relationships between (1) exclusive cigarette, dual cigarette and e-cigarette,
marijuana, and PDNP with negative affect symptoms, and (2) alcohol with externalizing
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symptoms. Similar latent profiles emerged across the three waves specifically where the
low symptom class was largest (65.5% to 72.9%) and the comorbid class was smallest
(6.1% to 8.2%). Network structure and connectivity did not significantly differ by wave;
however, edge-weight comparisons identified some stronger connections among the
substance use behaviors and mental disorder symptoms from preceding to subsequent
waves.
Conclusions. The results from the four different studies fill extensive gaps in the
comorbidity research. This dissertation identified specific combinations of substance
use behaviors and mental disorder symptoms, determined which sociodemographic
factors play a role in specific comorbidity profiles, and assessed the patterns of
comorbidity among three waves of data. These results support the need to approach
substance use and mental disorders from a more holistic perspective, taking
comorbidity into account to better support the overall wellbeing of the individual. The
results can inform robust and targeted prevention strategies to effectively mitigate the
substantial burden and societal costs of comorbidity in the U.S. population.
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CHAPTER 2: THE ASSOCIATION BETWEEN NEGATIVE AFFECT AND
EXTERNALIZING SEVERITY WITH CURRENT USE OF CIGARETTES, ECIGARETTES, AND ALCOHOL IN ADULTS: WAVE 1 OF THE POPULATION
ASSESSMENT OF TOBACCO AND HEALTH (PATH) STUDY
Introduction. Concurrent tobacco/alcohol use is common in adults, and associated with
the severity of symptoms experienced by those with mental health disorders. However,
few studies have explored this relationship across different combinations of tobacco
products [i.e., conventional cigarette (CIG) and electronic cigarette (ECIG)] and alcohol.
Objective. Examine the association of lifetime mental disorder symptom severity and
past 30-day combinations of CIG, ECIG, and alcohol use.
Methods. Data from the Wave 1 (2013-2014) Population Assessment of Tobacco and
Health study were used. A total of 15,947 adults aged 18 years or older with complete
study information were included. Multinomial logistic regression analyses were
performed to determine the relationship between lifetime negative affect/externalizing
severity and past 30-day use of tobacco and alcohol, adjusting for nicotine dependence
(ND), sex, age, race, education, and income.
Results. Negative affect severity was more strongly associated with CIG and alcohol
use (moderate AOR= 1.47, 95% CI= 1.22-1.77; high AOR= 1.29, 95% CI= 1.03-1.61) as
well as alcohol-exclusive use (moderate AOR= 1.58, 95% CI= 1.27-1.96; high AOR=
1.31, 95% CI= 1.05-1.64) while externalizing severity was more strongly associated with
ECIG and alcohol use (high AOR= 2.97, 95% CI= 1.84-4.81, moderate AOR= 2.29, 95%
CI= 1.53-3.43) when accounting for ND compared to none. The relationship between
externalizing severity with ECIG use was dependent on alcohol being used with ECIG.
Conclusions. The associations between psychopathology (negative affect vs.
externalizing severity) vary by different combinations of alcohol, CIG, and ECIG.
Further, these relationships may be mediated through ND. Future investigations into the
comorbidity between mental disorder symptoms with tobacco and alcohol use should
consider use of specific substances and their combination.
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CHAPTER 3: LATENT CLASSES OF COMORBID SUBSTANCE USE AND
NEGATIVE AFFECT AND EXTERNALIZING SYMPTOMS AND THEIR ROLE IN
ADULT SUBSTANCE USE DISORDER SEVERITY
Introduction. SUD poses a substantial burden on the United States’ health system.
Many prevention efforts exist to slow the progression or prevent SUD from occurring.
Substance use and mental health comorbidity profiles could predict SUD severity,
further informing prevention and intervention strategies.
Objective. Identify latent classes of comorbid substance use as well as negative affect
and externalizing symptoms and assess their ability to predict SUD severity.
Methods. Latent class analysis of past-month endorsement of negative affect and
externalizing symptoms and past 30-day substance use will be used for each wave
separately. We tested the degree to which demographic and social factors influence the
probability of class membership. The probability of comorbidity class membership will
be included in regression models to test the predictive probability of SUD severity.
Results. A four-class solution was considered to best fit the data and were categorized:
low symptom (N=23,571, 72.9%), negative affect (N=4,098, 12.7%), externalizing
(N=2,691, 8.3%), and comorbid (N=1,960, 6.1%). Substance use varied across the
mental disorder symptoms. Exclusive cigarette use, dual cigarette and e-cigarette use,
marijuana use, and prescription drugs not described more commonly occurred in the
negative affect class while exclusive e-cigarette and alcohol use more commonly
occurred with the externalizing class. Women and people with low socioeconomic status
had higher odds of membership in the comorbid and negative affect classes. Social
satisfaction was a very strong factor associated with the comorbid and negative affect
classes. Latent class membership predicting SUD severity performed similarly to a
model where the symptoms were grouped separately (i.e., negative affect symptoms,
externalizing symptoms, and substance use behaviors).
Conclusions. A four-class solution best described the comorbidity structure in a
nationally representative sample of U.S. adults. Certain substance use behaviors were
more commonly associated with specific mental disorder symptoms. Demographic
factors and a potentially modifiable social factor were significantly associated with latent
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class membership. Overall, prediction of SUD severity was poor for latent class
membership as well as substance use behaviors and mental disorder symptoms group
separately. These results identify the need for prevention efforts required to mitigate
development of more severe course of illness. Future work should consider other
methodological approaches (e.g., factor mixture modeling and network analysis) to
further investigate the comorbidity structure of U.S. adults.
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CHAPTER 4: A NETWORK APPROACH TO SUBSTANCE USE, NEGATIVE
AFFECT, AND EXTERNALIZING COMORBIDITY IN U.S. ADULTS
Introduction. Use of conventional cigarettes (CIG), alcohol, marijuana, and sedatives
[i.e., benzodiazepines and barbiturates]) commonly co-occur with negative affect and
externalizing disorders. It is unclear how these relationships extend to electronic
cigarettes (ECIG) and prescription drugs not prescribed (i.e., sedatives, tranquilizers,
and painkillers [PDNP]), and whether they differ by gender.
Objective. Detail substance use, negative affect, and externalizing symptom networks,
and compare by gender.
Methods. Data from Wave 1 of the adult PATH sample was used to test a network
model of past 30-day substance use, negative affect symptoms, and externalizing
symptoms. Global and local differences in men and women networks were tested
through visual comparisons, global strength invariance, network structure invariance,
and edge strength invariance.
Results. Overall, networks were consistent between men and women. The strongest
substance use/mental health symptom connections estimated as edge-weights (EW)
were between marijuana with lying (EW = 0.60, 95% CI = 0.49; 0.70), marijuana with
engaging in fights (EW = 0.54, 95% CI = 0.27; 0.81), PDNP with having trouble sleeping
(EW = 0.53, 95% CI = 0.40; 0.66), and alcohol and impulsivity (EW = 0.48, 95% CI =
0.42; 0.53).
Conclusions. There were many weak connections throughout the substance use and
negative affect/externalizing network. A few important connections were identified and
encourage future study. In particular, PDNP was most strongly associated with negative
affect while marijuana, alcohol and PDNP use were most strongly associated with
externalizing.
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CHAPTER 5: PRELIMINARY PATTERNS OF SUBSTANCE USE AND MENTAL
DISORDER SYMPTOM COMORBIDITY IN ADULTS OVER TIME
Introduction. Patterns of co-occurring substance use and mental health conditions are
well-described in youth and young adult populations. It remains unclear whether these
patterns continue into adulthood.
Objective. Perform a preliminary assessment to determine the stability of substance use
and mental disorder comorbidity across three years of data (2013-2016) using both
latent class and network analyses.
Methods. Latent class analyses were conducted cross-sectionally for each wave of data
(Wave 1, Wave 2, Wave 3). Class probability parameters, item response probability
parameters, transition patterns and results from the multinomial logistic regression were
compared across the three waves. Network models were estimated, and three tests of
network invariance were used to test significant differences in network models by wave.
Results. Four-class solutions generated from the latent class analyses were compared
by wave. Similar latent profiles emerged across the three waves specifically where the
low symptom class was largest (65.5% to 72.9%) and the comorbid class was smallest
(6.1% to 8.2%). Overall, when individuals transitioned from one class to another, they
typically transitioned into the low symptom class (62.3% to 66.8%) from preceding to
subsequent wave. Network structure and connectivity did not significantly differ by
wave; however, edge-weight comparisons identified some stronger connections among
the substance use behaviors and mental disorder symptoms from preceding to
subsequent waves.
Conclusions. The comorbidity structure is consistent across waves. The connections
between these behaviors and symptoms may become stronger at each wave.
Therefore, investment of time, money, and other resources are encouraged to support
those experiencing comorbidity as they are unlikely to change in adulthood
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CHAPTER 1: INTRODUCTION
Substance use disorder
Substance use disorder (SUD) develops as a result of prolonged use of any
psychoactive substance at high doses and/or frequencies, and is defined as the
continued use of alcohol and/or drugs despite clinically significant impairment, including
health problems, disability, and failure to meet major responsibilities at work, school, or
home.1–3 The essential feature of a SUD is a cluster of cognitive, behavioral, and
physiological symptoms showing that the individual continues substance use despite
significant substance-related problems.2 Diagnosis of SUD is based on a pathological
pattern of behaviors related to the use of a substance.2
SUD represents a significant public health burden because of the life-years lost
due to disability, impaired quality of life, disruption of work and family relationships, and
death from accidents or overdose.4 In 2018, approximately 19.3 million American adults
met diagnostic criteria for a past-year SUD,5 and drug abuse and addiction cost society
an estimated $600 billion every year.6

Substance use disorder and mental health comorbidity
SUD commonly co-occurs across substances and with mental disorders.
Approximately 6% of American adults are affected with SUD.2,7,8 Of those affected with
SUD, about 50% have a co-occurring or comorbid mental illness such as negative affect
(i.e., behaviors such as depression or anxiety where the distress of an affected
individual is expressed inward) or externalizing disorders (i.e., behaviors such as
attention-deficit hyperactivity disorder where the distress of an affected individual is
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expressed outward).5 Further, many people affected with SUD also engage in use of
other substances. For example, alcohol use disorder and nicotine dependence are
commonly reported in approximately 25-50% of those with marijuana, cocaine,
prescription opioid, and heroin use disorders.9 Some common mental disorders that
have been associated with SUDs (e.g., tobacco, alcohol, marijuana, cocaine, sedatives)
include anxiety disorders, depressive disorders, conduct disorder, ADHD, and antisocial
personality disorder.9–17
Comorbid substance use and mental disorders represent a substantial burden to
the American health care system. Of the approximately 20 million adults in the United
States (U.S.) who experience a SUD, half also have a co-occurring mental illness.5
People with comorbid substance use and mental disorders suffer from more severe
health outcomes compared to those who experience one disorder.18 Substance use and
mental disorders are the leading cause of disease burden in the U.S. This has
increased from 2779 DALYs (age standardized disability adjusted life years) in 1990 to
3355 DALYs in 2015.19 Additionally, the U.S. has the highest rate of death due to
substance use and mental disorders together at an age standardized death rate = 12.0
per 100,000 compared to an average of 4.9 per 100,000 in similarly wealthy countries
(e.g., France = 6.5 per 100,000; Canada = 5.8 per 100,000; United Kingdom = 5.2 per
100,000; Netherlands = 2.5 per 100,000).19 The economic burden of substance use and
mental disorder comorbidity, due to treatment spending from all public and private
sources, is expected to increase from $171.7 billion in 2009 to $280.5 billion in 2020.20
Co-occurring mental disorders, without SUD, are also common. Negative affect
disorders like depression and anxiety are frequently associated with one another.21,22
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Examples of negative affect symptoms include feeling depressed, feeling anxious,
having sleep trouble, or becoming distressed or upset about the past. Negative affect
symptoms are commonly reported in those with externalizing disorders.23 Externalizing
disorders reflect distress expressed outward which is commonly diagnosed as attention
deficit hyperactivity disorder (ADHD), oppositional defiant disorder, conduct disorder,
antisocial personality disorder, and sometimes SUD.22 Examples of externalizing
symptoms include having a hard time paying attention or listening, feeling restless,
acting impulsively, lying or conning, threatening people, and starting physical fights with
people.
SUD is a common condition that affects millions of Americans and represents a
substantial burden to the U.S. healthcare system. Addressing SUD has been
complicated by comorbid mental disorders and co-occurring substance use.
Consequently, detailing and addressing SUD and comorbid SUD represent an important
goal to improve the health of Americans.

Current state of SUD measurement
The American Psychiatric Association’s Diagnostic and Statistical Manual of
Mental Disorders, Fifth Edition (DSM-V) is a classification of mental disorders, including
SUD, with associated criteria designed to facilitate more reliable diagnoses of these
disorders.2 To date, the DSM-V is the standard reference for clinical practice and is
considered the best description of how mental disorders are expressed.2 In the DSM-V,
substance-related disorders encompass ten separate classes of drugs: alcohol;
caffeine; cannabis; hallucinogens (with separate categories for phencyclidine [or
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similarly acting arylcyclohexylamines] and other hallucinogens); inhalants; opioids;
sedatives, hypnotics, and anxiolytics; stimulants (amphetamine-type substances,
cocaine, and other stimulants); tobacco; and other (or unknown) substances. For a
twelve-month period for diagnoses, two of the eleven criteria are required: (1) take
substance in larger amounts or over longer period than intended, (2) express consistent
desire to cut down or regulate use, (3) spent a great deal of time obtaining or using the
substance, or recovering from its effects, (4) intense desire or urge for the substance
(craving), (5) use results in failure to fulfill major role obligations, (6) continues use
despite persistent social or interpersonal problem, (7) reduced involvement in activities
because of use, (8) risky use in situations which are physically hazardous, (9) continued
use despite physical or psychological problems, (10) requiring an increased dose of
substance to achieve desired effect (tolerance), and (11) withdrawal symptoms.
Diagnostic criteria allow a severity rating along with diagnosis: mild SUD defined as two
or three symptoms, moderate SUD defined as four or five symptoms, and severe SUD
defined as six or more symptoms.
The International Classification of Disease, Tenth Revision, Clinical Modification
(ICD-10-CM) is the other main diagnostic classification systems for SUD in the United
States.24 The World Health Organization produces the ICD-10-CM with the primary
focus for mental and behavioral disorder classification to help countries reduce the
disease burden of mental disorders.24 It is the standard transaction code set for
diagnosis under the Health Insurance Portability and Accountability Act (HIPAA) and is
used to track disease burden, mortality statistics, and to ensure appropriate billing.25
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The ICD-10-CM lists the same ten substances as the DSM followed by a list of
specifiers under larger categories including abuse, dependence, and use.
There are other instruments used in clinical and non-clinical settings to identify
and measure SUD and SUD severity, overall or by specific substance. Common
evidence-based instruments include the Addiction Severity Index (ASI), Alcohol Use
Disorders Identification Test (AUDIT), Drug Abuse Screen Test (DAST), Fagerstrom
Test for Nicotine Dependence (FTND), and the Global Appraisal for Individual Needs
(GAIN).26–28 These tools are useful to assess SUD and SUD severity in settings such as
epidemiologic research of large populations where it is impractical to establish
diagnoses.27,28 This is important because substance use that does not result in a
diagnosis of SUD remain pervasive throughout American society.8 For example, 85.6%
of American adults engage in alcohol use.29 Of these, 25.8% engage in patterns of use
that would not necessarily lead to a diagnosis of alcohol use disorder such as binge
drinking (i.e., consuming 5 or more alcoholic drinks for males or 4 or more alcoholic
drinks for females on the same occasion) in the past-month.29 Additionally, 8.3% of
Americans 12 years of age and older reported past-month marijuana use with intensity
of use increasing (i.g.,11.1% of heavy use in 1992 to 35.4% in 2014).30 Further, there is
increasing evidence that environmental stressors such as the current COVID-19
pandemic can influence sub-threshold use towards problematic use.31,32 Nevertheless,
there are few effective strategies that address sub-threshold use in order to address
population-level mental health issues in people with who do not meet criteria for SUD.
Consequently, the use of other tools that can evaluate substance use beyond
disordered substance use is particularly useful to detail population-level substance use
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that measure sub-threshold SUD. Nevertheless, a common limitation of current SUD
instruments is that none of these tools address SUD comorbidity. Therefore, it has been
challenging to characterize SUD comorbidity with currently available measurement
tools. Instead, research has focused on modeling SUD comorbidity across measures of
substance use and mental disorders.

Conceptual models of SUD-mental disorder comorbidity
Epidemiological research of substance use, negative affect, and externalizing
disorders has typically studied comorbidity from three major perspectives. These
models attempt to either identify or confirm an association between symptoms or
disorders, test the causal relationship between comorbid disorders, or describe the
patterns of overlap across disorders or symptoms.12,22,33–41 To date, these models have
concluded: (1) substance use behaviors and disorders co-occur,34–36,42 (2) negative
affect and externalizing symptoms and disorders co-occur,22,38–40 and (3) substance use
behaviors/disorders co-occur with negative affect and externalizing
symptoms/disorders.12,33,41 However, the use of each model has often been completed
in isolation and this approach produces gaps in our understanding of comorbidity. The
section below reviews the models that have been used to study comorbidity, their
strengths and weaknesses, and identifies needs to expand insights that could be gained
from these models.
Common cause model. To date, the major psychiatric classification systems (i.e.,
DSM-V and ICD-10) measure SUD, negative affect, and externalizing disorders as
single latent constructs based on observable symptoms.43 Therefore, SUD represents a
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latent or unobservable construct of disease (denoted as a circle) that causes the
observable symptoms (denoted as squares) which are measured to diagnose SUD
(e.g., substance use taken in large amounts, cravings, social problems, and cessation
attempts) (Figure 1.1). Based on the DSM’s approach to diagnosis, at least two of the
eleven symptoms listed in the criteria above are needed to result in a diagnosis of SUD.
This model is called the common cause model. It has also been referred to as the
medical model and has also been applied to physical conditions.44,45

Figure 1.1: Common Cause Model of Disease

The common cause model assumes that the disease has a common pathogenic
pathway or an etiology in which the mechanism is fully understood.45 However, common
pathogenic pathways for mental disorders, including SUDs, have not been identified.45–
48

Additionally, the common cause model is unidimensional and does not account for

comorbidity. These models become complicated to interpret when we take multiple
disorders, and their overlapping symptomatology, into account. This is problematic
because there is a high degree of comorbidity that is not accounted for through our
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current diagnostic classification systems resulting in potential misclassification of
disorder diagnosis. The internalizing-externalizing model presents an extension to the
common cause model to account for comorbidity between internalizing and
externalizing mental disorders.
Internalizing-Externalizing Model. The internalizing-externalizing model is a twofactor model of internalizing and externalizing factors that explain the interrelationships
of psychiatric disorders, seen in Figure 1.2.22,38 In this model, internalizing disorders
like mood (major depressive disorder and dysthymia) and anxiety (generalized anxiety
disorder, separation anxiety disorder, phobias, obsessive-compulsive disorder)
disorders reflect a similar construct, and are associated with or explains the variance of
the internalizing factor. Externalizing disorders like ADHD, oppositional defiant disorder,
conduct disorder, antisocial personality disorder, and sometimes SUDs reflect a
separate construct, an externalizing factor. The internalizing and externalizing factors
can also be correlated in this model, indicating that internalizing and externalizing
disorders are comorbid with each other.22 This model has received considerable
attention for understanding co-occurring psychiatric disorders, including SUDs, as latent
factors in adults.22,38–40
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Internalizing

Depression

Depression
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Anxiety

PTSD
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SUD
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Conduct
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Disorder
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Figure 1.2: Internalizing-Externalizing Model. In the internalizing-externalizing model, the
observable symptoms (in boxes) are caused by an unobserved internalizing and externalizing
latent variables (in circles). This model allows there to be some correlation between the
internalizing and externalizing latent variables.

The internalizing-externalizing model assumes that negative affect disorders
represent a latent negative affect construct with externalizing disorders, including SUD
represent a latent externalizing construct. Statistically, these latent factors represent the
proportion of variance shared between the observed disorder (i.e., depression) and the
latent construct (i.e., internalizing). This model extends the common cause model
because it accounts for the comorbidity between internalizing and externalizing
disorders. This model predominantly focuses on mental disorders as latent constructs
and does not include a robust set of substance use behaviors. This method explains the
relationships between the observed disorders or symptoms that explain the latent
construct by calculating the model implied covariance. However, this calculation does
not describe the unobserved heterogeneity in the population to identify different
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comorbidity patterns in a population. This is a limitation of the negative internalizingexternalizing model.
Network Model. The network model is a relatively new psychometric approach
that can reduce the lack of clarity on the relationships between the observed disorders
or symptoms that explain the latent construct and address the associations between the
observed disorders or symptoms. A network model is likely to support a deeper
understanding of comorbidity because it conceptualizes symptoms as mutually
interacting, often reciprocally reinforcing elements of a complex network.46 The network
approach is based on the idea that comorbidities arise from shared symptoms between
disorders which can capture complexity and individual variation in psychopathology.49
The network approach naturally accommodates comorbidities as a central part of its
theory.50 In the network approach, comorbidity represents causal relationships between
symptoms in which pathways can bridge symptoms that are part of multiple disorders.46
Using a network model, symptoms, rather than disorders, are considered within the
network structure. Rather than the disorder acting as the underlying cause of all
symptoms, it is the symptoms that mutually interact and set a person into a disordered
mental health state.
An example of the use of a network model is detailed in Figure 1.3 to summarize
comorbidity of symptoms for SUD and depression. Symptoms found in depression and
SUD include insomnia and weight loss. Within a network model, the symptoms make up
a comorbid network structure of several symptoms that is specific to the person. This
model conceptualizes how symptoms of different disorders function together specifically
to produce a comorbid disordered state. The network approach explains the co-
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occurrence of mental disorder symptoms, including substance use behaviors, as
resulting from direct interactions between these symptoms.50 In network analysis, the
term interaction is used to explain the reciprocal action or influence of symptoms. In the
context of network analysis, interaction is not used to test whether an effect can be
greater than (positive interaction, synergism) or less than what we would expect
(negative interaction, antagonism).51

Depressed
mood

Diminished
interest or
loss of
pleasure

Feelings of
worthlessness

Cessation
attempts

Weight
loss

Node

Edge

Insomnia

Social
problems

Substance
use taken in
large
amounts

Figure 1.3: Network Model of Depression and SUD symptoms. The network model of
depression and SUD is made of nodes (circles) and edges (lines connecting nodes). This is a
directed network (arrows are directed from source to target node) where one symptom can lead
to the activation of another. The depression symptoms in red are clustered together to the left of
the network. The SUD symptoms in blue are clustered together to the right of the network.
Insomnia and weight loss (in purple) are symptoms that occur in both depression and SUD and
act as bridges between the disorders. The positioning and the distance between the
symptoms/nodes within the network have implications for the comorbidity structure of
depression and SUD.

Patterns of symptom-symptom or symptom-behavior interactions can be
encoded in a network structure.45 Measured symptoms and behaviors are represented
as nodes. Nodes are connected by edges (seen in Figure 1.3). Edges represent the
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interactions between the nodes. Nodes that directly activate each other (i.e.,
demonstrate an association) are connected while nodes that do not directly activate
each other are not. Changes that occur outside the network, external forces, can
influence the symptoms and the interactions between the symptoms.45
Principles underlying the network approach imply the etiology of mental disorders
as a process of spreading activation in a symptom network.45 For example, if a
symptom arises (for any reason), it may influence the probability that a connected
symptom will activate as well.45 A mental disorder will arise when a group of tightly
coupled symptoms activate, and the cluster becomes self-sustaining.45 Although
symptom interactions may be most active within symptoms sets that are associated with
a given mental disorder, these interactions do not stop at diagnostic boundaries.45
In network theory, diagnosis is conceptualized as a process where the presence
of symptoms is identified by clinicians and any symptom-symptom interactions that
sustain themselves.45 An example of sustained symptom-symptom interactions could be
a phenomenon in which one’s depressive mood results in a lack of restful sleep which
could lead to greater fatigue which may ultimately sustain their depressed mood,
rendering the person to be diagnosed with a depressive disorder. Treatment could then
evolve to intervene on the symptom interactions (i.e., directly change the state of one or
more symptoms), the external field (i.e., remove triggering causes or add a protective
layer to mitigate the symptom activation), or the network (i.e., modify the symptomsymptom connections).

Longitudinal trends for SUD and comorbidity
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An inherent limitation of the models previously described is that the analysis is
done at a single point in time. Previous studies have described that substance use
behaviors, including past month substance use, can change over time. The gateway
hypothesis of substance use posits that single and extensive use of alcohol and tobacco
products can function as an entrance to polysubstance use, the use of at least two
different psychotropic substances.52–54 There is also evidence that certain mental health
conditions can increase the risk of developing future mental health conditions,
sometimes more severe. For example, chronicity of depressive symptoms increases the
likelihood of anxiety and substance use disorders.2,55,56 Studies of adolescents have
reported that (1) externalizing problems (i.e., ADHD, ODD, CD) in youth precede
substance use in both boys and girls whereas (2) substance use (i.e., alcohol and
marijuana) in youth predict negative affect disorders in adulthood specifically for
women.57–61 Less is known about how these trends continue in adulthood. Therefore,
greater investigation into substance use behaviors over time with mental health
conditions are necessary to further develop the literature around longitudinal trends for
SUD and comorbidity.

Common knowledge gaps across all chapters
The gold-standard diagnostic classification systems (i.e., DSM and ICD-10-CM)
in the United States describe disorders as single latent constructs or single dimensions
rather than considering disorders as multidimensional. Nevertheless, the American
Psychiatric Association recognizes that mental disorders do not always fit completely
within the boundaries of a single disorder.2 This approach to diagnosis may be limited
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and could benefit from additional insight because (1) comorbidity is common and (2) the
current tools do not consider comorbidity within the context of diagnosis. Additionally, in
order to receive a diagnosis, a person must have the appropriate number of criteria to
reach a diagnostic threshold and access to a physician or person qualified to diagnose.
Using a threshold approach in current classification systems may underestimate the
number of people who experience substance use and mental disorders, especially
those that present as comorbidities. Consequently, current SUD research suffers from
the unidimensional approach that does not account for comorbidity. Further, addressing
SUD comorbidity could benefit from knowledge of the patterns of the symptoms
underlying an SUD diagnosis. Such a symptoms approach to measuring comorbidity
(e.g., past-month substance use or endorsement of mental disorder symptom) may be
better in estimate the prevalence of comorbidity correctly. Furthermore, better prediction
of additional health outcomes and more targeted prevention and intervention strategies
are likely to result in a more accurate representation of comorbidity prevalence.
Patterns of comorbidity are not the same although current knowledge is based on
homogeneous samples. People present with different combinations of substance use
behaviors and mental health conditions due to biological, social, and environmental
reasons.2,12,16,62–66 Further, much of the comorbidity research so far has been
conducted in clinical samples rather than population-based samples. Therefore, a
robust set of substance use behaviors and mental disorder symptoms in a large sample
of nationally representative adults are required to close this knowledge gap and
appropriately characterize comorbidity. This assessment of comorbidity in a larger
sample of U.S. adults will shed light on the comorbidity profiles that exist in the general
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population, expanding the current literature of clinical samples. Furthermore, factors that
influence these associations must also be considered. Appropriate characterizations are
important to target and personalize treatment and result in greater success in prognosis
for people experiencing comorbidity.
Although SUD comorbidity is persistent across the life course, it is unclear whether
patterns of comorbidity remain stable or change over time. Some studies report that
comorbidity does not readily change, while others explain shifts in substance use and
mental health conditions.67–69 Consequently, assessment of comorbidity over time is
needed to better understand the stability and/or continuity of comorbidity, and what
factors may be associated with these trends. These studies will help to better
understand the progression or regression of symptoms or behaviors in adults, and
identify how to better support individuals experiencing comorbidity.

The goal of the dissertation
The research goal of this dissertation is to address the aforementioned
knowledge gaps (current SUD research suffers from the unidimensional approach that
does not account for comorbidity; patterns of comorbidity are not the same, although
current knowledge is based on homogeneous samples; and it is unclear whether
patterns of comorbidity remain stable or changes over time) by characterizing the
comorbidity between substance use, including tobacco use, and mental disorder
symptoms measured as negative affect and externalizing symptoms in a populationbased sample. This is characterized in Table 1.1. These characterizations are needed
to better support people experiencing substance use and mental disorder comorbidity.
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Table 1.1: Assumptions, strengths, and limitations of conceptual models
Common
cause model

Internalizingexternalizing
model

Network
model

Assumptions

Strengths

Disease has a
common
pathogenic
pathway or an
etiology in which
the mechanism
is fully
understood

Used by DSM,
ICD-10-CM

Internalizing
disorders
represent a
latent
internalizing
construct with
externalizing
disorders,
including SUD
represent a
latent
externalizing
construct
Internalizing and
externalizing
factors can also
be correlated
Comorbidities
arise from
shared
symptoms
between
disorders which
can capture
complexity and
individual
variation in
psychopathology

Limitations
Etiology for
SUD/mental
disorders not
fully
understood

Does not
account for
comorbidity
Extension of
Rarely
common cause accounts for
model
substance use
behaviors
Accounts for
high level
Does not
comorbidity
describe the
between
unobserved
internalizing
heterogeneity
and
in the
externalizing
population to
disorders
identify
different
comorbidity
patterns in a
population
Can use
symptom level
data

New
methodological
approach

Naturally
accommodates
comorbidities
as a central
part of its
theory

Does not follow
DSM or ICS10-CM
approach to
diagnosis

Addressed in
Dissertation
All chapters
address the
limitation of
the common
cause model
by accounting
for comorbidity
Chapter 2 and
5 (Aims 1 and
3)

Chapter 4 and
5 (Aims 2 and
3)
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Chapter 2 is a preliminary assessment of comorbidity. Multinomial logistic
regression analyses will be used to determine the association between lifetime negative
affect severity, externalizing severity and nicotine dependence (ND) and current use of
tobacco (cigarettes and e-cigarettes) and alcohol, adjusting for sex, age, race,
education and income. Two adjusted multinomial regression models are considered.
The first model only includes negative affect and externalizing severity, adjusting for the
correlation between the two factors. The second model builds on the first model by
including ND to determine if ND explained more of the association between substance
use.
Chapter 3 addresses the knowledge gap of diagnostic classifications, comorbidity
profiles, and addresses factors associated with the comorbidity profiles by (1) estimating
latent classes of comorbid substance use as well as negative affect and externalizing
symptoms and (2) assessing their ability to predict SUD severity. The latent class
approach is a type of mixture modeling used to identify unobserved heterogeneity in a
population and find meaningful groups of people that are similar based on their
responses to measured items.70 This approach follows the common cause model in that
the measured items (i.e., substance use behaviors and mental disorder symptoms) give
rise to the latent unobservable disorder or in this case, comorbidity, and extends the
internalizing-externalizing model by accounting for one overall latent class. Latent class
analysis goes beyond the multinomial regression and allows for the consideration of
multiple substance use and mental disorder symptom combinations. Analyses related to
this chapter also move beyond the descriptiveness of the latent class approach and use
the predictive probabilities generated from the latent class analysis to predict a health
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outcome, SUD severity. The prediction analyses allow us to determine whether
comorbidity versus a single construct (i.e., substance use, negative affect or
externalizing separately) is important in predicting a distal health outcome.
Chapter 4 builds on the knowledge developed in Chapter 3 by detailing
substance use, negative affect, and externalizing symptom networks. Network analysis
is a complement to the latent class approach. Network analysis does not follow the
common cause model yet it posits that the substance use behaviors and mental
disorder symptoms mutually interact and comorbidities arise from shared symptoms
between disorders which can capture complexity and individual variation in
psychopathology. The network approach allows for us to determine if symptoms cross
over diagnostic boundaries. We also extend past the network approach and test
whether there are differences in the network structure and connectivity by gender.
Chapter 5 addresses the knowledge gap of stability or movement of comorbidity
structures by assessing the structure over time using the results from the latent class
and network analyses. Pairwise comparisons occur in two separate approaches. First,
using results from latent class analyses of three waves of adult data, we (1) compare
the class probabilities across the waves, (2) assess the item response patterns for each
class by wave, and (3) identify the transition patterns to determine the stability or
movement among the classes. Second, network comparison tests including global
strength, network structure, and edge strength will be tested to determine if there are
differences in the comorbidity networks by wave.

Setting and measures
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All chapters use adult data from the Population Assessment of Tobacco and
Health (PATH) Study.71 Chapters 2, 3, and 4 use data from the first wave of
participants. Chapter 5 uses data from waves 1, 2, and 3 to assess the comorbidity
patterns in adults across time. Information regarding the sample size, dates of data
collection, and the weighted response rate among participants is provided in Table 1.2.
Table 1.2: PATH Information for Waves 1, 2, and 3
Weighted
Response
Rate*
Wave 1
32,320
September 2013 – December 2014
74.0%
Wave 2
28,362
October 2014 – October 2015
83.2%
Wave 3
28,148
October 2015 – October 2016
78.4%
*Weighted response rate among participants is conditional on Wave 1 participation.
Sample
Size

Data Collection

The PATH study launched in 2011 in response to the Family Smoking Prevention
and Tobacco Control Act in order to inform the Food and Drug Administration’s
regulatory activities.71 This study is a collaborative effort among the National Institute on
Drug Abuse, National Institutes of Health, and the Center for Tobacco Products at the
Food and Drug Administration. There are eight primary objectives for the PATH study:
1. “Identify and explain between-person differences and within-person changes in
tobacco-use patterns, including the rate and length of use by specific product
type and brand, product/brand switching over time, uptake of new products, and
dual- and poly-use of tobacco products (i.e., use of multiple products within the
same time period and switching between multiple products).
2. Identify between-person differences and within-person changes in risk
perceptions regarding harmful and potentially harmful constituents, new and
emerging tobacco products, filters and other design features of tobacco products,
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packaging, and labeling; and identify other factors that may affect use, such as
social influences and individual preferences.
3. Characterize the natural history of tobacco dependence, cessation, and relapse,
including readiness and self-efficacy to quit, motivations for quitting, the number
and length of quit attempts, and the length of abstinence related to various
tobacco products.
4. Update the comprehensive baseline and subsequent waves of data on tobaccouse behaviors and related health conditions, including markers of exposure and
tobacco-related disease processes identified from the collection and analysis of
biospecimens, to assess between-person differences and within-person changes
over time in health conditions potentially related to tobacco use, particularly with
use of new and different tobacco products, including modified-risk tobacco
products.
5. Assess associations between TCA-specific actions and tobacco-product use, risk
perceptions and attitudes, use patterns, cessation outcomes, and tobaccorelated intermediate endpoints (e.g., biomarkers of exposure and biomarkers
related to disease). Analyses will attempt to account for other potential factors,
such as demographics, local tobacco-control policies, and social, familial, and
economic factors, that may influence the observed patterns.
6. Assess between-person differences and within-person changes over time in
attitudes, behaviors, exposure to tobacco products, and related biomarkers
among and within population sub-groups identified by such characteristics as
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race-ethnicity, gender, and/or age, or by risk factors, such as pregnancy or cooccurring substance use or mental health disorders.
7. To the extent to which sample sizes are sufficient, assess and compare samples
of former and never users of tobacco products for between-person differences
and within-person changes in relapse and uptake, risk perceptions, and
indicators of tobacco exposure and disease processes.
8. Use data from the PATH Study's baseline and follow-up waves on tobacco-use
behaviors, attitudes, and related health conditions, including potential markers of
exposure and related disease processes identified from the analysis of
biospecimens, to screen and subsample respondents for participation in
formative and/or nested studies conducted during and after the PATH Study's
waves of data and biospecimen collection”71
PATH is a nationally representative longitudinal cohort study of the civilian, noninstitutionalized household population of the U.S. aged 9 and older at Wave 1, and
participants engaged in all levels of tobacco use ranging from never using tobacco to
frequent use. Participants were selected through a four-stage stratified area probability
sample design, with a two-phase design for sampling adults at the final stage71:
1. Selected stratified sample of geographical primary sampling units (PSU) (i.e.,
county or group of counties)
2. Within each PSU, smaller geographical segments were formed and a sample of
these segments was drawn
3. Sampling frame consisted of residential addresses located in the segments
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4. Selected adults and youth from the sampled households identified at these
addresses (with varying sampling rates of adults by age, race, and tobacco
status).
a. Adults were sampled in two phases:
i. Sampling used information provided in the household screener
ii. Sampling used information provided by the adult
Study domains include tobacco use behavior, attitudes and beliefs, and tobaccorelated health outcomes. Specific topics are included in Table 1.3.
Table 1.3: Topics assessed in PATH Study
Tobacco Products
Measures/Topics
Associated with
Tobacco Products
Cigarettes
Ever use
E-cigarettes/Electronic
Recency of use
nicotine products
Frequency of use
Cigars (traditional, cigarillos,
Amount of use
filtered)
Brands used
Pipe tobacco
Purchase details
Hookah
Use of flavored
Smokeless tobacco (snus
products
pouches and other forms of
Harm and
smokeless tobacco)
addictiveness
Dissolvable tobacco
Reasons for use
Bidis and kreteks (youth only)

Additional Topics
Poly use
Nicotine dependence
Packaging and health
warnings
Risk and harm perceptions
Secondhand smoke exposure
Marketing and advertising
Media use
Demographics
Health
Psychosocial and mental
health
Substance use
Cessation
Peer and family influences

Participants responded to tobacco-specific items including tobacco-use patterns,
risk perceptions and attitudes towards current and newly emerging tobacco products,
tobacco initiation, cessation, relapse behaviors, and health outcomes.72 Participants
also responded to non-tobacco items (e.g., media use, peer and family influences,
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health effect outcomes, and industry advertising and promotion).72 A detailed list of the
measures used in the dissertation are provided below.
Past Month Tobacco and Substance Use. Six substance use categories were
used in this dissertation: exclusive cigarette, exclusive e-cigarette, dual cigarette and ecigarette, alcohol, marijuana, and prescription drugs not prescribed (PDNP) including
painkillers, sedatives, tranquilizers. Current cigarette use was endorsed if the
respondent indicated ever smoking a cigarette (even one or two puffs), has smoked at
least 100 or more cigarettes in his or her entire life, and now smokes cigarettes every
day or some days, while also excluding the current use of e-cigarettes. Current ecigarette use was endorsed if the respondent indicated ever using an e-cigarette (even
one or two puffs), ever smoked e-cigarettes fairly regularly, and now uses e-cigarettes
every day or some days, while also excluding the current use of cigarettes. Current dual
cigarette and e-cigarette use was identified if the respondent indicated that they were a
current cigarette and current e-cigarette user. Current alcohol, marijuana, and PDNP
was endorsed if the respondent indicated ever using the substance and has used the
substance within the past 30 days. Only past month or current use of the substances
was considered (coded as 1, else = 0) to reduce the potential for recall bias and ensure
for accurate overlap with negative affect and externalizing symptoms occurring in the
same time frame.
Negative Affect and Externalizing Severity and Symptoms. Negative affect and
externalizing symptoms were measured using the Global Appraisal of Individual
Needs—Short Screener (GAIN-SS).73 The GAIN-SS refers to negative affect as
“internalizing symptoms”; however, these symptoms provided within the GAIN-SS are
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better represented as “negative affect”. Negative affect refers to the experience of
negative drive states such as depression, anxiety, and stress,74 and therefore, is a more
appropriate term for these symptoms compared to “internalizing”. Negative affect will be
the term used for the rest of the dissertation.
The GAIN-SS is derived from the full GAIN instrument and identifies individuals at
risk for mental health disorders using a continuous measure of severity.73 The full GAIN
assessment is a validated, standardized biopsychosocial assessment and
recommended for use in epidemiologic samples.28,73 Four questions were used to
measure negative affect symptoms that asked the last time you had significant
problems with:
(1) “feeling trapped, lonely, sad, blue, depressed, or hopeless about the future,”
(2) “sleep trouble- such as bad dreams, sleeping restlessly or falling asleep during
the day,”
(3) “feeling very anxious, nervous, tense, scared, panicked or something bad was
going to happen,” and
(4) “becoming very distressed and upset when something reminded you of the past.”
Externalizing symptoms were also measured using the GAIN-SS.28,73 Seven questions
were used to assess externalizing symptoms. Items asked the last time you did the
following two or more times:
(1) “lied or conned to get things you wanted or to avoid having to do something,”
(2) “had a hard time paying attention at school, work or home,”
(3) “had a hard time listening to instructions at school, work or home,”
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(4) “were a bully or threatened other people,”
(5) “started physical fights with other people,”
(6) “felt restless or the need to run around or climb on things” and
(7) “gave answers before the other person finished asking the question.”
The items selected to identify negative affect and externalizing symptoms from the
GAIN-SS instrument are ordinal and measures people across four times periods: past
month, 2 to 12 months, over a year ago, and never.
Ethical considerations
This research uses publicly available secondary data, where information is
recorded by the investigator in a manner that subjects cannot be identified (either
directly or through identifiers). Therefore, this is considered exempt by the Virginia
Commonwealth University School of Medicine Institutional Review Board.

42

CHAPTER 2: THE ASSOCIATION BETWEEN NEGATIVE AFFECT AND
EXTERNALIZING SEVERITY WITH CURRENT USE OF CIGARETTES, ECIGARETTES, AND ALCOHOL IN ADULTS: WAVE 1 OF THE POPULATION
ASSESSMENT OF TOBACCO AND HEALTH (PATH) STUDY1
INTRODUCTION
Tobacco and alcohol are two of the most common substances used in the United
States (U.S.).75,76 In 2018, approximately 20.9% of U.S. adults were current
conventional cigarette (CIG) smokers and 55.3% reported drinking alcohol in the past
month.77–79 Among individuals with alcohol use disorder, 23.8% also had nicotine
dependence and 12.9% of individuals with nicotine dependence also had alcohol use
disorder.9 Concurrent use of CIG and alcohol represents a major public health concern
because they have been associated with more negative health outcomes such as
increased risk of cardiovascular disease, cirrhosis, head and neck cancers, liver cancer,
pancreatitis, and psychiatric comorbidity than the exclusive use of either substance.80–82
To date, it is unclear whether the factors associated with co-occurring tobacco and
alcohol use are specific to CIG or extend to electronic cigarettes (ECIG).
Although dual use of ECIG and CIG is common and increasing in the U.S.,83 the
trends related to this form of tobacco use with alcohol remain unclear. In 2018, 57.3%
and 25.2% of former CIG users were engaged in ever-use and current-use of ECIGs,
respectively.84 Approximately 9.7% of current ECIG users also engaged in CIG use.84 In
2014, about 16% of current smokers were also current ECIG users.85 Recent studies
have reported that current ECIG users are at an increased risk of harmful alcohol use
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This chapter has been modified from the original manuscript accepted for publication in Addictive
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compared to ECIG non-users,86,87 with dual CIG and ECIG use resulting in more pastmonth total drinks compared to exclusive-ECIG users.88 However, compared to studies
of CIG use and alcohol, there is far less knowledge regarding the co-occurring use of
ECIG and alcohol. Consequently, there is a need to examine the use of ECIG, CIG, and
alcohol, which may be associated with more severe or different risk factors than dual or
exclusive use of any of these three substances.
Negative affect (e.g., depression and anxiety) and externalizing [e.g., attentiondeficit hyperactivity disorder (ADHD) and conduct disorder] psychopathology2,16,73,89–91
are important mental health factors that have been consistently associated with
exclusive use of either CIG or alcohol. A meta-analysis reported that current CIG
smokers had a two-fold increased risk of depression relative to never and former CIG
users.92 Further, adults with depression are more likely to smoke and are less likely to
be successful at quitting than adults without depression.93 Whether this bidirectional
association is maintained among ECIG users is unclear. The relationship between the
use of alcohol, CIG, and ECIG, and negative affect and externalizing psychopathology
is currently undetermined. Prior studies of the relationship between psychopathology
and tobacco products, specifically ECIG, as well as alcohol typically focus on youth and
young adults. These results indicate ECIGs are commonly used with other substances
(i.e., CIG, alcohol, marijuana and opiates) and associated with mental health
symptomatology (i.e., diagnosis of ADHD, PTSD, anxiety, and substance use
disorders).94–97 However, it is unclear if these associations are specific to youth and
young adults, or if they also occur across adulthood.
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This study addresses the aforementioned knowledge gaps by examining the
association of lifetime mental disorder symptom severity and past 30-day combinations
of CIG, ECIG, and alcohol use. We asked the following questions: (1) is there an
association between negative affect/externalizing severity across combinations of CIG,
ECIG, and alcohol use in US adults, and (2) is there a difference in severity based on
tobacco product type (CIG vs. ECIG)? We expect (1) a significant, positive association
between negative affect/externalizing severity across all combinations of CIG, ECIG,
and alcohol use. For exploratory aim (2), we expect that this association varies with type
and number of tobacco products used (i.e., CIG associated with negative affect; ECIG
associated with externalizing/negative affect; CIG + ECIG associated with negative
affect/externalizing).

METHODS
Study material and participants
Data from 32,320 adults aged 18 years and older participating in the first wave
(2013-2014) of the Population Assessment of Tobacco and Health (PATH) study were
used.71 PATH is a nationally representative longitudinal cohort study of the civilian, noninstitutionalized adult household population of the U.S., and participants engaged in all
levels of tobacco use.72 The household screener response rate was 54%.71 The
weighted response rate among participants was 74%.73

Study representativeness
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Participants with missing data on tobacco and alcohol measures, mental health
symptoms, or covariates were not included in the analysis (N=16,373). Survey
respondents of the analytic sample endorsed greater substance use overall, negative
affect/externalizing severity, and nicotine dependence (ND) than those not included in
the analytic sample. The participants in the analytic sample were more likely to be men,
aged 25-54 with lower levels of education and lower annual household income than
those who were missing.

Measures
Current tobacco and alcohol use. Current tobacco and alcohol use was
measured as an aggregate variable indicating the degree of past-month use of CIG,
ECIG, and alcohol, and was developed from individual current-use items defined
according to the National Health Interview Survey (2017) and listed in Table 2.1.98
Table 2.1: Individual criteria used to define current-use of alcohol, cigarettes, or ecigarettes.
Code

Current Alcohol Use

Current Cigarette (CC)
Use

Current E-Cigarette (EC)
Use

• Ever smoked a CC (even • Ever used an EC (even 1-2
1-2 puffs)
times)
• Smoked ≥ 100 CC in
• Ever smoked EC fairly
lifetime
regularly
• Smoke CC every day or
• Now use EC every day or
some days
some days
• Never used alcohol
• Never smoked a CC
• Never used an EC
0
• Ever used alcohol but • Smoked ≤ 99 CC in
• Do not smoke EC regularly
not in past 30 days
lifetime
• Do not use EC now
• Do not smoke CC now
Depending on responses, subjects were classified as current users (coded as 1), or noncurrent users (coded as 0).
1

• Ever used alcohol in
past 30 days
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The outcome variable was developed as an eight-level categorical variable: (1)
alcohol-exclusive; (2) CIG-exclusive; (3) ECIG-exclusive; (4) CIG and alcohol; (5) ECIG
and alcohol; (6) CIG and ECIG; (7) alcohol, CIG, and ECIG; and (8) non-use. This
variable allowed us to evaluate the relationships between all combinations of alcohol,
CIG, and ECIG use and negative affect/externalizing severity, with non-users as a
reference group.
Negative affect/ externalizing severity. Negative affect and externalizing severity
were measured in PATH using the Global Appraisal of Individual Needs—Short
Screener (GAIN-SS).73 The GAIN-SS is derived from the full GAIN instrument assessing
individuals at risk for mental disorders using a continuous measure of severity. The full
GAIN assessment is a reliable and validated biopsychosocial assessment
recommended for use in epidemiologic samples.28,73,99 There was good internal
consistency among the negative affect (Cronbach’s α=0.85) and externalizing
(Cronbach’s α=0.80) items in the analytic sample.
Items used to measure negative affect/externalizing symptoms are listed in Table
2.2. Responses were measured across four time periods: past month, 2-12 months,
over a year ago, and never. Lifetime negative affect/externalizing items were coded as
past month, 2-12 months, or over a year ago = 1 vs never = 0. The binary responses
were summed to reflect a scale score of the number of lifetime symptoms. The score
ranging from 0-4 negative affect symptoms and 0-7 externalizing symptoms were
categorized into low (0), moderate (1-2), and high (3+) severity). These cut points were
previously recommended based on validation analyses of the dimensional measures
and have high predictive validity in other samples.28,73,99 Higher scores indicate
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increased severity, a greater likelihood for diagnosis with a mental health disorder, and
increased need for services.73 Negative affect/externalizing severity were highly
correlated with one another (r=0.68, ASE=0.0051, p<0.001).
Table 2.2 Items used to measure negative affect, externalizing, and nicotine
dependence.
Negative
affect
Symptoms*

Last time respondent had significant problem with:

Externalizing
Symptoms*

Last time respondent engaged in the following behaviors 2-3 times:

Nicotine
Dependence

WISDM: Primary

ǂ

• feeling trapped, lonely, sad, blue, depressed, or hopeless about the future
• sleep trouble - such as bad dreams, sleeping restlessly or falling asleep during
the day
• feeling very anxious, nervous, tense, scared, panicked, or that something bad
was going to happen
• becoming very distressed and upset when something reminded you of the past
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

lied or conned to get things you wanted or to avoid having to do something
had a hard time paying attention at school, work or home
had a hard time listening to instructions at school, work, or home
were a bully or threatened other people
started physical fights with other people
felt restless or the need to run around or climb on things
gave answers before the other person finished asking the question
I find myself reaching for [product] without thinking about.
I frequently crave [product].
My urges keep getting stronger if I don’t use [product].
Tobacco products control me.
My [product] use is out of control.
I usually want to use [product] right after I wake up.
I can only go a couple of hours without using [product].
I frequently find myself almost using [product] without thinking about it.

WISDM: Secondary
• Using [product] would really help me feel better if I’ve been feeling down.
• Using [product] helps me think better.
• I [would] feel alone without my [product].
NDSS
• I would find it really hard to stop using [product].
• I would find it hard to stop using [product].
• After not using [product] for a while, I need to use [product] in order to feel less
restless and irritable.
• After not using [product] for a while, I need to use [product] in order to keep
myself from experiencing discomfort.
DSM: Impaired Control
• In the past 12 months, did you find it difficult to keep from using [product] in
places where it was prohibited?
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*Responses were measured across four time periods: past month, 2-12 months, over a year ago, and never.
Participants indicating that they experienced a symptom at any time were coded as 1. Participants indicating that
they never experienced an item were coded as 0. Binary responses were summed to reflect a scale score with a
range of 0-4 symptoms for negative affect and 0-7 symptoms for externalizing. The scores were categorized into
low (0), moderate (1-2), and high (3+) severity based on the recommended cut points.
ǂ Responses for WIDSM: Primary, WIDSM: Secondary, and NDSS were measured based on level of agreement
from 1 = not true of me at all to 5 = extremely true to me. Response option for DSM: Impaired Control was 1 = Yes
and 0 = No. These were summed to reflect a scale score with a range of 0-76 with higher values indicating greater
ND.

Covariates. The role of nicotine dependence (ND) was included as a potential
confounder. Adults with mental health disorders may have higher levels of ND as a
result of tobacco product use.100,101 Similarly, there is a strong association between ND
and all levels of alcohol use.102 People who engage in ECIG and CIG dual use have
greater ND than exclusive use of either ECIG or CIG.103,104 Sixteen items [8 from
Wisconsin Inventory of Smoking Dependence Motives (WIDSM): Primary, 3 from
WISDM: Secondary, 4 from Nicotine Dependence Syndrome Scale (NDSS), 1 from
Diagnostic and Statistical Manual of Mental Disorders (DSM): Impaired Control] were
used to measure ND and are listed in Table 2.2. These 16 items were recommended to
use as a common instrument to assess ND across different tobacco product users from
a differential item function analysis.27 The items were summed into one continuous
variable ranging from 0-76, with higher values indicating greater ND.
Sex, age, race/ethnicity, education, and annual household income were also
included as covariates because they are consistently associated with mental health, and
tobacco and alcohol use.61,73,105–114
Age, measured in PATH as a seven-level categorical variable, was recategorized to have a uniform distribution with six levels (18-24, 25-34, 35-44, 45-54,
55-64, and 65 years or older). Education, measured in PATH as a six-level categorical
variable, was re-categorized as a five-level categorical variable with a uniform
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distribution [less than high school, GED/high school graduate, some college (no degree)
or Associate’s degree, Bachelor’s degree, and Advanced degree]. Race/ethnicity was
measured as a four-level categorical race variable and included information from a
separate variable that accounted for Hispanic ethnicity (Non-Hispanic White, NonHispanic Black, Non-Hispanic Other, and Hispanic Multicultural). The significance of the
association between these variables and tobacco and alcohol use was tested as a
series of unadjusted multinomial logistic regressions (Table 2.4).

Statistical analyses
Unadjusted multinomial logistic regression was used to test the association
between tobacco and alcohol use and negative affect/externalizing severity. Tests were
repeated after adjustment for sex, age, race, education, and annual household income.
Two adjusted multinomial regression models were considered: the first model included
only negative affect/externalizing severity, adjusting for the correlation between the two
factors, while the second model also included ND to determine the degree to which ND
explained the association between mental health severity and substance use. Odds
ratios (OR) or adjusted odds ratios (AOR) and 95% confidence intervals (95% CI),
profiled from estimates of standard error, are reported. All analyses were performed in
SAS software, Version 9.4 (SAS Institute Inc, Cary, NC) and accounted for complex
survey design and sampling weight using PROC SURVEYFREQ and PROC
SURVEYLOGISTIC. Fay’s method, a variant of balanced repeated replication method,
was used to form replication weights in variance estimation in all analyses.
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RESULTS
Descriptive statistics
Data from 15,947 participants with complete information were analyzed. Almost
one quarter of the population engaged in alcohol-exclusive use (24.0%), 22.4% in CIGexclusive use, and 1.3% in ECIG-exclusive use (Table 2.3). Across the different
combinations of tobacco and alcohol use, 33.3% engaged in CIG and alcohol use, 1.7%
engaged in ECIG and alcohol use, 2.0% engaged in CIG and ECIG, and 3.2% engaged
in alcohol, CIG, and ECIG use. Almost half of the sample endorsed high negative affect
(47.9%) and high externalizing (44.7%) severity. The mean ND was 37.0 (range=1-76,
standard deviation=0.23) for the sample (Table 2.3).
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Table 2.3: Overall Frequencies of the Analytic Sample (n = 15,947, Weighted N = 61,482,491)—PATH Wave 1 (20132014)
n (Weighted %)
Sex*
Male
9039 (59.6)
Female
6908 (40.4)
Age*
18-24 years old
4304 (17.7)
25-34 years old
3580 (24.3)
35-44 years old
2696 (18.3)
45-54 years old
2579 (18.5)
55-64 years old
1871 (14.1)
65 years or older
917 (7.1)
Race*
Non-Hispanic White
10257 (68.2)
Non-Hispanic Black
2305 (13.8)
Non-Hispanic Other
1218 (6.4)
Hispanic Multiracial
2167 (11.7)
Education*
Less than high school
2304 (13.4)
GED/High school graduate
5385 (35.5)
Some college (no degree) or Associate’s degree
5931 (34.9)
Bachelor's degree
1685 (11.9)
Advanced degree
642 (4.3)
Annual Household Income*
Less than $10,000
3532 (19.5)
$10,000 to $24,999
4120 (24.8)
$25,000 to $49,999
3746 (24.2)
$50,000 to $99,999
2974 (20.2)
$100,000 or more
1575 (11.4)
* Indicates a significant difference at p <0.05.
a
Indicates mean and standard deviation (95% CL for the mean = 36.6-37.5)

n (Weighted %)
Negative Affect Severity*
Low
Moderate
High
Externalizing Severity*
Low
Moderate
High
Nicotine Dependence
Tobacco and Alcohol Use*
Alcohol only
CC only
EC only
CC and Alcohol
EC and Alcohol
CC and EC
Alcohol, CC, and EC
None

4310 (28.1)
3731 (24.0)
7906 (47.9)
4058 (26.8)
4436 (28.5)
7453 (44.7)
37.0 (0.23)a
3603 (24.0)
3678 (22.4)
219 (1.3)
5387 (33.3)
288 (1.7)
336 (2.0)
558 (3.2)
1878 (12.2)
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Unadjusted multinomial logistic regression analysis
Compared to subjects with low negative affect severity, those with high negative
affect severity were significantly more likely to engage in alcohol, CIG, and ECIG use
(OR=3.42, 95% CI=2.48-4.72), CIG and ECIG use (OR=2.24, 95% CI=1.63-3.08), ECIG
and alcohol use (OR=2.20, 95% CI=1.57-3.09), CIG and alcohol use (OR=2.28, 95%
CI=1.97-2.65), CIG-exclusive use (OR=1.69, 95% CI=1.42-2.02), and alcohol-exclusive
use (OR=1.42, 95% CI=1.20-1.69) than no use. Relative to those with low externalizing
severity, subjects with high externalizing severity were more likely than not to engage in
every level of tobacco and alcohol use except ECIG use, especially alcohol, CIG, and
ECIG use (OR=4.56, 95% CI=3.31-6.30) and ECIG and alcohol use (OR=4.23, 95%
CI=2.84-6.29). There were significant, positive associations between ND and alcohol,
CIG, and ECIG use (OR=1.05, 95% CI=1.05-1.06), CIG and ECIG use (OR=1.08, 95%
CI=1.07-1.08), CIG and alcohol use (OR=1.05, 95% CI=1.04-1.05), and CIG-exclusive
use (OR=1.06, 95% CI=1.06-1.07). Females, relative to males, had significantly
increased odds for CIG and ECIG use (OR=1.74, 95% CI=1.35-2.25), CIG and alcohol
use (OR=1.21, 95% CI=1.06-1.38), ECIG-exclusive use (OR=1.99, 95% CI=1.45-2.74),
and CIG-exclusive use (OR=1.65, 95% CI=1.43-1.90), except for alcohol-exclusive use
(OR=0.71, 95% CI=0.61-0.84). There were significant associations by age, race,
education, and annual household income (Table 2.4).
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Table 2.4: Summary of Unadjusted Bivariate Associations by Level of Current Tobacco and Alcohol Use (n = 15,947, Weighted N = 61,482,491)
Alcohol,
Cigarette, and
E-cigarette
OR (95% CI)

Cigarette and
E-cigarette

E-cigarette and
Alcohol

Cigarette and
Alcohol

E-cigarette
Only

Cigarette
Only

Alcohol
Only

OR (95% CI)

OR (95% CI)

OR (95% CI)

OR (95% CI)

OR (95% CI)

OR (95% CI)

Reference
1.71 (1.14-2.56)
3.42 (2.48-4.72)

Reference
1.50 (0.96-2.36)
2.24 (1.63-3.08)

Reference
1.36 (0.89-2.08)
2.20 (1.57-3.09)

Reference
1.79 (1.52-2.11)
2.28 (1.97-2.65)

Reference
1.12 (0.71-1.77)
1.30 (0.89-1.88)

Reference
1.37 (1.10-1.71)
1.69 (1.42-2.02)

Reference
1.66 (1.36-2.01)
1.42 (1.20-1.69)

Reference
2.32 (1.59-3.39)
4.56 (3.31-6.30)

Reference
1.67 (1.15-2.42)
2.22 (1.61-3.05)

Reference
2.84 (1.91-4.23)
4.23 (2.84-6.29)

Reference
2.00 (1.68-2.38)
2.58 (2.19-3.03)

Reference
1.01 (0.67-1.52)
1.31 (0.89-1.94)

Reference
1.21 (1.01-1.43)
1.31 (1.11-1.55)

Reference
2.04 (1.70-2.44)
2.29 (1.91-2.76)

1.05 (1.05-1.06)
1.08 (1.07-1.08)
1.00 (0.99-1.01)
Sex
Male
Reference
Reference
Reference
Female
1.24 (0.98-1.56)
1.74 (1.35-2.25)
1.26 (0.94-1.69)
Age
18-24 years old
Reference
Reference
Reference
25-34 years old
1.75 (1.37-2.25)
3.62 (2.53-5.20)
1.69 (1.21-2.35)
35-44 years old
1.28 (0.87-1.88)
2.93 (2.00-4.31)
0.84 (0.55-1.30)
45-54 years old
0.57 (0.41-0.79)
1.78 (1.15-2.75)
0.69 (0.44-1.10)
55-64 years old
0.46 (0.32-0.66)
1.99 (1.31-3.02)
0.64 (0.38-1.07)
65 years or older
0.16 (0.07-0.35)
1.42 (0.70-2.88)
0.31 (0.14-0.66)
Race
White
Reference
Reference
Reference
Non-Hispanic Black
0.23 (0.16-0.35)
0.35 (0.23-0.55)
0.45 (0.27-0.73)
Non-Hispanic Other
0.70 (0.44-1.12)
0.60 (0.38-0.94)
0.98 (0.56-1.72)
Hispanic Multicultural
0.32 (0.23-0.46)
0.32 (0.20-0.52)
0.35 (0.22-0.57)
Education
Less than high school
Reference
Reference
Reference
GED/High school
2.30 (1.61-3.28)
1.15 (0.75-1.78)
2.22 (1.16-4.26)
Some college
4.79 (3.28-6.99)
1.72 (1.16-2.56)
4.75 (2.60-8.67)
Bachelor's degree
4.91 (3.26-7.39)
1.68 (0.99-2.86)
5.04 (2.47-10.32)
Advanced degree
3.67 (1.98-6.82)
0.69 (0.28-1.69)
2.32 (0.62-8.63)
Income
< $10,000
Reference
Reference
Reference
$10,000-24,999
1.94 (1.42-2.64)
1.49 (1.05-2.12)
1.31 (0.82-2.09)
$25,000-49,000
2.59 (1.85-3.62)
1.41 (0.98-2.02)
2.00 (1.41-2.83)
$50,000-99,999
2.95 (2.01-4.32)
1.33 (0.86-2.05)
3.03 (2.06-4.46)
>=$100,000
2.88 (1.83-4.53)
1.06 (0.59-1.91)
3.37 (2.16-5.24)
Bolded values indicate estimate significant a p < 0.05
The “none” category is used in reference for the tobacco and alcohol use outcome.

1.05 (1.04-1.05)

1.00 (0.99-1.01)

1.06 (1.06-1.07)

0.97 (0.96-0.97)

Reference
1.21 (1.06-1.38)

Reference
1.99 (1.45-2.74)

Reference
1.65 (1.43-1.90)

Reference
0.71 (0.61-0.84)

Reference
2.42 (2.02-2.89)
1.95 (1.57-2.42)
1.55 (1.28-1.87)
1.21 (0.98-1.49)
0.60 (0.47-0.76)

Reference
1.86 (1.08-3.20)
1.49 (0.89-2.51)
2.01 (1.26-3.21)
1.04 (0.60-1.80)
1.03 (0.51-2.11)

Reference
2.53 (2.04-3.12)
2.27 (1.81-2.86)
2.25 (1.89-2.68)
2.02 (1.64-2.49)
1.90 (1.47-2.47)

Reference
1.40 (1.17-1.67)
0.90 (0.72-1.12)
0.76 (0.63-0.93)
0.63 (0.48-0.83)
0.47 (0.36-0.61)

Reference
0.61 (0.51-0.73)
0.72 (0.56-0.91)
0.48 (0.40-0.57)

Reference
0.37 (0.20-0.67)
1.00 (0.57-1.76)
0.58 (0.40-0.86)

Reference
0.50 (0.42-0.60)
0.66 (0.53-0.82)
0.50 (0.41-0.61)

Reference
0.63 (0.51-0.77)
0.81 (0.62-1.06)
0.67 (0.53-0.83)

Reference
1.50 (1.24-1.81)
2.13 (1.78-2.56)
2.34 (1.85-2.97)
1.50 (1.07-2.10)

Reference
1.51 (0.90-2.53)
2.31 (1.46-3.64)
1.86 (1.00-3.46)
1.85 (0.75-4.56)

Reference
0.96 (0.80-1.17)
0.96 (0.80-1.15)
0.65 (0.48-0.88)
0.40 (0.27-0.59)

Reference
1.74 (1.39-2.17)
3.58 (2.89-4.43)
7.16 (5.41-9.49)
6.73 (4.80-9.44)

Reference
1.33 (1.09-1.62)
1.63 (1.36-1.97)
1.98 (1.58-2.48)
1.72 (1.38-2.14)

Reference
1.07 (0.62-1.83)
1.21 (0.77-1.92)
1.82 (1.07-3.08)
1.33 (0.68-2.62)

Reference
1.26 (1.03-1.54)
1.08 (0.89-1.31)
0.90 (0.71-1.14)
0.53 (0.38-0.72)

Reference
1.30 (1.07-1.59)
1.66 (1.35-2.05)
3.04 (2.42-3.82)
5.07 (3.91-6.57)

Variable
Negative Affect Severity
Low
Moderate
High
Externalizing Severity
Low
Moderate
High
Nicotine Dependence
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Adjusted multinomial logistic regression analysis
Model 1: Negative affect/externalizing severity
Compared to subjects with low negative affect severity, those with high negative
affect severity were significantly more likely to engage in alcohol, CIG, and ECIG use
(AOR=2.01, 95% CI=1.30-3.09), CIG and alcohol use (AOR=1.61, 95% CI=1.30-2.00),
and CIG-exclusive use (AOR=1.42, 95% CI=1.13-1.79) than none (Table 2.5).
Participants with moderate negative affect severity, compared to low, were significantly
more likely to engage in CIG and alcohol use (AOR=1.52, 95% CI=1.27-1.81), CIGexclusive use (AOR=1.26, 95% CI=1.01-1.58), and alcohol-exclusive use (AOR=1.53,
95% CI=1.24-1.90) than none. Participants with high externalizing severity, compared to
low, had 113% greater odds of alcohol, CIG, and ECIG use (AOR=2.13, 95% CI=1.363.34), 54% greater odds of CIG and ECIG use (AOR=1.54, 95% CI=1.04-2.28), 196%
greater odds of ECIG and alcohol use (AOR=2.96, 95% CI=1.82-4.80), 74% greater
odds of CIG and alcohol use (AOR=1.74, 95% CI=1.38-2.20), and 69% greater odds of
alcohol-exclusive use (AOR=1.69, 95% CI=1.33-2.14) than no use. Participants with
moderate externalizing severity, compared to low, were significantly more likely to
engage in alcohol, CIG, and ECIG use (AOR=1.56, 95% CI=1.02-2.40), ECIG and
alcohol use (AOR=2.32, 95% CI=1.55-3.46), CIG and alcohol use (AOR=1.54, 95%
CI=1.26-1.88), alcohol-exclusive use (AOR=1.60, 95% CI=1.32-1.94) than no use.
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Table 2.5: Model 1 - Multinomial Logistic Regression for Level of Current Tobacco and Alcohol Use (n = 15,947, Weighted N = 61,482,491)

Variable
Negative Affect Severity
Low
Moderate
High
Externalizing Severity
Low
Moderate
High
Sex
Male
Female
Age
18-24 years old
25-34 years old
35-44 years old
45-54 years old
55-64 years old
65 years or older
Race
White
Non-Hispanic Black
Non-Hispanic Other
Hispanic Multicultural
Education
Less than high school
GED/High school
Some college
Bachelor's degree
Advanced degree
Income
< $10,000
$10,000-24,999
$25,000-49,000
$50,000-99,999
>=$100,000

Alcohol,
Cigarette, and
E-cigarette
AOR (95% CI)

Cigarette and
E-cigarette

E-cigarette and
Alcohol

Cigarette and
Alcohol

E-cigarette
Only

Cigarette
Only

Alcohol
Only

AOR (95% CI)

AOR (95% CI)

AOR (95% CI)

AOR (95% CI)

AOR (95% CI)

AOR (95% CI)

Reference
1.37 (0.88-2.13)
2.01 (1.30-3.09)

Reference
1.23 (0.77-1.98)
1.46 (0.99-2.14)

Reference
0.98 (0.61-1.56)
1.20 (0.78-1.83)

Reference
1.52 (1.27-1.81)
1.61 (1.30-2.00)

Reference
1.03 (0.64-1.67)
1.00 (0.62-1.61)

Reference
1.26 (1.01-1.58)
1.42 (1.13-1.79)

Reference
1.53 (1.24-1.90)
1.21 (0.97-1.51)

Reference
1.56 (1.02-2.40)
2.13 (1.36-3.34)

Reference
1.33 (0.90-1.97)
1.54 (1.04-2.28)

Reference
2.32 (1.55-3.46)
2.96 (1.82-4.80)

Reference
1.54 (1.26-1.88)
1.74 (1.38-2.20)

Reference
0.88 (0.57-1.37)
1.15 (0.69-1.93)

Reference
1.04 (0.86-1.25)
1.04 (0.82-1.32)

Reference
1.60 (1.32-1.94)
1.69 (1.33-2.14)

Reference
1.11 (0.87-1.40)

Reference
1.57 (1.19-2.06)

Reference
1.23 (0.91-1.66)

Reference
1.12 (0.98-1.29)

Reference
2.01 (1.45-2.79)

Reference
1.52 (1.30-1.78)

Reference
0.72 (0.61-0.84)

Reference
1.72 (1.33-2.23)
1.22 (0.85-1.76)
0.57 (0.41-0.80)
0.48 (0.33-0.70)
0.19 (0.09-0.40)

Reference
3.95 (2.73-5.71)
3.25 (2.17-4.87)
1.90 (1.20-3.00)
2.13 (1.39-3.28)
1.58 (0.76-3.30)

Reference
1.70 (1.22-2.39)
0.80 (0.52-1.23)
0.70 (0.43-1.12)
0.68 (0.40-1.17)
0.38 (0.17-0.85)

Reference
2.44 (2.03-2.93)
1.93 (1.55-2.42)
1.54 (1.27-1.87)
1.23 (0.98-1.54)
0.66 (0.50-0.88)

Reference
1.97 (1.12-3.47)
1.54 (0.90-2.64)
2.08 (1.28-3.39)
1.11 (0.63-1.94)
1.13 (0.53-2.42)

Reference
2.74 (2.21-3.40)
2.53 (2.00-3.20)
2.32 (1.92-2.80)
2.07 (1.65-2.60)
1.89 (1.41-2.54)

Reference
1.21 (0.99-1.47)
0.70 (0.55-0.89)
0.65 (0.53-0.80)
0.55 (0.41-0.73)
0.43 (0.32-0.59)

Reference
0.32 (0.21-0.48)
0.59 (0.38-0.93)
0.36 (0.25-0.52)

Reference
0.36 (0.23-0.57)
0.60 (0.38-0.94)
0.33 (0.20-0.54)

Reference
0.64 (0.38-1.08)
0.89 (0.51-1.56)
0.43 (0.26-0.73)

Reference
0.73 (0.60-0.88)
0.69 (0.55-0.88)
0.54 (0.44-0.66)

Reference
0.40 (0.22-0.73)
1.06 (0.62-1.81)
0.66 (0.44-0.99)

Reference
0.44 (0.37-0.53)
0.72 (0.58-0.89)
0.47 (0.38-0.59)

Reference
1.00 (0.81-1.25)
0.64 (0.49-0.84)
0.90 (0.71-1.14)

Reference
1.68 (1.15-2.44)
2.65 (1.77-3.97)
2.48 (1.63-3.77)
2.05 (1.07-3.90)

Reference
0.98 (0.62-1.53)
1.32 (0.85-2.05)
1.25 (0.69-2.28)
0.53 (0.21-1.35)

Reference
1.63 (0.83-3.22)
2.62 (1.39-4.97)
2.25 (1.07-4.72)
1.06 (0.29-3.95)

Reference
1.23 (1.01-1.50)
1.51 (1.23-1.86)
1.50 (1.15-1.96)
0.97 (0.68-1.40)

Reference
1.32 (0.79-2.22)
1.79 (1.12-2.86)
1.31 (0.72-2.40)
1.29 (0.53-3.15)

Reference
0.90 (0.73-1.10)
0.89 (0.72-1.09)
0.63 (0.46-0.87)
0.41 (0.28-0.59)

Reference
1.43 (1.12-1.82)
2.46 (1.94-3.13)
4.13 (3.04-5.62)
3.82 (2.59-5.63)

Reference
1.78 (1.28-2.48)
2.05 (1.44-2.93)
2.17 (1.46-3.23)
2.04 (1.26-3.29)

Reference
1.28 (0.88-1.85)
1.05 (0.72-1.53)
0.94 (0.59-1.48)
0.80 (0.43-1.50)

Reference
1.22 (0.76-1.97)
1.70 (1.17-2.48)
2.47 (1.62-3.77)
2.76 (1.72-4.41)

Reference
1.25 (1.01-1.56)
1.38 (1.12-1.71)
1.61 (1.24-2.07)
1.43 (1.11-1.85)

Reference
0.95 (0.56-1.61)
0.98 (0.61-1.57)
1.37 (0.81-2.32)
1.03 (0.51-2.06)

Reference
1.12 (0.90-1.40)
0.92 (0.74-1.14)
0.76 (0.59-0.99)
0.51 (0.36-0.72)

Reference
1.26 (1.03-1.54)
1.39 (1.12-1.73)
2.22 (1.74-2.82)
3.13 (2.33-4.22)

Bolded values indicate estimate significant a p < 0.05
The “none” category is used in reference for the tobacco and alcohol use outcome.
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Participants with high negative affect severity, compared to low, had the greatest
odds for alcohol, CIG, and ECIG use rather than no use while adjusting for externalizing
severity, sex, age, race, education, and annual household income. Participants with
high externalizing severity, compared to low, had the greatest odds for ECIG and
alcohol use rather than no use while adjusting for negative affect severity, sex, age,
race, education, and annual household income.

Model 2: Negative affect, externalizing, and ND
Compared to subjects with low negative affect severity, those with high negative
affect severity were more likely to engage in CIG and alcohol use (AOR=1.29, 95%
CI=1.03-1.61) and alcohol-exclusive use (AOR=1.31, 95% CI=1.05-1.64) than no use
(Table 2.6). Similar associations were found between moderate negative affect severity,
relative to low, and CIG and alcohol use (AOR=1.47, 95% CI=1.22-1.77) and alcoholexclusive use (AOR=1.58, 95% CI=1.27-1.96) than no use. Participants with high
externalizing severity, compared to low, had 79% greater odds for alcohol, CIG, and
ECIG use (AOR=1.79, 95% CI=1.15-2.78), 197% greater odds of ECIG and alcohol use
(AOR=2.97, 95% CI=1.84-4.81), 53% greater odds of CIG and alcohol use (AOR=1.53,
95% CI=1.21-1.92), and 75% greater odds of alcohol-exclusive use (AOR=1.75, 95%
CI=1.38-2.22) than no use. Subjects with moderate externalizing severity, compared to
low, were more likely to engage in ECIG and alcohol use (AOR=2.29, 95% CI=1.533.43), CIG and alcohol use (AOR=1.41, 95% CI=1.16-1.72), and alcohol-exclusive use
(AOR=1.62, 95% CI=1.33-1.97) than no use when adjusting for ND. ND was
significantly associated with all combinations of tobacco and alcohol use, compared to
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none, except for ECIG and alcohol use (AOR=1.00, 95% CI=0.99-1.01) and ECIGexclusive use (AOR=1.00, 95% CI=0.99-1.01).
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Table 2.6: Model 2 - Multinomial Logistic Regression for Level of Current Tobacco and Alcohol Use (Including Nicotine Dependence) (n = 15,947, Weighted N =
61,482,491)

Variable
Negative Affect Severity
Low
Moderate
High
Externalizing Severity
Low
Moderate
High
Nicotine Dependence
Sex
Male
Female
Age
18-24 years old
25-34 years old
35-44 years old
45-54 years old
55-64 years old
65 years or older
Race
White
Non-Hispanic Black
Non-Hispanic Other
Hispanic Multicultural
Education
Less than high school
GED/High school
Some college
Bachelor's degree
Advanced degree
Income
< $10,000
$10,000-24,999
$25,000-49,000
$50,000-99,999
>=$100,000

Alcohol,
Cigarette, and
E-cigarette
AOR (95% CI)

Cigarette and
E-cigarette

E-cigarette and
Alcohol

Cigarette and
Alcohol

E-cigarette
Only

Cigarette
Only

Alcohol
Only

AOR (95% CI)

AOR (95% CI)

AOR (95% CI)

AOR (95% CI)

AOR (95% CI)

AOR (95% CI)

Reference
1.33 (0.85-2.07)
1.53 (1.00-2.36)

Reference
1.21 (0.74-1.97)
1.02 (0.68-1.53)

Reference
0.97 (0.61-1.56)
1.19 (0.78-1.81)

Reference
1.47 (1.22-1.77)
1.29 (1.03-1.61)

Reference
1.04 (0.64-1.68)
1.00 (0.62-1.60)

Reference
1.22 (0.96-1.55)
1.08 (0.85-1.38)

Reference
1.58 (1.27-1.96)
1.31 (1.05-1.64)

Reference
1.42 (0.93-2.17)
1.79 (1.15-2.78)

Reference
1.16 (0.77-1.74)
1.23 (0.82-1.85)

Reference
2.29 (1.53-3.43)
2.97 (1.84-4.81)

Reference
1.41 (1.16-1.72)
1.53 (1.21-1.92)

Reference
0.87 (0.56-1.37)
1.16 (0.69-1.95)

Reference
0.92 (0.76-1.13)
0.88 (0.70-1.11)

Reference
1.62 (1.33-1.97)
1.75 (1.38-2.22)

1.06 (1.05-1.07)

1.08 (1.07-1.09)

1.00 (0.99-1.01)

1.05 (1.04-1.05)

1.00 (0.99-1.01)

1.06 (1.05-1.06)

0.97 (0.97-0.98)

Reference
1.17 (0.92-1.48)

Reference
1.65 (1.26-2.16)

Reference
1.22 (0.91-1.65)

Reference
1.17 (1.01-1.35)

Reference
2.02 (1.46-2.80)

Reference
1.58 (1.34-1.86)

Reference
0.71 (0.60-0.83)

Reference
1.30 (1.01-1.68)
0.76 (0.53-1.09)
0.33 (0.24-0.45)
0.28 (0.19-0.41)
0.12 (0.06-0.27)

Reference
2.76 (1.92-3.97)
1.74 (1.15-2.63)
0.92 (0.60-1.42)
1.06 (0.67-1.68)
0.90 (0.43-1.92)

Reference
1.74 (1.23-2.46)
0.82 (0.53-1.29)
0.72 (0.44-1.16)
0.70 (0.41-1.20)
0.39 (0.17-0.89)

Reference
1.96 (1.63-2.37)
1.34 (1.07-1.68)
1.00 (0.83-1.20)
0.81 (0.64-1.03)
0.48 (0.36-0.64)

Reference
2.01 (1.12-3.60)
1.58 (0.90-2.76)
2.12 (1.31-3.43)
1.12 (0.64-1.98)
1.16 (0.53-2.53)

Reference
2.11 (1.69-2.63)
1.62 (1.28-2.06)
1.38 (1.13-1.68)
1.26 (0.99-1.60)
1.31 (0.96-1.77)

Reference
1.32 (1.09-1.61)
0.82 (0.64-1.04)
0.77 (0.62-0.95)
0.65 (0.48-0.86)
0.51 (0.37-0.70)

Reference
0.40 (0.26-0.61)
0.69 (0.44-1.09)
0.55 (0.38-0.81)

Reference
0.48 (0.30-0.77)
0.75 (0.48-1.18)
0.57 (0.35-0.94)

Reference
0.64 (0.38-1.08)
0.89 (0.51-1.57)
0.43 (0.25-0.73)

Reference
0.87 (0.71-1.06)
0.79 (0.62-1.00)
0.77 (0.62-0.95)

Reference
0.40 (0.22-0.73)
1.06 (0.62-1.83)
0.65 (0.43-1.00)

Reference
0.55 (0.45-0.67)
0.85 (0.67-1.08)
0.73 (0.58-0.91)

Reference
0.95 (0.76-1.19)
0.63 (0.48-0.83)
0.79 (0.62-1.01)

Reference
1.82 (1.24-2.66)
3.41 (2.26-5.14)
4.40 (2.83-6.85)
3.98 (2.09-7.59)

Reference
1.10 (0.70-1.71)
1.77 (1.13-2.76)
2.48 (1.37-4.52)
1.16 (0.46-2.92)

Reference
1.60 (0.82-3.15)
2.55 (1.33-4.87)
2.16 (1.00-4.67)
1.02 (0.27-3.84)

Reference
1.31 (1.07-1.60)
1.82 (1.46-2.25)
2.32 (1.76-3.06)
1.60 (1.11-2.31)

Reference
1.31 (0.78-2.20)
1.79 (1.12-2.85)
1.32 (0.72-2.40)
1.29 (0.52-3.19)

Reference
0.97 (0.78-1.20)
1.09 (0.87-1.37)
1.04 (0.75-1.46)
0.70 (0.48-1.03)

Reference
1.39 (1.09-1.78)
2.23 (1.73-2.85)
3.33 (2.43-4.56)
3.02 (2.02-4.52)

Reference
1.86 (1.34-2.58)
2.32 (1.62-3.32)
2.45 (1.64-3.67)
2.57 (1.56-4.25)

Reference
1.39 (0.96-2.01)
1.27 (0.86-1.88)
1.12 (0.71-1.78)
1.09 (0.57-2.08)

Reference
1.22 (0.75-1.97)
1.69 (1.16-2.47)
2.44 (1.59-3.74)
2.74 (1.70-4.42)

Reference
1.30 (1.05-1.61)
1.52 (1.24-1.87)
1.76 (1.38-2.25)
1.74 (1.34-2.26)

Reference
0.94 (0.56-1.59)
0.96 (0.60-1.54)
1.35 (0.80-2.28)
1.02 (0.51-2.03)

Reference
1.18 (0.95-1.46)
1.04 (0.85-1.29)
0.86 (0.67-1.10)
0.65 (0.45-0.92)

Reference
1.26 (1.02-1.55)
1.37 (1.10-1.70)
2.15 (1.68-2.76)
2.87 (2.12-3.89)

Bolded values indicate estimate significant a p < 0.05
The “none” category is used in reference for the tobacco and alcohol use outcome.
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Participants with high negative affect severity, compared to low, had the greatest
odds for alcohol-exclusive use rather than no use while adjusting for externalizing
severity, ND, sex, age, race, education, and annual household income. Participants with
high externalizing severity, compared to low, had the greatest odds for ECIG and
alcohol use rather than no use while adjusting for negative affect severity, ND, sex, age,
race, education, and annual household income.
Additional models compared results across all categories of reference groups to
establish differences for each category of tobacco/alcohol use (Appendix A,
Supplemental Table 2.1). All significant associations between negative
affect/externalizing severity and tobacco and alcohol combinations were significantly
lower when referencing alcohol, CIG, and ECIG as well as ECIG and alcohol use.
Conversely, significant positive associations were found between negative
affect/externalizing severity and tobacco and alcohol combinations when referencing
CIG and ECIG use, ECIG-exclusive, and CIG-exclusive. Results were mixed when
referencing CIG and alcohol use, and alcohol-exclusive use.

DISCUSSION
Our study is one of the first to examine the relationships between negative
affect/externalizing severity and combinations of CIG, ECIG, and alcohol use across
adulthood. There were three major results. First, strong, positive associations with
negative affect/externalizing severity at various levels of CIG, ECIG, and alcohol use
were detected. Overall, negative affect severity was more strongly associated with CIG
and alcohol use as well as alcohol-exclusive use while externalizing severity was more
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strongly associated with ECIG and alcohol use when accounting for ND. Second, ECIG
may represent a new and underappreciated substance related to externalizing
psychopathology. Alcohol was significantly associated with psychopathology when
ECIG was included. Third, ND may mediate the relationship between negative
affect/externalizing severity and various levels of CIG, ECIG, and alcohol use.

Patterns of tobacco and alcohol use vary by negative affect/externalizing severity
We detected specific patterns of association between tobacco and alcohol use
with negative affect/externalizing severity. Specifically, high negative affect severity had
a higher magnitude of association with CIG and alcohol use as well as alcohol-exclusive
use. In contrast, externalizing severity was more strongly associated with ECIG and
alcohol use. These results expand on recent positive associations that were detected
between mental disorder symptoms and exclusive use of tobacco products in adults.73
Specifically, multiple mental disorder symptoms (i.e., higher severity) was generally
associated with use of more than one substance, except for alcohol. To date, individuals
with co-occurring mental health disorders have been reported to have a more severe
course of illness, health and social consequences, more difficulties when seeking and in
treatment, or worse treatment outcomes than people with a single disorder.18
Additionally, tobacco use has been reported to be higher among people with mental
health problems (e.g., major depressive disorder, generalized anxiety, schizophrenia,
and/or antisocial personality/conduct disorder).90,115,116 These results suggest that
patterns, rather than a dose-response, of tobacco and alcohol use are associated with
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negative affect/externalizing severity. Further investigation of these comorbidity
patterns, including tobacco use, is required.

ECIG use associated with externalizing severity with co-occurring alcohol use
Negative affect/externalizing severity were not significantly associated with
ECIG-exclusive use. This is inconsistent with previous work, perhaps due to differences
in defining ECIG use.73 Specifically, we expanded our study of “ECIG use” to include a
commonly occurring form of tobacco use- dual use of ECIG and CIG. Our results
provide a more detailed and nuanced description of the relationship between negative
affect/externalizing psychopathology and ECIG use by parsing out co-occurring CIG
and alcohol use from ECIG.
Concurrent ECIG and alcohol use, however, was significantly associated with
externalizing severity. Further, compared to low externalizing severity, high and
moderate externalizing severity showed stronger association with alcohol use of any
kind (i.e., alcohol, CIG, and ECIG use; ECIG and alcohol use; CIG and alcohol use; and
alcohol-exclusive use). This association between externalizing and alcohol is consistent
with prior studies,38,117,118 and this association remains when ECIGs are used with
alcohol. This finding builds upon previous work that has established more harmful
alcohol use with ECIG use in that externalizing symptoms are associated with this
pattern of use. More research is needed to better understand the relationship between
different combinations of tobacco and alcohol, including ECIG, and psychopathology.
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ND may mediate the relationship between negative affect/externalizing severity and
current tobacco and alcohol use in adults
The magnitude of the associations between negative affect/externalizing severity
and levels of tobacco/alcohol use were reduced, although generally remained
significant, when ND was included. The associations between negative affect severity
and alcohol, CIG, and ECIG use and CIG-exclusive use as well as externalizing severity
and CIG and ECIG use were no longer statistically significant. ND may explain more of
the relationship between negative affect severity and alcohol, CIG, and ECIG use as
well as CIG-exclusive use. Previous work has indicated that externalizing behaviors act
as a precursor or factor involved in substance use, especially alcohol use.38,117,118
Therefore, the relationship between externalizing severity and alcohol use in adults,
whether exclusive or with tobacco, is expected to be mediated or have an indirect effect
through ND. In an ad hoc mediation analysis,119 ND was determined to be a significant
mediator between negative affect/externalizing and tobacco and alcohol use. This is
consistent with prior work that has identified ND as a mediator between mental
conditions.120 We also included a test for SUD severity (GAIN-SS) as a mediator in
models including ND since it measures broader substance use behavior, including
alcohol. However, no significant direct or indirect effect of SUD was detected. As
mediation is inherently a causal hypothesis, we recommend future researchers to
confirm this with a longitudinal analysis to accurately model a mediation pathway in the
context of the transactional effect between tobacco initiation and ND development.

Strengths and limitations
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These results should be interpreted while considering the following points. First,
these data were collected in 2013-2014, so these analyses do not capture more recent
ECIG products (i.e., pod-mods). Consequently, these results may not be generalizable
to the current generation of ECIG devices. Second, the analytic sample size was
reduced from the Wave 1 sample after removing participants with missing data. Many
participants (N=13,865) were removed due to a skip pattern identified for the ND items
used to calculate the composite ND item. If a participant was not a current tobacco user,
a former 12-month tobacco user, or a current experimental tobacco user, they were not
asked the ND items. ND is contingent upon tobacco initiation121; therefore, it was
inappropriate to code these missing observations as 0. Therefore, there is systematic
bias introduced by the missingness; however, results from sensitivity analyses in which
all missing observations on the ND items were coded as 0 did not demonstrate
differences that would alter the overall study conclusions. Third, use of self-reported
data has the potential to introduce misclassification bias, which may underestimate the
magnitude of associations. However, this would lead to an attenuation of effect sizes,
rather than an overestimation. Fourth, the GAIN-SS measures negative
affect/externalizing symptom severity rather than psychiatric diagnoses. We recognize
use of symptom data as a strength, as we are more likely to capture true rates of mental
health disorders without relying on disease-specific diagnoses. There is growing support
for the use of subthreshold or transdiagnostic symptoms over traditional diagnoses to
better explain the high rates of comorbidity among common mental disorders,
particularly when characterizing population-based samples.122 Therefore, these results
represent the full distribution of severity across several mental health domains. Future
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investigations should test these associations with negative affect and externalizing
symptoms rather than a composite severity score to further detail comorbidity patterns.
Fifth, to answer our research questions, this study focused on current CIG, ECIG, and
alcohol use, and ND. We could not determine if ND was due to the CIG or ECIG use or
another tobacco product that was not included in these analyses. Future studies are
encouraged to explore direct associations with other tobacco products and ND. Sixth,
by using only data from Wave 1, direction of causation cannot be determined and future
longitudinal studies are needed.

Conclusions
Negative affect and externalizing severity were strongly associated with multiple
levels of CIG, ECIG, and alcohol use in this study. The magnitude of association varied
by the tobacco product used. Overall, negative affect severity was more strongly
associated with CIG and alcohol use as well as alcohol-exclusive use while
externalizing severity was more strongly associated with ECIG and alcohol use when
accounting for ND. ECIG may represent a new and underappreciated substance related
to externalizing psychopathology. The magnitudes of these associations were reduced
when ND was included in the model, indicating that ND may mediate the association
between negative affect/externalizing severity and current tobacco and alcohol use.
Future work is encouraged to investigate the different patterns of tobacco and alcohol
use (i.e., using latent variable and network approaches) since our results suggest
patterns of use rather than a dose-response relationship between tobacco and alcohol
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use and negative affect/externalizing severity. Longitudinal studies could provide deeper
insight into the stability of these patterns over time.
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CHAPTER 3: LATENT CLASSES OF COMORBID SUBSTANCE USE AND
NEGATIVE AFFECT AND EXTERNALIZING SYMPTOMS AND THEIR ROLE IN
ADULT SUBSTANCE USE DISORDER SEVERITY

INTRODUCTION
Substance use disorder (SUD) results from the prolonged use of any
psychoactive substance at high doses and/or frequencies, and is defined as continued
use despite associated health and social problems.2,123 SUD poses a substantial burden
on the United States’ health system, with almost 20 million American adults meeting
diagnostic criteria for a past-year SUD in 2018.5 Of the 20 million adults in the United
States (U.S.) who experience a SUD, half also have a co-occurring mental disorder.5
The co-occurrence of mental disorders is common among people who use substances
or engage in polysubstance use, consuming more than one substance over a defined
period.10,12,35 People with co-occurring tobacco use, substance use, and mental
disorders have more severe courses of mental illness, more severe health and social
consequences, more difficulties seeking and receiving treatment, and worse treatment
outcomes compared to people with a singular disorder.18 Therefore, people who
experience greater comorbidity may be at a greater risk for SUD severity.

Study of Comorbidity Characterizes Common Patterns of Co-Occurring Disorders
Historically, comorbidity research involving substance use or symptoms
underlying mental disorders has generally focused on the identification and description
of either polysubstance use or mental disorder classes, separately. These studies have
identified several specific subcategories of either SUD or mental disorders. For
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example, a recent study examined past-month polysubstance use among a small
sample of psychiatric inpatients with co-occurring mental disorder and SUDs. This study
identified three polysubstance use profiles: cannabis and alcohol (35.1%), alcohol only
(49.3%), and polysubstance use including cocaine plus alcohol and marijuana
(15.7%).35 Other latent class analyses of substance use focus on a sample of specific
substance users. For example, a five-class solution was most optimal in describing
polysubstance use in a small sample of lifetime cocaine users: past 30-day tobacco use
only (45%), past 30-day alcohol, marijuana and tobacco use (31%), past 30-day
tobacco, prescription opioid and sedative use (13%), past 30-day cocaine, alcohol,
marijuana and tobacco use (9%), and past 30-day cocaine and multiple polysubstance
use (2%).37 Another study of opioid-dependent patients identified a two-class solution:
severe comorbidity with high rates of other SUDs specifically amphetamine and
sedative (10%), and a less severe comorbidity class with moderate rates of nicotine,
alcohol, cannabis, and cocaine disorders (90%).36 Overall, the comorbidity
characteristics are different depending on the population being studied.
In another study assessing only mental disorder comorbidity, a four-class
solution best described the sample: low psychopathology (84.0%), internalizing (9.9%),
externalizing (4.5%), and high psychopathology (1.6%).41 The high psychopathology
class was more strongly associated with lifetime suicide attempt, compared to the
internalizing and externalizing classes.41 The internalizing and externalizing classes had
overall higher odds of lifetime affective and substance use disorders, respectively.41
These four class solutions are commonly identified in mental disorder only
comorbidity.41,124
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Detailing comorbidity between substance use and mental disorders has only
recently been addressed and confirms the strength of association between these two
conditions. For example, a more recent study evaluated the class structure of substance
use and mental disorders together and identified a four-class solution: low disorder
(73.6%); mental health and low SUD (10.6%); alcohol, cannabis, and low mental health
disorder (12.2%); and polysubstance use and moderate mental health disorder
(3.5%).12 Mental disorders were more likely to occur with polysubstance use disorders
in young adults.12 Another study accounting for both mental and SUDs also identified a
four-class solution: little psychopathology (62.5%), internalizing disorders (16.9%),
externalizing disorders (16.4%), and both internalizing/externalizing disorders (4.2%).124
The most severe class, internalizing/externalizing disorder, demonstrated elevated rates
for both mental disorders as well as alcohol (85.4%), cannabis (76.2%), and hard drug
use disorders (61.1%) while the internalizing class had moderate alcohol use disorder
endorsement (34.2%) and the externalizing class had greater endorsement of alcohol
(84.2%), cannabis (82.0%), and hard drug disorders (53.7%).124 As a whole, these
studies confirm and demonstrate a consistent comorbidity structure that likely takes
form in four classes. These studies also identify a larger, low psychopathology group
and a smaller yet more severe comorbidity group with more moderate comorbidity
somewhere in between. The severe comorbidity group has higher endorsement of
mental disorders and substance use behaviors. Understanding and identifying these
comorbidity profiles have the potential to better support people with comorbidity through
risk assessment and interventions.41
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Limitations in Current Approach to Studying Comorbidity
Despite recent advancements in the study of comorbid SUD, several gaps in
knowledge remain. First, the current comorbidity literature usually considers diagnosis
to measure substance use and mental disorders. However, the overlap between
symptoms from multiple disorders and the simultaneous co-occurrence of multiple
disorders is very common. The current classification systems are limited in their ability
to characterize comorbidity and may neglect to appropriately account for these
overlaps. Therefore, using symptom-level data and a more recent measure of
substance use behaviors (i.e., past-month substance use) will not only account for
these overlaps, but these measurements could also indicate severity. For example,
people who engaged in past-month use compared to people who used in the past-year
may be more likely to have higher levels of SUD severity. Furthermore, there may be an
underestimation of the population level burden of comorbidity due to the measurement
of substance use and mental disorder through diagnostic classifications only. People
who use substances or experience mental health problems that are not severe enough
to receive a diagnosis or have access to a diagnosis are not included.117 Most
substance-related health and social problems occur among individuals who are not
addicted or have a SUD diagnosis.8 Consequently, using subthreshold measures may
better address this issue of underreporting while also accounting for the overlap
between substance use behaviors and mental health conditions.
Second, tobacco use is rarely considered in comorbidity research, despite
consistent literature supporting the association of tobacco use and mental
disorders.12,41,92 Nicotine dependence occurs in a substantial proportion of individuals
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with alcohol use disorder (23.8%), marijuana use disorder (32.6%), cocaine use
disorder (47.7%), prescription opioid use disorder (45.4%), and heroin use disorder
(66.3%).9 Negative affect (e.g., depression and anxiety) and externalizing [e.g.,
attention-deficit hyperactivity disorder (ADHD) and conduct disorder]
psychopathology2,16,73,89–91 are important mental health factors that have been
consistently associated with exclusive use of conventional cigarettes (CIG). A metaanalysis reported that current CIG users had a two-fold increased risk of depression
relative to never and former CIG users.92 Further, adults with depression are more likely
to smoke and are less likely to be successful at quitting than adults without
depression.93 With the increase in access and use of electronic cigarettes (ECIG) alone
and in CIG users,84,125 it is increasingly important to consider this alternative method of
nicotine delivery in comorbidity research alongside CIG use.
Third, comorbidity is typically studied using smaller samples of more severely
disordered participants,35 which does not provide a sense of the etiology of comorbidity
for people who are affected with lower levels of severity. This is unfortunate, because
people with lower levels of comorbid severity are expected to make up at least 2/3 of
the U.S. population.12,41,124 Consequently, there is a gap in our understanding of
comorbidity across the population. Specifically, it is unclear whether the latent class
structure of SUD comorbidity from clinical samples will be detected in a populationbased sample where severity of SUD is generally lower. Nevertheless, populationbased study samples can measure SUD severity using screeners like the Addiction
Severity Index (ASI), Alcohol Use Disorders Identification Test (AUDIT), Drug Abuse
Screen Test (DAST), Fagerstrom Test for Nicotine Dependence (FTND), and the Global
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Appraisal for Individual Needs (GAIN).26–28 These instruments are useful to assess SUD
and SUD severity in settings that cannot specifically assess diagnosis. Use of these
instruments can therefore capture people who (1) have subthreshold levels of
impairment, and (2) may not have access to a physician to receive a diagnosis.
Therefore, it is possible to model the relationship among a robust set of substance use
behaviors, including tobacco, and mental disorder symptoms in a large, nationally
representative sample to detail the comorbidity between SUDs and mental disorders on
a population-level.

Use of Comorbidity Details to Predict SUD Severity
In addition to the aforementioned limitations, the detailing of comorbidity between
co-occurring substance use and mental disorder has primarily been descriptive (i.e.,
developing comorbidity profiles) with some tests of association between comorbidity
profiles and other factors (i.e., demographic characteristics, early life factors [i.e.,
parental factors], psychiatric diagnoses, suicide attempts, self-efficacy in abstinence,
and treatment involvement).12,35,41 However, there have been few advancements in
improving treatment outcomes and reducing the prevalence of mental disorders and/or
SUDs.9 Consequently, there has been a stated need for comorbidity research due to the
“insufficient information” that exists today.126 Recent studies have suggested the value
in accounting for patterns of substance use and comorbidity to categorize SUD. Such
detail is expected to improve the identification of individuals at risk for high SUD
severity.41 Consequently, it is possible that establishing a “comorbidity profile” may be

72

useful to screen individuals for SUD risk in order to appropriately address additional risk
factors.
Comorbidity profiles are also expected to be associated with sociodemographic
characteristics like sex, age, race, education, annual household income, and perceived
social connectedness. Being female is a significant predictor of membership for a
mental health disorder class,12 internalizing or negative affect class and high
psychopathology class.41 People who are older in age (65 years and older) and black,
non-Hispanic are significantly protected from membership in internalizing or negative
affect, externalizing and high psychopathology classes.41 Higher income level is also
indicative of a protective relationship from membership in internalizing or negative
affect, externalizing, and high psychopathology classes.41 Perceived social
connectedness and support have been found to protect adults against substance use
behaviors and mental disorder symptoms.127,128 Therefore, these sociodemographic
characteristics must be considered when developing comorbidity profiles to predict SUD
severity.

Purpose, research questions, and hypotheses
Prediction modeling using the probability of class membership is an extension to
previous LCA work that can further inform prevention and potential intervention
strategies among polysubstance users with varying levels of mental disorder symptoms.
The three goals for this study are: (1) identify latent classes of comorbid substance use
behaviors and mental disorder symptoms using LCA, (2) determine if there are
differences in comorbidity by demographic and social factors, and (3) predict SUD
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severity using the probability of comorbidity class membership severity in the first wave
of adult data from the Population Assessment of Tobacco and Health study. Based on
previous literature, we expect substance use to vary across the mental disorder
symptoms. More substance use behaviors will cluster with highly comorbid mental
disorder classes. Certain demographic factors will increase the risk of highly comorbid
class membership, while social satisfaction will decrease risk. Higher probabilities of
class membership in the highly comorbid and externalizing classes will predict greater
SUD severity compared to probability of class membership in the low comorbidity and
negative affect classes. This research will support population-level strategies to prevent
or treat SUDs, including nicotine dependence, and the development of more severe
mental health problems.

METHODS
Setting
Wave 1 adult data (N=32,320) from the Population Assessment of Tobacco and
Health (PATH) study was used.71 These data are cross-sectional and were collected
between September 2013 and December 2014. PATH is a nationally representative
longitudinal cohort study of the civilian, non-institutionalized household population of the
U.S., and participants engaged in all levels of tobacco use ranging from never using
tobacco to frequent use.
The weighted response rate among participants was 74.0% for Wave 1.73
Participants responded to tobacco-specific items including tobacco-use patterns, risk
perceptions and attitudes towards current and newly emerging tobacco products,
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tobacco initiation, cessation, relapse behaviors, and health outcomes.72 Participants
also responded to non-tobacco items (e.g., media use, peer and family influences,
health effect outcomes, and industry advertising and promotion).72

Study representativeness
Participants with missing data on the substance use, negative affect, and
externalizing measures were not included in the analysis (N= 2,109). Survey
respondents of the analytic sample endorsed significantly greater substance use
overall, negative affect symptoms, and externalizing symptoms (except for fighting)
compared to those not included in the analytic sample. The participants in the analytic
sample were more likely to be Non-Hispanic white, men, aged 25-54 with higher levels
of education and annual household income than those who were missing.

Measures
Seventeen variables were studied: six substance use variables, four negative
affect variables, and seven externalizing variables.
Past Month Tobacco and Substance Use. Six substance use categories were
used in this study: exclusive cigarette, exclusive e-cigarette, dual cigarette and ecigarette, alcohol, marijuana, and prescription drugs not prescribed (PDNP) including
painkillers, sedatives, tranquilizers. Only past month or current use of the substances
was considered (coded as 1, else = 0) to reduce the potential for recall bias and ensure
for accurate overlap with negative affect and externalizing symptoms occurring in the
same time frame.
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Past Month Negative Affect and Externalizing Symptoms. Negative affect and
externalizing symptoms were measured using the Global Appraisal of Individual
Needs—Short Screener (GAIN-SS).73 The items selected to identify negative affect and
externalizing symptoms from the GAIN-SS instrument are ordinal and measures people
across four times periods: past month, 2 to 12 months, over a year ago, and never.
Participants indicating that they experienced a symptom within the past month were
coded as 1. Participants indicating that they experienced the symptom 2 to 12 months
ago, over a year ago, and never were coded as 0. Only past month or current negative
affect and externalizing symptoms were considered reducing the potential for recall bias
and ensure accurate overlap with substance use occurring in the same time frame.
Past Month Substance Use Disorder Symptoms. Substance use disorder (SUD)
severity was measured using the Global Appraisal of Individual Needs—Short Screener
(GAIN-SS).73 Seven questions were used to measure SUD symptoms that asked the
last time:
(1) “used alcohol/drugs weekly or more often,”
(2) “spent a lot of time getting alcohol/drugs,”
(3) “spent a lot of time using or recovering from alcohol or other drugs,”
(4) “kept using alcohol or other drugs even though it was causing social problems,
leading to fights, or getting you into trouble with other people,”
(5) “your use of alcohol or other drugs reduced your involvement in activities at work,
school, home or social events,”
(6) “had withdrawal problems such as shaky hands, throwing up, having trouble
sitting still or sleeping,” and
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(7) “use of alcohol/drugs to avoid withdrawal.”
These items are ordinal and measures people across four time periods: past month,
2 to 12 months, over a year ago, and never. Participants indicating that they
experienced a symptom within the past month were coded as 1. Participants indicating
that they experienced the symptom 2 to 12 months ago, over a year ago, and never
were coded as 0. Only past month or current SUD symptoms was considered to reduce
the potential for recall bias and ensure accurate overlap with substance use, negative
affect symptoms, and externalizing symptoms occurring in the same time frame. The
binary responses were summed to reflect a scale score of the number of current SUD
symptoms. The score ranging from 0 to 7 SUD symptoms will be categorized into low
(0), moderate (1-2), and high (3+) severity). This is the final measure used as the SUD
severity outcome. These are the recommended cut points based on validation analyses
of the dimensional measure.28 The ordinal severity categories were informed by other
studies, showing concurrent and high predictive validity in other samples.28,73,99 A higher
score indicates increased severity, a greater likelihood for diagnosis with a SUD, and
increased need for services.73 There is substantial overlap with the symptoms identified
in the GAIN-SS and the symptoms identified in the DSM-5 as the GAIN-SS uses
symptoms from the DSM to generate dimensional symptom count measures (Table
3.1).28,129
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Table 3.1: Overlap between SUD Symptoms for DSM-5 Diagnostic Criteria and GAINSS
DSM
DSM Symptom Description
GAIN-SS Symptom
Criterion
Description
Taking substance in larger
Used alcohol/drugs weekly or
amounts or over a longer period
more often
than initially intended.
Expressing a persistent desire to
cut down or regulate use and may
report unsuccessful attempts to do
so.
Spending a great deal of time
Spent a lot of time getting
Impaired
obtaining the substance, using the alcohol/drugs
Control
substance, or recovering from its
Spent a lot of time using or
effects.
recovering from alcohol or other
drugs
Craving manifested by an intense
desire or urge for the drug that
may occur at any time but is more
likely in an environment in which
drug use has previously occurred.
Recurrent substance use results in Your use of alcohol or other
failure to fulfill major role
drugs reduced your involvement
obligations at work, school, or
in activities at work, school,
home.
home or social events
Continuing substance use despite Kept using alcohol or other
persistent social/interpersonal
drugs even though it was
Social
problems exacerbated by the
causing social problems,
Impairment
effects of the substance.
leading to fights, or getting you
into trouble with other people
Giving up or reducing important
Your use of alcohol or other
social, occupational, or
drugs reduced your involvement
recreational activities because of
in activities at work, school,
substance use.
home or social events
Recurrent substance use in
physically hazardous situations.
Risky Use
Continuing use despite knowledge
that persistent physical or
psychological problems are
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exacerbated or caused by
substance use.
Markedly increased dose of the
substance required to achieve
desired effect.
Withdrawal symptoms specific to a
Pharmacology drug class.

Had withdrawal problems such
as shaky hands, throwing up,
having trouble sitting still or
sleeping
Use of alcohol/drugs to avoid
withdrawal
Note: SUD is diagnosed with the occurrence of two or more symptoms. 2 – 3
symptoms = mild presentation, 4 – 5 symptoms = moderate presentation and 6 or
more symptoms = severe presentation. GAIN-SS symptom severity is categorized as
0 symptoms = low severity, 1-2 symptoms = moderate severity, and 3 or more
symptoms = high severity.
Covariates. Sociodemographic variables such as sex, age, race, education,
annual household income, and social satisfaction were included as auxiliary variables to
predict the probability of class membership. These factors were chosen because they
have been identified by previous studies to significantly predict latent class
membership.12,41,127,128 Sex was a binary variable with one level representing male and
the other level representing female. Age, measured in PATH as a seven-level
categorical variable, was re-categorized to have a uniform distribution with six levels
(18-24, 25-34, 35-44, 45-54, 55-64, and 65 years or older). Race/ethnicity was
measured as a four-level categorical race variable and included information from a
separate variable that accounted for Hispanic ethnicity (Non-Hispanic White, NonHispanic Black, Non-Hispanic Other, and Hispanic Multicultural). Education, measured
in PATH as a six-level categorical variable, was re-categorized as a five-level
categorical variable with a uniform distribution [less than high school, GED/high school
graduate, some college (no degree) or Associate’s degree, Bachelor’s degree, and
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Advanced degree]. Annual household income was measured as a five-level categorical
variable: less than $10,000, $10,000 to $24,999, $25,000 to $49,999, $50,000 to
$99,999, and $100,000 or more. Level of satisfaction with social activities and
relationships was measured as a five-level categorical variable: extremely satisfied, very
satisfied, moderately satisfied, a little satisfied, and not at all satisfied.

Statistical analysis
Latent Class Analysis. Latent Class Analysis (LCA) was used to assign
participants into classes of substance use and/or mental disorders using their
responses to self-report measures of substance use, negative affect, and externalizing
symptoms while accounting for demographic and environmental factors as predictors of
class membership. The general goal of an LCA is to define an unobserved, latent
variable (i.e., comorbidity) as a set of classes where the observed variables or items
(i.e., substance use and negative affect-externalizing symptoms) are locally
independent.130 Local independence or conditional independence is a condition in which
the observed items are independent of one another, condition on the level of the latent
variable.130 This means that the relationship or correlation between the observed items
represents a distinct domain that is fully explained by the level of the latent class and
that there is no residual correlation between the items.70,131 LCA accounts for the
observed covariation between substance use and mental disorder symptoms and offers
objective indices of class classification accuracy that are not available in traditional
cluster analysis methods.132
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LCA models are produced by estimating item probability parameters and class
probability parameters.70 Item probability parameters represent the probability of
endorsing an item conditional on latent class membership. It can also be referred to as
the item response probabilities or conditional item probabilities.70 An LCA estimates the
probability of being in a latent class conditional on the probability of endorsing a
measured item. The combination of these two parameters is used to estimate the
probability of being in a latent class with the marginal item probability for item !! =
1 (& = 1,2, … *) given by:
"

,-!! = 1. = / ,(0 = 1),(!! = 1|0 = 1)

(1)

#$%

where ! is a categorical latent variable 0 with 3 classes (0 = 1; 1 = 1, 2, … , 3) across
* binary items.70 Specifically, class probability parameter ,(0 = 1) reflects the
probability that a person in a given latent class has of endorsing the specific item.70 The
class probability parameter specifies the prevalence of each class in the population or
the relative frequency of class membership.70 Further, the item probability parameter or
conditional item probability for a given class is defined by the logistic regression:

,-!! = 150 = 1. =

1
1 + exp (−;!# )

(2)

where the ;!# is the logit for each of the !! ′s for each of the latent classes, 1.70 The
class probability parameter or the prevalence of each class in the population is =# =
,(0 = 1).70
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Model Selection. Five LCA models, ranging from 2-6 classes were tested and
included the seventeen variables of interest. Models were evaluated using measures of
model fit, model parsimony, and entropy.
Model fit quantifies how well a model explains the data. Model fit is assessed as
the -2 log-likelihood which and reflects how much unexplained variation there is in the
estimated model. Model fit comparisons generally test which model best explained the
data by using a likelihood ratio test (LRT) which compares the relative fit of two models
that differ by a set of parameter restrictions.133 The traditional LRT is a hypothesis test
that compares two nested models:

>?@ = −2 log D

>& (EF)
>' (EF)

(3)

where G represents the likelihood for the null model and H represents the
likelihood of the nested model. The estimated values of a traditional LRT follow a chisquare distribution with the number of degrees of freedom equal to the difference in
parameter numbers between the two models that will be compared.133,134
Model fit comparisons for LCA do not meet certain regularity assumptions that
must be satisfied133,134 and as such the use of classic LRT for model comparison is not
appropriate. Specifically, LCA violates the assumption that the additive property of the
likelihood ratio statistic can assess the statistical difference between pairs of
hierarchically related models, meaning that one model is a constrained form of the
other.135 Consequently, model fit for the LCA was assessed using a Lo-Mendell-Rubin
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adjusted likelihood ratio test (LMRT) rather than the traditional LRT.133,134 The LMRT
approximates the likelihood ratio test distribution which can be used for comparing
nested latent class models.70 LMRT uses the adjusted asymptotic distribution of the
likelihood ratio statistic and compares the improvement in fit between neighboring class
models (i.e., comparing 1 − 1 and the 1 class models) with a p-value that can be used
to determine if there is a statistically significant improvement in the fit for the inclusion of
one more class.70
Model parsimony was used to assess how well the model explains the data while
accounting for differences in the number of model parameters estimated in models with
different. Parsimony was evaluated using Akaike information criteria (AIC), Bayesian
information criteria (BIC), and sample-size adjusted BIC. AIC was estimated as:
IJ0 = −2 log > + 2K

(4)

where L is the likelihood function, p is the number of free model parameters.70,136
The benefit of using AIC is that it measures the closeness of the estimated model to the
true model among the competing models.136 The smallest value of the AIC is selected
as the more parsimonious model.136
Bayesian information criteria (BIC)137 was estimated as:

LJ0 = −2 log > + K log(M)

(5)

where −2 log > is -2 times the log-likelihood of the estimated model and M is the
number of observations. BIC aids model selection by penalizing the number of factors in
a model.138 The smaller BIC indicates a more parsimonious model.
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Sample-size adjusted BIC139 builds on BIC by replacing the same size M in the
BIC equation above with M*. It was estimated as:
M* = (M + 2)/24

(6)

PQ&!GRDQ LJ0 = −2 log > + K log[(M + 2)/24]

(7)

The benefit of sample-adjusted BIC is that it accounts for the sample size.
Simulation studies have confirmed that BIC and sample-size adjusted BIC are better
indicators of the number of latent classes than AIC.70
Entropy is commonly used as a model selection criterion that indicates the
model’s ability to classify a person in a latent class (i.e., level of separation).133 It
measures aggregated classification uncertainty and reflects accuracy of class
membership assignment.133 Classification uncertainty is assessed at the individual level
by posterior probabilities from the estimated model.140 Therefore, entropy identifies the
estimated model’s ability to classify an individual into a class based on their poster
probability of having endorsed a specific item. There is little distinction between classes
when posterior probabilities across the classes are very similar. Entropy ranges from 0
to 1 and a higher entropy represents a better fit; values > 0.80 indicate the latent
classes highly discriminate.133
Joint evaluation of parsimony, entropy, and model fit was used to identify the
LCA model that best explained the data. Consequently, models with lower values for
AIC and BIC were preferred. Models with a larger entropy value were preferred because
they strongly discriminate between classes. Statistically significant results from the
LMRT were used to determine the model with the lowest number of classes that best fit
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the data. Interpretability and average latent class probabilities were also considered in
determining optimal class solution.70,141
The best fitting model was also used to assign class membership to each
participant. This assignment of class membership was then used in the multinomial
logistic regression and prediction analyses as detailed below.
Multinomial Logistic Regression. Multinomial regression was used to determine
whether any covariates were significantly associated with membership of a latent class.
142

Multinomial regression was conducted using the three-step method (R3STEP) via

the AUXILIARY statement in Mplus. This approach was used to identify the variables to
use as covariates in the third step multinomial logistic regression. A multinomial
regression tests the association between any set of categorical or continuous predictors
with a categorical outcome as:
,(0 = 1|U) =

1
1 + DVK()*+,)

(8)

where p has a categorical latent variable 0 with U as the covariate of interest (i.e.,
sex, age, race, education, annual household income, and level of satisfaction with social
activities and relationships). The intercept is denoted as W and the regression coefficient
is X. This approach was used in order for the latent class model and the latent class
predictor model to be obtained automatically142 rather than introducing potential bias by
performing a multinomial regression after the latent class models were selected.
Prediction Analysis. Cumulative receiver operator characteristic (ROC) curves
(developed from the cumRoc3 MACRO143) were used to: (1) estimate the ability of the
class membership probabilities created from the LCA to predict SUD severity; (2)
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estimate ability of the substance use variables, negative affect symptoms, and
externalizing symptoms to each separately predict SUD severity; and (3) compare the
predictive ability of the two approaches. This comparison was addressed in order to
determine if establishing latent class membership performed better compared to the use
of separate variables for predicting SUD severity.
The classic ROC curve is computed by comparing a binary outcome Y with a
continuous measure X where each observed level of X is evaluated as a candidate cut
point discriminating observed Y = 1 (positive) from Y = 2 (negative).143 Traditionally,
ROC curves have been used to establish the value of a diagnostic test measured as a
binary outcome. Results from a ROC curve analysis provides results that support in the
identification of the threshold that distinguishes a positive test from a negative test.144
The correct classifications among positive outcomes are the true positives (TP). The
correct classifications of the negative outcomes are the true negatives (TN). The
incorrect classifications among negative outcomes are the false positives and the
among the positive outcomes the false negatives. These classifications are used to
compute the sensitivity (i.e., probability that an observation with a positive outcome is
correctly classified as positive [sensitivity = TP/(TP + FN)]) and specificity (i.e.,
probability that an observation with a negative outcome is correctly classified as
negative [specificity = TN/(TN + FP)]) of a test. The coordinates of a ROC curve are
computed where the x-axis is the false positive rate (i.e., 1 – specificity) and the y-axis
is the sensitivity or true positive rate.143
A cumulative ROC curve analysis extends the classical empirical ROC curve by
discriminating three or more ordinal outcome levels on a shared continuous scale.143
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The cumulative ROC calculates the area under the curve (AUC) which explains the
ability of a continuous measurement to discriminate between ordinal outcome levels
(i.e., 3-level SUD severity outcome). In this case, the AUC is the probability that an
observation with a higher severity SUD outcome will have a higher continuous
measurement (i.e., higher class probability) than an observation with a lower severity
SUD outcome.143 An AUC of 0.5 represents no discriminating ability (i.e., no better than
chance) versus an AUC of 1.0 represents perfect discrimination between the groups.145
The probability of the SUD severity (P./0 ) for class membership (V% ) was
estimated as follows:

P./0 =

exp [X1 + X% V% ]
(1 + exp[X1 + X% V% ])

(9)

where X1 is the intercept, and X% is the estimated regression coefficient for the
probability of latent class membership (V% ).146
Predictive probabilities were generated from four ordinal logistic regression
models. The main model of interest estimated the probability of class membership
(generated from the LCA) and SUD severity. Three additional models were run using
predictive probabilities from regressing substance use variables, negative affect
symptoms, and externalizing symptoms separately on SUD severity.
Statistical Programs, Handling Missingness and Complex Sampling Design. Data
management, summary statistics, and the prediction analysis were performed in SAS
9.4. All LCA was conducted in MPlus.147 Participants with missing data were not
included in the latent class analysis (N = 2,109, missing data patterns = 256). Complex
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sampling design was accounted for in SAS 9.4 using PROC SURVEYFREQ (to
generate summary statistics) and PROC SURVEYLOGISTIC (to generate the predictive
probabilities from the logistic regression models), and in MPlus using the WEIGHT
option.

RESULTS
Summary statistics
The sample was 51.9% female and 66% Non-Hispanic White. Age was evenly
distributed among the sample. Most of the sample had at least a GED or high school
education (88.4%), had an annual household income of more than $25,000 (65.9%),
and were very (46.1%) or extremely (22.3%) satisfied with their social activities and
relationships. Current alcohol use was most frequently reported (52.4%), followed by
exclusive cigarette use (16.6%), marijuana use (7.1%) and PDNP (5.1%). Sleep trouble
was the most common past-month negative affect symptom reported (26.7%), followed
by feeling very anxious (16.1%), feeling depressed (13.4%), and becoming distressed
about the past (12.5%). The most frequently endorsed past-month externalizing
symptom was giving answers before the other person finished asking the question
(32.0%), followed by having a hard time paying attention (14.6%) and having a hard
time listening to instructions (10.4%). Most of the sample indicated low past month SUD
severity (63.2%, Table 3.2).
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Table 3.2: Wave 1 Summary Statistics
Wave 1
(N=32320)
N (Weighted %)
Sex
Male
Female
Age
18-24
25-34
35-44
45-54
55-64
65+
Race
Non-Hispanic White
Non-Hispanic Black
Non-Hispanic Other
Hispanic Multiracial
Education
Less than high school
GED/High school graduate
Some college (no degree)
Bachelor’s degree
Advanced degree
Annual household income
Less than $10,000
$10,000- $24,999
$25,000- $49,999
$50,000- $99,999
$100,000 or more
Satisfaction with social activities and relationships
Extremely satisfied
Very satisfied
Moderately satisfied
A little satisfied
Not at all satisfied
Past month tobacco and substance use
Exclusive CIG
Exclusive ECIG
Dual CIG + ECIG
Alcohol
Marijuana
PDNP
Past month negative affect symptoms
Depressed

16306 (48.1)
15980 (51.9)
9110 (13.0)
6337 (17.7)
4930 (16.5)
4846 (17.9)
3971 (16.6)
3110 (18.2)
19295 (66.0)
4496 (11.2)
2429 (7.5)
4817 (13.3)
4233 (11.6)
9765 (29.5)
11300 (31.0)
4498 (17.8)
2311 (10.1)
5668 (13.7)
6768 (20.4)
6670 (23.0)
6140 (24.9)
3914 (18.0)
6942 (22.3)
13742 (46.1)
8157 (23.7)
2376 (5.6)
1001 (2.3)
10381 (16.6)
578 (0.9)
996 (1.5)
17787 (52.4)
4392 (7.1)
1950 (5.1)
5692 (13.4)
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Sleeping
Anxious
Distressed/Past
Past month externalizing symptoms
Lied
Attention
Listening
Bully
Fights
Restless
Answered
Past month SUD severity
Low
Moderate
High

9564 (26.7)
6864 (16.1)
5605 (12.5)
3245 (7.1)
5831 (14.6)
4128 (10.4)
737 (1.7)
404 (0.7)
2953 (6.2)
11399 (32.0)
16481 (63.2)
8985 (31.7)
2156 (5.1)

Class membership and item-response probabilities
A four-class model was identified as best fitting the data and was selected to
conduct additional analyses (Table 3.3). Classes from the 4-class model were labeled
based on the highest conditional probabilities that characterized the class. The
characteristics and patterns for each class are detailed below. Figure 3.1 displays the
probability of being categorized within one of the four classes (i.e., the class
membership probabilities) given the specific patterns of past-month substance use and
endorsement of negative affect and externalizing symptoms in the past month (i.e., item
response probabilities or conditional probability).
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Table 3.3: Wave 1 LCA Model Fit and Parsimony
AIC

BIC

SampleSize
Adjusted
BIC

Entropy

Ho LL

LMRT

p-value

LC 1

LC 2

LC 3

LC 4

7339
24981
(22.7%)
(77.3%)
2637
7375
22308
3 class 307151.6
307596
307427.5
0.773
-155626
4184.516
<0.05
(8.2%)
(22.8%)
(69.0%)
1960
2691
23571
4098
4 class 303521.4 304116.6
303891
0.844
-153520
3640.512
<0.05
(6.1%)
(8.3%)
(72.9%)
(12.7%)
1854
3800
2594
5497
5 class 302018.6 302764.7
302481.9
0.695
-151679
1508.737
0.6834
(5.7%)
(11.8%)
(8.0%)
(17.0%)
734
1383
5385
2500
6 class 301484.8 302381.8
302041.7
0.718
-150917
559.354
0.7626
(2.3%)
(4.3%)
(16.7%)
(7.7%)
NOTE: AIC = Akaike information criteria, BIC = Bayesian information criteria, LL = log likelihood, LMRT = Lo Mendell Rubin Test, LC = latent class
2 class

311322.5

311616

311504.7

0.864

-176279

41085.86

LC 5

LC 6

18575
(57.5%)
3658
(11.3%)

18659
(57.7%)

<0.05
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Low-Symptom Class. Most participants were categorized as being in the low
symptom class (N=23,571, 72.9%). This class, overall, had lower conditional
probabilities for endorsing all items compared to the other classes. Consequently,
participants in this class had a low probability of endorsing most substance use and
negative affect/externalizing items. However, the conditional probability of exclusive
cigarette use was marginally higher for the low symptom class compared to the
externalizing class (13.6% vs. 12.9%) meaning that a person in the low symptom class
had a 13.6% probability for endorsing exclusive cigarette use in the past month.
Negative Affect Class. The negative affect class (N=4,098, 12.7%) had higher
conditional probabilities for the four negative affect symptoms compared to the low
symptom class, and externalizing class. A person was more likely to endorse exclusive
CIG, dual CIG and ECIG, marijuana, and PDNP use if they were in the negative affect
class compared to the low symptom, and externalizing classes. This class represents a
population of people who more commonly endorse the four negative affect symptoms
along with past-month substance use, excluding ECIG.
Externalizing Class. The externalizing class (N=2,691, 8.3%) had higher
conditional probabilities for all seven externalizing symptoms compared to low
symptom, and negative affect classes except for the “start physical fights with other
people” (Externalizing class = 0.7%, Negative Affect class = 2.00%). The conditional
probability for exclusive ECIG and alcohol use was greater for those in the externalizing
class compared to the low symptom, and negative affect classes. Therefore, this class
represents adults who experience higher levels of externalizing symptoms along with
exclusive ECIG and alcohol use.
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Comorbid Class. Approximately 6% of participants were categorized as being in
the comorbid class (N=1,960, 6.1%). Compared to the other classes, this class had
higher conditional probabilities for all items except for alcohol use (Comorbid class =
57.8%, Externalizing class = 64.4%). This class represents a small population of people
who, overall, have high endorsement of all seventeen items and, therefore, may indicate
more severe presentation of substance use and mental disorder symptom severity.

WAVE 1 - 4 CLASS SOLUTION
Comorbid N=1960 (6.1%)

Externalizing N=2691 (8.3%)

Low Symptom N=23571 (72.9%)

Negative Affect N=4098 (12.7%)
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Figure 3.1: Four class solution of substance use behaviors and mental disorder
symptoms.
Associations between Sociodemographic Factors and Substance Use/Mental Disorder
Classes
Males were significantly less likely than females to be classified in the comorbid
(OR = 0.72, 95% CI = 0.63-0.82, p < 0.05) and negative affect (OR = 0.74, 95% CI =
0.66-0.83, p < 0.05) classes relative to the low symptom class (Table 3.4).
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As age increased, the odds of class membership decreased for all classes
relative to the low symptom class. Therefore, the youngest age group (18-24 years) had
the highest odds of class membership compared to the oldest age group (65 years and
older), relative to the low symptom class (Comorbid Class OR = 10.02, 95% CI = 7.0614.24, p < 0.05; Negative Affect Class OR = 3.88, 95% CI = 3.11-4.83, p < 0.05;
Externalizing Class OR = 3.39, 95% CI = 2.69-4.28, p < 0.05). Respondents who
identified as Non-Hispanic Black, Hispanic Multicultural, and Non-Hispanic Other were
significantly less likely than respondents who identified as Non-Hispanic White to be
classified in any of the classes relative to the low symptom class.
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Table 3.4 Wave 1 - Association Between Demographic and Social Variables with Probability
of Latent Class Membership
Comorbid Class
OR (95% CI)

Negative Affect
OR (95% CI)

Sex
Female
REF
REF
Male
0.72 (0.63-0.82)*
0.74 (0.66-0.83)*
Age
18-24 years
10.02 (7.06-14.24)*
3.88 (3.11-4.83)*
25-34 years
6.00 (4.17-8.64)*
2.39 (1.90-3.01)*
35-44 years
4.10 (2.83-5.94)*
1.69 (1.32-2.16)*
45-54 years
3.77 (2.60-5.47)*
1.52 (1.19-1.93)*
55-64 years
2.27 (1.54-3.36)*
1.44 (1.12-1.85)*
65 years and older
REF
REF
Race
Non-Hispanic White
REF
REF
Non-Hispanic Black
0.48 (0.40-0.59)*
0.76 (0.64-0.89)*
Non-Hispanic Other
0.73 (0.57-0.94)*
0.72 (0.56-0.91)*
Hispanic Multiracial
0.50 (0.41-0.61)*
0.78 (0.66-0.93)*
Education
Less than high school
1.53 (1.05-2.21)*
1.62 (1.22-2.15)*
GED/High school graduate
1.37 (0.98-1.92)
1.42 (1.10-1.83)*
Some college (no degree)
1.79 (1.29-2.47)*
1.36 (1.06-1.75)*
Bachelor’s degree
1.35 (0.94-1.93)
1.16 (0.88-1.53)
Advanced degree
REF
REF
Income
Less than $10,000
2.54 (2.03-3.18)*
1.61 (1.32-1.95)*
$10,000- $24,999
2.02 (1.62-2.51)*
1.51 (1.25-1.83)*
$25,000- $49,999
1.45 (1.16-1.81)*
1.11 (0.92-1.33)
$50,000- $99,999
1.00 (0.78-1.27)
0.99 (0.82-1.20)
$100,000 or more
REF
REF
Level of satisfaction with social activities and relationships
Extremely Satisfied
REF
REF
Very satisfied
1.65 (1.31-2.07)*
1.55 (1.31-1.85)*
Moderately satisfied
8.15 (6.54-10.15)*
4.53 (3.78-5.43)*
A little satisfied
34.19 (26.40-44.29)*
11.09 (8.70-14.14)*
Not at all satisfied
95.87 (66.32-138.58)* 22.62 (15.44-33.16)*
Note: Low symptom class was the reference level for the outcome.
* Indicates a p-value < 0.05

Externalizing
OR (95% CI)
REF
1.00 (0.87-1.14)
3.39 (2.69-4.28)*
1.81 (1.40-2.33)*
1.46 (1.11-1.91)*
1.13 (0.86-1.50)
0.98 (0.73-1.32)
REF
REF
0.62 (0.51-0.77)*
0.69 (0.53-0.89)*
0.65 (0.52-0.80)*
0.79 (0.57-1.09)
0.80 (0.61-1.05)
1.08 (0.85-1.37)
1.10 (0.85-1.42)
REF
0.83 (0.65-1.06)
0.55 (0.44-0.68)
0.84 (0.68-1.04)
1.21 (1.00-1.46)*
REF
REF
1.42 (1.18-1.70)*
2.66 (2.18-3.26)*
3.08 (2.17-4.39)*
3.67 (1.62-8.31)*

Compared to those with an advanced degree, participants with lower education
levels were significantly more likely to be in the comorbid (Less than High School OR =
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1.53; Some College/No Degree OR = 1.79) and negative affect (Less than High School
OR = 1.62; GED/High School Graduate OR = 1.42; Some College/No Degree OR =
1.36) classes relative to the low symptom class. The associations between education
level and the externalizing class were not statistically significant. Compared to an
income of $100,000 or more, those with annual household incomes of $99,999 and
below were significantly more likely to be in the comorbid (Less than $10,000 OR =
2.54; $10,000-$24,999 OR = 2.02; $25,000-$49,999 OR = 1.45) and negative affect
(Less than $10,000 OR = 1.61; $10,000-$24,999 OR = 1.51) classes, compared to the
low symptom class (Table 3.4).
A reduction in social satisfaction was associated with membership in comorbid,
negative affect, and externalizing classes. For example, compared to being extremely
satisfied, as social satisfaction decreased, the likelihood of being in the comorbid class
increased (Not at all satisfied OR = 95.87, 95% CI = 66.32-138.58, p < 0.05). Similarly,
compared to participants who were extremely satisfied, participants who were not at all
satisfied were about 23 times more likely to be categorized in the negative affect class
(OR = 22.62, 95% CI = 15.44-33.16, p < 0.05) and almost four time more likely to be in
the externalizing class (OR = 3.67, 95% CI = 1.62-8.31, p = 0.002). This relationship
was not detected for the alcohol class.
Prediction modeling
Data generated from the LCA model (i.e., class membership and probability of
class membership) were exported from Mplus and imported into SAS to determine the
predictive ability of the latent class on SUD severity. Class membership significantly
predicted SUD severity (Table 3.5).
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Table 3.5: Prediction of the probability of class membership and SUD severity
SUD Severity
Latent Class
Odds Ratio (95% Confidence Interval)
Low Symptom Class
REF
Comorbid Class
2.31 (2.07-2.59)*
Externalizing Class
1.54 (1.38-1.72)*
Negative Affect Class
1.51 (1.38-1.65)*
* Indicates a p-value < 0.0001.
Relative to the low symptom class, membership in the comorbid class increased
the odds of SUD severity by 2.31 times (OR = 2.31, 95% CI = 2.07-2.59, p < 0.0001).
The externalizing and negative affect classes had similar relationships with SUD
severity (Externalizing OR = 1.54, 95% CI = 1.38-1.72, p < 0.0001; Negative Affect OR
= 1.51, 95% CI = 1.38-1.65, p < 0.0001). These estimates were unadjusted since the
sociodemographic covariates were accounted for in the development of the latent
classes.

AREA UNDER THE CURVE COMPARISONS
SUD 0 vs 1,2

SUD 0,1 vs 2

0.7
0.65
0.6
0.55
0.5
0.45
0.4

Negative Affect

Externalizing

Substance Use

Class Membership

SUD 0 vs 1,2

0.5063

0.5224

0.5725

0.5093

SUD 0,1 vs 2

0.5132

0.4744

0.6479

0.5142

Figure 3.2: Area under the curve comparisons generated from the cumulative ROC
Curves
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Cumulative ROC curves (see Appendix B, Supplemental Figures 3.1-3.8) were
generated to determine if latent class membership (combining substance use behaviors,
negative affect, and externalizing symptoms) was a better predictor of specific levels of
SUD severity compared to any of the indicators that make up the latent class
separately. Past-month substance use behaviors best predicted SUD severity. For
example, the area under the curve (AUC; i.e., the degree of separability) for past-month
substance use to predict low SUD severity versus moderate/high SUD severity was
0.57 (Figure 3.2). This means that the substance use variables would only be correct in
predicting SUD severity about 57% of the time. Further, the AUC improved when
predicting low/moderate SUD severity versus high SUD severity (AUC = 0.6479).
Therefore, at this threshold (low/moderate vs high SUD severity), the predictive ability
increased from 57% to 65%. The ability of the latent class to predict SUD severity was
marginally better than the negative affect and externalizing indicators for the
low/moderate versus high SUD severity (Class Membership AUC = 0.51; Negative
Affect AUC = 0.51; Externalizing AUC = 0.47). Therefore, substance use behaviors
measured alone performed better at predicting SUD severity compared to comorbid
substance use as reflected in comorbid latent class membership.
Overall, AUCs ranged from 0.47 (low/moderate SUD severity vs high SUD
severity level for externalizing) to 0.65 (low/moderate SUD severity vs high SUD
severity for substance use behaviors) meaning that predictions of SUD severity were
only correct about 47-65% of the time.
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DISCUSSION
To our knowledge, this is one of the first studies to use a latent class approach to
describe comorbidity between substance use behaviors and mental disorder symptoms
together in a large nationally representative sample of U.S. adults. This study also used
information from the latent class analysis to predict a health outcome, SUD severity.
There are three major results from this study. First, a four-class solution (i.e., low
symptom class, negative affect class, externalizing class, and comorbid class) best
described the data. These classes also allowed us to understand what symptoms and
substance use behaviors commonly occur together in this sample, confirming our
hypothesis that substance use would vary across mental disorder symptoms. For
example, exclusive cigarette, dual cigarette and e-cigarette, marijuana, and PDNP use
more commonly occurred in the negative affect class while exclusive e-cigarette and
alcohol use more commonly occurred with the externalizing class. Second,
sociodemographic factors were significantly associated with latent class membership
and social satisfaction was a strong factor associated with the comorbid and negative
affect classes. Third, latent class membership predicting SUD severity performed
similarly to a model where the symptoms were grouped separately (i.e., negative affect
symptoms, externalizing symptoms, and substance use behaviors).

Class prevalences and underestimation
The four-class solution was determined to best fit the data for this sample. This is
consistent with prior latent class results that have identified a four-class solution to be
most optimal. Salom et al. identified a four-class solution of comorbid polysubstance
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use and mental health disorders in young adults: low disorder (73.6%); mental health
and low SUD (10.6%); alcohol, cannabis, and low mental health disorder (12.2%); and
polysubstance use and moderate mental health disorder (3.5%).12 Other studies have
also found that four-class solutions are most optimal in their samples with the low
psychopathology class being the largest group (62.5% to 84.0%) followed by an
internalizing or negative affect class with some substance use endorsement (i.e.,
alcohol use disorder), an externalizing class with high endorsement of substance use
problems (i.e., nicotine dependence, alcohol use disorder, and drug use disorder), and
a comorbid or both internalizing or negative affect/externalizing with high endorsement
of substance use problems class as the smallest group (1.1% to 4.2%).41,124 Therefore,
our results confirm and support a four-class solution to best explain substance use and
mental disorder comorbidity in U.S. adults.
Similar to other latent class findings, the low symptom class was most common
in this sample (72.3%, N=23,571). This suggests that most American adults may
engage in some substance use (i.e., current CIG or alcohol use) while also experiencing
some mental disorder symptoms, specifically impulsivity or sleep problems, but
otherwise have low endorsement of other substance use behaviors and mental disorder
symptoms. Almost thirty percent (27.7%) of the sample, however, were categorized in
the other three remaining classes based on higher probabilities of endorsing substance
use or mental disorder symptom items. These people have the potential to be
underestimated or not accounted for based on the current classification systems due to
their subthreshold levels of possible impairment. This presents a missed opportunity to
identify the comorbid substance use and mental disorder symptoms, and potentially
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prevent the comorbidity from becoming progressively worse. Therefore, this part of the
population could benefit from refined detection and possible intervention (e.g., access to
support or educational materials). Early detection could result in better intervention
outcomes and better overall mental health outcomes.

Patterns of substance use varies by negative affect and externalizing classes
Exclusive cigarette, dual cigarette and e-cigarette, marijuana, and PDNP use had
higher endorsement in the negative affect class. In comparison, exclusive e-cigarette
and alcohol use had higher endorsement in the externalizing class. These patterns may
be helpful in identifying people at risk for development of more severe comorbidity in
public health spaces. The implications of these results are considered below.
Negative affect class
Previous work reports that people who engage in conventional cigarette use are
at an increased risk of negative affect disorders like depression and anxiety.90,92 The
relationship between negative affect symptoms and dual cigarette and e-cigarette use is
not as well understood. Our prior analysis (see Chapter 2) showed that the combined
use of alcohol, cigarette and e-cigarette was significantly associated with high negative
affect severity while dual cigarette and e-cigarette use was not significantly associated
with any level of negative affect severity after adjusting for demographic covariates.148
The LCA results add to our understanding of psychopathology, confirming the
association between dual cigarette and e-cigarette use with negative affect symptoms,
especially as this dual use is currently increasing in adults, specifically young adults.83
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There was higher endorsement for past-month marijuana use in the negative
affect class compared to the externalizing class. There is a vast literature demonstrating
the association between marijuana use and negative affect symptoms such as anxiety
and depression.149–152 Additionally, marijuana use has been increasing at a greater rate
in women, who are more likely to endorse negative affect symptoms, compared to men
over the last decade (40% increase for men, 53% increase for women from 2006 to
2016).153 Therefore, the reason there is greater endorsement of marijuana in the
negative affect versus the externalizing class may be because women are more likely to
make up the negative affect class.
The finding of high endorsement of PDNP in the negative affect class is
consistent with the literature. Evidence suggests that opioid use, a substance measured
within PDNP, is associated with PTSD symptoms.154 Other studies have also identified
that people in SUD treatment for nonmedical use of prescription painkillers like opioids,
almost half (43%) have a diagnosis or symptoms of anxiety and depression.155
Externalizing class
The item response probability for exclusive e-cigarette use was higher for the
externalizing class compared to the low symptom and negative affect classes. This is
not supported by our prior analysis (see Chapter 2) where exclusive e-cigarette use was
not significantly associated with negative affect or externalizing severity using a
multinomial logistic regression.148 However, e-cigarette and alcohol use together were
significantly associated with externalizing severity.148 Given that alcohol use is widely
accepted to be associated with externalizing behaviors,38,117,118 we hypothesized that
the alcohol use may drive the relationship between e-cigarette and externalizing
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severity when alcohol was used with e-cigarettes (i.e., dual use). Nevertheless, the
results from this LCA study support that exclusive e-cigarette use may be more related
to externalizing symptoms than negative affect. As e-cigarettes continue to increase in
use,125 it is important to understand how this electronic nicotine delivery system differs
from conventional cigarette use. Some studies have identified similarities in that both
deliver nicotine and result in poor health outcomes specifically related to the lungs.125
However, regarding comorbidity with mental disorder symptoms, e-cigarettes may
present differently than conventional cigarettes. Alcohol use was also endorsed at a
greater probability in the externalizing class compared to the negative affect and low
symptom classes. This is consistent with prior studies that suggest that alcohol use
contributes to a latent factor of externalizing behaviors.38,117,118

Sociodemographic characteristics and latent class membership
As age increased, the odds of class membership decreased. This is consistent
with previous work, where younger people are at greater risk for mental health and
substance use problems compared to people in older age categories.41 This could
indicate an increase in substance use initiation which is typical in younger age
categories.156 This also matches with the age of onset for most mental disorders as
roughly 50% to 75% of all lifetime mental disorders start by the mid-teens and mid-20s,
respectively.2 Therefore, broad prevention strategies that address all latent class
profiles could be helpful in supporting younger people with comorbidity.
Compared to Non-Hispanic White participants, those in all other race categories
were less likely to be in any of the latent classes. Another study has also identified the
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association between race and comorbidity, whereas those who identify as Non-Hispanic
White are at increased risk of latent class membership compared to individuals in other
racial/ethnic groups, specifically Non-Hispanic Black and Hispanic Other.41 There are
many potential reasons why this occurs. First, Non-Hispanic White populations are
overrepresented in psychopathology and comorbidity research.123 It is also likely that
diagnoses of comorbidity are optimized for the Non-Hispanic White population rather
than across all groups. Therefore, it has been more difficult to draw associations with
other racial/ethnic groups. Second, due to the historical distrust in the U.S. healthcare
system, people of other racial/ethnic groups may be less likely to participate in research
and indicate that they participate in substance use behaviors or experience mental
disorder symptoms.157 However, a likely conclusion that is not an artifact of study
sampling or potential misclassification could be the strong levels of resiliency in other
racial/ethnic groups, specifically seen in African Americans or those who identify as
Black.158 This is known as the black-white mental health paradox and explains that
Black Americans tend to experience similar or relatively low rates of psychiatric
disorders compared to Whites despite higher stress exposure, greater material
hardship, and worse physical health.158 While it is important to support those who
identify as Non-Hispanic White, it remains important to continue being inclusive of all
racial/ethnic categories in comorbidity research to develop more consistent results and
provide the appropriate level of support and targeted prevention efforts.
Women had higher odds of membership in the comorbid and negative affect
classes. This is consistent with previous LCA work that has shown that women are
more likely to be in a comorbid or internalizing/negative affect class.12,41,124 Men,
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however, were not significantly associated with membership in the externalizing class.
Men typically have higher rates of alcohol use and endorse more externalizing
symptoms and disorders. This may due to the robust set of other items included in the
generation of the latent classes.
Compared to those at higher levels of socioeconomic status, people at lower
levels of socioeconomic status had a greater risk of membership in the comorbid and
negative affect classes. This is consistent with previous studies. For example, a
longitudinal study of 34,653 noninstitutionalized U.S. adults identified that low levels of
household income were associated with several lifetime mental disorders and a
reduction in household income was associated with increased risk of incident mood,
anxiety or substance use disorders compared to respondents with no change in
income.159 Additionally, prior work has identified that higher income and education
levels represent a protective relationship from membership in internalizing or negative
affect, externalizing, and high psychopathology classes.41
The magnitudes of the association between social satisfaction and the comorbid
as well as negative affect classes were very large. Social satisfaction was also
associated with the externalizing class. Those who were less satisfied with their social
lives had greater odds of externalizing class membership. Although not incredibly
precise, the association between social satisfaction and class membership may be a
place to intervene, as social satisfaction is (1) a more easily modifiable factor compared
to other demographic characteristics and (2) demonstrates a protective association. For
example, as people became less satisfied with their social activities and relationships,
their odds of membership in the comorbid, negative affect, or externalizing classes
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significantly increased. Therefore, if social satisfaction can improve (i.e., becoming more
content with one’s activities and relationships with the support of a psychological
therapist or counselor), there could be a decrease in the risk of belonging to the
comorbid, negative affect, or externalizing classes. This buffering effect through social
support has been demonstrated previously160 and could be an opportunity to intervene
or prevent further development of comorbid or negative affect psychopathology.

Limited ability to predict SUD severity
The comorbid class had the strongest association with SUD severity when
predicting SUD severity using class membership in a multinomial logistic regression.
The comorbid class had greater endorsement of past month substance use behaviors,
except for alcohol use, and mental disorder symptoms compared to the other classes.
This finding indicates that people with endorsement of more items at greater rates are
associated with greater SUD severity. Therefore, we assumed that by grouping
symptoms together and describing them as they occur using a latent modeling
approach, we would be better able to predict health outcomes than assessing these
symptoms separately. However, the cumulative ROC analyses showed that the ability of
latent class membership to predict SUD severity was no better than the symptoms
grouped separately (i.e., negative affect symptoms, externalizing symptoms, and
substance use behaviors). Further, predictions of SUD severity were only correct about
47-65% of the time.
The poor ability of latent class membership to predict SUD severity may be due
to the incongruency between measurement tool used and population assessed. The
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outcome measure, SUD severity, was created to approximate SUD diagnosis. This tool
was originally validated in populations which were oversampled with SUD in order to
appropriately distinguish between SUD and no SUD.28 Therefore, the tool used to
measure SUD may not perform as well in a sample of people who experience
subthreshold levels of SUD or other mental disorders. Classes generated from other
methods like factor mixture modeling131 that can account for heterogeneous groups (i.e.,
SUD and no SUD) may be better in predicting SUD severity. Another reason could be
due to misclassification bias introduced by the measurement used for negative affect
and externalizing symptoms, and SUD severity. We could be misclassifying individuals
by collapsing 2 to 12 months, over a year ago, and never into one reference category to
compare to the past-month endorsement. Additionally, the negative affect and
externalizing symptoms were correlated, which may also affect the ability of either items
to predict SUD severity. Future studies should consider using a factor mixture modeling
approach to determine comorbidity’s predictive ability of SUD severity. Until then, it may
be that disorders do better at predicting SUD severity compared to subthreshold or
symptom-level measures.

Strengths and limitations
There are several strengths and limitations to this study. First, this study used
data from a large, nationally representative sample of U.S. adults allowing for the
generalizability of these results to the adult, noninstitutionalized population in the U.S.
However, participants included in this study differed significantly from participants with
missing data as those included had greater endorsement of substance use, negative
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affect symptoms, and externalizing symptoms. Therefore, these participants may not
represent the U.S. adult population. Additionally, these data are cross-sectional and this
study cannot resolve causal inference. As more waves of data are collected, we will be
able to assess the stability of this class structure along with changes in class
membership using longitudinal methods (e.g., latent transition analysis) especially
considering the more recent changes in substance use over time (e.g., the increase in
e-cigarette and marijuana use).
Second, the substance use and mental disorder symptoms measure comorbidity
within the same time frame (i.e., past month endorsement of substance use as well as
the negative affect-externalizing symptoms and SUD severity). There is potential
misclassification due to how the measure was developed by collapsing the 2 to 12
months, over a year ago, and never response options into one group (coded as 0 vs
past-month coded as 1). People who endorsed a symptom in the last 2 to 12 months or
over a year ago differ from people who never endorsed a symptom. Future work could
consider (1) developing a three-level categorical variable that separates those who
never endorsed a symptom from those who endorsed a symptom in the last 2 to 12
months and over a year ago to compare with the past-month level, or (2) maintain the
original four levels of the item to avoid losing information through dichotomizing or recategorizing the variables. Our binary measurement, however, allowed us to model
current comorbid polysubstance use and negative affect and externalizing symptoms
while also predicting SUD severity within the same time period. Additionally, by using
symptom measures, we accommodate and provide a better understanding of
comorbidity compared to a diagnostic classification system.117 Additionally, it is
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important to note that although the cut points for SUD severity have acceptable
reliability, validity, and overlap with DSM-5 SUD criterion in this sample, we may not be
appropriately treating these variances as a continuous probability. Future research is
encouraged to evaluate the SUD severity items and consider measurement techniques
such as the use of quantiles161 to confirm that the categorization of the SUD severity
variable is appropriate for the population being studied (i.e., based on the distribution of
population’s responses).
Third, the assessment of factors associated with class membership is limited to
the demographic and social factors included in this study. There could be other factors
associated with comorbidity that were not included and could result in residual
confounding. Future work should investigate the association of other environmental
factors on class membership to better understand the influence of additional social
determinants of health on comorbidity.
Fourth, we ran an ordinal regression model for the prediction analysis. However,
the model violated the proportional odds assumption (chi-square = 439.2, p-value <
0.0001). This means that the relationship between any two pairs of the outcome groups
(i.e., low vs moderate/high SUD severity and low/moderate vs high SUD severity) was
not statistically the same. We also ran a multinomial regression model because of the
assumption violation. However, results from a multinomial regression were consistent
with the ordinal regression results and, therefore, we presented the ordinal regression
results in order to be synonymous with results presented from the cumulative ROC
curves. Nevertheless, predicting SUD severity is a strength. It is an extension to the
primarily descriptive ability of using an LCA. Further, by utilizing the ROC curves, we
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were able to identify the ability of latent class membership to predict SUD severity and
compare that to the substance use behaviors and mental disorder symptoms
separately.
Fifth, a LCA model was used to assign participants into comorbidity classes
using their responses to self-report measures of substance use, negative affect, and
externalizing symptoms. This approach is considered to be important to discover
classes based on observed data and characterize participants based on latent class
membership. LCA was selected to compare results with previous studies that assessed
for comorbidity and be used in clinical and research settings specifically for risk
assessment and treatment.41 Further, the interpretability of LCA results (i.e.,
classifications and assigning individuals to groups based on their item endorsement)
can be easily translated for use in clinical settings by identifying individuals at potential
risk for increased comorbidity severity based on their current substance use and mental
disorder symptoms. It is possible that messaging could be developed based on the
latent classes identified in this study. Results could be shared with policy makers so
they may allocate more resources toward developing comorbid support in clinical
spaces.
Nevertheless, there are several limitations related to the use of the LCA model.
Specifically, by using categorical data to assign individuals into discrete classes, there
may be a loss of information that would emerge from a model that accounts for a
continuous distribution. For example, we observed parallel trends of the item response
probabilities across the classes. This observation suggests that there could be a
continuous distribution to these data and that a dimensional presentation, rather than
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discrete, may be more appropriate in characterizing the comorbidity within the
population. Therefore, the discrete latent classes generated from the LCA may not
represent the actual types of individuals in the population.162 Additionally, the conditional
independence assumption of the LCA model can also be seen as a limitation.
Conditional independence simplifies the presentation of underlying classes in a
population based on consistent patterns in the data (i.e., item response probabilities) yet
it may be an over-simplification or biased representation of the true heterogeneity in the
population.163 It may not be true that the latent class fully explains the relationship
between the observed variables. A possible solution to address both major LCA
limitations is the use of a factor mixture model. The factor mixture model uses a hybrid
of latent class and factor analysis where the latent variable allows for the classification
of individuals into groups while the factor models the heterogeneity of the disorder
within the latent class, relaxing the conditional independence assumption.131 This is
useful because comorbidity class membership and the range of severity within and
across classes can be modeled concurrently.164 A factor mixture model estimates a
factor score for each individual which quantifies the heterogeneity within a class;
however, there is no model-based classification of individuals because individuals are
assumed to be from the same homogeneous population.164 Network analysis can also
assess comorbidity structure without the assumption of conditional independence, and
is an approach used in Chapter 4.
Sixth, we could not use the bootstrap likelihood ratio test as an additional
examination of model fit when accounting for complex sampling design during the LCA.
LCA includes a bootstrap likelihood ratio test to test for model fit across models with
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various classes. However, it could not be performed when using weighted data to
account for complex sampling design. Consequently, we relied on the Lo-Mendell-Rubin
adjusted likelihood ratio test along with other parsimony metrics to decide on the optimal
class solution. This is considered a promising and appropriate approach when
determining the number of classes from an LCA model.165
Seventh, this is a sample of mainly healthy people and as such, the
dimensionality of comorbidity may be different here compared to a sample of people
diagnosed with psychiatric conditions (e.g., those who are institutionalized). This
approach should be replicated in other samples to confirm or refute the dimensionality
of comorbidity. Nevertheless, the results from this sample detail the patterns of mental
disorder symptoms and substance use behaviors in a broader population in order to
appropriately characterize comorbidity at a population level. This is important because
substance use and/or mental disorder symptoms that do not result in a diagnosis
remain pervasive throughout American society.8 Undiagnosed individuals may go
untreated and untreated mental illness, including SUD, represents $300 billion due to
losses in productivity annually.166 Therefore, it is important to identify and detail patterns
of substance use and mental health outcomes throughout the full population in addition
to those at highest risk for disorders or those who are affected.117131

Conclusions
In a nationally representative sample of U.S. adults, four latent classes were
most optimal at describing mental disorder symptom and substance use comorbidity.
Negative affect symptoms were commonly seen with exclusive CIG use, dual CIG and
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EIG use, marijuana, and PDNP use. Externalizing symptoms were commonly seen with
exclusive ECIG use and alcohol. Social satisfaction may be an important factor to
consider when intervening on comorbidity. Comorbidity of latent class membership was
similar to negative affect, externalizing, and substance use behaviors, separately, in
predicting SUD severity. This may suggest that network psychometrics may be a better
approach to understanding the predictive ability of comorbidity for other health
outcomes. Future research may benefit from using a network approach to better
understand comorbidity.
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CHAPTER 4: A NETWORK APPROACH TO SUBSTANCE USE, NEGATIVE
AFFECT, AND EXTERNALIZING COMORBIDITY IN U.S. ADULTS2

INTRODUCTION
Substance use (e.g., tobacco, alcohol, marijuana, and sedatives [i.e.,
benzodiazepines and barbiturates]) commonly co-occurs with negative affect disorders
(i.e., behavioral problems that manifest and are maintained within the individual167) such
as depression and anxiety, and externalizing disorders (i.e., behavioral problems that
manifest as negative outward behavior acting on the external environment168) like
attention-deficit hyperactivity disorder (ADHD). These comorbidities are summarized in
Table 4.1.11,89,91,149–152,169–183
Many of the most consistent results regarding comorbidity have focused mainly
on disorder, as seen in Table 4.1. However, other papers have used different substance
use measures (e.g., initiation, recency of use, quantity of use) and they too have seen
comorbidity with mental disorders and mental disorder symptoms.151,152,169,178,179,181
Given the consistency of results in disorder and other use measures, it is worth the
effort to focus on lower levels of symptomatology and explore the etiology of
comorbidity below the diagnostic threshold.

2

A modified version of this chapter was submitted for publication to Addictive Behaviors, Special Issue on
Networks, Complexity and Addictive Behaviors.
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Table 4.1: Summary of Previously Reported Comorbidity by Substance
Substance
Co-Occurring Substance use
Comorbid Mental Health
Use Disorder
Alcohol
Major depressive disorder
Tobacco
Marijuana
Generalized anxiety disorder
ADHD
Marijuana
Anxiety disorders
Opioids
Depressive disorders
Alcohol
ADHD
Conduct disorder
Alcohol use disorder
Depression
Marijuana
Tobacco use disorder
Anxiety
Substance use disorders
Conduct disorder
Tobacco use disorder
Depressive disorders
Alcohol use disorder
Anxiety disorders
Sedatives
Opioids
General illicit drug use
Tobacco
Depression
Alcohol
Anxiety
Opioids
Marijuana
PTSD
Sedatives
Conduct disorder
To date, it is unclear whether the same patterns of comorbidity identified with
substances such as conventional cigarettes (CIG), alcohol, and marijuana extend to
relatively new products including electronic cigarettes (ECIG) and use of prescription
drugs in a manner not previously prescribed (e.g., sedatives, tranquilizers, and
painkillers) which have increased in popularity over the past several years. For
example, the prevalence of ECIG use has increased from 2.4% in 2012 to 7.6% in
2018.125 Further, the patterns of some substance use in ECIG users have been reported
to be similar to that of CIG users. Specifically, ECIG use frequently occurs with alcohol
use and other substances.87,94,95,97 Similar to ECIG, the prevalence of PDNP (i.e.,
prescription drug use not prescribed, nonmedical use of a prescription drug including
recreational use) has also been increasing for the last fifteen years with overdose
deaths involving prescription opioids being four times greater in 2018 than in 1999.184
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People with SUDs and mental disorders are at a higher risk for nonmedical use of
prescription opioids.185 Of those in SUD treatment for nonmedical use of prescription
painkillers, almost half (43%) have a diagnosis or symptoms of anxiety and
depression.155 Additionally, opioids and sedatives are sometimes combined for
recreational use, resulting in a higher risk for comorbid mental conditions as well as
nonfatal and fatal overdoses.186,187 Therefore, as the prevalence of these substances
increase there has also been increasing evidence for their comorbidity with negative
affect/externalizing behaviors and other substances.

Patterns of mental health comorbidity focus on diagnoses rather than symptoms
Most research on the patterns of comorbidity between substance use,
externalizing, and negative affect behaviors has focused on diagnoses of disorders
rather than the symptoms underlying these diagnoses.22,39 However, this approach
neglects the inclusion of people who experience subthreshold levels of impairment and
results in a potential loss of information when summing symptoms to reach diagnosis.33
Most substance-related health and social problems occur among individuals who are
not addicted or have a SUD diagnosis.8 Additionally, many of these symptoms cross
over diagnostic boundaries.33,188 Consequently, there is a substantial gap in
understanding the overlap between substance use and mental disorder symptoms. By
using another measure like past-month substance use, it is possible to capture people
who use substances with and without a diagnosis of a SUD, allowing for a more robust
assessment of comorbidity patterns and accounting for overlaps between substance
use behaviors and mental disorder symptoms. If the focus were to remain solely on
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diagnosis, there would be no evidence to support people who experience subthreshold
use and comorbid mental disorder symptoms. Therefore, past-month substance use
offers an opportunity to study a larger population of people who use substances (i.e.,
those with and without disorder) as well as identify and intervene at the subthreshold
level to better support individuals experiencing comorbid substance use.

Gender differences in the comorbidity of substance use and mental health
Much of the substance use and SUD research has largely been conducted in
men. However, the prevalence of substance use in the U.S. has been increasing in
women.123 Further, negative affect/externalizing symptoms present differently in men
and women.2,123 For example, men are more likely to experience externalizing
disorders, while women are more likely to report negative affect disorders.123,183,189,190
Furthermore, comorbid psychiatric conditions occur more frequently in women with
SUDs compared to men.190,191 Consequently, the comorbidity between substance use
and psychopathology may also vary by gender.

Study goals and hypotheses
Network analyses of substance use or SUDs have yet to account for comorbid
mental disorders.34,192 Therefore, the primary goal of this study is to detail a network
system of past-month substance use as well as a wide range of negative
affect/externalizing symptoms, and quantify how well a given node can be predicted by
all other nodes it is connected to in the network using nodewise predictability. A
secondary goal of this study is to determine whether there are gender differences in the
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comorbidity network structure. Based on prior literature, we hypothesize that tobacco,
alcohol, marijuana, and PDNP will connect with negative affect, specifically depression
and anxiety symptoms, and tobacco, alcohol, and marijuana will connect with
externalizing symptoms, specifically impulsivity and conduct disorder symptoms. We
also expect differences in network structure by gender, with men experiencing greater
connection between substance use and externalizing symptoms and women with
greater connection between substance use and negative affect symptoms.

METHODS
Setting
Wave 1 adult data (N=32,320) from the Population Assessment of Tobacco and
Health (PATH) study were used.71 These data are cross-sectional and were collected
between September 2013 and December 2014. PATH is a nationally representative
longitudinal cohort study of the civilian, non-institutionalized household population of the
U.S., and participants engaged in all levels of tobacco use ranging from never using
tobacco to frequent use.
The weighted response rate among participants was 74.0% for Wave 1.73
Participants responded to tobacco-specific items including tobacco-use patterns, risk
perceptions and attitudes towards current and newly emerging tobacco products,
tobacco initiation, cessation, relapse behaviors, and health outcomes.72 Participants
also responded to non-tobacco items (e.g., media use, peer and family influences,
health effect outcomes, and industry advertising and promotion).72
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Study representativeness
Participants with missing data on the substance use, negative affect, and
externalizing measures were not included in the analysis (N= 2,109). Survey
respondents of the analytic sample endorsed significantly greater substance use
overall, negative affect symptoms, and externalizing symptoms (except for fighting)
compared to those not included in the analytic sample. The participants in the analytic
sample were more likely to be Non-Hispanic white, men, aged 25-54 with higher levels
of education and annual household income than those who were missing.

Measures
Past Month Tobacco and Substance Use. Six substance use categories were
used in this study: exclusive cigarette, exclusive e-cigarette, dual cigarette and ecigarette, alcohol, marijuana, and prescription drugs not prescribed (PDNP) including
painkillers, sedatives, tranquilizers. The summary of past-month substance use is
described in Table 4.2. Current dual cigarette and e-cigarette use were identified if the
respondent indicated they were a current cigarette and current e-cigarette user. Current
alcohol, marijuana, and PDNP was endorsed if the respondent indicated ever using the
substance and has used the substance within the past 30 days. Only past month or
current use of the substances was considered (coded as 1, else = 0) to reduce the
potential for recall bias and ensure for accurate overlap with negative affect and
externalizing symptoms occurring in the same time frame. These substance use
variables were nodes in the networks.
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Table 4.2: Summary of Past-Month Substance Use and Symptoms of Negative affect
and Externalizing Disorders
Past-Month
Tobacco and
Variable Definition
Substance
Use
Ever smoking a cigarette (even one or two puffs), has smoked at
Exclusive CIG
least 100 or more cigarettes in his or her entire life, and now
(or CIG)
smokes cigarettes every day or some days, while also excluding the
current use of e-cigarettes
Ever using an e-cigarette (even one or two puffs), ever smoked eExclusive ECIG
cigarettes fairly regularly, and now uses e-cigarettes every day or
(or ECIG)
some days, while also excluding the current use of cigarettes
Dual CIG +
That they were a current cigarette and current e-cigarette user
ECIG
Alcohol
Ever using alcohol and has used alcohol within the past 30 days
Ever using marijuana and has used marijuana within the past 30
Marijuana
days
Ever using prescription drugs not prescribed (PDNP) (i.e.,
PDNP
painkillers, sedatives, and tranquilizers) and has used PDNP within
the past 30 days
Past-Month
Negative
The last time you had significant problems with:
affect
Symptoms*
Feeling trapped, lonely, sad, blue, depressed, or hopeless about the
Depressed
future
Sleep trouble such as bad dreams, sleeping restlessly or falling
Sleeping
asleep during the day
Feeling very anxious, nervous, tense, scared, panicked or
Anxious
something bad was going to happen
Becoming very distressed and upset when something reminded you
Distressed/Past
of the past
Past-Month
Externalizing
The last time you did the following two or more times:
Symptoms*
Lied or conned to get things you wanted or to avoid having to do
Lied
something
Attention
Had a hard time paying attention at school, work or home
Listening
Had a hard time listening to instructions at school, work or home
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Bully
Were a bully or threatened other people
Fights
Started physical fights with other people
Restless
Felt restless or the need to run around or climb on things
Answered
Gave answers before the other person finished asking the question
* The items selected to identify negative affect and externalizing symptoms from the
GAIN-SS instrument are ordinal and measures people across four times periods: past
month, 2 to 12 months, over a year ago, and never. Participants indicating that they
experienced a symptom within the past month were coded as 1. Participants
indicating that they experienced the symptom 2 to 12 months ago, over a year ago,
and never were coded as 0.
Past Month Negative Affect and Externalizing Symptoms. Negative affect and
externalizing symptoms were measured using the Global Appraisal of Individual
Needs—Short Screener (GAIN-SS).73 The summary of past-month negative affect and
externalizing symptoms are described in Table 4.2. The items selected to identify
negative affect and externalizing symptoms from the GAIN-SS instrument are ordinal
and measures people across four times periods: past month, 2 to 12 months, over a
year ago, and never. Participants indicating that they experienced a symptom within the
past month were coded as 1. Participants indicating that they experienced the symptom
2 to 12 months ago, over a year ago, and never were coded as 0. Only past month or
current negative affect and externalizing symptoms were considered reducing the
potential for recall bias and ensure accurate overlap with substance use occurring in the
same time frame. The negative affect and externalizing symptoms, along with the
substance use variables, were nodes in the networks.
Covariates. Networks were stratified by gender to confirm significant differences
in comorbidity networks by gender. Men and women experience substance use and
mental disorders differently; therefore, it is important to test these differences by
stratifying the networks. Previous work shows that women are more likely to experience
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negative affect symptoms while men are more likely to experience externalizing
symptoms.41,123 Men also tend to participate in substance use more regularly than
women and experience substance use problems at twice the rate as females.123
Therefore, it is important to determine how these comorbidities present by gender.

Statistical Analysis
Summary Statistics. Summary statistics were generated for the sample using
PROC SURVEYFREQ in SAS 9.4 to account for complex sampling design.
Network Analysis. A network model can support a deeper understanding of
comorbidity because it conceptualizes symptoms as mutually interacting, often
reciprocally reinforcing elements of a complex network.46 The network approach is
based on the idea that comorbidities arise from shared symptoms between disorders
which can capture complexity and individual variation in psychopathology.49 The
network approach naturally accommodates comorbidities as a central part of its
theory.50 In the network approach, comorbidity represents causal relationships between
symptoms in which pathways can bridge symptoms that are part of multiple disorders.46
Using a network model, symptoms, rather than disorders, are considered within the
network structure. Rather than the disorder acting as the underlying cause of all
symptoms, it is the symptoms that mutually interact and set a person into a disordered
mental health state.
Within a network model, the symptoms make up a comorbid network structure of
several symptoms that is specific to the person. This model conceptualizes how
symptoms of different disorders function together specifically to produce a comorbid
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disordered state. The network approach explains the co-occurrence of mental disorder
symptoms, including substance use behaviors, as resulting from direct interactions
between these symptoms.50 In network analysis, the term interaction is used to explain
the reciprocal action or influence of symptoms. In the context of network analysis,
interaction is not used to test whether an effect can be greater than (positive interaction,
synergism) or less than what we would expect (negative interaction, antagonism).51
Patterns of symptom-symptom or symptom-behavior interactions can be explained
using a network structure.45
An example of the use of a network model is detailed in Figure 4.1 to summarize
comorbidity of symptoms for SUD and depression. The network model of SUD and
depression is made of symptoms denoted as nodes (circles) and the associations
between the symptoms denoted as edges (lines connecting nodes). Every node in a
network is connected by edges. Edges represent the interactions between the nodes.
Nodes that directly activate each other (i.e., are associated with one another) are
connected with an estimated edge, while nodes that do not directly activate each other
are not. This figure details a directed network where arrows are directed from one node
to another, indicating that one symptom can lead to the activation of another.
Depression symptoms (red) are clustered together to the left of the network. SUD
symptoms (blue) are clustered together to the right of the network. Insomnia and weight
loss (in purple) are symptoms that occur in both depression and SUD and act as
bridges between the disorders. The positioning and the distance between the
symptoms/nodes within the network have implications for the comorbidity structure of
depression and SUD.
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mood
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Figure 4.1: Network Model of Depression and SUD symptoms.

Overall Network Modeling Strategy. Two sets of network analyses were
completed to evaluate the connections between substance use behaviors and negative
affect/externalizing symptoms. The first analysis estimated network models in the entire
sample and also tested for the consistency of network connections by gender (i.e.,
network comparison tests). The second set of network analyses consisted of model
evaluation to establish the nodewise metrics (i.e., centrality and predictability), and
accuracy/stability of the network models as detailed below. This second set of analyses
is common to all networks, regardless of the presence or absence of gender
differences.
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Network Model Estimation. All networks were estimated using an Ising Model in
R 3.6.0 using the IsingFit package.193 Ising model selection uses the Extended
Bayesian Information Criteria (EBIC) to measure model parsimony for moderate sample
sizes and for a high number of variables by accounting for the number of unknown
parameters and the complexity of the model space.194–196 Models determined to best
explain the data using EBIC were interpreted for relevant relationships.193,197 Edges
between two nodes were estimated at most pairwise, after adjusting for all other
substance use, negative affect, and externalizing variables.196 Edges were compared
against each other to determine strength. Networks were visualized using the qgraph
package.198 Blue edges illustrate positive partial correlations; red edges illustrate
negative partial correlations. The wider the edge, the stronger the correlation.
The Ising model contains two node-specific parameters: an interaction parameter
and a node parameter. The interaction parameter, !!" , represents the strength of the
interaction between variables j and k. The node parameter, τj, represents the
autonomous disposition of the variable to take the value of one, regardless of
neighboring variables. The model estimates these parameters with logistic regressions,
iteratively, (i.e., one variable is regressed on all others).196 The conditional probability of
#$ given all other nodes #\$ '( given by:

Pθ+x# -x$% . =

exp [τ# x# + x# ∑&∈(\# β#& x& ]
1 + exp[ τ# + ∑&∈(\# β#& x& ]

(10)
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where 8 = (8* , 8+ , … , 8, ) and 8- = 0 >? 1. The node parameter or intercept is τj , the
threshold of the variable. The interaction parameter or slope is !!" , the connection
strength between the relevant nodes.196
A network approach was conducted to estimate the edges, or connections
between the nodes (i.e., denoted as lines between the nodes and are called edges) as
partial correlations among a set of binary items (i.e., current substance use behaviors
[exclusive cigarette, exclusive e-cigarette, dual cigarette and e-cigarette, alcohol,
marijuana, and PDNP], four negative affect symptoms, and seven externalizing
symptoms).34,196,199
Network Comparisons to Test for Gender Differences. Gender differences across
networks were evaluated using two approaches. First, visual comparisons using an
average layout established differences in the magnitude and direction (i.e., positive or
negative) of edge-weights between nodes. Second, three tests of network invariance
were used to test significant differences in network models by gender: global strength
invariance, network structure invariance, and edge strength invariance.
Global strength invariance. The global strength invariance hypothesis tested
whether the overall level of connectivity in a network was identical between men and
women. The global strength invariance hypothesis tests the weighted absolute sum of
all edges in the networks (i.e., @ or the sum of the unique variance in the network).200
*
The null hypothesis specifies that the connectivity for a network in men (A-!
) and
+
*
+
2
women (A-!
) are equal: B. : ∑0-/* ∑!1- -A-!
- = ∑0-/* ∑!1- -A-!
-, where A-!
is the edge-

weights between nodes ' and $ of network D.
For all ' < $, the distance @ between two networks if defined as:
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*
+
*
+
@+A-!
, A-!
. = |∑0-/* ∑!1- (-A-!
- − -A-!
-)|

(11)

The test of global strength invariance was accomplished through permutation
testing procedure as implemented in the NetworkComparisonTest package201 to
statistically assess the difference in global strength by gender. Briefly, permutation
testing was conducted by repeatedly rearranging the data and calculating the test
statistic of each permutation.
Network structure invariance. A test of the network structure invariance
hypothesis was conducted to determine whether network structures were identical by
gender. This test was conducted by comparing the maximum differences in the edge
weights between all nodes in the networks.200 The null hypothesis that specifies all
edges are equal is: B. : H* = H+ , where H2 denotes a symmetric I 8 I matrix that
contains the edge weights of graphical model D. Therefore, gender difference in
network structure would be detected if any of the edge weights between the nodes are
determined to be different by gender.
The test of network structure invariance computed the maximum difference (J)
2
in network edge-weights (A-!
between nodes ' and $ of network D) by gender. The

maximum statistic provides the largest value among each element of a vector which
*
contains the differences in unique edge weights of networks in men (A-!
) and women
+
(A-!
). This is defined as:
*
+
*
+
J+A-!
− A-!
. = KL8-! |A-!
− A-!
|

(12)
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for ' < $ (i.e., the upper triangle of the matrix Ω). This metric functioned as the test
statistic, and followed the same permutation procedure used to test the global strength
invariance.
Edge strength invariance. A test of the edge strength invariance hypothesis was
conducted to determine if a specific edge between two nodes was equally strong by
gender. Edge strength is also referred to as the edge weight, quantified as the
magnitude of an edge. This is the magnitude of association between two nodes. The
*
+
null hypothesis for this test is B. : A-!
= A-!
. This was assessed by taking the absolute

difference in edge strength (A-! ) between two nodes (' LMN $, O>? ' < $) of interest then
testing differences between nodes across all other node combinations in the
networks200:

*
+
*
+
P+A-!
, A-!
. = |A-!
− A-!
|

(13)

Network Model Evaluation. Once network models were produced, the network
structure was detailed across four categories: centrality (i.e., the influence of a node in a
network), nodewise predictability (i.e., how well a given node can be predicted by all
other nodes it is connected to in the network), model accuracy (i.e., the degree to which
the model correctly describes the data), and model stability (i.e., the degree to which
network estimates are expected in other samples). The aggregate evaluation of these
edge-related metrics provides additional detail regarding how nodes within a network
connect with one another and the degree to which a given network model is expected to
consistently explain the data.
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Centrality. Three centrality metrics (closeness, betweenness, and node strength)
were computed for all three networks (full sample, men only, women only) in order to
detail how nodes (i.e., substance use behaviors and negative affect-externalizing
symptoms) interact with one another within a network.
Closeness quantifies how well a node is indirectly connected to other nodes.197
Closeness is a measure of reach or importance of an individual node, based on the
number of connections of that node, localized to that node. It considers the indirect ties
to other nodes in addition to immediate connections. The closeness of a node is the
reciprocal of the sum of the shortest path distances from the node to all n-1 other
nodes. The higher closeness centrality, the shorter reach to other symptoms in the
network meaning the more connected the symptom is to other symptoms in the
network.
Betweenness refers to how critical a node is to a network as a bridging node to
all other nodes in the network. It quantifies the number of times a node act as a bridge
between the shortest path of two other nodes.197 Betweenness is a measure of
centrality based on the shortest path length connecting any two nodes. For a given
node, betweenness is the sum of the fraction of all possible shortest paths that pass
through that node. The more of these shortest paths that go through a node, the higher
their betweenness centrality. Betweenness identifies bridges or go-betweens to identify
other symptoms that may be key players in the comorbidity network.
The node strength also known as degree of a node is the number of edges that
touches that node. It quantifies how well a node is directly connected to other nodes.197
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Nodes that have many edges would be considered to have a high node strength
because it indicates more connectedness to other nodes.
All centrality estimates were standardized using z-scores in order to compare the
metrics across the networks. Additional details for each centrality metric calculated from
the example network model visualized in Figure 4.2 is summarized in Table 4.3.

Figure 4.2: Example Network Model
Table 4.3: Calculations, Examples and Interpretations of Node Centrality Metrics
Derived from Example Network Model
Metric
Calculation
Figure Example
Interpretation
Closeness
Reciprocal of the Values for closeness
Nodes B and C have
sum of the
centrality for each node:
the highest
shortest path
A = 0.75, B = 1.0, C = 1.0, closeness value
distances from
and D = 0.75.
because they only
the given node to
have a shortest path
all n-1 other
Sum of shortest paths for
of 1 to all other
nodes.
node A:
nodes in the graph.
(A—B) = 1
Nodes A and D have
Calculated as:
(A—C) = 1
a shortest path of 2
1/(sum of
(A—D) = 2
to one another.
shortest path
Total = 4
distances from
given node/3).
Closeness for node A is
calculated: 1/[4/3] = 0.75.
Betweenness For a given node, Betweenness centrality is
Nodes B and C have
the sum of the
as follows: A = 0.0, B =
higher betweenness
fraction of all
0.166, C = 0.166, and D = centrality compared
possible shortest 0.
to nodes A and D.
paths that pass
Nodes B and C are
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through that
node.

All possible shortest paths:
(A—B), (A—C), (A—C—
D), (A—B—D), (C—D),
(B—D), and (B—C). Only
the A—D path that
includes C is counted in
the calculation of for
betweenness.

between nodes A
and D. One must go
through B and C to
connect to nodes A
and D.

Betweenness for node C
is = 1/6 = 0.166.
Strength

Count of the
number of edges
that touches a
given node.

Strength
A=2
B=3
C=3
D=2

Nodes B and C have
the highest strength
and have greater
connectedness
compared to nodes A
and D.

Nodewise Predictability. In addition to evaluating network structure as
summarized above, it is important to also analyze nodewise predictability. The concept
of predictability complements the interpretation of network structures. Specifically,
nodewise predictability quantifies how well a given node can be predicted by all the
other adjacent nodes it is connected to in the network.202 Estimating predictability is
crucial for three reasons. First, it considers how much of the variance at a given node is
explained by the edges connected to it. Consequently, an edge that explains 50% of the
variance of a node will be considered more important than an edge that explains 0.5%
of the variance of the node. Second, the predictability at one node can provide an
expectation regarding the extent to which a specific node is influencing another node.
Therefore, nodewise predictability can produce expectations regarding whether a node
can be influenced by intervening on the nodes that are connected to it. Third, estimates
of predictability across nodes indicates whether a network (or portion of the network) is
influenced by itself through strong interactions between nodes (i.e., high predictability)
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or whether it is mostly determined by other factors that are not included in the network
(i.e., low predictability).202 Consequently, interpretation of nodewise predictability can
yield important insight about the whole network in addition to those related to network
structure (i.e., centrality).
Estimation of Predictions in Network Model. Nodewise predictability is estimated
by computing the mean of the conditional distribution of a specific node given all its
neighboring nodes.

F
B

E

C

A
D

Figure 4.3: Six-node network to determine nodewise predictability of Node A

For example, in a six-node network (Figure 4.3) consisting of nodes A, B, C, D, E
and F, an estimated network is produced and the probability of observing a node (A)
within the network given the nodes that are connected to it (C and D) is estimated as:
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P(A = k|S, T) =

exp {µ& }
∑4
3/* exp{µ& }

(14)

where A is a node measured as a binary variable and k indicates the category, K
is the number of categories that the node (for a binary node, K = 2). C and D represent
the nodes adjacent to A. µ& represents the mean of the conditional distribution at node
A and is estimated as:
µ& = !." + !5" S + !6" T

(15)

where !5" S and !6" T represent the edge weights of nodes C and D on node A.
Therefore, the probability of observing a specific value at node A depends on the
influence of nodes C and D on node A.
Quantifying Predictability Using Categorical Data. The estimation of nodewise
predictability for categorical data establishes how close estimated predictabilities at
each node compared to the observed values in the data. The predictability of a network
that uses continuous data is estimated as a proportion of the variance for the network
model that is explained by the predictability measure, measured as:

X7+ = 1 −

YL?(Z[ − Z)
YL?(Z)

(16)

where YL? is the variance, Z[ is a vector of predictions for Z as defined in equation
14, and Z is the vector of observed values in the data. All variables are centered to
reflect a mean of zero in order to remove the possibility that an intercept from a given
node can affect the predictability measure. When X+ = 1, a node can be perfectly
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predicted by its neighboring nodes. In comparison, when X+ = 0, a node cannot be
predicted by all its neighboring nodes in the network.
The estimation of nodewise predictability for categorical data differs from that of
continuous data. In particular, the use of categorical data necessitates the estimation of
a value of “normalized accuracy” which parallels the estimation of nodewise
predictability by centering the mean to be equal to zero. Normalized accuracy is
estimated by removing the marginal effects at each node (i.e., probabilities of the
categories when ignoring all other variables) to determine how well a given node was
predicted by all other nodes in the network. The utility of normalized accuracy can be
exemplified using a hypothetical sample with 100 observations, where ten observations
have a score of zero and 90 observations with a score of one. The marginal
probabilities for the node are I0 = 0.1 and I1 = 0.9. Further, if all other nodes in the
network do not contribute to predicting whether a node has a value of 1 or 0, it is
possible to predict a value of one for all cases. Subsequently, a 90% correct
classification would be estimated. However, this is misleading and results in an inflated
estimate of predictability because nothing can be predicted by all the other nodes.
Normalized accuracy is estimated to remove the accuracy that occurs from the “trivial”
prediction from other nodes using marginal of the variable (I1 = 0.9) alone. Therefore,
normalized accuracy is estimated as the ratio between the additional accuracy due to
the remaining nodes in the network and one minus the accuracy of the node alone:
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Z,89: =

where Z =

*
,

Z − KL8{I. , I* , … , I: }
1 − max{I. , I* , … , I: }

(17)

∑,-/* ∥ (_- = ŷ- ), which reflects the proportion of correct predictions

(accuracy/correct classification). Additionally, I. , I* ,… I: represent the marginal
probabilities of the categories for a node where ∥ is the indicator function for the event
a- = ab -̂ . For binary variables, the marginal probabilities are defined as I. and I* = 1 −
I. . Therefore, Z,89: indicates how much the node of interest can be predicted by all
other nodes in the network, beyond what is trivially predicted by the marginal
distribution. When Z,89: = 0, none of the other nodes contribute to the marginal in
predicting the node of interest. When Z,89: = 1, all other nodes perfectly predict the
node of interest.202
Interpreting and Visualizing Predictability Using Categorical Data. It is valuable to
interpret estimates of Z and Z,89: via network model visualization as a multi-colored
ring surrounding a node.

Figure 4.4: Visualizing the Nodewise Predictability of Categorical Data
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In Figure 4.4, the accuracy of a node from an intercept-only model (i.e., a model
estimating node predictability without the influence of the other nodes) is represented by
the orange part of the ring. The red part of the ring reflects the additional accuracy of
the node that is achieved by all the remaining nodes. The sum of the red and orange
sections represents Z, or the accuracy of the full model. Z,89: is the normalized
accuracy that is estimated as the ratio between the additional accuracy due to the
remaining nodes in the network and one minus the accuracy of the node alone (white +
red sections).
Model estimation to compute nodewise predictability was completed using the
mgm package.203 The estimated models for the nodewise prediction were the same as
those estimated using the IsingFit package because the approach was the same:
neighborhood selection-based method to estimate the binary-valued Ising model.202 The
predict ( ) function was used to compute the predictability for each node in the network,
specifying accuracy/correct classification, normalized accuracy, and the accuracy of the
intercept (marginal) model to visualize the decomposition of total accuracy.
Accuracy and Stability. Typical parameter estimates in a model provide some
indication of the degree of uncertainty around the estimate (e.g., standard error or
confidence intervals). However, such estimates are not automatically generated from a
network model. Consequently, a preliminary network model cannot provide insight
regarding the uncertainty of the parameters estimated. Additional calculations of
accuracy and stability related to the network parameter estimates can be produced to
establish confidence in the model’s ability to estimate the true value from the data.
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Tests of accuracy and stability established confidence in the network model’s
ability to generate the accurate estimate, allowing for appropriate interpretation of
results. Therefore, network accuracy and stability tested the inferences about the
network structure and centrality indices. Accuracy and stability were calculated in three
steps: (1) estimating the accuracy of estimated edge-weights, by drawing bootstrapped
confidence intervals, (2) investigating the stability of centrality indices, and (3) testing
whether edge-weights and centrality estimates for different variables differ from each
other using a bootstrapped difference test.197
Edge-weight accuracy (i.e., the accuracy of estimated network connections) was
assessed by obtaining confidence intervals around the estimated edge-weights using
non-parametric bootstrapping (bootnet package204).197 Confidence intervals generated
around the estimated edge-weights identifies the precision of the edge-weight and
whether the confidence intervals overlap with the bootstrapped confidence intervals of
other edge-weights. An edge-weight with high accuracy has a narrow confidence
interval that does not overlap with the confidence interval of other edges. The nonparametric bootstrapping evaluated whether edge-weights for the variables in the
network differed from each other in three steps: (1) estimate the difference between the
bootstrap value of two edge-weights using non-parametric bootstrap, (2) construct
bootstrapped confidence interval around difference scores, and (3) test the model with
estimated connections against a model of the null hypothesis to establish whether edgeweights differed from one another by checking if zero was in the bootstrapped
confidence interval.197 Results from the edge-weight accuracy test are visualized as a
plot.
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Centrality stability refers to the degree to which an estimate of a centrality metric
(i.e., closeness, betweenness, or strength) is consistent after re-estimating the network
in other samples with characteristics similar to the study sample. Centrality stability can
be estimated for each metric separately, and answers the question: “Does the order of
the centrality indices remain the same after re-estimating the network with a smaller
sample?”
The stability of the centrality indices is quantified as a correlation stability
coefficient (i.e., CS-coefficient). The CS-coefficient represents the maximum proportion
of observations that can be dropped from the original sample. The higher the CScoefficient the greater the stability of the centrality indices. A CS-coefficient should not
be below 0.25 and preferably above 0.5 for appropriate interpretation of the results. In
step 2, centrality stability was investigated by using a case-dropping subset bootstrap
procedure where a centrality metric was obtained for the dataset. Then, networks were
re-estimated after subsetting the sample to determine if the CS-coefficient for the
centrality indices retained a correlation of 0.5 in at least 95% of the samples.197
The estimation of a bootstrapped difference test (nonparametric bootstrap) was
used to test the degree to which edge and centrality estimates differ from each other
across variables. A bootstrapped difference test uses the difference between the
bootstrapped value of one edge weight/centrality and another edge weight/centrality
using non-parametric bootstrap and constructs a bootstrapped confidence interval
around difference scores. The bootstrapped difference test identifies whether (1) a
specific edge (e.g., A—B) is significantly larger than another edge (e.g., A—C) and (2)
the centrality of node A is significantly larger than the centrality of node B. If the
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confidence interval generated from the bootstrapped difference test includes zero than
the two edges or two centrality metrics of interest are considered to not differ
significantly from each other. This bootstrapped difference test was done for the
estimated edge-weights and node strength.
Missingness and Complex Sampling Design. Missing data were removed using
listwise deletion (N = 2,109). Complex sampling design was not accounted for in the
estimation of the network models.

RESULTS
Summary statistics
32,320 participants were included in the overall sample, and 30,211 participants
had complete data for all nodes. The sample was 51.9% female and 66.0% NonHispanic White. Age was evenly distributed across the sample. Most of the sample had
at least a GED or high school education (88.4%) and an annual household income of
more than $25,000 (65.9%). Past-month alcohol use was most frequently reported
(52.4%), followed by CIG use (16.6%), and marijuana use (7.1%, Table 4.4). Sleep
trouble was the most common past-month negative affect symptom reported (26.7%),
followed by feeling very anxious (16.1%), feeling depressed (13.4%), and becoming
distressed about the past (12.5%) (Table 4.4). Giving answers before the other person
finished asking the question was the most common past-month externalizing symptom
(32.0%), followed by having a hard time paying attention (14.6%) and listening to
instructions (10.4%).
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Table 4.4: Demographic Characteristics of the Overall Sample by Gender
Men
(N=16306, 48.1%)
N (Weighted %)

Women
(N=15980, 51.9%)
N (Weighted %)

Age*
18-24
4609 (13.6)
25-34
3232 (18.6)
35-44
2448 (16.4)
45-54
2428 (18.0)
55-64
2039 (16.7)
65+
1547 (16.8)
Race*
Non-Hispanic White
9815 (66.8)
Non-Hispanic Black
2129 (11.0)
Non-Hispanic Other
1266 (7.8)
Hispanic Multiracial
2383 (12.4)
Education*
Less than high school
2287 (12.1)
GED/High school graduate
5187 (30.6)
Some college (no degree)
5353 (29.6)
Bachelor’s degree
2237 (17.6)
Advanced degree*
1132 (10.1)
Annual household income*
Less than $10,000
2519 (11.9)
$10,000- $24,999
3287 (19.4)
$25,000- $49,999
3453 (23.3)
$50,000- $99,999
3338 (25.8)
$100,000 or more
2220 (19.6)
Past month tobacco and substance use
CIG*
5435 (19.0)
ECIG*
299 (1.0)
Dual CIG + ECIG*
533 (1.7)
Alcohol*
9550 (56.3)
Marijuana*
2611 (9.1)
PDNP *
914 (4.7)
Past month negative affect symptoms
Depressed*
2513 (12.1)
Sleeping*
4313 (24.6)
Anxious*
2931 (14.0)
Distressed/Past*
2459 (11.2)
Past month externalizing symptoms
Lied*
1763 (8.2)
Attention*
2712 (13.9)
Listening
1976 (10.2)
Bully
384 (1.8)
Fights*
258 (0.9)
Restless*
1661 (7.3)
Answered*
5459 (30.5)
*Significantly different between men and women at p = 0.05 level.

Overall
(N=32320, 100%)
N (Weighted %)

4495 (12.5)
3103 (16.9)
2478 (16.7)
2409 (17.9)
1929 (16.5)
1558 (19.5)

9110 (13.0)
6337 (17.7)
4930 (16.5)
4846 (17.9)
3971 (16.6)
3110 (18.2)

9467 (65.4)
2364 (11.3)
1162 (7.3)
2429 (14.1)

19295 (66.0)
4496 (11.2)
2429 (7.5)
4817 (13.3)

1938 (11.1)
4570 (28.5)
5942 (32.4)
2260 (18.1)
1176 (10.0)

4233 (11.6)
9765 (29.5)
11300 (31.0)
4498 (17.8)
2311 (10.1)

3144 (15.3)
3477 (21.4)
3214 (22.8)
2797 (24.0)
1692 (16.5)

5668 (13.7)
6768 (20.4)
6670 (23.0)
6140 (24.9)
3914 (18.0)

4942 (14.3)
278 (0.8)
463 (1.3)
8231 (48.8)
1780 (5.3)
1035 (5.4)

10381 (16.6)
578 (0.9)
996 (1.5)
17787 (52.4)
4392 (7.1)
1950 (5.1)

3178 (14.6)
5249 (28.7)
3931 (18.0)
3143 (13.6)

5692 (13.4)
9564 (26.7)
6864 (16.1)
5605 (12.5)

1480 (6.0)
3114 (15.2)
2148 (10.6)
352 (1.6)
146 (0.5)
1292 (5.3)
5937 (33.4)

3245 (7.1)
5831 (14.6)
4128 (10.4)
737 (1.7)
404 (0.7)
2953 (6.2)
11399 (32.0)
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Network Comparisons by Gender
The range of the magnitudes of the tetrachoric correlations between were similar
for men and women: substance use and negative affect symptoms rMen = 0.001-0.33,
rWomen = 0.07-0.30, substance use and externalizing symptoms rMen = 0.01-0.31, rWomen=
-0.03-0.36, and negative affect and externalizing symptoms rMen = 0.34-0.61, rWomen=
0.32-0.61 (Table 4.5). This suggested few gender differences between comorbid
substance use and negative affect/externalizing symptoms.
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Table 4.5: Tetrachoric correlations for Men (N =16,306) and Women (N =15,980)
1
2
3
4
5
6
7
1. CIG
1
-0.94*
-0.999*
0.03*
0.26*
0.20*
0.20*
2. ECIG
-0.94*
1
-0.958*
-0.02
0.01*
0.10*
0.08*
3. Dual CIG + ECIG
-0.999*
-0.92*
1
0.06*
0.21*
0.21*
0.12*
4. Alcohol
0.04*
0.01
0.06*
1
0.38*
0.04
0.06*
5. Marijuana
0.27*
0.10*
0.18*
0.32*
1
0.28*
0.30*
6. PDNP
0.21*
0.06
0.21*
0.06*
0.30*
1
0.32*
7. Depressed
0.16*
0.001
0.16*
0.07*
0.25*
0.28*
1
8. Sleeping
0.12*
0.05
0.16*
0.10*
0.17*
0.32*
0.71*
9. Anxious
0.16*
0.01
0.20*
0.06*
0.22*
0.33*
0.79*
10. Distressed/Past
0.18*
0.05
0.22*
0.07*
0.26*
0.32*
0.77*
11. Lied
0.07*
0.11*
0.12*
0.19*
0.30*
0.26*
0.50*
12. Attention
0.03*
0.07*
0.17*
0.15*
0.23*
0.22*
0.58*
13. Listening
0.07*
0.01
0.16*
0.07*
0.21*
0.23*
0.57*
14. Bully
0.17*
0.07
0.14*
0.12*
0.27*
0.26*
0.45*
15. Fights
0.17*
0.07
0.11*
0.05
0.31*
0.30*
0.36*
16. Restless
0.06*
0.03
0.15*
0.11*
0.26*
0.16*
0.45*
17. Answered
0.01
0.05
0.13*
0.22*
0.20*
0.14*
0.34*
* Significant association at p < 0.05 level.
Note: Correlations for women are on the top diagonal. Correlations for men are on the bottom diagonal.

8
0.18*
0.10*
0.15*
0.07*
0.20*
0.33*
0.70*
1
0.74*
0.69*
0.43*
0.55*
0.55*
0.43*
0.35*
0.43*
0.36*

9
0.21*
0.10*
0.19*
0.07*
0.29*
0.34*
0.79*
0.73*
1
0.81*
0.53*
0.61*
0.61*
0.53*
0.42*
0.49*
0.40*

10
0.21*
0.08*
0.15*
0.07*
0.30*
0.34*
0.75*
0.66*
0.79*
1
0.56*
0.59*
0.59*
0.53*
0.46*
0.47*
0.39*

11
0.10*
0.03
0.03
0.12*
0.35*
0.26*
0.49*
0.42*
0.49*
0.54*
1
0.57*
0.53*
0.54*
0.46*
0.45*
0.44*

12
0.09*
0.09*
0.17*
0.12*
0.25*
0.25*
0.58*
0.56*
0.61*
0.57*
0.53*
1
0.91*
0.48*
0.36*
0.53*
0.49*

13
0.12*
0.14*
0.14*
0.08*
0.22*
0.26*
0.54*
0.54*
0.58*
0.55*
0.52*
0.91*
1
0.50*
0.40*
0.51*
0.45*

14
0.16*
0.09
0.05
0.07*
0.27*
0.19*
0.45*
0.35*
0.45*
0.46*
0.52*
0.47*
0.48*
1
0.73*
0.45*
0.42*

15
0.17*
-0.03
0.09
0.08*
0.36*
0.28*
0.44*
0.36*
0.47*
0.47*
0.51*
0.34*
0.38*
0.66*
1
0.46*
0.31*

16
0.07*
0.04
0.09*
0.15*
0.26*
0.17*
0.46*
0.46*
0.50*
0.49*
0.40*
0.52*
0.51*
0.38*
0.46*
1
0.52*

17
0.06*
0.02
0.09*
0.23*
0.19*
0.18*
0.32*
0.35*
0.37*
0.35*
0.38*
0.48*
0.47*
0.33*
0.28*
0.49*
1
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The average layouts between networks for men and women did not indicate
substantial differences by gender (Figure 4.5). The tobacco cluster was also quite
similar for both men and women. The edge weight between “Bully” and “Fights” was
thicker (i.e., greater) in the male network compared to the female network. Some nodes
had more or fewer edges, depending on the network. The following nodes had more
edges in women: PDNP, feeling depressed, feeling anxious, attention difficulties,
fighting, and restlessness. The following nodes had more edges in men: CIG, alcohol,
feeling distressed about the past, lying, listening difficulties, and giving answers before
person finished asking the question.

Figure 4.5 Network Structure by Gender

The edge-weights (EW) were significantly different (p < 0.05) between men and
women for eight edges: (1) alcohol—marijuana (EWMen = 0.87, EWWomen = 1.08), (2)
alcohol—sleeping problems (EWMen = 0.08, EWWomen = 0), (3) marijuana—feeling
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anxious (EWMen = 0, EWWomen = 0.15), (4) ECIG—lying (EWMen = 0.25, EWWomen = 0), (5)
alcohol—lying (EWMen = 0.31, EWWomen = 0), (6) alcohol—attention difficulties (EWMen =
0.25, EWWomen = 0), (7) lying—attention difficulties (EWMen = 0.86, EWWomen = 0.56),
alcohol—listening difficulties (EWMen = -0.11, EWWomen = 0).
Despite some node-specific relationships that differed by gender, the overall
structure of the networks (maximum difference = 1.33, p-value = 0.32) and the global
strength (Men = 53.4, Women = 50.9, p-value = 0.46) did not significantly differ between
men and women. Therefore, the overall structure and connectivity was not different
across men and women, and we focus detailing overall network results for men and
women together first, then we subsequently provide information for men and women
separately to further detail these networks.

Overall Network
The overall network consisted of 17 nodes (Figure 4.6). The network had 94 nonzero edges out of 136 possible edges (density=0.691), indicating that 69.1% of possible
connections were identified in the network. The figure below shows the estimated
network structure of 6 substance use behaviors (in green), 4 negative affect symptoms
(in blue), and 7 externalizing symptoms (in yellow). The network structure is an Ising
model, which is a network of partial correlation coefficients. Especially strong
connections emerged between the tobacco use nodes, between “Attention” and
“Listening”, and “Fights” and “Bully”. The negative affect symptoms were positioned
between the substance use behaviors and externalizing symptoms, with many of the
nodes lying on the periphery of the network.
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Figure 4.6: Overall Network of Substance Use, Negative Affect and Externalizing
Comorbidity

The assessment of the accuracy of estimated network connections demonstrated
that many edge-weights significantly differ from one-another (Appendix C, Supplemental
Figure 4.1). Results from the edge-weights significant difference test for the overall
sample network can be found in Appendix C, Supplemental Figure 4.2. Tobacco
products were negatively associated with one another (CIG—ECIG = -4.74 [95% CI = 5.50; -3.98], dual CIG + ECIG—CIG = -4.60 [95% CI = -5.82; -3.39], dual CIG + ECIG—
ECIG = -2.66 [95% CI = -4.11; -1.21]) (Appendix C, Supplemental Table 4.1).
Externalizing symptoms also demonstrated strong connections with one another.
For example, attention difficulties had the strongest connection with listening difficulties
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(EW = 3.47, 95% CI = 3.36; 3.58). Bullying was positively associated with fighting (EW =
2.40, 95% CI = 2.10; 2.70).
The connections between PDNP were strongest with negative affect symptoms.
Specifically, the connections with the largest magnitudes were PDNP—sleeping
problems (EW = 0.53, 95% CI = 0.40; 0.66), PDNP—feeling anxious (EW=0.31, 95% CI
= 0.17; 0.46), and PDNP—feeling distressed about the past (EW = 0.31, 95% CI = 0.16;
0.45).
The connections between marijuana, alcohol, and PDNP use were strongest with
externalizing symptoms. Specifically, the connections with the largest magnitudes were
marijuana—lying (EW = 0.60, 95% CI = 0.49; 0.70), marijuana—fighting (EW = 0.54,
95% CI = 0.27; 0.81), alcohol—answered (EW = 0.48, 95% CI = 0.42; 0.53),
marijuana—restlessness (EW = 0.37, 95% CI = 0.26; 0.49) and PDNP—fighting (EW =
0.36, 95% CI = 0.001; 0.72).
The investigation of the stability of centrality indices demonstrated that closeness
(CS coefficient = 0.517) and strength (CS coefficient = 0.594) were stable enough for
interpretation. The betweenness CS coefficient (0.206), however, was too low to
interpret for the overall network (Appendix C, Supplemental Figure 4.3). Significant
differences between node strength were also tested and are displayed in Appendix C,
Supplemental Figure 4.4.
The centrality metrics are provided in the Table 4.6, and also depicted as zscores in Appendix C, Supplemental Figure 4.5. “CIG” has the greatest strength in the
network (strength = 2.39), followed by “Dual CIG + ECIG” (strength = 1.47), “ECIG”
(strength = 0.92), and “Anxious” (strength = 0.38). Nodes with the greatest closeness
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centrality include “Lied” (closeness = 2.34), “Marijuana” (closeness = 1.46), “Fights”
(closeness = 1.24), and “Bully” (closeness = 0.75). Alcohol was lowest for strength, and
ECIG was lowest for closeness. Both are seen on the periphery of the network.
Table 4.6. Node Centrality Indices for the Overall
Sample
Strength
Closeness
CIG
2.39
-1.00
ECIG
0.92
-1.51
Dual CIG + ECIG
1.47
-0.59
Alcohol
-2.01
-1.07
Marijuana
-0.18
1.46
PDNP
-1.02
-0.41
Depressed
-0.35
-0.59
Sleeping
-0.21
0.05
Anxious
0.38
-0.08
Distressed/Past
0.27
0.13
Lied
-0.11
2.34
Attention
0.70
0.49
Listening
-0.25
-0.68
Bully
-0.18
0.75
Fights
-0.51
1.24
Restless
-0.54
-0.003
Answered
-0.78
-0.53
Men-Only Network
The men-only network consisted of 17 nodes (N = 15,268) visualized in Figure
4.7. The network had 85 non-zero edges out of 136 possible edges. Figure 4.7 shows
the estimated network structure of 6 substance use behaviors (in green), 4 negative
affect symptoms (in blue), and 7 externalizing symptoms (in yellow). The network
structure is an Ising model, which is a network of partial correlation coefficients. Similar
connections emerged between the tobacco use nodes, between “Attention” and
“Listening”, and “Fights” and “Bully”.
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Figure 4.7: Men-Only Network of Substance Use, Negative Affect and
Externalizing Comorbidity

The assessment of the accuracy of estimated network connections demonstrated
that many edge-weights significantly differed from one-another (Appendix C,
Supplemental Figure 4.6). Results from the edge-weights significant difference test for
the overall sample network can be found in Appendix C, Supplemental Figure 4.7.
Especially strong connections emerged among “Dual CIG + ECIG” and “CIG” (edge
weight = -5.31), “CIG” and “ECIG” (edge weight = -4.16), “Dual CIG + ECIG” and “ECIG”
(edge weight = -1.55), “Attention” and “Listening” (edge weight = 3.45), and “Bully” and
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“Fights” (edge weight = 2.59). Other connections were absent like “Exclusive CIG” and
“Sleeping” (edge weight = 0) (Appendix C, Supplemental Table 4.2).
The investigation of the stability of centrality indices demonstrated that strength
(CS coefficient = 0.517) was stable enough for interpretation. Closeness (CS coefficient
= 0.361) was lower than the preferred 0.50, but higher than 0.25. Closeness metrics
should be interpreted with caution. The betweenness CS coefficient (0.128), however,
was too low to interpret for the men-only network (Appendix C, Supplemental Figure
4.8). Significant differences between node strength were also tested and are displayed
in Appendix C, Supplemental Figure 4.9.
The centrality metrics are provided in the Table 4.7, and also depicted as zscores in Appendix C, Supplemental Figure 4.10. “CIG” had the greatest strength in the
network (strength = 2.62), followed by “Dual CIG + ECIG” (strength = 1.16), “Anxious”
(strength = 0.71), and “Attention” (strength = 0.67). Nodes with the greatest closeness
centrality included “Distressed/Past” (closeness = 1.62), “Lied” (closeness = 1.57), and
“Bully” (closeness = 1.15). Alcohol was lowest for all centrality metrics.
Table 4.7: Node Centrality Indices for the Men-Only
Sample
Strength
Closeness
CIG
2.62
-0.27
ECIG
0.07
-1.77
Dual CIG + ECIG
1.26
0.0004
Alcohol
-1.87
-1.91
Marijuana
-0.32
0.46
PDNP
-1.19
-0.55
Depressed
-0.39
-0.31
Sleeping
-0.37
0.27
Anxious
0.71
0.59
Distressed/Past
0.56
1.62
Lied
0.11
1.57
Attention
0.67
-0.01
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Listening
Bully
Fights
Restless
Answered

-0.09
-0.08
-0.49
-0.55
-0.66

-0.76
1.15
0.65
0.09
-0.81

Women-Only Network
The women-only network consisted of 17 nodes (N = 14,925) visualized in Figure
4.8. The network had 84 non-zero edges out of 136 possible edges. Figure 4.8 shows
the estimated network structure of 6 substance use behaviors (in green), 4 negative
affect symptoms (in blue), and 7 externalizing symptoms (in yellow). The network
structure is an Ising model, which is a network of partial correlation coefficients. Similar
connections emerged between the tobacco use nodes, between “Attention” and
“Listening.”

Figure 4.8: Women-Only Network of Substance Use, Negative Affect and Externalizing
Comorbidity
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The assessment of the accuracy of estimated network connections suggested
that many edge-weights significantly differed from one-another (Appendix C,
Supplemental Figure 4.11). Results from the edge-weights significant difference test for
the overall sample network can be found in Appendix C, Supplemental Figure 4.12.
Especially strong connections emerged among “Dual CIG + ECIG” and “CIG” (edge
weight = -3.98), “CIG” and “ECIG” (edge weight = -3.48), “Dual CIG + ECIG” and “ECIG”
(edge weight = -1.96), “Attention” and “Listening” (edge weight = 3.49), and “Bully” and
“Fights” (edge weight = 2.04). Other connections were absent like “CIG” and “Alcohol”
(edge weight = 0) (Appendix C, Supplemental Table 4.3).
Closeness (CS coefficient = 0.439) and strength (CS coefficient = 0.361) were
lower than the preferred 0.50, but higher than 0.25. Closeness and strength metrics
should be interpreted with caution. The betweenness CS coefficient (0.128), however,
was too low to interpret for the women-only network (Appendix C, Supplemental Figure
4.13). Significant differences between node strength were also tested and are displayed
in Appendix C, Supplemental Figure 4.14.
The centrality metrics are provided in Table 4.8, and also depicted as z-scores in
Appendix C, Supplemental Figure 4.15. “CIG” had the greatest strength in the network
(strength = 1.91), followed by “Dual CIG + ECIG” (strength = 1.35), “Attention” (strength
= 1.13), and “Anxious” (strength = 1.03). Nodes with the greatest closeness centrality
included “Lied” (closeness = 2.25), “Anxious” (closeness = 1.13), and “Marijuana”
(closeness = 0.95). Alcohol was lowest for strength, and PDNP was lowest for
closeness. Both are seen on the periphery of the network.
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Table 4.8: Node Centrality Indices for the WomenOnly Sample
Strength
Closeness
CIG
1.91
-0.34
ECIG
0.17
-1.34
Dual CIG + ECIG
1.35
0.38
Alcohol
-2.27
-0.94
Marijuana
0.08
0.95
PDNP
-1.11
-1.42
Depressed
-0.13
0.41
Sleeping
-0.29
0.01
Anxious
1.03
1.13
Distressed/Past
0.37
0.63
Lied
0.02
2.25
Attention
1.13
0.31
Listening
-0.05
-0.56
Bully
-0.48
-0.12
Fights
-0.23
0.76
Restless
-0.57
-0.97
Answered
-0.95
-1.15
Nodewise Predictability
Nodewise predictability results are summarized in Table 4.9 and are graphically
depicted in Figure 4.9. The predictability measures accuracy/correct classification and
normalized accuracy. The accuracy of the intercept (marginal) model was also used to
estimate the decomposition of the total accuracy in the intercept model (Table 4.9,
Accuracy of Intercept column, orange) and the contribution of other variables (Table 4.9,
Correct Classification – Accuracy of Intercept Model column). Figure 4.9 visualizes the
results from Table 4.9. The colors in the ring around the node indicate the accuracy of
the intercept model (orange) and the total accuracy (orange plus red). The normalized
accuracy is the ratio red/ (red + white).
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Table 4.9. Nodewise Predictability Values
Variable
Total Accuracy
Normalized
(Accuracy/Correct
Accuracy
Classification)
CIG
ECIG
Dual CIG + ECIG
Alcohol
Marijuana
PDNP
Depressed
Sleeping
Anxious
Distressed/Past
Lied
Attention
Listening
Bully
Fights
Restless
Answered

0.687
0.982
0.969
0.590
0.861
0.938
0.878
0.808
0.876
0.883
0.904
0.908
0.914
0.977
0.987
0.909
0.707

0.037
0.000
0.000
0.041
0.011
0.001
0.312
0.357
0.422
0.330
0.048
0.498
0.332
0.024
-0.027
0.009
0.186

Accuracy of
Intercept
(Marginal)
Model
0.675
0.982
0.969
0.572
0.859
0.938
0.823
0.701
0.785
0.825
0.899
0.817
0.871
0.976
0.987
0.908
0.640

Correct
Classification –
Accuracy of
Intercept Model
(Contribution
from other
variables)
0.012
0
0
0.018
0.002
0
0.055
0.107
0.091
0.058
0.005
0.091
0.043
0.001
0
0.001
0.067

Results from the CIG node are detailed as an example by which to interpret
results. The normalized accuracy (i.e., estimate of nodewise predictability for use with
categorical variables) was 0.037. The normalized accuracy was computed by taking the
ratio of the contribution from other variables (0.012) to the contribution from other
variables (0.012) plus one minus the total accuracy: 0.012/0.012 + 0.313 = 0.037.
Therefore, 3.7% of the CIG node could be predicted by all other nodes in the network.
Further, the total accuracy of the CIG node was 68.7% (0.675 + 0.012 = 0.687).
Therefore, most of accuracy of the CIG node (67.5%) was due to contributions of this
node specifically. Since the other variables do not strongly contribute to the
predictability of CIG, it is expected that successful intervention on past-month CIG use
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specifically could potentially address use by 68.7%. In contrast, intervention for other
behaviors related to past-month CIG use is likely to influence this behavior by 3.7%.
Results for the CIG node are compared against the Anxious node, where a
greater proportion of the predictability was due to other nodes. The normalized accuracy
of the Anxious node was 0.422 meaning that 42.2% of the Anxious node could be
predicted by all other nodes in the network. Furthermore, the total accuracy of the
Anxious node was 87.6%, meaning that the majority of accuracy of the Anxious node
(42.2%) was due to contributions of other nodes in the network, not the Anxious node
specifically (45.4%). Unlike the CIG node, successful intervention on other nodes
connected to the Anxious node could potentially address this symptom by 87.6%.

Figure 4.9: Mixed Graphical Model Estimated on the Data. Green edges indicate
positive relationships and red edges indicate negative relationships. The orange part of
the ring indicates the accuracy of the intercept model. The red part of the ring is the
additional accuracy achieved by all remaining variables. The sum of both orange and
red is the accuracy of the full model A. The normalized accuracy Anorm is the ratio
between the additional accuracy due to the remaining variables (red) and one minus the
accuracy of the intercept model (white + red).
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Nodes with greater strength and greater magnitudes in edge-weights were
predicted better (e.g., Dual CIG + ECIG and Attention) than nodes with fewer or weaker
edges (e.g., Alcohol). Alcohol (0.590), CIG (0.687), and Answered (0.707), and had the
lowest total accuracy in the network whereas Fights (0.987), ECIG (0.982), and Bully
(0.977) had the highest total accuracy. Interestingly, the predictability of fights, ECIG,
and Bully had no contribution from the other variables (correct classification = 0 or near
0). Other nodes also had a correct classification of 0 (i.e., Dual CIG + ECIG and PDNP)
meaning that other nodes in the network did not predict the node at hand beyond the
intercept model. Additional accuracy due to the remaining variables contributed to the
predictive ability of the negative affect items as well as Attention, Listening, and
Answered externalizing items (denoted by the red portion of the ring).
The average predictability as estimated across the accuracy/correct classification
column for all nodes was 0.85, indicating that 85% of the variance of the network was
explained by the nodes in the network. Therefore, the network was largely determined
by itself through strong mutual interactions between nodes. Intervention on any of these
nodes would likely result in a decrease of a neighboring symptom, especially for nodes
with higher contribution from other variables in the network.

DISCUSSION
To our knowledge, this is one of the first studies to investigate a comorbidity
network including substance use behaviors and a wide range of mental disorder
symptoms in a large sample of U.S. adults. There were two major results from this
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study. First, networks for men and women did not significantly differ in structure and
connectivity, although there were significant differences by gender between specific
nodes. Second, the overall network structure and edge-weights confirmed the
connections of substance use behaviors, negative affect symptoms, and externalizing
symptoms in the network. Yet, there were edges that crossed the construct boundaries
(i.e., substance use, negative affect, externalizing), identifying connections across these
three constructs. Furthermore, high predictability of all nodes indicated the network was
largely determined by itself through strong mutual interactions between nodes. These
results suggest that symptom connections, including substance use, (1) do not
significantly differ between men and women, and (2) connect based on construct with
some overlap.

No gender differences between overall networks but some gender-specific differences
between nodes
There were no significant gender differences for the overall comorbidity
networks. This was inconsistent with our hypothesis based on expectations developed
in the prior literature.123,190 In general, these studies report a higher prevalence of
alcohol, tobacco, illicit substance use, and externalizing problems in men and greater
negative affect symptoms and comorbidity in women.123,183,189,190 Differences in the
network structures may be due to the measurement of past-month substance use and
mental health symptom endorsement rather than diagnosis. There were gender
differences in higher severity due to use of aggregate sum scores. However, this
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difference was not present in a comorbidity network of people experiencing
subthreshold levels of use or symptoms.205,206
Some gender-specific differences were discovered between nodes. These are
detailed below:
(1) Alcohol—marijuana (EWMen = 0.87, EWWomen = 1.08): One would likely expect
that this connection between alcohol and marijuana would have a larger
magnitude for men, especially given that men experience more substance use
and externalizing behaviors.123,183,189,190 However, as men have a higher
prevalence of marijuana use, women have demonstrated a greater increase in
use over time.153 From 2006-2016, the rate of marijuana use increased 40% for
men (from 8.1% to 11.3%), and 63% for women (from 4.1% to 6.7%).153 Data
also suggest that women have a faster development of cannabis use disorder
with poorer outcomes compared to men.153 Therefore, the alcohol—marijuana
connection may be a greater connection of interest in women, but should also not
be discounted in men.
(2) Alcohol—sleeping problems (EWMen = 0.08, EWWomen = 0): There was a small
positive connection between alcohol use and sleeping problems for men where
there was no edge present for women, indicating that alcohol use was associated
with sleeping problems in men. The relationship between alcohol use and sleep
disturbances is well established.207 A recent study conducted in the United
Kingdom identified that men who maintained a heavy volume of drinking over
three decades, had unstable consumption patterns, and sustained hazardous
drinking had worse sleep profiles compared to men without these problems while
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results for women were mixed.208 This relationship is consistent with the literature
and should continue to be a relationship of interest in comorbidity research.
(3) Marijuana—feeling anxious (EWMen = 0, EWWomen = 0.15): Women have
demonstrated a greater increase in marijuana use over time compared to men,
although men have a higher prevalence of marijuana use.153 Women with
cannabis use disorder are more likely to experience anxiety and depression
compared to men with cannabis use disorder.153 This relationship is consistent
with prior work and underscores the importance of marijuana use and anxiety
problems in women.
(4) ECIG—lying (EWMen = 0.25, EWWomen = 0): Men reported more ECIG use and
lying behaviors compared to women. This is consistent with research that has
established women reporting less substance use, including e-cigarettes, and
externalizing behaviors compared to men.123,183,189,190,209 Additionally, this
significantly different edge demonstrates that this connection is not present in
women where other positive connections exist for the lying node (e.g., attention
difficulties—lying). This relationship may be of more importance in men versus
women.
(5) Alcohol—lying (EWMen = 0.31, EWWomen = 0) and Alcohol—attention
difficulties (EWMen = 0.25, EWWomen = 0): Men consistently drink more alcohol
and have a higher likelihood of alcohol use disorders compared to women.210–212
Similarly, men experience more externalizing symptoms than women.123,183,189,190
The relationship between with alcohol and externalizing symptoms is in line with
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prior research and these results confirm the importance of this relationship,
especially with lying and attention difficulties, in men.
(6) Lying—attention difficulties (EWMen = 0.86, EWWomen = 0.56): Lying and
attention difficulties are externalizing behaviors that are associated with each
other in both men and women. The association between attention difficulties,
commonly seen with ADHD, and emotional dysregulation is well recognized.213
Emotional dysregulation encompasses emotional expressions and experiences
that are context-inappropriate, which is clinically expressed as irritability.213
Those with irritability can react to the external stimuli in ways that are overly
angry and aggressive214; however, the connection between attention difficulties
and lying is not well understood. This connection should be investigated further,
especially in men as we see a stronger magnitude of association compared to
women.
(7) Alcohol—listening difficulties (EWMen = -0.11, EWWomen = 0): The relationship
between alcohol and listening difficulties is not as well understood compared to
other externalizing symptoms identified with alcohol use. Listening difficulties can
be classified as an inattention ADHD symptom.2 The comorbidity between ADHD
and alcohol has been identified14,15,215 yet our results reflect a negative
relationship between listening difficulties and alcohol for men and no relationship
for women. This may be because the inattention ADHD symptom may be less
likely to be associated with alcohol use compared to the hyperactivity/impulsivity
ADHD symptoms.216 However, results are mixed.216–219 Further work is needed to
better understand this relationship by gender.
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Overall network connections with negative affect and externalizing symptoms varies by
substance
The largest edge-weight between any tobacco product and a negative affect or
externalizing symptom was found between dual use of CIG and ECIG and feeling
anxious. Furthermore, out of all potential connections with negative affect and
externalizing symptoms, ECIG was only connected to sleeping problems. Previous
studies of adolescents and young adults found ECIG use was associated with ADHD,
PTSD, anxiety and other SUDs.94,95,97 More research is needed to confirm the
relationship between ECIG and mental health symptoms in adults. It is possible that
these differences in results are due to the measurement of tobacco use. It is rare for
studies to exclude ECIG use from CIG use and vice versa, which misclassifies the
relationships between CIG and ECIG use to be more strongly associated than reality.
Consequently, the study of this association may be important to consider in future
research.
PDNP was connected to negative affect and externalizing symptoms with the
strongest connection found with sleeping problems, followed by fighting, feeling
anxious, and becoming distressed about the past. These results confirm previous work
which identified nonmedical prescription drug disorders with externalizing behaviors220
as well as negative affect behaviors, specifically opioids with PTSD symptoms.154
Marijuana had a relatively strong connection between two externalizing
symptoms (i.e., lying and fighting). These connections with conduct disorder specific
symptoms confirm and reinforce the association with marijuana use as stronger than
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with previously identified negative affect symptoms (i.e., anxiety and depression).149–152
Although these connections were not as strong as those within the construct, they exist
and demonstrate the overlapping nature among these symptoms and behaviors.
Alcohol was connected to the impulsivity item which is consistent with previous
alcohol focused literature demonstrating an association between highly impulsive
behaviors and alcohol use.221 A bidirectional relationship has been identified in that
impulsivity significantly increases the risk for initiation, continuation, and excessive
alcohol use and can also result from acute intoxication and long-term alcohol abuse. 221
These results confirm this association specifically with a past month measure of alcohol
use and through the externalizing symptom of giving an answer before a question is
finished being asked.
Finally, several weaker and negative connections remain across substances and
negative affect/externalizing symptoms although there were some strong connections
across constructs, which is supported by the prior literature.89,149,169–173 These broad,
though weaker connections emphasize the complexity of the comorbidity across
substance use and negative affect/externalizing disorders.

Node Centrality and Predictability
Strength and closeness were the only centrality metrics stable enough to
interpret for the overall, men, and women networks. Exclusive CIG use and dual CIG
and ECIG use were the two nodes with the largest strength in all three networks. This
means that these two types of tobacco use had the most connections to other nodes in
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these networks. This may be due to the oversampling of tobacco users in the PATH
data or due to tobacco use being common across the other behaviors.
Lying, acting as a bully, physical fighting, feeling anxious, feeling distressed
about the past, and marijuana use were the nodes with the highest closeness centrality
for the three networks. Based on these results, we could consider lying, acting as a
bully, and physical fighting as more important externalizing nodes in the comorbidity
structure compared to the others given their stronger measure of indirect ties to other
nodes in the network. Similarly, we could assume that feeling anxious and feeling
distressed about the past may be a more important negative affect node in the
comorbidity structure as it has a closer measure of reach compared to the other
negative affect symptoms. Marijuana use could also be considered an important
substance use node in the comorbidity structure based on its high closeness centrality.
Nodes with more and stronger edges had higher node predictability compared to
other nodes in the network with lower strength. The overall high predictability of all
nodes in the network, however, has implications for potential intervention. Since, on
average, 85% of the variance of a node was explained by its neighbors, then one could
intervene on one of these symptoms which could affect the entire network. The negative
affect variables had the highest predictability contributed from other nodes in the
network. Therefore, if we wanted to reduce anxiousness, the network model suggests
intervening on the variables that are closely connected to the anxious node: sleep
problems, feeling depressed, and feeling distressed about the past. Nodewise
predictability tells us we might reduce anxiousness by approximately 87.6% (total

162

accuracy) if we were to intervene on sleep problems, feeling depressed, and feeling
distressed about the past.
The node with the overall lowest centrality in all networks was past month alcohol
use. This is consistently low across all networks, perhaps because in the way alcohol
was measured in this study. Past month alcohol use is not indicative of severity or
problematic alcohol use. Therefore, people who indicated past month alcohol use were
not likely to also indicate other substance use behaviors and mental disorder symptoms,
as demonstrated by the low strength and closeness. More severe measures of
problematic alcohol use, however, may perform differently in a comorbidity network.
Future work should consider other measures of alcohol use in determining comorbidity
structure of substance use behaviors and mental disorder symptoms.

Strengths and limitations
These results should be evaluated in light of the following limitations. First,
conclusions that are drawn from this study are not indicative of severe psychopathology
or SUD because it uses a population-based sample and data from subthreshold
behaviors. Therefore, we cannot draw conclusions about disorders. Nevertheless, the
purpose of this project was to better understand how the wide range of behaviors and
symptoms interact in a typical sample of adults. Second, the items included in the
networks were dichotomized either from combining multiple measures as seen in the
substance use items or from collapsing the ordinal negative affect/externalizing items.
This strategy results in a loss of information, but allows for easier interpretation of the
results, especially since all items overlap regarding time (i.e., past-month endorsement).
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Additionally, the items included in the network analysis represent three separate
constructs (i.e., substance use, negative affect problems, and externalizing problems)
and this presents a potential limitation regarding nodewise predictability because these
constructs are correlated. This could result in edge-weights indicating how similar the
variables are and do not necessarily reflect mutual influence. Therefore, further
investigation in the nodewise predictability of these items is warranted. Future analyses
could include three categorical items that represent the constructs and then test for
nodewise predictability. Third, these models did not adjust for the influence of other
sociodemographic variables. Therefore, there may be some residual confounding.
Fourth, these data are cross-sectional. We cannot draw any causal inferences from
these networks. Future research is encouraged to study these networks over time. Fifth,
networks can only be estimated with complete data. Approximately 2,109 participants
were missing data on all seventeen items and not included in the estimation of the
overall network. There may be potential for social desirability or misclassification biases
in that the people with missing information on these items did not want to endorse their
substance use or mental disorder symptoms.
A strength of this project includes the use of accuracy, stability and comparison tests
to ensure that the inferences made by these study results were appropriate.

Conclusions
Results emphasized many weak connections throughout the substance use and
negative affect/externalizing network and identified a few important connections for
future study. In particular, PDNP was most strongly associated with negative affect
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while marijuana, alcohol and PDNP use were most strongly associated with
externalizing. Future work should replicate these analyses in other large samples,
including additional nodes of importance and/or sociodemographic factors that may play
a role in the comorbidity structure and assess the stability of these networks over time.
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CHAPTER 5: PRELIMINARY PATTERNS OF SUBSTANCE USE AND MENTAL
DISORDER SYMPTOM COMORBIDITY IN ADULTS OVER TIME

INTRODUCTION
Comorbidity of substance use and mental health problems are more common
than exclusive substance use or mental health problems only.67 Comorbidity has been
detected consistently across age groups, and studies within a specific age group have
demonstrated different results. For example, younger age groups are at a greater risk of
experiencing substance use and mental health comorbidity compared to older age
groups.41,222 It is unclear, however, whether patterns of comorbidity in adults change
over time.

Substance use comorbidity over time
Several longitudinal studies identifying co-occurring substance use over time
have focused primarily on youth and young adults. These studies have discovered a
similar result in that substance use behaviors are relatively stable over time; however, if
there is a change in behavior, it usually moves from less severe to more severe (e.g.,
alcohol only to using multiple substances simultaneously [polysubstance use]).
Generally, early substance use (e.g., alcohol and illicit substances) in adolescents is
strongly associated with later substance use disorder (SUD) development.223
Longitudinal association studies in youth have demonstrated that ever tobacco use
predicts subsequent substance use224 while others have identified heavy alcohol use
predicting marijuana use during college.225,226 A latent transition analysis of adolescents
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identified three substance use groups (mild alcohol use, alcohol and moderate
marijuana use, and polysubstance use). Overall, adolescents generally remained in the
same group over time; however, when they did transition, adolescents were most likely
to move to a more harmful substance use status.227 Another longitudinal analysis of
vocational students (16 to 20 years) in Germany found a similar result. Approximately,
10% of alcohol users at baseline transitioned to polysubstance use of alcohol,
cigarettes, and marijuana at 18-month follow up.52 It is unclear whether this stability and
potential transition to more harmful substance use continues in adulthood.

Mental health comorbidity over time
Compared to co-occurring substance use, more is understood about co-occurring
mental health conditions in adults. There is evidence that less severe mental disorders
precede more severe disorders.2 Certain mental health conditions can increase the risk
of development of future mental health conditions. For example, chronicity of depressive
symptoms increases the likelihood of anxiety and substance use disorders.2,55,56
Epidemiologic studies have provided evidence for both continuity and change of mental
disorder comorbidity.67–69 Overall, the highest stability rates are documented in low
psychopathology and externalizing classes, whereas the internalizing or negative affect
and highly comorbid classes are moderately stable. Furthermore, results from a latent
transition analysis of a nationally representative sample demonstrated that internalizing
or negative affect presentations progressed toward remission, while comorbid and
externalizing presentations was notably symptomatic across time.67
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Substance use and mental health comorbidity over time
Less, however, is understood about the stability of substance use and mental
disorder comorbidity in adults over time. To date, comorbidity studies have reported that
(1) externalizing problems (e.g., ADHD, ODD, CD) in youth precede substance use in
both boys and girls whereas (2) substance use (e.g., alcohol and marijuana) in youth
predict internalizing or negative affect disorders in adulthood specifically for women.57–61
A systematic review and meta-analysis of prospective cohort studies suggests a
positive association between anxiety and later alcohol use disorders.228 More
longitudinal approaches to assessing the comorbidity structure over time is needed.
These studies will help to better understand the progression or regression of symptoms
or behaviors in adults, and identify how to better support individuals experiencing
comorbidity.

Study goals and hypotheses
The primary goal of this study is to perform a preliminary assessment of the
substance use and mental disorder symptom comorbidity patterns across three years of
data (2013-2016) using both latent class and network analyses. The secondary goal of
this study is to describe the similarities and differences in the patterns of comorbidity
across LCA and network analyses. Based on the current understanding of substance
use and mental disorder symptoms over time, we hypothesize that overall adult
comorbidity patterns will not significantly differ across time. However, we expect minor
changes in the relationship between a few behaviors and substances across waves.
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METHODS
Setting
The Population Assessment of Tobacco and Health (PATH) study is a nationally
representative longitudinal cohort study of the civilian, non-institutionalized household
population of the U.S., and participants engaged in all levels of tobacco use ranging
from never using tobacco to frequent use.72 Three waves of data were included in this
study.
Wave 1. Wave 1 adult data (N=32,320) are cross-sectional and were collected
between September 2013 and December 2014. The weighted response rate among
participants was 74.0% for Wave 1.73 This interview rate is conditional on completion of
the Wave 1 screener.
Wave 2. Wave 2 adult data (N=28,362) were collected between October 2014
and October 2015. The weighted response rate among participants was 83.2% and is
conditional on Wave 1 participation.71
Wave 3. Wave 3 adult data (N=28,148) were collected between October 2015
and October 2016. The weighted response rate among participants was 78.4% and is
conditional on Wave 1 participation.71
Study Representativeness. New participants introduced at Waves 2 or 3 were
excluded. This includes youth that “aged up” into the adult questionnaires. Therefore,
we included the same adults from Wave 1 through Wave 3 resulting in Wave 2 N =
26,444 and Wave 3 N = 26,239.
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Participants with missing data on the substance use, negative affect, and
externalizing measures were not included in the analysis (NWave1= 2,109, NWave2= 852,
NWave3= 880). Survey respondents of the analytic sample endorsed significantly greater
substance use overall, negative affect symptoms, and externalizing symptoms (except
for fighting in Waves 1-3 and bullying in Waves 2-3) compared to those not included in
the analytic sample. The participants in the analytic sample were more likely to be NonHispanic white, men, aged 25-54 with higher levels of education and annual household
income than those who were missing.

Measures
Past Month Tobacco and Substance Use. Six substance use categories were used
in this study: exclusive cigarette, exclusive e-cigarette, dual cigarette and e-cigarette,
alcohol, marijuana, and prescription drugs not prescribed (PDNP) including painkillers,
sedatives, tranquilizers. Only past month or current use of the substances was
considered (coded as 1, else = 0) to reduce the potential for recall bias and ensure for
accurate overlap with negative affect and externalizing symptoms occurring in the same
time frame.
Past Month Negative Affect and Externalizing Symptoms. Negative affect and
externalizing symptoms were measured using the Global Appraisal of Individual
Needs—Short Screener (GAIN-SS).73 Four questions were used to measure negative
affect symptoms that asked the last time you had significant problems with:
(1) “feeling trapped, lonely, sad, blue, depressed, or hopeless about the future,”
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(2) “sleep trouble- such as bad dreams, sleeping restlessly or falling asleep during
the day,”
(3) “feeling very anxious, nervous, tense, scared, panicked or something bad was
going to happen,” and
(4) “becoming very distressed and upset when something reminded you of the past.”

Externalizing symptoms were also measured using the GAIN-SS. Seven questions were
used to assess externalizing symptoms. Items asked the last time you did the following
two or more times:
(1) “lied or conned to get things you wanted or to avoid having to do something,”
(2) “had a hard time paying attention at school, work or home,”
(3) “had a hard time listening to instructions at school, work or home,”
(4) “were a bully or threatened other people,”
(5) “started physical fights with other people,”
(6) “felt restless or the need to run around or climb on things” and
(7) “gave answers before the other person finished asking the question.”

The items selected to identify negative affect and externalizing symptoms from the
GAIN-SS instrument are ordinal and measures people across four times periods: past
month, 2 to 12 months, over a year ago, and never. Participants indicating that they
experienced a symptom within the past month were coded as 1. Participants indicating
that they experienced the symptom 2 to 12 months ago, over a year ago, and never
were coded as 0. Only past month or current negative affect and externalizing
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symptoms were considered reducing the potential for recall bias and ensure accurate
overlap with substance use occurring in the same time frame.
Covariates. Sex, age, race, education, annual household income, and level of
satisfaction with social activities and relationships were included as covariates in the
generation of latent class models for Waves 1, 2, and 3. Sex was a binary variable with
one level representing male and the other level representing female. Age, measured in
PATH as a seven-level categorical variable, was re-categorized to have a uniform
distribution with six levels (18-24, 25-34, 35-44, 45-54, 55-64, and 65 years or older).
Race/ethnicity was measured as a four-level categorical race variable and included
information from a separate variable that accounted for Hispanic ethnicity (Non-Hispanic
White, Non-Hispanic Black, Non-Hispanic Other, and Hispanic Multicultural). Education,
measured in PATH as a six-level categorical variable, was re-categorized as a five-level
categorical variable with a uniform distribution [less than high school, GED/high school
graduate, some college (no degree) or Associate’s degree, Bachelor’s degree, and
Advanced degree]. Annual household income was measured as a five-level categorical
variable: less than $10,000, $10,000 to $24,999, $25,000 to $49,999, $50,000 to
$99,999, and $100,000 or more.
Level of satisfaction with social activities and relationships was measured as a
five-level categorical variable: extremely satisfied, very satisfied, moderately satisfied, a
little satisfied, and not at all satisfied.
These covariates were included as auxiliary variables to predict the probability of
class membership. Covariates were not included or adjusted for in the development of
the networks for Waves 1, 2, and 3.
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Statistical analysis
Summary Statistics. Data management and summary statistics for the three
waves were done in SAS 9.4. Data were then exported from SAS and imported into
Mplus to conduct the LCA. Results from the LCA were then imported back into SAS to
evaluate the pairwise comparisons. The original data generated in SAS were also
imported into R to estimate the network structures.

Latent Class Comparisons
Latent Class Analysis. Latent class analysis (LCA) is a type of mixture modeling
used to identify unobserved heterogeneity in a population and find meaningful groups of
people that are similar based on their responses to measured items.70,141 The observed
items (i.e., six substance use behaviors, four negative affect symptoms, and seven
externalizing symptoms) are independent of each other given an individual’s response
on the latent variable meaning that the latent variable (i.e., comorbidity class) explains
why the observed items are related to one another.130 LCA accounts for the observed
covariation between substance use and mental disorder symptoms and offers objective
indices of class classification accuracy that are not available in traditional cluster
analysis methods.132
Two parameters are estimated in the LCA model: item probability parameters
and class probability parameters. Item probability parameters represent the probability
of endorsing an item conditional on latent class membership. It can also be referred to
as the item response probabilities or conditional item probabilities. Class probability
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parameters reflect the probability that a person in a given latent class has of endorsing
the specific item. The class probability parameter specifies the prevalence of each class
in the population or the relative frequency of class membership. Therefore, a LCA
estimates the probability of being in a latent class conditional on the probability of
endorsing a measured item.70 More detail on LCA is provided in the methods section of
Chapter 3.
Model Selection. A four-class solution was determined to be most optimal in the
LCA for Wave 1 (Chapter 3). Therefore, only a four-class solution was generated for
Waves 2 and 3 for comparison. Lo-Mendell-Rubin adjusted likelihood ratio test (LMRT),
Akaike information criteria (AIC), Bayesian information criteria (BIC), sample-size
adjusted BIC, and entropy were tested to show model fit and parsimony. More detail on
these fit and parsimony tests are provided in the methods section of Chapter 3. A
smaller AIC and BIC, a larger entropy, and statistically significant results from the LMRT
are conditions that determine a more optimal class solution.
Multinomial Logistic Regression. Multinomial regression was used to determine
whether any covariates were significantly associated with membership of a latent
class.142 Multinomial regression was conducted using the three-step method (R3STEP)
via the AUXILIARY statement in Mplus. This approach was used in order for the latent
class model and the latent class predictor model to be obtained automatically142 rather
than introducing potential bias by performing a multinomial regression after the latent
class models were selected. More detail of the multinomial logistic regression procedure
is provided in the methods section of Chapter 3.
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Latent Class Analysis Comparisons. Class probability parameters, item response
probability parameters, transition patterns and results from the multinomial logistic
regression were compared across the three waves. Differences in class and item
response probability parameters were compared. Transition patterns were identified to
determine the stability of movement among the classes across the waves. Odds ratios
from the multinomial logistic regression were discussed.
Handling Missingness and Complex Sampling Design. Data management,
summary statistics, and transition tables for latent class comparisons were performed in
SAS 9.4. All LCA was conducted in MPlus. Missing data were removed (NWave 1 = 256,
NWave 2 = 166, NWave 3 = 198). Complex sampling design was accounted for in SAS 9.4
using PROC SURVEYFREQ (to generate summary statistics), and in Mplus using the
WEIGHT option.

Network Comparisons
Network Analysis. Patterns of associations or interactions between substance
use behaviors and mental disorder symptoms can be encoded in a network structure.45
Measured symptoms and behaviors (i.e., substance use behaviors and negative affect
and externalizing symptoms) are represented as nodes. Nodes are connected by
edges. Edges represent the interactions between the nodes. Nodes that directly activate
each other (i.e., demonstrate an association) are connected while nodes that do not
directly activate each other are not. Three networks were generated for comparison,
one for each wave. The resulting networks produced patterns of symptom-symptom or
symptom-substance use interactions.45
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Network Model Estimation. All networks were estimated using an Ising Model in
R 3.6.0 (IsingFit package193) to estimate the associations between the nodes (i.e.,
edges) as partial correlations among a set of binary items (i.e., current substance use
behaviors [exclusive cigarette, exclusive e-cigarette, dual cigarette and e-cigarette,
alcohol, marijuana, and PDNP], four negative affect symptoms, and seven externalizing
symptoms).34,196,199 Ising model selection uses the Extended Bayesian Information
Criteria (EBIC) to measure model parsimony for moderate sample sizes and for a high
number of variables by accounting for the number of unknown parameters and the
complexity of the model space.194–196 Models determined to best explain the data using
EBIC were interpreted for relevant relationships.193,197 Edges between two nodes were
estimated at most pairwise, after adjusting for all other substance use, negative affect,
and externalizing variables.196 Edges were compared against each other to determine
strength. Networks were visualized using the qgraph R package.198 Blue edges illustrate
positive partial correlations; red edges illustrate negative partial correlations. The wider
the edge, the stronger the correlation.
The Ising model contains two node-specific parameters: the interaction
parameter and the node parameter. Details on how these parameters were calculated
are provided in the methods section of Chapter 4.
Network Comparisons to Test for Differences by Wave. Differences by wave
were evaluated using two approaches. First, visual comparisons using an average
layout established differences in the magnitude and direction (i.e., positive or negative)
of edge-weights between nodes. Second, three tests of network invariance were used
to test significant differences in network models by wave. Greater detail of the three
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tests of network invariance is provided in the methods section of Chapter 4. These tests
were done in a pairwise fashion in the following order: Wave 1 was compared to Wave
2, Wave 2 was compared to Wave 3, and Wave 1 was compared to Wave 3.
The global strength invariance hypothesis tested whether the overall level of
connectivity in a network was identical between the waves. The global strength
invariance hypothesis tests the weighted absolute sum of all edges in the networks or
the sum of the unique variance in the network.200
A test of the network structure invariance hypothesis determined whether
network structures were identical by wave by comparing the maximum differences in the
edge-weights between all nodes in the networks.200
Edge strength invariance hypothesis was tested to determine if a specific edge
between two nodes was equally strong between the waves. Edge strength is also
referred to as the edge weight, quantified as the magnitude of an edge. This is the
magnitude of association between two nodes.200
Handling Missingness and Complex Sampling Design. Participants with missing
data were removed using listwise deletion (NWave 1 = 2,109, NWave 2 = 852, NWave 3 = 880).
Complex sampling design was not accounted for in the estimation of the network
models.

RESULTS
Summary statistics
The overall sample size decreased from Wave 1 (N=32,320) to Wave 3
(N=26,239) as shown in Table 5.1. Women (51.9 to 52.1%) and those who identified as

177

Non-Hispanic White (65.8 to 66.0%) made up the majority of the samples across the
waves. Age was evenly distributed. Most of the samples had at least a GED or high
school education, an annual household income of more than $25,000, and were at least
moderately satisfied with their social activities and relationships.
Endorsement of past month substance use and mental disorder symptoms
remained stable across the waves. Alcohol was the most commonly reported past
month substance used (52.4% to 54.4%), followed by CIG (16.6%) and marijuana (7.1%
to 9.7%). Sleep problems were the most commonly reported past month negative affect
symptom (25.4% to 27.0%) followed by feeling anxious (16.0% to 16.5%). Giving
answers before the other person finished asking the question was the most common
past month externalizing symptom (28.5% to 32.0%), followed by having a hard time
paying attention (14.6% to 15.4%) and listening to instructions (10.4% to 11.3%).
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Table 5.1: Characteristics of the Samples by Wave

Sex
Male
Female
Age
18-24
25-34
35-44
45-54
55-64
65+
Race
Non-Hispanic White
Non-Hispanic Black
Non-Hispanic Other
Hispanic Multiracial
Education
Less than high school
GED/High school graduate
Some college (no degree)
Bachelor’s degree
Advanced degree
Annual household income
Less than $10,000
$10,000- $24,999
$25,000- $49,999
$50,000- $99,999
$100,000 or more
Satisfaction with social activities and relationships
Extremely satisfied
Very satisfied
Moderately satisfied
A little satisfied
Not at all satisfied
Past month tobacco and substance use
CIG
ECIG
Dual CIG + ECIG
Alcohol
Marijuana
PDNP
Past month negative affect symptoms
Depressed
Sleeping
Anxious
Distressed/Past
Past month externalizing symptoms
Lied
Attention
Listening
Bully
Fights

Wave 1
(N=32,320)
N (Weighted
%)

Wave 2
(N=26,444)
N (Weighted
%)

Wave 3
(N=26,239)
N (Weighted
%)

16306 (48.1)
15980 (51.9)

13067 (47.9)
13354 (52.1)

12830 (47.9)
13386 (52.1)

9110 (13.0)
6337 (17.7)
4930 (16.5)
4846 (17.9)
3971 (16.6)
3110 (18.2)

6259 (11.1)
5674 (17.8)
4200 (16.8)
4030 (17.5)
3507 (17.3)
2770 (19.5)

6546 (10.8)
5824 (17.8)
3971 (16.4)
3804 (17.5)
3389 (17.5)
2703 (20.0)

19295 (66.0)
4496 (11.2)
2429 (7.5)
4817 (13.3)

15757 (65.9)
3774 (11.2)
1948 (7.7)
3949 (13.4)

15368 (65.8)
3808 (11.2)
1946 (7.6)
4067 (13.5)

4233 (11.6)
9765 (29.5)
11300 (31.0)
4498 (17.8)
2311 (10.1)

3159 (10.9)
7516 (27.8)
9567 (32.3)
3971 (18.4)
2106 (10.6)

3101 (10.8)
7591 (27.8)
9416 (32.0)
3944 (18.7)
2074 (10.8)

5668 (13.7)
6768 (20.4)
6670 (23.0)
6140 (24.9)
3914 (18.0)

4358 (12.3)
5598 (19.9)
5665 (22.9)
5415 (26.2)
3519 (18.7)

4192 (11.4)
5384 (19.1)
5672 (22.9)
5546 (26.8)
3658 (19.8)

6942 (22.3)
13742 (46.1)
8157 (23.7)
2376 (5.6)
1001 (2.3)

5285 (20.9)
11295 (46.8)
7015 (24.2)
1975 (5.8)
812 (2.3)

5630 (21.4)
10578 (44.6)
6895 (24.6)
2119 (6.6)
939 (2.7)

10381 (16.6)
578 (0.9)
996 (1.5)
17787 (52.4)
4392 (7.1)
1950 (5.1)

8373 (16.6)
593 (1.2)
1069 (2.0)
15312 (54.4)
4363 (8.9)
1707 (5.4)

7904 (16.6)
703 (1.5)
938 (1.8)
14749 (53.9)
4630 (9.7)
1737 (5.8)

5692 (13.4)
9564 (26.7)
6864 (16.1)
5605 (12.5)

4639 (13.6)
7745 (27.0)
5602 (16.5)
4577 (13.1)

4421 (13.2)
7152 (25.4)
5433 (16.0)
4493 (12.7)

3245 (7.1)
5831 (14.6)
4128 (10.4)
737 (1.7)
404 (0.7)

2399 (6.6)
4818 (15.3)
3480 (11.3)
635 (1.7)
331 (0.7)

2360 (6.4)
4798 (15.4)
3478 (11.3)
641 (1.7)
336 (0.7)
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Restless
Answered

2953 (6.2)
11399 (32.0)

2125 (5.9)
8390 (29.8)

2112 (5.6)
8033 (28.5)

Latent Class Comparisons
Four class solution
The four-class model was selected for interpretation in Wave 1 because (1) the
AIC, BIC, and sample-size adjusted BIC were smallest for the four-class solution
compared to the three- and two- class solutions, and (2) the LMRT was statistically
significant, rejecting the five-class model when compared to the four-class model. A
four-class solution was also selected for Waves 2 and 3 to compare latent classes
across waves (Table 5.2).
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Table 5.2: Model Parsimony and Fit Statistics for Five-Class Solution by Wave
AIC

BIC

Sample-Size
Adjusted BIC

Entropy

Ho LL

LMRT

p-value

Wave 1

303521

304117

303891

0.844

-153520

3641

<0.05

Wave 2

252434

253015

252789

0.847

-127721

3134

<0.05

Wave 3

249796

250377

250151

0.787

-125429

1196

0.5789

LC 1

LC 2

LC 3

LC 4

1960
(6.1%)
1727
(6.5%)
2140
(8.2%)

2691
(8.3%)
2316
(8.8%)
5400
(20.6%)

23571
(72.9%)
3478
(13.2%)
17176
(65.5%)

4098
(12.7%)
18922
(71.6%)
1524
(5.8%)

NOTE: AIC = Akaike information criteria, BIC = Bayesian information criteria, LL = log likelihood, LMRT = Lo Mendell Rubin Test, LC = latent
class
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Class probability
The four classes were labeled based on the characteristics of the item response
probabilities of the specific class. The low symptom class was most common across the
three waves and gradually decreased from Wave 1 to Wave 3 (NWave 1 = 23,571, 72.9%;
NWave 2 = 18,922, 71.6%; NWave 3 = 17,176, 65.5%). The comorbid class was the least
common across the three waves and gradually increased from Wave 1 to Wave 3
(NWave 1 = 1,960, 6.1%; NWave 2 = 1,727, 6.5%; NWave 3 = 2,140, 8.2%), seen in Table 5.3.
Table 5.3: Class Probability by Wave
Low
Comorbid
Comorbid
Class
Class
Wave 1
Wave 2
Wave 3

Externalizing
Class

Low
Symptom
Class

Negative
Affect Class

Substance
Use Class

N (Weighted %)

N (Weighted %)

N (Weighted %)

N (Weighted %)

N (Weighted %)

N (Weighted %)

1960 (6.1%)
1727 (6.5%)
2140 (8.2%)

--5400 (20.6%)

2691 (8.3%)
2316 (8.8%)
--

23571 (72.9%)
18922 (71.6%)
17176 (65.5%)

4098 (12.7%)
3478 (13.2%)
--

--1524 (5.8%)

The externalizing and negative affect classes remained stable at Waves 1 and 2.
At Wave 3, however, the classes changed in composition. Rather than externalizing and
negative affect classes, low comorbid and substance use classes emerged.

Item response probabilities
Figures 5.1 – 5.3 display the item-probability plots for the four-class solution for
Waves 1, 2, and 3. Tables 5.4 – 5.6 presents the corresponding conditional probability
or item response probability values for the four comorbidity classes for Waves 1, 2, and
3. There are seventeen items (six substance use, four negative affect, and seven
externalizing items) along the x-axis of each plot. The y-axis represents the probability
of endorsing a given item. The four lines, called profiles, correspond to the four classes
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in the LCA solution and the values are the conditional item probabilities for each of the
seventeen items across the four classes.
The comorbid and the low symptom classes were the most extreme classes that
consistently emerged across the three waves. The comorbid class, overall, had high
probability of endorsing most items while the low symptom class generally had low
probability of endorsing all items except for endorsing past 30-day alcohol use.
Similar profiles emerged across Waves 1 and 2, particularly for the negative
affect and externalizing classes. The negative affect class had high item response
probabilities on the four negative affect items: feeling depressed (40.2% to 45.5%),
sleeping problems (63.5% to 67.0%), feeling anxious (57.3% to 58.3%), and feeling
distressed about the past (37.7% to 42.3%). The externalizing class had high item
response probabilities on the seven externalizing items: lying (13.8% to 17.9%),
attention problems (75.7% to 78.0%), listening problems (55.3% to 56.9%), bullying
(2.8% to 3.4%), getting into physical fights (0.7% to 1.0%), restlessness (15.9% to
16.9%), and giving an answer before a question is finished being asked (62.9% to
65.3%).
In Wave 3, a low comorbid and substance use class emerged. The low comorbid
class resembled the comorbid class with similar peaks yet overall lower item
endorsement compared to the comorbid class. This was specifically noticeable for the
negative affect and externalizing symptoms where the item response probabilities were
second highest relative to the comorbid class for all negative affect and externalizing
items except for getting into physical fights. The substance use class had higher item
response endorsement for cigarette (43.1%), alcohol (76.1%), and marijuana (69.9%)
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use compared to all other classes. Item response probabilities were also high for ecigarette use (2.9%), dual cigarette and e-cigarette use (3.4%), and PDNP (7.9%).

WAVE 1 - 4 CLASS SOLUTION
Comorbid N=1960 (6.1%)

Externalizing N=2691 (8.3%)

Low Symptom N=23571 (72.9%)

Negative Affect N=4098 (12.7%)
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Figure 5.1: Wave 1 - Four-Class Solution of Substance Use Behaviors and Mental
Disorder Symptoms
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Table 5.4: Wave 1 Item Response Probability Values for Four Latent
Classes

CIG
ECIG
Dual CIG + ECIG
Alcohol
Marijuana
PDNP
Depressed
Sleeping
Anxious
Distressed/Past
Lied
Attention
Listening
Bully
Fights
Restless
Answered

Comorbid
N=1960
(6.1%)

Externalizing
N=2691
(8.3%)

Low Symptom
N=23571
(72.9%)

Negative Affect
N=4098
(12.7%)

34.20%
1.90%
4.60%
57.80%
21.00%
17.70%
79.20%
90.30%
92.40%
80.10%
39.40%
91.20%
74.30%
13.60%
5.60%
34.70%
70.30%

12.90%
1.30%
1.60%
64.40%
10.30%
5.20%
10.50%
40.10%
14.50%
8.20%
17.90%
75.70%
55.30%
3.40%
0.70%
15.90%
65.30%

13.60%
0.70%
1.00%
49.60%
4.30%
2.90%
1.60%
11.30%
1.40%
1.10%
1.50%
1.00%
0.50%
0.20%
0.00%
1.50%
22.00%

26.20%
1.00%
2.50%
56.40%
13.20%
10.50%
45.50%
67.00%
57.30%
42.30%
13.50%
8.90%
2.70%
3.00%
2.00%
11.30%
43.20%
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WAVE 2 - 4 CLASS SOLUTION
Comorbid N=1727 (6.5%)

Externalizing N=2316 (8.8%)

Low Symptom N=18922 (71.6%)

Negative Affect N=3478 (13.2%)
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Figure 5.2: Wave 2 - Four-Class Solution of Substance Use Behaviors and Mental
Disorder Symptoms
Table 5.5: Wave 2 Item Response Probability Values for Four Latent Classes

CIG
ECIG
Dual CIG + ECIG
Alcohol
Marijuana
PDNP
Depressed
Sleeping
Anxious
Distressed/Past
Lied
Attention
Listening
Bully
Fights
Restless
Answered

Comorbid
N=1727
(6.5%)

Externalizing
N=2316
(8.8%)

Low Symptom
N=18922
(71.6%)

Negative Affect
N=3478
(13.2%)

30.10%
2.20%
6.00%
59.70%
22.30%
16.00%
81.60%
90.30%
91.40%
84.60%
41.30%
92.60%
78.10%
13.30%
5.90%
33.90%
69.20%

12.80%
1.70%
2.00%
65.80%
11.60%
5.80%
10.60%
44.70%
17.00%
9.80%
13.80%
78.00%
56.90%
2.80%
1.00%
16.90%
62.90%

14.20%
1.00%
1.40%
52.00%
5.90%
3.50%
1.50%
10.40%
0.00%
1.30%
1.20%
0.90%
0.50%
0.20%
0.10%
1.30%
18.70%

24.10%
1.60%
3.10%
55.70%
14.50%
9.10%
40.20%
63.50%
58.30%
37.70%
11.50%
7.20%
2.20%
2.50%
1.10%
7.50%
41.90%
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WAVE 3 - 4 CLASS SOLUTION
Comorbid N=2140 (8.2%)

Low Comorbid N=5400 (20.6%)

Low Symptom N=17176 (65.5%)

Substance Use N=1524 (5.8%)
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Figure 5.3: Wave 3 - Four-Class Solution of Substance Use Behaviors and Mental
Disorder Symptoms
Table 5.6: Wave 3 Item Response Probability Values for Four Latent Classes

CIG
ECIG
Dual CIG + ECIG
Alcohol
Marijuana
PDNP
Depressed
Sleeping
Anxious
Distressed/Past
Lied
Attention
Listening
Bully
Fights
Restless
Answered

Comorbid
N=2140
(8.2%)
35.20%
3.30%
5.00%
58.00%
26.00%
16.20%
81.90%
89.50%
93.20%
84.50%
38.10%
70.80%
59.60%
12.60%
6.30%
30.90%
64.30%

Low Comorbid
N=5400
(20.6%)
13.50%
1.60%
2.10%
59.90%
8.90%
8.30%
24.50%
49.60%
31.70%
21.80%
11.90%
40.30%
28.30%
2.30%
0.60%
10.70%
51.20%

Low Symptom
N=17176
(65.5%)
11.70%
1.00%
1.10%
48.30%
0.00%
3.20%
1.10%
9.50%
1.30%
0.80%
0.50%
0.50%
0.00%
0.10%
0.00%
0.40%
15.30%

Substance Use
N=1524
(5.8%)
43.10%
2.90%
3.40%
76.10%
69.90%
7.90%
3.30%
11.70%
4.70%
3.80%
3.90%
1.60%
0.00%
0.90%
0.70%
4.30%
28.30%
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Transitions based on cross-sectional results
Individuals in the sample were assigned to one of the four classes based on the
LCA posterior probabilities. This was done for Waves 1, 2, and 3 and class membership
information was merged across the waves to create cross-classification tables. The
tables were used to describe individual movement among the comorbidity classes over
time. Table 5.7 includes cross tabulations for three transition points (i.e., Wave 1 to
Wave 2, Wave 2 to Wave 3, and Wave 1 to Wave 3). To read the Table 5.7, start with
the preceding wave first and look to where people move to the subsequent wave.
Interpret the proportion forward whereas 9.5% of individuals in the negative affect class
at Wave 1 transitioned to the comorbidity class at Wave 2. It is not appropriate,
however, to interpret this proportion backwards (i.e., 9.5% of those in the comorbid
class at Wave 2 were in the negative affect class at Wave 1).
Table 5.7: Transition Tables based on Cross-Sectional LCA Results (%)
W2
W3
LS
NA
W2
COM L COM
LS
SU
65.4%
16.8% 100% COM 7.6% 21.5% 64.3% 6.6% 100%
64.3%
15.9% 100% EXT 7.8% 20.2% 65.0% 6.1% 100%
65.1%
16.2% 100% LS
8.4% 20.5% 65.3% 5.8% 100%
62.3%
15.0% 100% NA
8.2% 20.7% 64.9% 6.1% 100%
W3
W1
COM L COM
LS
SU
COM 8.2%
21.0%
64.9%
6.0% 100%
EXT 7.1%
20.2%
66.8%
5.9% 100%
LS
8.7%
20.2%
65.0%
6.1% 100%
NA
7.6%
22.6%
64.2%
5.6% 100%
W1 = Wave 1, W2 = Wave 2, W3 = Wave 3, COM = comorbidity class, NA = negative affect class, EXT
= externalizing class, LS = low symptom class, L COM = low comorbid, SU = substance use
W1
COM
EXT
LS
NA

COM
8.6%
9.5%
9.5%
9.8%

EXT
9.2%
10.2%
8.9%
10.0%

The values shaded in grey are values that describe stability in membership
status. For example, 8.6% of individuals who were in the comorbidity class in Wave 1
remained in the comorbidity class in Wave 2. The values that are not shaded describe
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movement among the classes. For example, of the individuals who were in the
comorbid class in Wave 1, 16.8% transitioned into the negative affect class in Wave 2.
The low symptom class was the most stable class for all transitions (62.3% to 66.8%).
From Wave 1 to Wave 2, the negative affect class was second to the low symptom
class in stability (15.0%) followed by the externalizing class (10.2%).
As seen in all three transition tables, overall, when individuals transitioned, they
typically to transitioned into the low symptom class (62.3% to 66.8%). The second most
common transition was to the low comorbid class (20.2% to 22.6%) from Wave 2 to
Wave 3 and Wave 1 to Wave 3.

Sociodemographic characteristics
In Waves 1 and 2, males were significantly less likely than females to be
classified in the comorbid and negative affect classes relative to the low symptom class,
seen in Tables 5.8 – 5.10. In Wave 3, this relationship between sex and probability of
latent class membership extended to the low comorbid class where men were less likely
to be classified in the low comorbid class (OR = 0.79, 95% CI = 0.70-0.89), Table 5.10.
However, males were more likely than females to be classified in the substance use
class relative to the low symptom class in Wave 3 (OR = 1.98, 95% CI = 1.73-2.27),
Table 5.10.
For all waves, a trend emerged for age across all classes: as age increased, the
odds of class membership decreased for all classes relative to the low symptom class.
Therefore, the youngest age group (18-24 years) had the highest odds of class
membership compared to the oldest age group (65 years and older), relative to the low
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symptom class (Tables 5.8 – 5.10). In Waves 1 and 2, the relationship between age and
probability of latent class membership was largest in magnitude for the comorbid class.
In Wave 3, the magnitude of association between age and the comorbid class (18-24
years ORWave3 = 13.99, 95% CI = 9.83-19.90) was smaller than the substance use class
(18-24 years ORWave3 = 30.75, 95% CI = 18.99-49.81), Table 5.10.
Respondents who identified as Non-Hispanic Black, Hispanic Multicultural, and
Non-Hispanic Other were significantly less likely than respondents who identified as
Non-Hispanic White to be classified in any of the classes relative to the low symptom
class across all waves except for the relationship between Non-Hispanic Black and the
substance use class in Wave 3 (OR = 1.10, 95% CI = 0.93-1.29).
Generally, all education levels relative to having an advanced degree increased
one’s odds for membership in the comorbid classes for all waves, negative affect
classes for Waves 1 and 2, and the substance use class for Wave 3, relative to the low
symptom class across all three waves. The opposite relationship emerged between
education and the externalizing classes for Waves 1 and 2, and the low comorbid class
for Wave 3. Relative the having an advanced degree, generally all education levels
demonstrated a protective effect for membership in the externalizing classes, especially
in Wave 2 (Tables 5.8 – 5.9). The same relationship between education and latent class
membership emerged between income and latent class membership except for the low
comorbid class in Wave 3. Yet, these associations were not statistically significant (Less
than $10,000 ORWave3 = 1.20, 95% CI = 0.94-1.53; $10,000-$24,999 ORWave3 = 1.14,
95% CI = 0.93-1.39; $25,000-$49,999 ORWave3 = 1.07, 95% CI = 0.89-1.28; $50,000$99,999 ORWave3 = 1.01, 95% CI = 0.85-1.19), Table 5.10.
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Compared to being extremely satisfied, as social satisfaction decreased, the
likelihood of being in the comorbid (Not at all satisfied ORWave1 = 95.87, 95% CI = 66.32138.58; Not at all satisfied ORWave2 = 83.35, 95% CI = 54.05-128.53; Not at all satisfied
ORWave3 = 88.94, 95% CI = 58.93-134.24), negative affect (Not at all satisfied ORWave1 =
22.62, 95% CI = 15.44-33.16; Not at all satisfied ORWave2 = 18.34, 95% CI = 11.6628.84), externalizing (Not at all satisfied ORWave1 = 3.67, 95% CI = 1.62-8.31; Not at all
satisfied ORWave2 = 6.31, 95% CI = 3.12-12.78), low comorbid (Not at all satisfied
ORWave3 = 8.78, 95% CI = 5.47-14.12), and substance use (Not at all satisfied ORWave3 =
4.21, 95% CI = 2.40-7.41) classes significantly increased. A dose-response relationship
was identified with each level decrease of social satisfaction for every latent class
across all waves.
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Table 5.8: Wave 1 - Association Between Demographic and Social Variables on Probability of Latent Class
Membership*
Comorbid Class
Externalizing Class
Negative Affect Class
OR (95% CI)
OR (95% CI)
OR (95% CI)
Sex
REF
REF
REF
Female
0.72 (0.63-0.82)
1.00 (0.87-1.14)
0.74 (0.66-0.83)
Male
Age
18-24 years
10.02 (7.06-14.24)
3.39 (2.69-4.28)
3.88 (3.11-4.83)
25-34 years
6.00 (4.17-8.64)
1.81 (1.40-2.33)
2.39 (1.90-3.01)
35-44 years
4.10 (2.83-5.94)
1.46 (1.11-1.91)
1.69 (1.32-2.16)
45-54 years
3.77 (2.60-5.47)
1.13 (0.86-1.50)
1.52 (1.19-1.93)
55-64 years
2.27 (1.54-3.36)
0.98 (0.73-1.32)
1.44 (1.12-1.85)
REF
REF
REF
65 years +
Race
REF
REF
REF
Non-Hispanic White
Non-Hispanic Black
0.48 (0.40-0.59)
0.62 (0.51-0.77)
0.76 (0.64-0.89)
Non-Hispanic Other
0.73 (0.57-0.94)
0.69 (0.53-0.89)
0.72 (0.56-0.91)
Hispanic Multiracial
0.50 (0.41-0.61)
0.65 (0.52-0.80)
0.78 (0.66-0.93)
Education
Less than high school
1.53 (1.05-2.21)
0.79 (0.57-1.09)
1.62 (1.22-2.15)
GED/High school graduate
1.37 (0.98-1.92)
0.80 (0.61-1.05)
1.42 (1.10-1.83)
Some college (no degree)
1.79 (1.29-2.47)
1.08 (0.85-1.37)
1.36 (1.06-1.75)
Bachelor’s degree
1.35 (0.94-1.93)
1.10 (0.85-1.42)
1.16 (0.88-1.53)
REF
REF
REF
Advanced degree
Income
Less than $10,000
2.54 (2.03-3.18)
0.83 (0.65-1.06)
1.61 (1.32-1.95)
$10,000- $24,999
2.02 (1.62-2.51)
0.55 (0.44-0.68)
1.51 (1.25-1.83)
$25,000- $49,999
1.45 (1.16-1.81)
0.84 (0.68-1.04)
1.11 (0.92-1.33)
$50,000- $99,999
1.00 (0.78-1.27)
1.21 (1.00-1.46)
0.99 (0.82-1.20)
REF
REF
REF
$100,000 or more
Level of satisfaction with social activities and relationships
REF
REF
REF
Extremely satisfied
Very satisfied
1.65 (1.31-2.07)
1.42 (1.18-1.70)
1.55 (1.31-1.85)
Moderately satisfied
8.15 (6.54-10.15)
2.66 (2.18-3.26)
4.53 (3.78-5.43)
A little satisfied
34.19 (26.4-44.29)
3.08 (2.17-4.39)
11.09 (8.70-14.14)
Not at all satisfied
95.87 (66.32-138.58)
3.67 (1.62-8.31)
22.62 (15.44-33.16)
*Reference low symptom class
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Table 5.9: Wave 2 - Association Between Demographic and Social Variables on Probability of Latent
Class Membership*
Comorbid Class
Externalizing Class
Negative Affect Class
OR (95% CI)
OR (95% CI)
OR (95% CI)
Sex
Female
REF
REF
Male
0.57 (0.49-0.66)
1.01 (0.87-1.17)
Age
18-24 years
8.17 (5.73-11.64)
2.75 (2.09-3.62)
25-34 years
5.48 (3.79-7.92)
2.29 (1.73-3.04)
35-44 years
4.39 (3.01-6.39)
1.97 (1.48-2.63)
45-54 years
3.60 (2.46-5.28)
1.30 (0.96-1.77)
55-64 years
2.33 (1.56-3.49)
1.17 (0.85-1.62)
65 years +
REF
REF
Race
Non-Hispanic White
REF
REF
Non-Hispanic Black
0.43 (0.35-0.53)
0.51 (0.39-0.65)
Non-Hispanic Other
0.80 (0.59-1.09)
0.58 (0.43-0.77)
Hispanic Multiracial
0.62 (0.50-0.78)
0.53 (0.41-0.69)
Education
Less than high school
1.28 (0.86-1.90)
0.51 (0.34-0.77)
GED/High school graduate
1.26 (0.89-1.78)
0.62 (0.47-0.82)
Some college (no degree)
1.58 (1.14-2.21)
0.94 (0.73-1.19)
Bachelor’s degree
1.08 (0.74-1.59)
0.91 (0.71-1.17)
Advanced degree
REF
REF
Income
Less than $10,000
2.14 (1.66-2.76)
0.78 (0.57-1.07)
$10,000- $24,999
1.87 (1.46-2.39)
0.89 (0.69-1.15)
$25,000- $49,999
1.29 (1.01-1.65)
0.98 (0.79-1.22)
$50,000- $99,999
1.01 (0.78-1.30)
0.90 (0.73-1.10)
$100,000 or more
REF
REF
Level of satisfaction with social activities and relationships
Extremely satisfied
REF
REF
Very satisfied
1.79 (1.35-2.35)
1.60 (1.3-1.97)
Moderately satisfied
8.36 (6.4-10.91)
3.24 (2.59-4.05)
A little satisfied
33.21 (24.27-45.45)
4.47 (3.05-6.54)
Not at all satisfied
83.35 (54.05-128.53)
6.31 (3.12-12.78)

REF
0.70 (0.62-0.79)
2.59 (2.09-3.22)
1.88 (1.49-2.36)
1.40 (1.11-1.78)
1.44 (1.14-1.82)
1.31 (1.03-1.68)
REF
REF
0.81 (0.69-0.95)
0.74 (0.55-0.99)
0.73 (0.61-0.88)
1.42 (1.04-1.94)
1.40 (1.07-1.85)
1.48 (1.13-1.93)
1.06 (0.79-1.41)
REF
1.63 (1.31-2.04)
1.52 (1.23-1.87)
1.18 (0.97-1.44)
0.90 (0.73-1.10)
REF
REF
1.69 (1.4-2.03)
4.07 (3.35-4.94)
10.9 (8.35-14.23)
18.34 (11.66-28.84)

*Reference low symptom class
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Table 5.10: Wave 3 - Association Between Demographic and Social Variables on Probability of Latent
Class Membership*
Comorbid Class
Low Comorbid Class Substance Use Class
OR (95% CI)
OR (95% CI)
OR (95% CI)
Sex
Female
REF
REF
Male
0.78 (0.68-0.91)
0.79 (0.70-0.89)
Age
18-24 years
13.99 (9.83-19.90)
3.23 (2.66-3.94)
25-34 years
8.31 (5.81-11.90)
2.00 (1.64-2.45)
35-44 years
5.49 (3.80-7.94)
1.45 (1.18-1.80)
45-54 years
4.15 (2.87-6.00)
1.26 (1.02-1.56)
55-64 years
2.16 (1.48-3.15)
1.27 (1.03-1.57)
65 years +
REF
REF
Race
Non-Hispanic White
REF
REF
Non-Hispanic Black
0.45 (0.37-0.56)
0.61 (0.52-0.73)
Non-Hispanic Other
0.76 (0.57-1.01)
0.68 (0.53-0.86)
Hispanic Multiracial
0.57 (0.46-0.71)
0.61 (0.51-0.73)
Education
Less than high school
1.64 (1.12-2.40)
0.76 (0.57-0.99)
GED/High school graduate
1.34 (0.94-1.89)
0.81 (0.65-1.01)
Some college (no degree)
1.68 (1.20-2.34)
1.04 (0.85-1.27)
Bachelor’s degree
0.98 (0.68-1.42)
0.89 (0.72-1.11)
Advanced degree
REF
REF
Income
Less than $10,000
2.87 (2.20-3.76)
1.20 (0.94-1.53)
$10,000- $24,999
2.19 (1.70-2.81)
1.14 (0.93-1.39)
$25,000- $49,999
1.43 (1.12-1.83)
1.07 (0.89-1.28)
$50,000- $99,999
1.12 (0.86-1.45)
1.01 (0.85-1.19)
$100,000 or more
REF
REF
Level of satisfaction with social activities and relationships
Extremely satisfied
REF
REF
Very satisfied
1.92 (1.51-2.46)
1.56 (1.32-1.85)
Moderately satisfied
7.52 (5.98-9.45)
3.50 (2.91-4.20)
A little satisfied
36.74 (27.49-49.11)
7.17 (5.43-9.47)
Not at all satisfied
88.94 (58.93-134.24)
8.78 (5.47-14.12)

REF
1.98 (1.73-2.27)
30.75 (18.99-49.81)
17.64 (10.87-28.62)
11.45 (6.99-18.76)
7.46 (4.53-12.30)
6.39 (3.81-10.69)
REF
REF
1.10 (0.93-1.29)
0.61 (0.47-0.80)
0.54 (0.45-0.66)
2.08 (1.38-3.13)
2.34 (1.60-3.43)
2.25 (1.55-3.26)
1.62 (1.10-2.38)
REF
2.35 (1.84-2.99)
1.94 (1.55-2.43)
1.42 (1.14-1.76)
1.07 (0.85-1.34)
REF
REF
1.23 (1.04-1.44)
1.92 (1.59-2.30)
2.51 (1.86-3.39)
4.21 (2.40-7.41)

*Reference low symptom class
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Network Comparisons

Wave 1
The Wave 1 network consisted of 17 nodes (Figure 5.4). The network had 94
non-zero edges out of 136 possible edges (density=0.691), indicating that 69.1% of
possible connections were identified in the network. The network structure is an Ising
model, which is a network of partial correlation coefficients. Especially strong
connections emerged between the tobacco use nodes, between “Attention” and
“Listening”, and “Fights” and “Bully”. The negative affect symptoms were positioned
between the substance use behaviors and externalizing symptoms, with many of the
nodes lying on the periphery of the network. Edge-weights are shown in the Appendix D
(Supplemental Table 5.1).

Figure 5.4: Visualization of Wave 1 Network
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Wave 2
The Wave 2 network consisted of 17 nodes and had 84 non-zero edges out of
136 possible edges (density = 0.618), indicating that 61.8% of possible connections
were identified in the network (Figure 5.5). The network structure is an Ising model,
which is a network of partial correlation coefficients. Similar to Wave 1, strong
connections emerged between the tobacco use nodes, between “Attention” and
“Listening”, and “Fights” and “Bully”. The nodes were clustering based on their
respective groups rather than the negative affect symptoms lying between the
substance use behaviors and negative affect symptoms, as seen in the Wave 1
network. Edge-weights are shown in the Appendix D (Supplemental Table 5.2).

Figure 5.5: Visualization of Wave 2 Network
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Wave 3
The Wave 3 network consisted of 17 nodes and had 95 non-zero edges out of
136 possible edges (density = 0.699), indicating that 69.9% of possible connections
were identified in the network (Figure 5.6). The network structure is an Ising model,
which is a network of partial correlation coefficients. Similar to Waves 1 and 2, strong
connections emerged between the tobacco use nodes, between “Attention” and
“Listening”, and “Fights” and “Bully”. Edge-weights are shown in the Appendix D
(Supplemental Table 5.3).

Figure 5.6: Visualization of Wave 3 Network
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Wave 1 vs Wave 2 Comparison
There were not too many noticeable differences when visually comparing the
Wave 1 and Wave 2 networks (Figure 5.7). The direction of the edges (e.g., positive or
negative) was the same in both networks. The edge-weight between “Bully” and “Fights”
appears larger in Wave 2 compared to Wave 1. Some nodes had more or fewer
connections, depending on the network. For example, alcohol had six connections in
the Wave 1 network versus only three connections in the Wave 2 network.

Figure 5.7: Visual Comparison of Wave 1 and Wave 2 Networks
Nine edges (edge-weights = EW) were significantly different (p < 0.05) between
Wave 1 and Wave 2 (Table 5.11). Overall, these edges increased in magnitude from
Wave 1 to Wave 2 except for the connections between sleeping problems—restless
(EWWave 1= 0.37, EWWave 2 = 0.09), marijuana—PDNP (EWWave 1= 0.62, EWWave 2 = 0.37),
and CIG—sleeping problems (EWWave 1= 0.16, EWWave 2 = 0). Some connections existed
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in one wave where it did not in another: CIG—sleeping (EWWave 1= 0.16, EWWave 2 = 0)
and ECIG—distressed about the past (EWWave 1= 0, EWWave 2 = 0.42).

Table 5.11: Significant Edge Differences between Wave 1 and Wave 2
Node 1
Node 2
W1 Edge
W2 Edge
P-value
0.01
CIG
Marijuana
0.78
0.91
0.01
Marijuana
PDNP
0.62
0.37
0.04
CIG
Sleeping
0.16
0
0.03
ECIG
Distressed/Past
0
0.42
0.03
Anxious
Lied
0.25
0.46
0.01
Distressed/Past Listening
0.20
0.46
0.02
Attention
Listening
3.47
3.72
0.04
Bully
Fights
2.40
2.80
0.01
Sleeping
Restless
0.37
0.09
Despite some node-specific relationships that differed by wave, the overall
structure of the networks (maximum difference = 1.56, p-value = 0.23) and the global
strength (Wave 1 = 56.0, Wave 2 = 59.3, p-value = 0.27) did not significantly differ
between Wave 1 and Wave 2. Therefore, the overall structure and connectivity was not
different between Wave 1 and Wave 2.

Wave 2 vs Wave 3 Comparison
There were fewer differences between Waves 2 and 3 versus Waves 1 and 2
when visually comparing the networks (Figure 5.8). The direction of the edges was the
same in both networks. The magnitudes of the edge-weight appear very similar
between Waves 2 and 3. Some nodes had more or fewer connections depending on the
network. For example, marijuana had eight connections in the Wave 2 network versus
twelve connections in the Wave 3 network.
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Figure 5.8: Visual Comparison of Wave 2 and Wave 3 Networks
Nine edges were significantly different (p < 0.05) between Wave 2 and Wave 3
(Table 5.12). Five edges increased in magnitude from Wave 2 to Wave 3: Dual CIG +
ECIG—listening difficulties (EWWave 2= 0, EWWave 3 = 0.22), listening difficulties—fighting
(EWWave 2= 0, EWWave 3 = 0.40), feeling depressed—restlessness (EWWave 2= 0.14,
EWWave 3 = 0.44), alcohol—answered (EWWave 2= 0.44, EWWave 3 = 0.55), and bullying—
answered (EWWave 2= 0.38, EWWave 3 = 0.65). The remaining four edges decreased in
magnitude from Wave 2 to Wave 3.
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Table 5.12: Significant Edge Differences between Wave 2 and Wave 3
Node 1
Node 2
W2 Edge
W3 Edge
0.42
0
ECIG
Distressed/Past
Dual CIG + ECIG Listening
0
0.22
Marijuana
Listening
0
-0.2
Listening
Fights
0
0.4
CIG
Restless
0
-0.29
Depressed
Restless
0.14
0.44
Distressed/Past
Restless
0.43
0.23
Alcohol
Answered
0.44
0.55
Bully
Answered
0.38
0.65

P-value
0.03
0.02
0.02
0.02
0.02
0.02
0.04
0.03
0.05

Despite the nine node-specific relationships that differed by wave, the overall
structure of the networks (maximum difference = 1.32, p-value = 0.23) and the global
strength (Wave 2 = 59.3, Wave 3 = 60.0, p-value = 0.75) did not significantly differ
between Wave 2 and Wave 3. Therefore, the overall structure and connectivity was not
different between Wave 2 and Wave 3.

Wave 1 vs Wave 3 Comparison
There were few noticeable differences when visually comparing the Wave 1 and
Wave 3 networks (Figure 5.9). The direction of the edges (e.g., positive or negative)
was the same in both networks. The edge-weight between “Bully” and “Fights” appears
larger in Wave 3 compared to Wave 1.
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Figure 5.9: Visual Comparison of Wave 1 and Wave 3 Networks
Twenty-two edges were significantly different (p < 0.05) between Wave 1 and
Wave 3 (Table 5.13). Half of these edges increased in magnitude, specifically CIG—
marijuana (EWWave 1= 0.78, EWWave 3 = 0.93), anxious—distressed about the past
(EWWave 1= 1.63, EWWave 3 = 1.77), and attention difficulties—listening difficulties
(EWWave 1= 3.47, EWWave 3 = 3.66).
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Table 5.13: Significant Edge Differences between Wave 1 and Wave 3
Node 1
Node 2
W1 Edge
W3 Edge
CIG
Alcohol
0
-0.07
CIG
Marijuana
0.78
0.93
Marijuana
PDNP
0.62
0.32
Alcohol
Depressed
0
-0.09
CIG
Sleeping
0.16
0
ECIG
Sleeping
0.22
0
PDNP
Distressed/Past
0.31
0.08
Anxious
Distressed/Past
1.63
1.77
Alcohol
Lied
0.2
0
Marijuana
Lied
0.6
0.39
Sleeping
Lied
0.11
0.3
Sleeping
Attention
0.53
0.69
Dual CIG + ECIG Listening
0
0.22
Marijuana
Listening
0
-0.2
Distressed/Past
Listening
0.2
0.4
Attention
Listening
3.47
3.66
Listening
Fights
0
0.4
Bully
Fights
2.40
2.88
CIG
Restless
-0.09
-0.29
Depressed
Restless
0.19
0.44
Sleeping
Restless
0.37
0.14
Listening
Answered
0.34
0.48

P-value
0.01
0.01
0.01
0.03
0.04
0.04
0.04
0.05
0.01
0.02
0.03
0.04
0.04
0.02
0.05
0.03
0.03
0.03
0.04
0.01
0.02
0.05

Global strength did not significantly differ between Wave 1 and Wave 3 (Wave 1
= 56.0, Wave 3 = 60.0, p-value = 0.24). There was not a significant difference in the
maximum difference in edge weights between Waves 1 and 3 (maximum difference =
0.82, p-value = 0.60). Therefore, the overall structure and connectivity was not different
between Wave 1 and Wave 3.

Wave 1, Wave 2, and Wave 3 Network
The network including Waves 1, 2, and 3 consisted of 51 nodes (Figure 5.10).
The network had 233 non-zero edges out of 1275 possible edges (density=0.183),
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indicating that 18.3% of possible connections were identified in the network. The
network structure is an Ising model, which is a network of partial correlation coefficients.
Edge-weights within a respective wave reduced in magnitude. For example, the edgeweight between cigarette and e-cigarette for the Wave 1 only network was -4.74 and the
edge-weight in the network with three waves is -2.28. Edge-weights are shown in the
Appendix D (Supplemental Table 5.4-5.6).

Figure 5.10: Visualization of the Wave 1, Wave 2, and Wave 3 Network

Nodes clustered by wave with very little overlap. Only two edges connected from
Wave 1 to Wave 2: distressed about the past from Wave 1—dual cigarette and ecigarette from Wave 2 (EW = 0.05, tetrachoric correlation = 0.02, p-value = 0.30), and
lying from Wave 1—PDNP from Wave 2 (EW = -0.14, tetrachoric correlation = -0.02, p-
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value = 0.31). One edge connected from Wave 1 to Wave 3: marijuana from Wave 1—
feeling depressed from Wave 3 (EW = -0.07, tetrachoric correlation = -0.03, p-value =
0.02). No edges connected from Wave 2 to Wave 3. All other tetrachoric correlations
between waves were zero or near zero and were not statistically significant.

DISCUSSION
This is one of the first studies to use results from latent class and network
analyses to preliminarily assess whether comorbidity between substance use behaviors
and mental disorder symptoms changes over time in adults. There were three major
results from this study. First, both latent class profiles and network analyses suggested
that the comorbidity structure remained stable over time. Second, results from the latent
class comparisons demonstrated that for people that did transition to another class,
these transitions moved from a more severe class to a less severe or low symptom
class. Third, the edge strength invariance test suggested stronger connections among
the substance use behaviors and mental health symptoms from preceding to
subsequent waves.

Overall stability in latent profiles with transitions to low symptom class
Similar latent profiles emerged across the three waves in the cross-sectional
review of the four-class solution specifically where the low symptom class was largest
(65.5% to 72.9%) and the comorbid class was smallest (6.1% to 8.2%). These
consistencies also emerged in the multinomial regression analyses to determine which
sociodemographic factors were significantly associated with class membership. These
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results support previous work that have established a stability in substance use and
mental disorder comorbidity over time67–69 and are generally consistent with youth and
young adult studies.227
The largest difference was seen in Wave 3 where low comorbid and substance
use classes emerged rather than the externalizing and negative affect classes from
Waves 1 and 2. There are two potential reasons for this difference. First, it could be the
case that a four-class solution is not most optimal in Wave 3. Results from the entropy
and the Lo-Mendell-Rubin tests did not support the selection of a four-class solution as
most optimal. Yet, a four-class solution was selected in order to easily compare the
latent classes from Wave 3 to the latent classes from Waves 1 and 2. Another reason
could be that the composition of the latent classes shifted meaning that the comorbidity
profile changed from Wave 2 to Wave 3. However, this is not a probable reason
because the same people are included at each wave and a shift in their comorbidity
profiles is unlikely to occur over the course of a year.
The low symptom class was the most stable over the transition periods. Our
results suggest that there was a greater transition from the original class (i.e.,
comorbidity, negative affect, externalizing, low comorbid or substance use) to the low
symptom class compared to stability from the preceding to the subsequent waves. This
is inconsistent with substance use comorbidity research in adolescents, as they have
identified transitions from less to more severe substance use behaviors.12,223,226,227
However, results are consistent with prior mental disorder comorbidity literature that
explains both a continuity and a change.67,227 This transition may indicate that the
individual is receiving the resources and support necessary to remit to a less severe
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class. This could also result from characterizing symptom or behavior patterns rather
than diagnoses. Past month endorsement of a symptom or behavior may be more
flexible to transition compared to a diagnosis. A true longitudinal assessment like a
latent transition analysis is needed to confirm these transitions over time.

No difference in network structure over time but an increase in association between
symptoms and behaviors
There was no significant difference in overall structure and connectivity between
any pairwise network comparison. This finding supports the stability discovered in the
cross-sectional assessments of the latent classes. However, there were significant
differences in edge weights between the waves. These differences (1) occurred within
constructs (e.g., between two substance use behaviors) and across constructs (e.g.,
between a substance use behavior and negative affect symptom), and (2) generally
demonstrated an increase in magnitude from the preceding wave to the subsequent
wave. These discoveries enforce that the comorbidity structure was not dynamic, and
that connections were becoming stronger across a three-year time period.
There are many reasons why connections may increase across time. This could
be due to biological factors (i.e., onset of new disorder symptoms) or time-varying
changes (i.e., age or an increase in education and income). Another important
consideration, however, is the change in substance use and mental health conditions
due to cultural or environmental shifts. For example, there is potential for greater access
to and use of electronic cigarettes as new electronic nicotine delivery systems are
developed. Marijuana is also becoming more widely available in the United States
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because of changes in policies either decriminalizing or legalizing recreational use.
Other worldly events (e.g., the COVID-19 pandemic) may give rise to an increase in
substance use behaviors and mental health problems.32 The biological, time-varying,
cultural and environmental shifts have the potential to increase the connections of
substance use behaviors and mental disorder symptoms over time.
The network with all three waves of data was very sparse, and interesting
connections were not found between nodes in different waves. The data were merged
by an individual’s identification number; however, time was not accounted for in the
network model, meaning that this was not a true longitudinal analysis. Additionally, the
nodes in these networks only capture past month endorsement of substance use
behaviors and mental disorder symptoms. Therefore, it is unlikely that there would be
connections detected between the waves because nodes within a respective wave
represent a different time. Prior work has identified comorbid longitudinal relationships
by using diagnostic level measures after one year68 and three years67 from data
collected at baseline. Relationships have also been identified between depressive
symptoms (measured as the frequency of depressive symptoms within one week using
the Center for Epidemiologic Studies Depression Scale [CES-D]) and past month as
well as past year major depressive disorder diagnosis over seven years of data
collection.229 However, these studies did not utilize a network approach. There are
longitudinal network models for panel data in development that should be leveraged to
more accurately account for the longitudinal nature of these data and explore possible
connections over time.
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Complementary latent class and network results
Both analyses support stability in the comorbidity structures over time. The
preliminary assessments of comorbidity patterns of both approaches complement the
major results that (1) the comorbidity structure exists and remains relatively stable over
time, (2) if a transition occurs in the comorbidity profile, it is likely to move from more to
less severe, and (3) connections among the substance use behaviors and mental
disorder symptoms may be growing larger from preceding to subsequent wave.

Strengths and limitations
Results from this study should be interpreted with consideration of the following
limitations. First, these data were collected between 2013-2016. Three years is likely
not a long enough time frame to detect significant changes in comorbidity. Although
there were considerable cultural and environmental changes during this time (like the
increase and influx of e-cigarette availability and products, respectively, as well as
changes in marijuana legislation across the U.S.), we recommend a more updated
longitudinal assessment of the comorbidity structure especially in light of the COVID-19
pandemic. Second, the approaches used in this study were preliminary assessments of
the comorbidity patterns in a nationally representative sample of adults. A latent
transition analysis was not conducted. Additionally, we did not evaluate the differences
in item response patterns due the overwhelming nature of possible combinations (i.e.,
seventeen items across three time periods). A true longitudinal assessment (i.e., latent
transition analysis) is needed to ensure optimal class solution across the waves and
confirm the transitions found in this study. Third, the ability to perform a longitudinal
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network analysis for panel data is currently limited. This method is in the early stages of
development; therefore, we were limited to pairwise network comparisons. Researchers
should consider using this new approach (i.e., cross-lagged network models) to
investigate the comorbidity structure in future analyses. Fourth, PATH participants who
did not start the study at Wave 1 were not included in our study. This decreased the
sample size; however, we could account for any cohort effects by excluding them from
the study. Furthermore, participants included in the analyses differed significantly from
participants that were excluded due to missing data. Consequently, these results may
not be generalizable to the U.S. adult population. Fifth, the network models did not
adjust for the influence of other sociodemographic variables were not included in these
analyses. Therefore, there may be some residual confounding. Sixth, accuracy and
stability test for Waves 2 and 3 were not conducted; therefore, network results should
be interpreted with caution.

Conclusions
This is the first study to use complementary statistical methods, latent class and
network analysis, to evaluate substance use behavior and mental disorder symptom
comorbidity patterns in adults over time. These results suggest that the comorbidity
structure exists and remains stable. Furthermore, the connections between these
behaviors and symptoms are possibly becoming stronger. Therefore, investment of
time, money, and other resources are encouraged to support those experiencing
comorbidity as they are unlikely to change in adulthood. It is important to target and
maintain interventions based on comorbidity structures because the structure is not
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changing in composition, but is changing in strength. There is a need to support people
based on the comorbidities that they present, not just one behavior or symptom at a
time.
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CHAPTER 6: DISCUSSION

To date, current approaches to detection and prevention of comorbid SUD have
been limited by a focus on SUD exclusively even though substance use often co-occurs
across multiple substances and is often comorbid with mental disorders. This
dissertation sought to address the following knowledge gaps: (1) current SUD research
suffers from the unidimensional approach that does not account for comorbidity; (2)
patterns of comorbidity are not the same, although current knowledge is based on
homogeneous samples; and (3) it is unclear whether patterns of comorbidity remain
stable or changes. Therefore, the goal of this dissertation was to characterize the
comorbidity between substance use, including tobacco use, and mental disorder
symptoms measured as negative affect and externalizing symptoms in a populationbased sample by: preliminarily assessing comorbidity using multinomial regression
between lifetime negative affect severity, externalizing severity and nicotine
dependence, and current use of tobacco (cigarettes and e-cigarettes) and alcohol
(Chapter 2); identifying latent classes of comorbid substance use as well as negative
affect and externalizing symptoms and their ability to predict SUD severity (Chapter 3);
detailing substance use, negative affect, and externalizing symptom networks and
testing for differences in the network structure and connectivity by gender (Chapter 4);
and using pairwise comparisons from the LCA and network results to address stability
or movement of comorbidity structures over three waves of data (Chapter 5).
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Confirmation of the comorbidity structure in U.S. adults prompts a multidimensional
approach to substance use and mental disorders
Results from Chapters 3 and 4 distinguished different comorbidity groups and
identified how the substance use and mental disorder symptoms connected with each
other, respectively. These results confirm a robust comorbidity structure in U.S. adults
by characterizing seventeen substance use behaviors and mental disorder symptoms
into groups and identifying specific connections. The LCA results suggest that
approximately 21% of the sample made up the negative affect or externalizing classes
at Waves 1 and 2, and about 26% made up the low comorbid or substance use classes
at Wave 3. These individuals reflect a subpopulation with possible subthreshold levels
of impairment that may not be identified with current classification systems of substance
use and mental disorders. Network analysis results confirm that connections between
behaviors and symptoms overlap and cut across constructs (i.e., diagnostic
boundaries). Furthermore, these results identified comorbidity patterns, not singular
disorder in the population. This provides reason to reconsider our current
unidimensional approach to substance use and mental disorder comorbidity because
the prevalence of potential subthreshold level comorbidity in the population is
happening at a greater rate than the high comorbidity class (21-26% vs 6-8%). These
results support inclusion and regular study of additional substance use behaviors and
mental disorder symptoms at subthreshold levels. The robust comorbidity structure can
provide insight into the overall wellbeing of an individual. Dissertation results have the
potential to increase comorbidity awareness in clinicians and further help clinicians to
better target comorbidity because specific aspects of substance use and mental
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disorder symptoms that are more likely to occur with each other were identified. Future
studies could build upon these findings and explore how this comorbidity awareness
can be applied to clinical settings. In the future, comorbidity research done in the clinical
space could be translated to encourage increased communication about substance use
behaviors and mental disorder symptoms with clinicians and their clients to consider
comorbidity during health screenings, and support those affected with multiple
conditions more efficiently.

Substance use varied by mental disorder symptoms suggesting different comorbidity
profiles
Analysis of the Population Assessment of Tobacco and Health Study provided a
unique opportunity to study patterns of comorbidity across multiple tobacco products
(i.e., electronic- and conventional- cigarette use) in addition to substance use and
mental health comorbidity. A relatively novel tobacco product, e-cigarettes, was
included in the study while also accounting for the dual use of conventional cigarettes
and e-cigarettes rather than simply classifying any tobacco use through a measure of
nicotine dependence or considering conventional cigarette use only. Dual users
represent a novel and distinct class of tobacco users that must be accounted for,
especially when exploring comorbidity.230 This approach (1) allowed for a more detailed
investigation into how tobacco products present and connect with comorbid substance
use behaviors and mental disorder symptoms, and (2) limited the potential
misclassification bias introduced when dual users are not classified outside of
conventional or e-cigarette use.
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Results from Chapters 3 and 4 indicated that conventional cigarette use and dual
use of conventional cigarettes and e-cigarettes were associated with negative affect
symptoms, while the exclusive use of e-cigarettes was associated with externalizing
symptoms. This result differs from a prior study from Conway et al. (2017) that reported
e-cigarette use to have a larger magnitude of association with negative
affect/internalizing severity compared to externalizing symptoms.73 This difference is
likely due to the classification of tobacco product use. The Conway et al. paper
measured current e-cigarette use without excluding conventional cigarette use.
Nevertheless, dual use of e-cigarette and cigarette use is increasing in the U.S.83 and
about 16% of current smokers were also current e-cigarette users in 2014.85
Additionally, results in Chapter 2 identified patterns of association with mental disorder
symptoms varied by dual use and exclusive use. The results from this dissertation
encourage the study of three separate classes of tobacco products (i.e., exclusive
conventional cigarette use, exclusive e-cigarette use, and dual use of conventional and
e-cigarettes) in order to provide a clearer understanding of comorbidity profiles related
to substance use behaviors and mental disorder symptoms in U.S. adults.
Chapter 2 determined that the associations between psychopathology (negative
affect vs. externalizing severity) varied by different combinations of alcohol,
conventional cigarette and e-cigarette use. Negative affect severity was associated with
cigarette and alcohol use together as well as alcohol-exclusive use, while externalizing
severity was associated with e-cigarette and alcohol use together. These results confirm
that associations between negative affect and externalizing severity varies by different
combinations of alcohol, cigarette, and e-cigarette use.
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Chapter 3 results built on those of Chapter 2 by including a more robust set of
substance use and mental disorder symptom variables (i.e., adding marijuana,
prescription drugs not prescribed [PDNP], four negative affect symptoms, and seven
externalizing symptoms) and extending past multinomial regression by using a latent
class analysis approach to detail the patterns of specific substance use behaviors that
have different relationships with mental disorder symptoms. Specifically, exclusive
cigarette use, dual cigarette and e-cigarette use, marijuana use, and PDNP were
associated with a negative affect class. In contrast, exclusive e-cigarette and alcohol
use were associated with an externalizing class. Results from Chapter 3 confirmed the
relationship between conventional cigarette use and negative affect identified in Chapter
2, and provided more clarity on the relationships between dual cigarette and e-cigarette
use and negative affect as well as exclusive e-cigarette use and alcohol use with
externalizing symptoms.
Chapter 4 complemented the results from Chapter 3 by identifying the
magnitudes of specific connections between a unique pair of variables. PDNP,
marijuana use, dual use of cigarette and e-cigarette, and conventional cigarette use had
strong connections with negative affect symptoms. PDNP use was most strongly
associated with negative affect symptoms. Marijuana and alcohol use were most
strongly associated with externalizing symptoms. Results from the nodewise
predictability analysis identified which nodes were most important in influencing the
other nodes in the network, an important discovery regarding intervention.
It is often thought that interventions can be best developed using longitudinal
data. However, the use and incorporation of marginal effects in models have been

216

utilized more frequently in health systems research to establish expectations related to
interventions, particularly for cross-sectional data.231 An underappreciated result from
network models are the estimates of nodewise predictability, which are produced using
marginal effects. The nodewise predictability results discussed in Chapter 4 provided a
quantitative understanding into how effective intervention could be as well as guidance
on how to intervene on substance use behaviors and mental disorder symptoms (i.e.,
through a specific node of interest or neighboring nodes). Most of the nodes in the
model had a small normalized accuracy, meaning that most of the accuracy or
predictability of these nodes in the network were due to the contribution of the node in
question specifically rather than through the contribution of other nodes. The negative
affect symptoms, attention problems, listening problems, and impulsivity had larger
normalized accuracy in that the accuracy of these symptoms had larger contributions by
other nodes in the network. Therefore, intervention on any of the nodes would likely
influence any other behavior or symptom in the network since the network was largely
determined by itself through strong mutual interactions between nodes.
These results could help to inform future research in clinical spaces to target
specific behaviors and symptom combinations. This type of research could identify a
potential opportunity for clinicians and their patients/clients to have an open
conversation about substance use behaviors that may influence their mental health and
vice versa. A clinician could consider alternative approaches for someone with
comorbidity versus someone affected with a single condition. For example, if a person
were to present with co-occurring dual cigarette and e-cigarette use, a clinician could
consider asking questions about the person’s co-occurring negative affect symptoms.
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The alternative can happen as well: if a person were to present with negative affect
symptoms (i.e., feeling depressed, feeling anxious, experiencing sleeping problems,
and/or feeling distressed about the past), a clinician could ask questions about the
person’s co-occurring tobacco use, specifically conventional cigarette use or the
combination of cigarettes and e-cigarettes together.

Sociodemographic characteristics were associated with comorbidity
The results in Chapters 3, 4, and 5 were consistent with previous work,
particularly as it applies to gender.2,41,123 For instance, compared to men, women had
greater odds of membership in the comorbid, low comorbid, and negative affect latent
classes (Chapters 3 and 5). Compared to women, men had greater odds of
membership in the substance use latent class (Chapter 5). Results from Chapter 4
expanded the gender difference literature related to comorbidity by identifying specific
connections between comorbid substance use and mental disorder symptoms by
gender. Specifically, alcohol use and sleeping problems, exclusive e-cigarette use and
lying, alcohol use and lying, and alcohol use and attention difficulties were all stronger
for men than they were for women.
Chapters 3 and 5 emphasized the importance of age on comorbidity. Participants
of any age category (i.e., 18-24 years, 25-34 years, 35-44 years, 45-54 years, and 5564 years) compared to those ages 65 and older, had greater odds of latent class
membership for all classes. The magnitude of the association gradually decreased as
age increased. This is consistent with previous work where younger people are at
greater risk for mental health and substance use problems compared to people in older
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age categories.41 This matches the age of substance use initiation which typically
occurs in younger age categories, and age of onset for most mental disorders as
roughly 50% to 75% of all lifetime mental disorders start by the mid-teens and mid-20s,
respectively.2,154 Therefore, strategies targeting younger ages, specifically those
between the ages of 18-24 years, could be helpful in reducing comorbidity in younger
ages and possibly prevent comorbidity as age increases.
Chapters 3 and 5 highlighted the role of race/ethnicity on comorbidity and
encourage additional study in this area. For example, participants who described
themselves as belonging to non-White racial categories (i.e., Non-Hispanic Black, NonHispanic Other, Hispanic Multiracial) were less likely to be in any of the following latent
classes compared to those who categorized themselves as Non-Hispanic White:
comorbid, externalizing, negative affect, low comorbid, and substance use classes. This
result does support other findings typically identified in the Black-White mental health
paradox.158 This paradox has generally supported the idea that Black Americans
experience similar or relatively low rates of psychiatric disorders compared to Whites
despite higher stress exposure, greater material hardship, and worse physical health.158
Previous work exploring the Black-White mental health paradox has focused on single
psychiatric conditions158 and these results identify that this paradox is also present for
comorbidity.
Chapters 3 and 5 identified the role of education and income in comorbidity. In
general, low education and income were positively associated with membership in the
comorbid, negative affect, and substance use latent classes. However, a negative
relationship was discovered with low education and income and the externalizing class
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in Waves 1 and 2, and the low comorbid class in Wave 3. Prior work has identified that
higher education and income levels represent a protective relationship from
membership in internalizing or negative affect, externalizing, and high psychopathology
classes.41 Therefore, our result of low education and income being less likely to occur
with externalizing and low comorbid classes is different than what has previously been
identified. Future research should continue to include socioeconomic status variables in
the assessment of comorbidity to further clarify this association.
A social support variable was included in Chapters 3 and 5 because the
relationship between social support and substance use behaviors/disorders (1) is wellestablished in youth, but results are mixed, and (2) may be a potential modifiable factor
to use as part of intervention strategies to address substance use and mental disorder
symptom comorbidity. This variable also provided insight into how an individual’s
interpersonal relationships were associated with comorbidity as previous research has
only focused on a single outcome (e.g., substance use only).232,233 The associations
between social satisfaction and latent class membership reflected a potential doseresponse relationship where a decrease in social satisfaction significantly increased
odds of class membership. This represents a very interesting opportunity for potential
intervention because social satisfaction is an easier factor to influence or change
compared to the other demographic factors included in the analysis (i.e., sex, age, race,
education, and income). Specifically, the probability of class membership in comorbid,
negative affect, low comorbid, or substance use classes could decrease if social
satisfaction can be improved by increasing satisfaction with activities and relationships.
Epidemiologic and community-based participatory research studies have identified the
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benefit of improving social support and relationships to reduce the likelihood of
developing mental health and substance use problems.234–239 Consequently, social
satisfaction should be considered and implemented for public health prevention
strategies related to substance use and mental disorder symptom comorbidity,
supporting and expanding community-wide efforts to develop and increase social
satisfaction.

Comorbidity structure remained stable with transition to lower severity groups but
identification of stronger connections across three data points
Results from Chapter 5 confirmed prior research regarding substance use and
mental disorder symptom comorbidity67,69: the behaviors were stable across three
years. Both the LCA and network analyses showed that the overall comorbidity profiles
and network structures were consistent across waves. Further, evaluation of the
possible latent class transitions among the waves identified that people more commonly
transitioned from more severe class to a less severe class. However, stronger
connections were discovered in subsequent waves when specifically testing for
significant differences in edge-weights of substance use and mental disorder symptom
connections between the waves. Consequently, the connections between these
behaviors and symptoms may become stronger over time. Investment of time, money,
and other resources early in adulthood are encouraged to support those experiencing
comorbidity as the co-occurring behaviors and symptoms are likely to become more
severe in adulthood.
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Latent class analysis and network analysis produce complementary results
Although LCA and network approaches are different and follow different
conceptual frameworks, results from both arrived at similar conclusions described in
Table 6.1. Both LCA and network analysis identified relationships between (1) exclusive
cigarette, dual cigarette and e-cigarette, marijuana, and PDNP with negative affect
symptoms, and (2) alcohol with externalizing symptoms.
Table 6.1: Associations between substance use and mental disorder symptoms
identified through LCA and/or network analysis
Past Month Mental
Network
Past Month Substance Use
LCA
Disorder Symptom
Analysis
Exclusive cigarette
Negative affect
Yes
Yes
Dual cigarette and e-cigarette
Negative affect
Yes
Yes
Negative affect
Yes
Yes
Marijuana
Externalizing
Yes
PDNP
Negative affect
Yes
Yes
Exclusive e-cigarette
Externalizing
Yes
Alcohol
Externalizing
Yes
Yes
Latent class analysis was best at distinguishing different comorbidity in the population
while also accounting for the potential influence of sociodemographic factors compared
to the network analysis. Although the latent class analysis was unsuccessful at using
latent class membership to predict SUD severity, a strong relationship between class
membership and SUD severity was detected. This confirms and underscores the
importance of the relationship between comorbidity and SUD severity.
Network analysis was best at demonstrating the total number of connections
between substance use behaviors and mental disorder symptoms compared to the
LCA, while also showing which behaviors/symptoms were most influential in the
comorbidity network. These results identify important comorbid substance use
behaviors and mental disorder symptoms, informing a more targeted approach to
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comorbidity. There were no significant differences in network structure or connectivity
by gender, but specific connections were different and these differences were
consistent with other literature.2,153,209,240–243
These approaches complement each other because they fill the gaps of the other
approach. Latent class results identified heterogeneous groups in the population which
helped to inform which items were likely to happen with each other. Network analysis
results provided information regarding the strength of associations between two nodes.
For example, alcohol use had relatively high item response probabilities across all
classes, but was highest in the externalizing class. Network analysis results identified
that alcohol use was more strongly associated with the impulsivity externalizing
symptom compared to other externalizing symptoms. In addition to identifying which
substance use behaviors or mental disorder symptoms likely occur with one another,
network analysis complements the latent class results by identifying the magnitude of
the associations. Latent variable and network approaches should continue to be used in
comorbidity studies to further explore the comorbidity structure in other populations
including additional substance use behaviors and mental disorder symptoms.

Future considerations to address dissertation limitations
Symptom-level data (i.e., past month endorsement of substance use and
experiencing negative affect/externalizing symptoms) were used in these analyses to
address research gaps identified in Chapter 1. A strength of using symptom-level data
was that it limited recall bias and accurately accounted for comorbidity overlap (i.e.,
comorbidity occurring within the same time frame). However, it did not identify
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problematic or severe comorbidity. This limitation was obvious in two places in the
dissertation. First, the poor ability to predict SUD severity using latent class membership
in Chapter 3 may have been because of the past-month measurement. Second, pastmonth alcohol use was not necessarily indicative of problematic or harmful alcohol use.
This point was acknowledged specifically in Chapters 4 and 5 regarding why the alcohol
node was not well centralized or connected to others in the network. These points
should be considered when interpreting results from this dissertation.
Results estimated in this dissertation may be subject to bias due to missing data.
The sample was large and missing data did not influence the statistical power of the
models tested. However, the missing data may have represented a misclassification
bias in two ways. First, participants with missing data were significantly different than
those included in the analyses. Those included in the analyses were more likely to
endorse substance use, negative affect symptoms, and externalizing symptoms
compared to those who were missing. Also, the analytic sample were more likely to be
Non-Hispanic white, men, aged 25-54 years with higher levels of education and annual
household income than those who were missing. Consequently, these results may not
be generalizable to the U.S. adult population. Second, there was an expectation for
social desirability bias to play a role in the missing data, meaning that participants might
be less likely to endorse their true substance use behaviors and negative
affect/externalizing symptoms because of the stigmatization surrounding these
measures. This effect is expected to underestimate the study results. Although those
included in the analysis were more likely to endorse substance use behaviors and
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mental disorder symptoms, social desirability may still be at play and should be
considered when interpreting results.
Other statistical approaches are encouraged as the comorbidity research
continues to develop. First, the use of LCA was limited by the conditional independence
assumption and its inability to account for heterogeneous groups within the population
(i.e., SUD and no SUD). Consequently, factor mixture modeling (FMM)131 is suggested
to address this limitation. Unlike LCA, FMM does not operate under the conditional
independence assumption, meaning that it is not the latent class only that truly defines
why the classes emerge as they do. FMM may also better account for the people with
and without SUD in the sample and, therefore, has the potential to create latent classes
that better predict SUD severity.
Second, the comorbidity structure using LCA and network analysis was assessed
separately without the ability to account for both the variance that is unique to pairs of
variables (network approach) and the variance that is shared across all variables (LCA
approach). Therefore, a hybrid latent class and network model, also referred to as
residual network modeling244, should be a method considered in future work. The hybrid
latent class and network model allows for the estimation of structural equation modeling
(like LCA) without the assumption of conditional independence, and the estimation of a
network structure, while considering the fact that the covariance between items may be
partly due to latent factors.244 This approach may further detail the etiology of
comorbidity.
Finally, preliminary assessments of the comorbidity patterns over time were done
by assessing the latent class and network structure cross-sectionally at three separate
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time periods. However, a true longitudinal analysis to test whether the stability or
changes were statistically significant over time was not performed. Latent transition
analysis70,226 is a necessary next analysis to confirm the suspected trends discovered in
Chapter 5. A time-series network model245 should also be considered to similarly
estimate the comorbidity network structure over time. This method for panel data is in
development, but early results suggest it could be the network equivalent to a latent
transition analysis.245

Implications of dissertation results and final conclusions
In summary, there are three specific results from the dissertation that could apply
to public health practice. First, identification of specific substance use and mental
disorder symptom connections can be a useful starting point in discussing comorbidity.
Past-month PDNP was consistently identified to be strongly associated with negative
affect symptoms while alcohol use was consistently identified to be strongly associated
with externalizing symptoms. Therefore, building awareness of co-occurring negative
affect and externalizing symptoms in individuals who are engaged in these past month
substance use behaviors is an appropriate strategy in approaching the comorbidity
conversation and future comorbidity research particularly in clinical spaces.
Second, the nodewise predictability results showed strong mutual interactions
between all nodes. This implies that interventions on any of the six substance use
behaviors, four negative affect symptoms, and seven externalizing symptoms would
likely result in a change in the comorbidity network. Nodes with a greater proportion of
predictability due to other nodes (i.e., negative affect items, attention difficulties,

226

listening difficulties, and impulsivity) may be important to target due to their influence of
other nodes in the network. However, targeting one specific behavior or symptom may
not be the most effective strategy specifically given the pairwise comparison results that
show a stability in the comorbidity profile. Therefore, it is likely that interventions might
be most effective when targeting multiple behaviors and symptoms together.
Last, sociodemographic variables can be helpful in identifying potential risk for
specific comorbidity profiles. For example, a young woman between the ages of 18-24
years with a lower education level or income is at potential risk for membership in the
comorbid or negative affect classes. This demographic information could be used in
public health practice to offer services or programs to people who may likely fit into this
risk profile. Studies have identified the use of individual characteristics to create risk
profiles in machine learning algorithms to predict substance use disorder treatment
success.246–248 Risk profiles have been generated and used in community and clinical
settings to effectively target interventions.249,250 Additionally, the dose-response
relationship identified with social satisfaction and comorbidity represents a unique
opportunity to encourage overall social support and healthy interpersonal relationships,
especially when providing mental health and substance use services. Some studies
have identified that social support interventions (e.g., support group involvement and
utilizing family/friend support in a community-based substance abuse program) resulted
in reduced substance use.251–253 Improving social satisfaction could result in reduced
substance use and may be extended to reducing comorbidity.
Characterizations of the comorbidity structure provide more information on how
to approach substance use and mental disorders. Using a large sample of U.S. adults,
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this study identified specific combinations of substance use behaviors and mental
disorder symptoms, determined which sociodemographic factors play a role in specific
comorbidity profiles, and assessed the patterns of comorbidity among three waves of
data. These results support the need to approach substance use and mental disorders
from a more holistic perspective, taking comorbidity into account to better support the
overall wellbeing of the individual. The results can inform robust and targeted prevention
strategies to effectively mitigate the substantial burden and societal costs of comorbidity
in the U.S. population.
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Supplemental Table 2.1: Model 2 - Presentation of Different Reference Levels for Current Substance Use Outcome (Including Nicotine Dependence) (n = 15,947, Weighted N =
61,482,491)
Alcohol,
Cigarette and
E-cigarette and
Cigarette and
E-cigarette
Cigarette
Alcohol
None
Cigarette, and
E-cigarette
Alcohol
Alcohol
Only
Only
Only
E-cigarette
Variable
AOR (95% CI)
AOR (95% CI)
AOR (95% CI)
AOR (95% CI)
AOR (95% CI)
AOR (95% CI)
AOR (95% CI)
AOR (95% CI)
Negative Affect
Severity (ref=low)
Moderate
REF
0.91 (0.51-1.63)
0.73 (0.39-1.38)
1.11 (0.74-1.67)
0.78 (0.45-1.38)
0.92 (0.61-1.40)
1.19 (0.81-1.75)
0.75 (0.48-1.18)
High
REF
0.67 (0.40-1.11)
0.78 (0.44-1.38)
0.84 (0.56-1.27)
0.65 (0.38-1.10)
0.71 (0.46-1.10)
0.86 (0.57-1.28)
0.65 (0.43-1.01)
Externalizing Severity
(ref=low)
Moderate
REF
0.82 (0.48-1.39)
1.61 (0.92-2.82)
0.99 (0.66-1.51)
0.62 (0.34-1.10)
0.65 (0.44-0.97)
1.14 (0.73-1.77)
0.70 (0.46-1.08)
High
REF
0.69 (0.41-1.17)
1.66 (0.94-2.94)
0.86 (0.57-1.28)
0.65 (0.35-1.18)
0.49 (0.33-0.74)
0.98 (0.64-1.49)
0.56 (0.36-0.87)
Nicotine Dependence
REF
1.02 (1.01-1.03)
0.94 (0.93-0.95)
0.99 (0.98-1.00)
0.95 (0.93-0.96)
1.00 (0.99-1.00)
0.92 (0.91-0.93)
0.94 (0.94-0.95)
Negative Affect
Severity (ref=low)
Moderate
1.10 (0.62-1.96)
REF
0.81 (0.46-1.43)
1.22 (0.81-1.82)
0.86 (0.44-1.69)
1.01 (0.68-1.50)
1.30 (0.87-1.96)
0.83 (0.51-1.35)
High
1.50 (0.90-2.48)
REF
1.17 (0.67-2.02)
1.26 (0.88-1.81)
0.97 (0.58-1.64)
1.06 (0.75-1.51)
1.28 (0.90-1.83)
0.98 (0.65-1.47)
Externalizing Severity
(ref=low)
Moderate
1.23 (0.72-2.08)
REF
1.97 (1.11-3.50)
1.22 (0.84-1.78)
0.75 (0.46-1.25)
0.80 (0.56-1.14)
1.39 (0.93-2.09)
0.86 (0.57-1.30)
High
1.46 (0.86-2.47)
REF
2.42 (1.32-4.44)
1.24 (0.87-1.78)
0.94 (0.53-1.68)
0.72 (0.50-1.03)
1.42 (0.95-2.12)
0.82 (0.54-1.23)
Nicotine Dependence
0.98 (0.98-0.99)
REF
0.93 (0.92-0.94)
0.97 (0.97-0.98)
0.93 (0.92-0.94)
0.98 (0.98-0.99)
0.91 (0.90-0.91)
0.93 (0.92-0.94)
Negative Affect
Severity (ref=low)
Moderate
1.36 (0.72-2.57)
1.24 (0.70-2.19)
REF
1.51 (0.97-2.35)
1.07 (0.56-2.06)
1.26 (0.79-1.99)
1.62 (1.03-2.55)
1.03 (0.64-1.64)
High
1.29 (0.72-2.28)
0.86 (0.50-1.49)
REF
1.08 (0.73-1.61)
0.84 (0.46-1.52)
0.91 (0.61-1.36)
1.10 (0.73-1.65)
0.84 (0.55-1.28)
Externalizing Severity
(ref=low)
Moderate
0.62 (0.35-1.09)
0.51 (0.29-0.90)
REF
0.62 (0.42-0.91)
0.38 (0.23-0.63)
0.40 (0.28-0.59)
0.71 (0.47-1.06)
0.44 (0.29-0.66)
High
0.60 (0.34-1.06)
0.41 (0.23-0.76)
REF
0.51 (0.34-0.78)
0.39 (0.22-0.68)
0.30 (0.19-0.46)
0.59 (0.38-0.91)
0.34 (0.21-0.55)
Nicotine Dependence
1.06 (1.05-1.07)
1.08 (1.06-1.09)
REF
1.05 (1.04-1.06)
1.00 (0.99-1.02)
1.06 (1.05-1.07)
0.97 (0.96-0.99)
1.00 (0.99-1.01)
Negative Affect
Severity (ref=low)
Moderate
0.90 (0.60-1.36)
0.82 (0.55-1.23)
0.66 (0.43-1.03)
REF
0.71 (0.44-1.15)
0.83 (0.71-0.98)
1.07 (0.92-1.26)
0.68 (0.57-0.82)
High
1.19 (0.79-1.80)
0.79 (0.55-1.14)
0.93 (0.62-1.38)
REF
0.77 (0.49-1.23)
0.84 (0.73-0.97)
1.02 (0.85-1.22)
0.78 (0.62-0.97)
Externalizing Severity
(ref=low)
Moderate
1.01 (0.66-1.53)
0.82 (0.56-1.20)
1.62 (1.10-2.39)
REF
0.62 (0.41-0.94)
0.65 (0.58-0.74)
1.14 (0.97-1.36)
0.71 (0.58-0.86)
High
1.17 (0.78-1.76)
0.80 (0.56-1.15)
1.95 (1.28-2.95)
REF
0.76 (0.47-1.22)
0.58 (0.51-0.66)
1.14 (0.94-1.39)
0.66 (0.52-0.82)
Nicotine Dependence
1.01 (1.01-1.02)
1.03 (1.02-1.03)
0.95 (0.94-0.96)
REF
0.96 (0.95-0.97)
1.01 (1.01-1.01)
0.93 (0.93-0.93)
0.95 (0.95-0.96)
Bolded values indicate estimate significant a p < 0.05
Each model adjusts for sex, age, race, education, and annual household income.
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Supplemental Table 2.1 CONTINUED: Model 2 - Presentation of Different Reference Levels for Current Substance Use Outcome (Including Nicotine Dependence) (n = 15,947, Weighted
N = 61,482,491)
Alcohol,
Cigarette and
E-cigarette and
Cigarette and
E-cigarette
Cigarette
Alcohol
None
Cigarette, and
E-cigarette
Alcohol
Alcohol
Only
Only
Only
E-cigarette
Variable
AOR (95% CI)
AOR (95% CI)
AOR (95% CI)
AOR (95% CI)
AOR (95% CI)
AOR (95% CI)
AOR (95% CI)
AOR (95% CI)
Negative Affect
Severity (ref=low)
Moderate
1.28 (0.73-2.24)
1.16 (0.59-2.28)
0.94 (0.49-1.80)
1.41 (0.87-2.29)
REF
1.18 (0.72-1.91)
1.51 (0.95-2.42)
0.96 (0.60-1.55)
High
1.54 (0.91-2.61)
1.03 (0.61-1.72)
1.20 (0.66-2.18)
1.29 (0.81-2.06)
REF
1.09 (0.69-1.71)
1.32 (0.84-2.05)
1.00 (0.63-1.61)
Externalizing Severity
(ref=low)
Moderate
1.63 (0.91-2.91)
1.33 (0.80-2.19)
2.62 (1.59-4.31)
1.62 (1.06-2.46)
REF
1.06 (0.71-1.58)
1.85 (1.21-2.83)
1.14 (0.73-1.79)
High
1.55 (0.85-2.83)
1.06 (0.60-1.90)
2.57 (1.47-4.51)
1.32 (0.82-2.14)
REF
0.76 (0.47-1.24)
1.51 (0.93-2.47)
0.87 (0.51-1.46)
Nicotine Dependence
1.06 (1.05-1.07)
1.08 (1.06-1.09)
1.00 (0.99-1.01)
1.05 (1.04-1.06)
REF
1.06 (1.05-1.07)
0.97 (0.96-0.98)
1.00 (0.99-1.01)
Negative Affect
Severity (ref=low)
Moderate
1.09 (0.72-1.65)
0.99 (0.67-1.47)
0.80 (0.50-1.26)
1.20 (1.03-1.41)
0.85 (0.52-1.38)
REF
1.29 (1.07-1.55)
0.82 (0.65-1.04)
High
1.41 (0.91-2.19)
0.94 (0.66-1.34)
1.10 (0.74-1.64)
1.19 (1.03-1.38)
0.92 (0.58-1.45)
REF
1.21 (1.00-1.46)
0.92 (0.73-1.17)
Externalizing Severity
(ref=low)
Moderate
1.54 (1.03-2.29)
1.26 (0.88-1.80)
2.47 (1.68-3.64)
1.53 (1.35-1.73)
0.95 (0.63-1.41)
REF
1.75 (1.45-2.10)
1.08 (0.89-1.32)
High
2.03 (1.36-3.02)
1.39 (0.97-2.00)
3.37 (2.18-5.21)
1.73 (1.53-1.97)
1.31 (0.81-2.13)
REF
1.98 (1.62-2.42)
1.13 (0.90-1.43)
Nicotine Dependence
1.00 (1.00-1.01)
1.02 (1.01-1.03)
0.95 (0.94-0.95)
0.99 (0.99-0.99)
0.95 (0.94-0.96)
REF
0.92 (0.92-0.93)
0.95 (0.94-0.95)
Negative Affect
Severity (ref=low)
Moderate
0.84 (0.57-1.24)
0.77 (0.51-1.15)
0.62 (0.39-0.98)
0.93 (0.80-1.09)
0.66 (0.41-1.06)
0.78 (0.64-0.94)
REF
0.64 (0.51-0.79)
High
1.17 (0.78-1.75)
0.78 (0.55-1.11)
0.91 (0.61-1.36)
0.98 (0.82-1.18)
0.76 (0.49-1.19)
0.83 (0.69-1.00)
REF
0.76 (0.61-0.96)
Externalizing Severity
(ref=low)
Moderate
0.88 (0.56-1.37)
0.72 (0.48-1.08)
1.42 (0.94-2.13)
0.87 (0.74-1.03)
0.54 (0.35-0.83)
0.57 (0.48-0.69)
REF
0.62 (0.51-0.75)
High
1.02 (0.67-1.55)
0.70 (0.47-1.05)
1.70 (1.10-2.63)
0.88 (0.72-1.06)
0.66 (0.41-1.08)
0.51 (0.41-0.62)
REF
0.57 (0.45-0.73)
Nicotine Dependence
1.09 (1.08-1.10)
1.11 (1.10-1.11)
1.03 (1.02-1.04)
1.08 (1.07-1.08)
1.03 (1.02-1.04)
1.09 (1.08-1.09)
REF
1.03 (1.02-1.03)
Negative Affect
Severity (ref=low)
Moderate
1.33 (0.85-2.07)
1.21 (0.74-1.97)
0.97 (0.61-1.56)
1.47 (1.22-1.77)
1.04 (0.64-1.68)
1.22 (0.96-1.55)
1.58 (1.27-1.96)
REF
High
1.53 (1.00-2.36)
1.02 (0.68-1.53)
1.19 (0.78-1.81)
1.29 (1.03-1.61)
1.00 (0.62-1.60)
1.08 (0.85-1.38)
1.31 (1.05-1.64)
REF
Externalizing Severity
(ref=low)
Moderate
1.42 (0.93-2.17)
1.16 (0.77-1.74)
2.29 (1.53-3.43)
1.41 (1.16-1.72)
0.87 (0.56-1.37)
0.92 (0.76-1.13)
1.62 (1.33-1.97)
REF
High
1.79 (1.15-2.78)
1.23 (0.82-1.85)
2.97 (1.84-4.81)
1.53 (1.21-1.92)
1.16 (0.69-1.95)
0.88 (0.70-1.11)
1.75 (1.38-2.22)
REF
Nicotine Dependence
1.06 (1.05-1.07)
1.08 (1.07-1.09)
1.00 (0.99-1.01)
1.05 (1.04-1.05)
1.00 (0.99-1.01)
1.06 (1.05-1.06)
0.97 (0.97-0.98)
REF
Bolded values indicate estimate significant a p < 0.05
Each model adjusts for sex, age, race, education, and annual household income.
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APPENDIX B: CHAPTER 3

Supplemental Figure 3.1: Cumulative ROC Curve for Substance Use: SUD 0 vs 1,2

Supplemental Figure 3.2: Cumulative ROC Curve for Substance Use: SUD 0,1 vs 2

232

Supplemental Figure 3.3: Cumulative ROC Curve for Class Membership: SUD 0 vs 1,2

Supplemental Figure 3.4: Cumulative ROC Curve for Class Membership: SUD 0,1 vs 2
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Supplemental Figure 3.5: Cumulative ROC Curve for Negative Affect: SUD 0 vs 1,2

Supplemental Figure 3.6: Cumulative ROC Curve for Negative affect: SUD 0,1 vs 2
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Supplemental Figure 3.7: Cumulative ROC Curve for Externalizing: SUD 0 vs 1,2

Supplemental Figure 3.8: Cumulative ROC Curve for Externalizing: SUD 0,1 vs 2
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APPENDIX C: CHAPTER 4

Bootstrap mean

Sample

edge

−5.0

−2.5

0.0

2.5

Supplemental Figure 4.1: Results from Edge-Weight Accuracy Test for the Overall
Sample Network
The assessment of the accuracy of estimated network connections demonstrated that
many edge-weights significantly differ from one-another. Supplemental Figure 1 shows
the bootstrapped confidence intervals of estimated edge-weights for the estimated
overall network. The red line indicates the sample values and the gray area represent
the bootstrapped confidence intervals. Each horizontal line represents one edge of the
network, ordered from the edge with the highest edge-weight to the edge with the
lowest edge-weight. The y-axis labels have been removed to avoid cluttering. There
were narrow bootstrapped confidence intervals (narrowest 95% CI = -0.013; 0.013 for
alcohol—fighting; widest 95% CI = -4.112; -1.211 for ECIG—dual CIG + ECIG) around
the estimated edge-weights allowing for valid interpretation of edge-weights in the
network.
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edge

Supplemental Figure 4.2: Results from the Edge-Weights Significant Difference Test for
the Overall Sample Network
To test for significant difference between edges, a confidence interval was constructed
on the difference of two edges and the test was deemed significant if zero was not in
this confidence interval (represented as a black square in the grid). Supplemental
Figure 2 shows the bootstrapped difference test (alpha = 0.05) between edges weights
that were non-zero in the estimated network. Gray boxes indicate edges that do not
differ significantly from one-another and black boxes represent edges that do differ
significantly from one-another. Colored boxes correspond to the direction of the edge’s
magnitude (i.e., the negative “Dual CIG + ECIG” and “CIG” edge is red, the positive
“Attention” and “Listening” edge is blue). The labels have been removed to avoid
cluttering.
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Supplemental Table 4.1: Edge Matrix for the Overall Sample
1

1. CIG

2

3

4

5

6

7

8

9

10

11

12

13

14

15

0

-4.6

-2.66

0

0

0

0

0

5. Marijuana

0.78

0.62

0.83

1

0

6. PDNP

0.54

0.43

0.78

0

0.62

0

7. Depressed

0.12

0

0

0

0.28

0.11

0

8. Sleeping

0.16

0.22

0.15

0.04

0

0.53

1.16

0

9. Anxious

0.17

0

0.27

0

0

0.31

1.5

1.39

0

10. Distressed/Past

0.24

0

0.25

0

0.17

0.31

1.25

0.77

1.63

0

11. Lied

-0.1

0

-0.14

0.2

0.6

0.21

0.35

0.11

0.25

0.71

0

12. Attention

-0.22

0

0.15

0.18

0.13

0

0.47

0.53

0.49

0.36

0.71

0

13. Listening

0

0

0

0

0

0

0.13

0.33

0.36

0.2

0.35

3.47

0

14. Bully

0.23

0

0

0

0.13

0

0.23

0

0.44

0.39

0.91

0.25

0.42

0

15. Fights

0

0

0.54

0.36

0

0

0

0.45

0.76

0

0

2.4

0

3. Dual CIG + ECIG
4. Alcohol

17

0
-4.74

2. ECIG

16

0

0

16. Restless

-0.09

0

0

0.11

0.37

0

0.19

0.37

0.37

0.29

0.33

0.53

0.4

0.3

0.92

0

17. Answered

-0.05

0

0.1

0.48

0.11

0.07

0

0.35

0.27

0.17

0.59

0.69

0.34

0.48

0

1.1

0
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Average correlation with original sample
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Supplemental Figure 4.3: Results from Centrality Stability Test for the Overall Sample
Network
Supplemental Figure 4.3 shows the average correlations between centrality indices of
networks samples with persons dropped from the original sample to establish the
stability in the centrality indices. Lines represent the means of the centrality indices and
shaded areas indicate the range from the 2.5th quantile and the 97.5th quantile.
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Supplemental Figure 4.4: Results from the Centrality (Node Strength) Significant
Difference Test for the Overall Sample Network
Significant differences between node strength were also tested. Supplemental Figure
4.4 shows the bootstrapped difference tests (alpha = 0.05) between node strength of
the 17 nodes. Gray boxes indicate nodes that did not differ significantly from oneanother and black boxes represent nodes that do differ significantly from one-another
(e.g., the node strength of sleeping is significantly different from the node strength of
alcohol use). White boxes show the value of node strength.
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Supplemental Figure 4.5: Strength and Closeness Centrality Indices as Z-scores for the
Overall Sample Network
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Supplemental Figure 4.6: Results from Edge-Weight Accuracy Test for the Men-Only
Network
The assessment of the accuracy of estimated network connections demonstrated that
many edge-weights significantly differ from one-another. Supplemental Figure 4.6
shows the bootstrapped confidence intervals of estimated edge-weights for the
estimated overall network. The red line indicates the sample values and the gray area
represent the bootstrapped confidence intervals. Each horizontal line represents one
edge of the network, ordered from the edge with the highest edge-weight to the edge
with the lowest edge-weight. The y-axis labels have been removed to avoid cluttering.

242

edge

Supplemental Figure 4.7: Results from the Edge-Weights Significant Difference Test for
the Men-Only Network
Supplemental Figure 4.7 shows the bootstrapped difference test (alpha = 0.05) between
edges weights that were non-zero in the estimated network. Gray boxes indicate edges
that do not differ significantly from one-another and black boxes represent edges that do
differ significantly from one-another. Colored boxes correspond to the color of the edge
(i.e., the negative “Dual CIG + ECIG” and “CIG” edge is red, the positive “Attention” and
“Listening” edge is blue). The labels have been removed to avoid cluttering.
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Supplemental Table 4.2: Edge Matrix for the Men-Only Sample
1
1. CIG

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

0

2. ECIG

-4.16

0

3. Dual CIG + ECIG

-5.31

-1.55

0

0

0

0

0

5. Marijuana

0.81

0.48

0.76

0.87

0

6. PDNP

0.52

0

0.74

0

0.66

0

7. Depressed

0.11

0

0

0

0.22

0

0

8. Sleeping

0

0

0

0.08

0

0.47

1.16

0

9. Anxious

0.16

0

0.2

-0.08

0

0.34

1.51

1.39

0
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0.27

0

0.44

0

0.16

0.27

1.28

0.84

1.69

0
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-0.14

0.25

0
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0.29

0.32

0.07

0.37

0.71

0

12. Attention
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0

0

0.25

0.12

0

0.38

0.5

0.4

0.35
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0
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0

0

0
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0

0
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0

0

0

0.11
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0

0
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0

0
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0

0
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0

0
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0
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0

0

0

0
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0
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0.29
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0.19

0.4
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0.39
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0
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0
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0.46
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0

0
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0.27
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0
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17. Answered

17

0

244

Average correlation with original sample

betweenness

closeness

strength

1.0

0.5

0.0

−0.5

−1.0
90%

80%

70%

60%

50%

40%

30%

Sampled cases

Supplemental Figure 4.8: Results from Centrality Stability Test for the Men-Only
Network
Supplemental Figure 4.8 shows the average correlations between centrality indices of
networks samples with persons dropped from the original sample to establish the
stability in the centrality indices.
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Supplemental Figure 4.9: Results from the Centrality (Node Strength) Significant
Difference Test for the Men-Only Network
Significant differences between node strength were also tested. Supplemental Figure
4.9 shows the bootstrapped difference tests (alpha = 0.05) between node strength of
the 17 nodes. Gray boxes indicate nodes that do not differ significantly from oneanother and black boxes represent nodes that do differ significantly from one-another
(e.g., the node strength of restless is significantly different from the node strength of
alcohol use). White boxes show the value of node strength.
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Supplemental Figure 4.10: Strength and Closeness Centrality Indices as Z-scores for
the Men-Only Network
Supplemental Figure 4.10 shows the men-only network’s corresponding centrality
indices. Centrality indices are shown as z-scores.
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Supplemental Figure 4.11: Results from Edge-Weight Accuracy Test for the WomenOnly Network
The assessment of the accuracy of estimated network connections demonstrated that
many edge-weights significantly differ from one-another. Supplemental Figure 4.11
shows the bootstrapped confidence intervals of estimated edge-weights for the
estimated overall network. The red line indicates the sample values and the gray area
represent the bootstrapped confidence intervals. Each horizontal line represents one
edge of the network, ordered from the edge with the highest edge-weight to the edge
with the lowest edge-weight. The y-axis labels have been removed to avoid cluttering.
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edge

Supplemental Figure 4.12: Results from the Edge-Weights Significant Difference Test
for the Women-Only Network
Supplemental Figure 4.12 shows the bootstrapped difference test (alpha = 0.05)
between edges weights that were non-zero in the estimated network. Gray boxes
indicate edges that do not differ significantly from one-another and black boxes
represent edges that do differ significantly from one-another. Colored boxes correspond
to the color of the edge (i.e., the negative “Dual CIG + ECIG” and “CIG” edge is red, the
positive “Attention” and “Listening” edge is blue). The labels have been removed to
avoid cluttering.
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Supplemental Table 4.3: Edge Matrix for the Women-Only Sample
1
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Supplemental Figure 4.13: Results from Centrality Stability Test for the Women-Only
Network
Supplemental Figure 4.13 shows the average correlations between centrality indices of
networks samples with persons dropped from the original sample to establish the
stability in the centrality indices.
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Supplemental Figure 4.14. Results from the Centrality (Node Strength) Significant
Difference Test for the Women-Only Network
Significant differences between node strength were also tested. Supplemental Figure
4.14 shows the bootstrapped difference tests (alpha = 0.05) between node strength of
the 17 nodes. Gray boxes indicate nodes that do not differ significantly from oneanother and black boxes represent nodes that do differ significantly from one-another
(e.g., the node strength of lied is significantly different from the node strength of alcohol
use). White boxes show the value of node strength.
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Supplemental Figure 4.15: Strength and Closeness Centrality as Z-scores for the
Women-Only Network
Supplemental Figure 4.15 shows the women-only network’s corresponding strength and
closeness. Strength and closeness are shown as z-scores.

253

APPENDIX D: CHAPTER 5

254

Supplemental Table 5.1: Edge Matrix for the Wave 1 Sample
1
1. CIG

2

3

4

5

6

7

8

9

10

11

12

13

14

0

-4.6

-2.66

0

0

0

0

0

5. Marijuana

0.78

0.62

0.83

1

0

6. PDNP

0.54

0.43

0.78

0

0.62

0

7. Depressed

0.12

0

0

0

0.28

0.11

0

8. Sleeping

0.16

0.22

0.15

0.04

0

0.53

1.16

0

9. Anxious

0.17

0

0.27

0

0

0.31

1.5

1.39

0

10. Distressed/Past

0.24

0

0.25

0

0.17

0.31

1.25
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1.63

0

11. Lied

-0.1

0

-0.14

0.2

0.6

0.21

0.35

0.11
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0.71

0
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-0.22

0
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0.13

0

0.47

0.53

0.49

0.36

0.71

0

13. Listening

0

0

0

0

0

0

0.13

0.33

0.36

0.2
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3.47
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14. Bully
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0
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0
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0

0.44
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0.91
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0.11
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0.27

0.17
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Supplemental Table 5.2: Edge Matrix for the Wave 2 Sample
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0.06

0

0

0
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0
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0
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0
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0

0

0
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0.27
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0

-0.16

0

0

0.15

0.09

0

0.51

0.67

0.55

0.25

0.66

0

5. Marijuana
6. PDNP
7. Depressed

11. Lied
12. Attention

14

15

16

0

0

0

0

0

0

0.02

0.31
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0.35

3.72

0
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0

0.3

0

0

0
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0
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0

0
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0.68

0

0

2.8

0

16. Restless

0

0

0

0

0.48
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0.14
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Supplemental Table 5.3: Edge Matrix for the Wave 3 Sample
1
1. CIG
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0
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Supplemental Table 5.4: Edge Matrix for Wave 1, Wave 2, Wave 3 Network by Wave 1
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0.38

0.55
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0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

-0.07

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00
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W3
Attent
ion
W3
Listen
ing
W3
Bully
W3
Fights
W3
Restl
ess
W3
Answ
ered

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00
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Supplemental Table 5.5: Edge Matrix for Wave 1, Wave 2, Wave 3 Network by Wave 2
W2
Dual
W2
W2
W2
W2
W2
W2
W2
CIG + Alcoh Mariju W2
Depre Sleepi Anxio
CIG
ECIG
ECIG
ol
ana
PDNP ssed
ng
us
W1
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
CIG
W1
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ECIG
W1
Dual
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
CIG +
ECIG
W1
Alcoh
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ol
W1
Mariju
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ana
W1
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PDNP
W1
Depre
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ssed
W1
Sleepi
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ng
W1
Anxio
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
us
W1
Distre
0.00
0.00
0.05
0.00
0.00
0.00
0.00
0.00
0.00
ssed/
Past
W1
0.00
0.00
0.00
0.00
0.00
-0.14
0.00
0.00
0.00
Lied
W1
Attent
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ion
W1
Listen
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ing
W1
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Bully

W2
Distre
ssed/
Past

W2
Lied

W2
Attent
ion

W2
Listen
ing

W2
Bully

W2
Fights

W2
Restl
ess

W2
Answ
ered

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00
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W1
Fights
W1
Restl
ess
W1
Answ
ered
W2
CIG
W2
ECIG
W2
Dual
CIG +
ECIG
W2
Alcoh
ol
W2
Mariju
ana
W2
PDNP
W2
Depre
ssed
W2
Sleepi
ng
W2
Anxio
us
W2
Distre
ssed/
Past
W2
Lied
W2
Attent
ion

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

-2.58

-3.18

0.00

0.82

0.48

0.00

0.00

0.16

0.31

0.00

-0.09

0.00

0.00

0.00

-0.03

0.00

-2.58

0.00

-1.69

0.00

0.51

0.39

0.00

0.00

0.00

0.37

0.00

0.00

0.00

0.00

0.00

0.00

0.00

-3.18

-1.69

0.00

0.00

0.90

0.61

0.00

0.00

0.00

0.40

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.86

0.00

0.00

0.00

0.00

0.00

0.00

0.13

0.00

0.00

0.00

0.08

0.39

0.82

0.51

0.90

0.86

0.00

0.31

0.28

0.00

0.00

0.12

0.53

0.10

0.00

0.00

0.00

0.46

0.00

0.48

0.39

0.61

0.00

0.31

0.00

0.00

0.41

0.15

0.00

0.22

0.10

0.00

0.00

0.00

0.00

0.09

0.00

0.00

0.00

0.00

0.28

0.00

0.00

1.17

1.52

1.23

0.23

0.48

0.00

0.00

0.00

0.15

0.00

0.00

0.00

0.00

0.00

0.00

0.41

1.17

0.00

1.36

0.77

0.00

0.71

0.28

0.00

0.00

0.00

0.43

0.16

0.00

0.00

0.00

0.00

0.15

1.52

1.36

0.00

1.74

0.47

0.60

0.16

0.00

0.00

0.28

0.17

0.31

0.37

0.40

0.00

0.12

0.00

1.23

0.77

1.74

0.00

0.81

0.18

0.55

0.56

0.50

0.40

0.10

0.00

0.00

0.00

0.00

0.53

0.22

0.23

0.00

0.47

0.81

0.00

0.66

0.31

0.93

0.77

0.20

0.51

-0.09

0.00

0.00

0.13

0.10

0.10

0.48

0.71

0.60

0.18

0.66

0.00

3.69

0.00

0.14

0.70

0.65
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W2
Listen
ing
W2
Bully
W2
Fights
W2
Restl
ess
W2
Answ
ered
W3
CIG
W3
ECIG
W3
Dual
CIG +
ECIG
W3
Alcoh
ol
W3
Mariju
ana
W3
PDNP
W3
Depre
ssed
W3
Sleepi
ng
W3
Anxio
us
W3
Distre
ssed/
Past
W3
Lied

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.28

0.16

0.55

0.31

3.69

0.00

0.59

0.00

0.40

0.38

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.56

0.93

0.00

0.59

0.00

2.65

0.49

0.20

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.50

0.77

0.14

0.00

2.65

0.00

0.93

0.00

-0.03

0.00

0.00

0.08

0.46

0.00

0.15

0.00

0.28

0.40

0.20

0.70

0.40

0.49

0.93

0.00

1.21

0.00

0.00

0.00

0.39

0.00

0.09

0.00

0.43

0.17

0.10

0.51

0.65

0.38

0.20

0.00

1.21

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00
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W3
Attent
ion
W3
Listen
ing
W3
Bully
W3
Fights
W3
Restl
ess
W3
Answ
ered

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00
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Supplemental Table 5.6: Edge Matrix for Wave 1, Wave 2, Wave 3 Network by Wave 3
W3
Dual
W3
W3
W3
W3
W3
W3
W3
CIG + Alcoh Mariju W3
Depre Sleepi Anxio
CIG
ECIG
ECIG
ol
ana
PDNP ssed
ng
us
W1
CIG
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
W1
ECIG
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
W1
Dual
CIG +
ECIG
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
W1
Alcoh
ol
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
W1
Mariju
ana
0.00
0.00
0.00
0.00
0.00
0.00
-0.07
0.00
0.00
W1
PDNP
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
W1
Depre
ssed
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
W1
Sleepi
ng
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
W1
Anxio
us
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
W1
Distre
ssed/
Past
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
W1
Lied
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
W1
Attent
ion
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
W1
Listen
ing
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
W1
Bully
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

W3
Distre
ssed/
Past

W3
Lied

W3
Attent
ion

W3
Listen
ing

W3
Bully

W3
Fights

W3
Restl
ess

W3
Answ
ered

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00
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W1
Fights
W1
Restl
ess
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SAS File name: LCA W1 4132021
*In the ICPSR_36498 folder, select DS1001 and open the data file (36498-1001-Data) which is
a SAS Cport Transport file. Once this is open, formats are in, and can begin data management;
libname LCA "U:\CourtneyBlondino\PhD Epidemiology\LCA\Data Management";
*Recoding Missings;
data LCA.W1;
set da36498p1001;
*Current User Cigarette;
*R01_AC1002: Ever smoked a cigarette, even one or two puffs;
*R01_AC1005: Number of cigarettes smoked in your entire life;
*R01_AC1003: Now smoke cigarettes;
if R01_AC1002 = 1 AND R01_AC1005=6 AND R01_AC1003 in (1 2) then acur_cig = 1;
else if R01_AC1002 = 2 OR R01_AC1003=3 OR (R01_AC1003 in (1,2,.) AND R01_AC1005 in
(1,2,3,4,5)) then acur_cig=0;
else if R01_AC1002 = . OR R01_AC1003=. OR R01_AC1005=. then acur_cig = .;
*Current E-cigarette user;
*R01_AE1002: Ever used an e-cigarette, even one or two times;
*R01_AE1100: Ever smoked e-cigarettes fairly regularly;
*R01_AE1003: Now use e-cigarettes;
if R01_AE1002 = 1 AND R01_AE1100=1 AND R01_AE1003 in (1,2) then acur_ecig = 1;
else if R01_AE1001=2 OR R01_AE1002 = 2 OR R01_AE1003 = 3 OR (R01_AE1003 in (1,2,.) AND
R01_AE1100 = 2) then acur_ecig=0;
else if R01_AE1002 = . OR R01_AE1001=. OR R01_AE1003 = . OR R01_AE1100 = . then acur_ecig
= .;
***NOT USING FOR LCA************
********************************
*Current Traditional cigar user;
*if R01_AG9003 = 1 AND R01_AG1100TC=1 AND R01_AG1003TC in (1,2) then acur_cigr = 1;
*else if R01_AG1001=2 OR R01_AG9002_01 = 2 OR R01_AG9003= 2 OR R01_AG1003TC= 3 OR
(R01_AG1003TC in
*(1,2,.) AND R01_AG1100TC = 2) THEN acur_cigr = 0;
*ELSE IF R01_AG1001 = . OR R01_AG9003 = . OR R01_AG1100TC = . OR R01_AG1003TC = . OR
R01_AG9002_01 = . THEN
*acur_cigr = .;
*Current Cigarillo user;
*IF R01_AG9004=1 AND (R01_AG9009_01=1 OR R01_AG9009_03=1) AND R01_AG1100CG = 1 AND
R01_AG1003CG in
(1, 2) THEN acur_cigrlo= 1;
*ELSE IF R01_AG9004= 2 OR R01_AG1001=2 OR R01_AG9002_02 = 2 OR R01_AG1003CG=3 OR
R01_AG1100CG=2 OR (R01_AG9009_01=2 AND R01_AG9009_03=2) OR ((R01_AG9009_01=1
*OR R01_AG9009_03=1) AND R01_AG1100CG= 2 AND R01_AG1003CG=.) OR ((R01_AG9009_01=1 OR
*R01_AG9009_03=1) AND R01_AG1100CG=. AND R01_AG1003CG= 3) THEN acur_cigrlo= 0;
*ELSE IF R01_AG1001 = . OR R01_AG9004 = . OR R01_AG9009_03 = . OR R01_AG9009_01 = . OR
R01_AG1100CG = . OR R01_AG1003CG = . OR R01_AG9002_02 = . THEN acur_cigrlo = .;
*Current Filtered Cigar user;
*IF R01_AG9004=1 AND R01_AG9009_02=1 AND R01_AG1100FC = 1 AND R01_AG1003FC in (1, 2) THEN
acur_filcigr= 1;
*ELSE IF R01_AG9004= 2 OR R01_AG1001=2 OR R01_AG9002_02 = 2 OR R01_AG1003FC=3 OR
R01_AG1100FC=2 OR R01_AG9009_02=2
OR (R01_AG9009_02=1 AND R01_AG1100FC= 2 AND R01_AG1003FC=.) OR (R01_AG9009_02=1 AND
R01_AG1100FC=. AND
R01_AG1003FC= 3) THEN acur_filcigr=0;
*ELSE IF R01_AG9004 = . OR R01_AG9009_02 =. OR R01_AG1100FC = . OR R01_AG1003FC = . OR
R01_AG1001 = . OR R01_AG9002_02 = . THEN
*acur_filcigr = .;
*Current Use Any Cigar/Cigarillo;
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*IF (acur_cigr = 1 OR acur_cigrlo = 1 OR acur_filcigr = 1) THEN acur_fullcigr = 1;
*ELSE IF (acur_cigr = 0 AND acur_cigrlo = 0 AND acur_filcigr= 0) THEN acur_fullcigr = 0;
*ELSE IF acur_cigr = . OR acur_cigrlo = . OR acur_filcigr = . THEN acur_fullcigr = .;
*Current Pipe user;
*IF R01_AP1002 = 1 AND R01_AP1100=1 AND R01_AP1003 in (1,2) THEN acur_pipe= 1;
*ELSE IF R01_AP1001=2 OR R01_AP1002= 2 OR R01_AP1003= 3 OR (R01_AP1003 in (1,2,.) AND
R01_AP1100 = 2)
THEN acur_pipe=0;
*ELSE IF R01_AP1001 = . OR R01_AP1002 = . OR R01_AP1003 = . OR R01_AP1100 = . THEN
acur_pipe= .;
*Current Hookah User;
*IF R01_AH1002 = 1 AND R01_AH1100=1 AND R01_AH1003 in (1, 2) THEN acur_hook= 1;
*ELSE IF R01_AH1001=2 OR R01_AH1002= 2 OR R01_AH1003= 3 OR (R01_AH1003 in (1,2,.) AND
R01_AH1100 = 2)
*THEN acur_hook=0;
*ELSE IF R01_AH1002=. OR R01_AH1001=. OR R01_AH1003=. OR R01_AH1100=.
*THEN acur_hook=.;
*Current User Smokeless;
*IF (R01_AS1002_02=1 OR R01_AU1003 in (1,2)) AND R01_AS1100SM = 1 AND R01_AS1003SM in (1,
2) THEN acur_smls= 1;
*ELSE IF R01_AS1001=2 OR R01_AS1002_03=1 OR (R01_AS1002_02=2 AND R01_AU1003 in
(2,3,.)) OR R01_AS1003SM= 3 OR (R01_AS1003SM in (1,2,.) AND R01_AS1100SM = 2) THEN
acur_smls=0;
*ELSE IF R01_AS1002_02 = . OR R01_AU1003 = . OR R01_AS1100SM = . OR
R01_AS1003SM = . OR R01_AS1001 = . THEN acur_smls = .;
*Current User Snus;
*IF R01_AS1002_01=1 AND R01_AU1003 in (2, 3) AND R01_AS1100SU= 1 AND R01_AS1003SU in
(1,2) THEN acur_snus= 1;
*ELSE IF R01_AS1001=2 OR R01_AS1002_03=1 OR (R01_AS1002_01=2 AND R01_AS1002_02=1)
OR (R01_AS1002_01=1 AND R01_AU1003=1) OR (R01_AU1003 in (2,3) AND R01_AS1003SU= 3) OR
(R01_AU1003 in (2,3) AND
R01_AS1003SU in (1,2,.) AND R01_AS1100SU = 2) THEN acur_snus= 0;
*ELSE IF R01_AS1002_01 = . OR R01_AS1002_02 = . OR R01_AS1002_03 = . OR R01_AU1003 = . OR
R01_AS1100SU = . OR R01_AS1003SU =.
*OR R01_AS1001 = . THEN acur_snus=.;
*Current Use Any Smokeless/Snus;
*IF (acur_smls = 1 OR acur_snus = 1) THEN acur_fullsmkls = 1;
*ELSE IF (acur_smls = 0 AND acur_snus = 0) THEN acur_fullsmkls = 0;
*ELSE IF acur_smls = . OR acur_snus = . THEN acur_fullsmkls = .;
*Current User Dissolvable;
*IF R01_AD1002 = 1 AND R01_AD1100=1 AND R01_AD1003 in (1,2) THEN acur_diss= 1;
*ELSE IF R01_AD1001=2 OR R01_AD1002= 2 OR R01_AD1003= 3 OR (R01_AD1003 in (1,2,.) AND
R01_AD1100 = 2) THEN acur_diss=0;
*ELSE IF R01_AD1001 = . OR R01_AD1002 = . OR R01_AD1003 = . OR R01_AD1100 = . THEN
acur_diss = .;
*******************************
*******************************
NEW SUBSTANCES ADDED;
*Current Use Alcohol;
*R01_AX0084 is ever used alcohol
*R01_AX0073 is how long since last used alcohol and 1 is within the past 30 days;
if R01_AX0084 = 1 AND R01_AX0073 = 1 then acur_alc=1;
else if R01_AX0084 = 2 OR R01_AX0073 in (2,3) then acur_alc=0;
else if R01_AX0084= . OR R01_AX0073= . then acur_alc=.;
*Current User Marijuana;

289

*R01_AX0085 is ever used marijuana - look at measures spreadsheet in oral dis proposal
folder;

*R01_AX0078 is how long since last used marijuana and 1 is within the past 30 days;
if R01_AX0078 = 1 then acur_marijuana=1;
else if R01_AX0078 in (-1,2,3) then acur_marijuana=0;
else if R01_AX0078= . then acur_marijuana=.;

*Current User Ritalin or Adderall (prescription drugs not prescribed to you);
*R01_AX0089_01 is ever used ritalin or adderal
*R01_AX0081_01 is how long since last used ritalin or adderall and 1 is within the past
30 days;
*if R01_AX0089_01 = 1 AND R01_AX0081_01 = 1 then acur_ritadder=1;
*else if R01_AX0089_01 = 2 OR R01_AX0081_01 in (2,3) then acur_ritadder=0;
*else if R01_AX0089_01 = . OR R01_AX0081_01= . then acur_ritadder=.;
*Current User Painkillers, Sedatives, or Tranquilizers (prescription drugs not prescribed
to you);
*R01_AX0089_02 is ever used painkillers
*R01_AX0081_02 is how long since last used painkillers and 1 is within the past 30 days;
if R01_AX0089_02 = 1 AND R01_AX0081_02 = 1 then acur_painkiller=1;
else if R01_AX0089_02 = 2 OR R01_AX0081_02 in (2,3) then acur_painkiller=0;
else if R01_AX0089_02 = . OR R01_AX0081_02= . then acur_painkiller=.;
*Current User Cocaine or Crack
*R01_AX0220_01 is ever used cocaine or crack
*R01_AX0081_03 is how long since last used cocaine or crack and 1 is within the past 30
days;

*if R01_AX0220_01 = 1 AND R01_AX0081_03 = 1 then acur_cocaine=1;
*else if R01_AX0220_01 = 2 OR R01_AX0081_03 in (2,3) then acur_cocaine=0;
*else if R01_AX0220_01 = . OR R01_AX0081_03= . then acur_cocaine=.;
*Curent User Meth or Speed
*R01_AX0220_02 is ever used meth or speed
*R01_AX0081_04 is how long since last used meth or speed and 1 is within the past 30

days;

*if R01_AX0220_02 = 1 AND R01_AX0081_04 = 1 then acur_meth=1;
*else if R01_AX0220_02 = 2 OR R01_AX0081_04 in (2,3) then acur_meth=0;
*else if R01_AX0220_02 = . OR R01_AX0081_04= . then acur_meth=.;
*Current User Heroin, Inhalents, Solvents, Hallucinogens
*R01_AX0220_03 is ever used heroin, inhalents, solvents, hallucinogens
*R01_AX0081_05 is how long since last used heroin.... and 1 is within the past 30 days;
*if R01_AX0220_03 = 1 AND R01_AX0081_05 = 1 then acur_heroinplus=1;
*else if R01_AX0220_03 = 2 OR R01_AX0081_05 in (2,3) then acur_heroinplus=0;
*else if R01_AX0220_03 = . OR R01_AX0081_05 = . then acur_heroinplus=.;

*RACE;
*R01R_A_RACECAT3: DERIVED - Race from the interview (3 levels): 1 = white alone, 2 = black alone,
3 = other;
*R01R_A_HISP: DERIVED - Hispanic origin from the interview (2 levels): 1 = hispanic, 2 = not
hispanic;
NUMRACES = 0 ;
if R01R_A_RACECAT3 = 1 then NUMRACES = NUMRACES + 1 ;
if R01R_A_RACECAT3 = 2 then NUMRACES= NUMRACES + 1 ;
if R01R_A_RACECAT3 = 3 then NUMRACES = NUMRACES + 1 ;
if R01R_A_HISP = 1 then NUMRACES = NUMRACES + 1;
if (NUMRACES = 1 and R01R_A_RACECAT3 = 1 AND R01R_A_HISP=2) then R01R_A_ETHRACECAT7= 1 ; *NH
White;
if (NUMRACES = 1 and R01R_A_RACECAT3 = 2 AND R01R_A_HISP=2) then R01R_A_ETHRACECAT7= 2 ; *NH AA;
if (NUMRACES = 1 and R01R_A_RACECAT3 = 3 AND R01R_A_HISP=2) then R01R_A_ETHRACECAT7= 3 ; *NH
Other;
if (NUMRACES = 1 and R01R_A_HISP=1) then R01R_A_ETHRACECAT7= 4; *Hispanic Only;
if (NUMRACES > 1 and R01R_A_HISP=2) then R01R_A_ETHRACECAT7= 5; *NH Multiracial;
if (NUMRACES > 1 and R01R_A_HISP=1) then R01R_A_ETHRACECAT7= 6; *Hispanic Multiracial;
ELSE IF R01R_A_HISP=. OR R01R_A_RACECAT3 = . THEN R01R_A_ETHRACECAT7=.;
*AGE;
if R01R_A_AGECAT7=1 then age=1; *18-24;
else if R01R_A_AGECAT7=2 then age=2; *25-34;
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else
else
else
else
else

if R01R_A_AGECAT7=3 then age=3;
if R01R_A_AGECAT7=4 then age=4;
if R01R_A_AGECAT7=5 then age=5;
if R01R_A_AGECAT7 in (6 7) then
age=.;

*35-44;
*45-54;
*55-64;
age=6; *65 and older;

*EDUCATION;
if R01R_A_AM0018=1 then education=1; *less than high school;
else if R01R_A_AM0018 in (2 3) then education=2; *GED/high school graduate;
else if R01R_A_AM0018=4 then education=3; *Some college (no degree) or associates degree;
else if R01R_A_AM0018=5 then education=4; *Bachelor's degree;
else if R01R_A_AM0018=6 then education=5; *Advanced degree;
else education=.;
*LIMIT ALL MH VARIABLES TO PAST 30 DAYS;
******INTERNALIZING**********;
*R01_AX0161: Last time you had significant problems with: feeling very trapped, lonely, sad,
blue,
depressed or hopeless about the future;
if R01_AX0161 in (2, 3, 4) then depressed=0;
else if R01_AX0161 in (1) then depressed=1;
else if R01_AX0161 = . then depressed= .;
*R01_AX0162: Last time you had significant problems with: Sleep trouble - such as bad
dreams, sleeping restlessly or falling asleep during the day;
if R01_AX0162 in (2, 3, 4) then sleeping=0;
else if R01_AX0162 in (1) then sleeping=1;
else if R01_AX0162 = . then sleeping=.;
*R01_AX0163: Last time you had significant problems with: feeling very anxious, nervous, tense,
panicked or like something bad was going to happen;
if R01_AX0163 in (2, 3, 4) then anxious=0;
else if R01_AX0163 in (1) then anxious=1;
else if R01_AX0163 = . then anxious=.;
*R01_AX0164: Last time you had significant problems with: Becoming very distressed and
upset when something reminded you of the past;
if R01_AX0164 in (2, 3, 4) then ptsd=0;
else if R01_AX0164 in (1) then ptsd=1;
else if R01_AX0164 = . then ptsd=.;
******EXTERNALIZING**********;
*R01_AX0165: Last time you lied or conned to get something;
if R01_AX0165 in (2, 3, 4) then lied=0;
else if R01_AX0165 in (1) then lied=1;
else if R01_AX0165 = . then lied=.;
*R01_AX0166: Last time you did the following two or more times:
had a hard time paying attention at school, work or home;
if R01_AX0166 in (2, 3, 4) then attention=0;
else if R01_AX0166 in (1) then attention=1;
else if R01_AX0166 = . then attention=.;
*R01_AX0167: Last time you did the following two or more times: had a hard
time listening to instructions at school, work or home;
if R01_AX0167 in (2, 3, 4) then listening=0;
else if R01_AX0167 in (1) then listening=1;
else if R01_AX0167 = . then listening= .;
*R01_AX0168: Last time you did the following two or more times:
were a bully or threatened other people;
if R01_AX0168 in (2, 3, 4) then bully=0;
else if R01_AX0168 in (1) then bully=1;
else if R01_AX0168 = . then bully= .;
*R01_AX0169: Last time you did the following two or more times:
started physical fights with other people;
if R01_AX0169 in (2, 3, 4) then fights=0;
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else if R01_AX0169 in (1) then fights=1;
else if R01_AX0169 = . then fights= .;
*R01_AX0250: Last time felt restless/need to climb on things;
if R01_AX0250 in (2, 3, 4) then restless=0;
if R01_AX0250 in (1) then restless=1;
else if R01_AX0250 = . then restless=.;
*R01_AX0251: Last time gave answers before question was finished;
if R01_AX0251 in (2, 3, 4) then answered=0;
if R01_AX0251 in (1) then answered=1;
else if R01_AX0251 = . then answered=.;
******SUBSTANCE USE DISORDERS**********;
*R01_AX0170: Last time used alcohol/drugs weekly or more often;
if R01_AX0170 in (2, 3, 4) then weeklyuse=0;
if R01_AX0170 in (1) then weeklyuse=1;
else if R01_AX0170 = . then weeklyuse=.;
*R01_AX0171: Last time spent a lot of time getting alcohol/drugs;
if R01_AX0171 in (2, 3, 4) then timegetting=0;
if R01_AX0171 in (1) then timegetting=1;
else if R01_AX0171 = . then timegetting=.;
*R01_AX0193: Last time you spent a lot of time using or recovering from alcohol or other drugs;
if R01_AX0193 in (2, 3, 4) then timeusing=0;
if R01_AX0193 in (1) then timeusing=1;
else if R01_AX0193 = . then timeusing=.;
*R01_AX0172: Last time that you kept using alcohol or other drugs even though it was causing
social problems, leading to fights, or getting you into trouble with other people;
if R01_AX0172 in (2, 3, 4) then socialprob=0;
if R01_AX0172 in (1) then socialprob=1;
else if R01_AX0172 = . then socialprob=.;
*R01_AX0173: Last time that your use of alcohol or other drugs reduced your involvement in
activities at work, school, home or social events;
if R01_AX0173 in (2, 3, 4) then reducedact=0;
if R01_AX0173 in (1) then reducedact=1;
else if R01_AX0173 = . then reducedact=.;
*R01_AX0174: Last time that you had withdrawal problems such as shaky hands, throwing up,
having trouble sitting still or sleeping;
if R01_AX0174 in (2, 3, 4) then withdraw=0;
if R01_AX0174 in (1) then withdraw=1;
else if R01_AX0174 = . then withdraw=.;
*R01_AX0194: Use of alcohol/drugs to avoid withdrawal;
if R01_AX0194 in (2, 3, 4) then usetoavoid=0;
if R01_AX0194 in (1) then usetoavoid=1;
else if R01_AX0194 = . then usetoavoid=.;
*ALL PAST 30 DAY;
sud_score = sum(weeklyuse, timegetting, timeusing, socialprob, reducedact, withdraw, usetoavoid);
*OLD;
*SUD is 3 levels- no/low, moderate, and high;
*if sud_score in (0,1) then sud=0;
*if sud_score in (2,3) then sud=1;
*if sud_score in (4,5,6,7) then sud=2;
*if sud_score = . then sud=.;
*NEW = 1/16/20;
*SUD is 3 levels- no/low, moderate, and high;
if sud_score in (0) then sud=0;
if sud_score in (1,2) then sud=1;
if sud_score in (3,4,5,6,7) then sud=2;
if sud_score = . then sud=.;
*Dichotomize by 0 = no/low, 1 = moderate/high;

292

*if sud in (0) then sudbin1=0;
*if sud in (1, 2) then sudbin1=1;
*if sud = . then sudbin1 = .;
*Dichotomize by 0 = no/low/moderate, 1 = high;
*if sud in (0,1) then sudbin2=0;
*if sud in (2) then sudbin2=1;
*if sud = . then sudbin2 = .;
*R01_AX0170 + R01_AX0171 + R01_AX0172 + R01_AX0173 + R01_AX0174 + R01_AX0193 + R01_AX0194;
*Last time used alcohol/drugs weekly or more often;
*if R01_AX0170 = 1 then sudcon1=3;
*if R01_AX0170 = 2 then sudcon1=2;
*if R01_AX0170 = 3 then sudcon1=1;
*if R01_AX0170 = 4 then sudcon1=0;
*else if R01_AX0170 = . then sudcon1=.;
*Last time spent a lot of time getting alcohol/drugs;
*if R01_AX0171 = 1 then sudcon2=3;
*if R01_AX0171 = 2 then sudcon2=2;
*if R01_AX0171 = 3 then sudcon2=1;
*if R01_AX0171 = 4 then sudcon2=0;
*else if R01_AX0171 = . then sudcon2=.;
*Last time spent a lot of time using or recovering;
*if R01_AX0172 = 1 then sudcon3=3;
*if R01_AX0172 = 2 then sudcon3=2;
*if R01_AX0172 = 3 then sudcon3=1;
*if R01_AX0172 = 4 then sudcon3=0;
*else if R01_AX0172 = . then sudcon3=.;
*Last time alcohol/drugs causing social problems;
*if R01_AX0173 = 1 then sudcon4=3;
*if R01_AX0173 = 2 then sudcon4=2;
*if R01_AX0173 = 3 then sudcon4=1;
*if R01_AX0173 = 4 then sudcon4=0;
*else if R01_AX0173 = . then sudcon4=.;
*Reduced involvement with activities;
*if R01_AX0174 = 1 then sudcon5=3;
*if R01_AX0174 = 2 then sudcon5=2;
*if R01_AX0174 = 3 then sudcon5=1;
*if R01_AX0174 = 4 then sudcon5=0;
*else if R01_AX0174 = . then sudcon5=.;
*Withdrawal problems;
*if R01_AX0193 = 1 then sudcon6=3;
*if R01_AX0193 = 2 then sudcon6=2;
*if R01_AX0193 = 3 then sudcon6=1;
*if R01_AX0193 = 4 then sudcon6=0;
*else if R01_AX0193 = . then sudcon6=.;
*Use of alcohol/drugs to avoid withdrawal;
*if R01_AX0194 = 1 then sudcon7=3;
*if R01_AX0194 = 2 then sudcon7=2;
*if R01_AX0194 = 3 then sudcon7=1;
*if R01_AX0194 = 4 then sudcon7=0;
*else if R01_AX0194 = . then sudcon7=.;
*sudconscore = sum(sudcon1, sudcon2, sudcon3, sudcon4, sudcon5, sudcon6, sudcon7);
*****DUMMY CODING FOR THE COVARIATES******;
IF R01R_A_SEX=1 THEN SEXMALE_1=1;
ELSE SEXMALE_1=0;
IF R01R_A_SEX=2 THEN SEXFEMALE_2=1;
ELSE SEXFEMALE_2=0;
IF age=1 THEN AGE1824_1=1;
ELSE AGE1824_1=0;
IF age=2 THEN AGE2534_2=1;
ELSE AGE2534_2=0;
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IF age=3 THEN AGE3544_3=1;
ELSE AGE3544_3=0;
IF age=4 THEN AGE4554_4=1;
ELSE AGE4554_4=0;
IF age=5 THEN AGE5564_5=1;
ELSE AGE5564_5=0;
IF age=6 THEN AGE65_6=1;
ELSE AGE65_6=0;
IF R01R_A_ETHRACECAT7=1 THEN RACEWH_1=1;
ELSE RACEWH_1=0;
IF R01R_A_ETHRACECAT7=2 THEN RACEBL_2=1;
ELSE RACEBL_2=0;
IF R01R_A_ETHRACECAT7=3 THEN RACEOT_3=1;
ELSE RACEOT_3=0;
IF R01R_A_ETHRACECAT7=6 THEN RACEHI_6=1;
ELSE RACEHI_6=0;
IF education=1 THEN EDU_1=1;
ELSE EDU_1=0;
IF education=2 THEN EDU_2=1;
ELSE EDU_2=0;
IF education=3 THEN EDU_3=1;
ELSE EDU_3=0;
IF education=4 THEN EDU_4=1;
ELSE EDU_4=0;
IF education=5 THEN EDU_5=1;
ELSE EDU_5=0;
IF R01R_A_AM0030=1 THEN INC_1=1;
ELSE INC_1=0;
IF R01R_A_AM0030=2 THEN INC_2=1;
ELSE INC_2=0;
IF R01R_A_AM0030=3 THEN INC_3=1;
ELSE INC_3=0;
IF R01R_A_AM0030=4 THEN INC_4=1;
ELSE INC_4=0;
IF R01R_A_AM0030=5 THEN INC_5=1;
ELSE INC_5=0;
*extremely satisfied =1;
IF R01_AX0092=1 THEN SOC_1=1;
ELSE SOC_1=0;
IF R01_AX0092=2 THEN SOC_2=1;
ELSE SOC_2=0;
IF R01_AX0092=3 THEN SOC_3=1;
ELSE SOC_3=0;
IF R01_AX0092=4 THEN SOC_4=1;
ELSE SOC_4=0;
*not at all satisfied =5;
IF R01_AX0092=5 THEN SOC_5=1;
ELSE SOC_5=0;
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array change _numeric_;
do over change;
if change=-97777 then change=.;
else if change=-99999 then change=.;
else if change=-99988 then change=.;
else if change=-99977 then change=.;
else if change=-99955 then change=.;
else if change=-99911 then change=.;
else if change=-9 then change=.;
else if change=-8 then change=.;
else if change=-7 then change=.;
else if change=-1 then change=.;
else if change=-5 then change=.;
end;
run;

*******************NOW CHECK*********************;
*check dummies;
proc freq data=lca.w1;
table
R01R_A_SEX*SEXMALE_1
R01R_A_SEX*SEXFEMALE_2
age*AGE1824_1
age*AGE2534_2
age*AGE3544_3
age*AGE4554_4
age*AGE5564_5
age*AGE65_6
R01R_A_ETHRACECAT7*RACEWH_1
R01R_A_ETHRACECAT7*RACEBL_2
R01R_A_ETHRACECAT7*RACEOT_3
R01R_A_ETHRACECAT7*RACEHI_6
education*EDU_1
education*EDU_2
education*EDU_3
education*EDU_4
education*EDU_5
R01R_A_AM0030*INC_1
R01R_A_AM0030*INC_2
R01R_A_AM0030*INC_3
R01R_A_AM0030*INC_4
R01R_A_AM0030*INC_5
R01_AX0092*SOC_1
R01_AX0092*SOC_2
R01_AX0092*SOC_3
R01_AX0092*SOC_4
R01_AX0092*SOC_5;
run;
*check cig and ecig;
proc freq data=lca.w1;
table R01R_A_CUR_ESTD_CIGS*acur_cig;
table R01R_A_CUR_ESTD_ECIG*acur_ecig;
run;
proc freq data=lca.w1;
table R01_AX0078;
run;
***********************************************
*JULY 1 2020 - MAKING CC AND EC EXCLUSIVE VARS;
data lca.w1july20;
set lca.w1;
*first do multinomial - 4 levels;
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if acur_cig=0 and acur_ecig=0 then
else if acur_cig=1 and acur_ecig=0
else if acur_cig=0 and acur_ecig=1
else if acur_cig=1 and acur_ecig=1
else acur_dual=.;
run;

acur_dual=0;
then acur_dual=1;
then acur_dual=2;
then acur_dual=3;

*check;
proc freq data=lca.w1july20;
table acur_cig*acur_dual;
table acur_ecig*acur_dual;
run;
*then do the dummies;
data lca.w1july20b;
set lca.w1july20;
if acur_dual = 1 then acur_cignew=1;
else acur_cignew=0;
if acur_dual = 2 then acur_ecignew=1;
else acur_ecignew=0;
if acur_dual = 3 then acur_dualnew=1;
else acur_dualnew=0;
run;
*check;
proc freq data=lca.w1july20b;
table acur_cignew*acur_dual;
table acur_ecignew*acur_dual;
table acur_dualnew*acur_dual;
run;
*confirm marijuana is good;
proc freq data=lca.w1july20b;
table acur_marijuana;
run;

*check all substances;
proc freq data=lca.w1;
table acur_cig acur_ecig acur_alc acur_marijuana acur_painkiller;
run;
*check sud;
proc freq data=lca.w1;
table sud_score*sud;
run;
*check int/ext/sud;
proc freq data=lca.w1;
table acur_cig acur_ecig acur_alc acur_marijuana acur_painkiller
R01R_A_SEX age R01R_A_ETHRACECAT7 education R01R_A_AM0030 R01_AX0092
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
weeklyuse timegetting timeusing socialprob reducedact withdraw usetoavoid
sud;
run;

*Identify all variable want to keep;
*Now limit to the main variables that we want to keep;
data LCA.W1mplus;
set LCA.W1 (keep = caseid personid R01_A_PWGT
acur_cig acur_ecig acur_alc acur_marijuana acur_painkiller
R01R_A_SEX age R01R_A_ETHRACECAT7 education R01R_A_AM0030
R01_AX0092
SEXMALE_1 SEXFEMALE_2
AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6
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RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6
EDU_1 EDU_2 EDU_3 EDU_4 EDU_5
INC_1 INC_2 INC_3 INC_4 INC_5
SOC_1 SOC_2 SOC_3 SOC_4 SOC_5
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
weeklyuse timegetting timeusing socialprob reducedact withdraw
usetoavoid
sud );
*rename missings;
array change _numeric_;
do over change;
if change =. then change = -99999;
end;
run;
*Check frequencies;
proc contents data=LCA.W1mplus;
run;
*Maybe later- add weights back in;
proc surveyfreq data=LCA.W1 varmethod=BRR (fay=0.3);
table
acur_cig acur_ecig acur_alc acur_marijuana acur_painkiller
R01R_A_SEX age R01R_A_ETHRACECAT7 education R01R_A_AM0030
R01_AX0092
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
sud
/row chisq(secondorder);
weight R01_A_PWGT;
repweights R01_A_PWGT1 - R01_A_PWGT100;
run;
quit;
run;
*So far so good, let's pull this datset into MPlus and try LCA;

proc freq data=LCA.W1;
table acur_painkiller*acur_cig/chisq oddsratio plcorr;
run;
proc freq data=LCA.W1;
table acur_painkiller*sleeping/chisq oddsratio plcorr;
run;
proc freq data=LCA.W1;
table acur_painkiller*attention/chisq oddsratio plcorr;
run;
proc freq data=LCA.W1;
table acur_painkiller*sleeping*attention/chisq oddsratio plcorr;
run;
proc print data=LCA.W1;
var SOC_5 depressed;
run;
proc freq data=LCA.W1;
table SOC_5*depressed/ chisq oddsratio plcorr;
run;
*current use - conventional cigarette prevalence;
proc surveyfreq data=LCA.W1 varmethod=BRR (fay=0.3);
table
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acur_cig ;
weight R01_A_PWGT;
repweights R01_A_PWGT1 - R01_A_PWGT100;
run;
quit;
run;

*July 2 2020 re-run with new exclusive CC, exclusive EC, and dual variables;
data LCA.W1mplusJuly2020;
set LCA.w1july20b (keep = caseid personid R01_A_PWGT
acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller
R01R_A_SEX age R01R_A_ETHRACECAT7 education R01R_A_AM0030
R01_AX0092
SEXMALE_1 SEXFEMALE_2
AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6
RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6
EDU_1 EDU_2 EDU_3 EDU_4 EDU_5
INC_1 INC_2 INC_3 INC_4 INC_5
SOC_1 SOC_2 SOC_3 SOC_4 SOC_5
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
weeklyuse timegetting timeusing socialprob reducedact withdraw
usetoavoid
sud );
*rename missings;
array change _numeric_;
do over change;
if change =. then change = -99999;
end;
run;
proc freq data=LCA.W1mplusJuly2020;
table acur_marijuana;
run;
*New summary stats;
data LCA.W1mplusJuly2020weights;
set LCA.w1july20b (keep = caseid personid R01_A_PWGT
acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller
R01R_A_SEX age R01R_A_ETHRACECAT7 education R01R_A_AM0030
R01_AX0092
SEXMALE_1 SEXFEMALE_2
AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6
RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6
EDU_1 EDU_2 EDU_3 EDU_4 EDU_5
INC_1 INC_2 INC_3 INC_4 INC_5
SOC_1 SOC_2 SOC_3 SOC_4 SOC_5
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
weeklyuse timegetting timeusing socialprob reducedact withdraw
usetoavoid
sud
R01_A_PWGT1 - R01_A_PWGT100);
run;
*rename missings;
*array change _numeric_;
*do over change;
*if change =. then change = -99999;
*end;
*run;
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proc freq data=LCA.W1mplusJuly2020weights;
table acur_marijuana;
run;
proc surveyfreq data= LCA.W1mplusJuly2020weights varmethod=BRR (fay=0.3);
table acur_marijuana /row chisq(secondorder);
weight R01_A_PWGT;
repweights R01_A_PWGT1 - R01_A_PWGT100;
run;
quit;
run;
proc surveyfreq data= LCA.W1mplusJuly2020weights varmethod=BRR (fay=0.3);
table acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana acur_painkiller
R01R_A_SEX age R01R_A_ETHRACECAT7 education R01R_A_AM0030
R01_AX0092
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
sud
/row chisq(secondorder);
weight R01_A_PWGT;
repweights R01_A_PWGT1 - R01_A_PWGT100;
run;
quit;
run;

proc surveyfreq data= LCA.W1 varmethod=BRR (fay=0.3);
table acur_marijuana
/row chisq(secondorder);
weight R01_A_PWGT;
repweights R01_A_PWGT1 - R01_A_PWGT100;
run;
quit;
run;
*confirm marijuana is good;
proc surveyfreq data=lca.w1july20b varmethod=BRR (fay=0.3);
table acur_marijuana
/row chisq(secondorder);
weight R01_A_PWGT;
repweights R01_A_PWGT1 - R01_A_PWGT100;
run;
quit;
run;

proc mi data=lca.w1july20b seed=14832 nimpute=0 simple;
var acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana acur_painkiller
R01R_A_SEX age R01R_A_ETHRACECAT7 education R01R_A_AM0030
R01_AX0092
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
sud ;
run;

****4/13/2021;
data LCA.W1mplusJuly2020weights4132021;
set LCA.w1july20b (keep = caseid personid R01_A_PWGT
acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller
R01R_A_SEX age R01R_A_ETHRACECAT7 education R01R_A_AM0030
R01_AX0092
SEXMALE_1 SEXFEMALE_2
AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6
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RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6
EDU_1 EDU_2 EDU_3 EDU_4 EDU_5
INC_1 INC_2 INC_3 INC_4 INC_5
SOC_1 SOC_2 SOC_3 SOC_4 SOC_5
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
weeklyuse timegetting timeusing socialprob reducedact withdraw
usetoavoid
sud
R01_A_PWGT1 - R01_A_PWGT100);

*rename missings;
array change _numeric_;
do over change;
if change =. then change = -99999;
end;
run;

proc surveyfreq data=lca.W1mplusJuly2020weights4132021 varmethod=BRR (fay=0.3);
table acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
/row chisq(secondorder);
weight R01_A_PWGT;
repweights R01_A_PWGT1 - R01_A_PWGT100;
run;
quit;
run;
*export lca.W1mplusJuly2020weights4132021
1 - run lca in mplus
*need to rerun the summary stats for wave 1 from this data set =
LCA.W1mplusJuly2020weights4132021;!!!
2 - take results import into sas for prediction
3 - take that into network??
;

***Missing vs nonmissing for W1;
proc contents data=lca.w1july20b;
run;
data lca.w1missingtest;
set lca.w1july20b;
if (acur_cignew=.) or (acur_ecignew=.) or (acur_dualnew=.) or (acur_alc=.) or
(acur_marijuana=.) or (acur_painkiller=.) or
(R01R_A_SEX=.) or (age=.) or (R01R_A_ETHRACECAT7=.) or (education=.) or (R01R_A_AM0030=.) or
(R01_AX0092=.) or
(depressed=.) or (sleeping=.) or (anxious=.) or (ptsd=.) or
(lied=.) or (attention=.) or (listening=.) or (bully=.) or (fights=.) or
(restless=.) or (answered=.) or
(sud=.) then compare=0;
else compare=1;
run;
ods pdf;
proc freq data=lca.w1missingtest;
table compare;
run;
*complete data/analytic sample (compare = 1) = 24039;
*missing (compare = 0) = 8281;
********************************
*compare missing and nonmissing;
*look at column percent;
proc freq data=lca.w1missingtest;
table acur_cignew*compare/chisq;
run;
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*sig different: analytic sample engages in more cig use , chi sq = <.0001;
proc freq data=lca.w1missingtest;
table acur_ecignew*compare/chisq;
run;
*sig different: analytic sample engages in more ecig use , chi sq = 0.002;
proc freq data=lca.w1missingtest;
table acur_dualnew*compare/chisq;
run;
*sig different: analytic sample engages in more dual use , chi sq = <.0001;
proc freq data=lca.w1missingtest;
table acur_alc*compare/chisq;
run;
*sig different: analytic sample engages in more alcohol use , chi sq = <.0001;
proc freq data=lca.w1missingtest;
table acur_marijuana*compare/chisq;
run;
*sig different: analytic sample engages in more, chi sq =<.0001;
proc freq data=lca.w1missingtest;
table acur_painkiller*compare/chisq;
run;
*sig different: analytic sample engages in more, chi sq=<.0001;
*demos;
proc freq data=lca.w1missingtest;
table R01R_A_SEX*compare
age*compare
R01R_A_ETHRACECAT7*compare
education*compare
R01R_A_AM0030*compare
R01_AX0092*compare/chisq;
run;
*sig difference sex: more males, less women in analytic sample;
*sig difference by age: more in categories 2, 3, 4 (25-54) in analytic sample;
*sig difference by race: more white, less other cats in analytic sample;
*sig difference by edu: higher edu levels in analytic sample;
*sig difference by income: higher income levels in analytic sample;
*sig difference by social: missing had more extremely and very satisfied;
*internalizing;
proc freq data=lca.w1missingtest;
table depressed*compare
sleeping*compare
anxious*compare
ptsd*compare/chisq;
run;
*sig diff for all: analytic sample has higher endorsement of all 4 symptoms;
*externalizing;
proc freq data=lca.w1missingtest;
table lied*compare
attention*compare
listening*compare
bully*compare
fights*compare
restless*compare
answered*compare/chisq;
run;
*sig diff for all except fights: all others - analytic sample has higher endorsement of the other
6 symptoms;
*sud;
proc freq data=lca.w1missingtest;
table sud*compare/chisq;
run;
*sig diff: analytic sample has higher endorsement of moderate and high sud severity;
ods pdf close;
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MPLUS File name: WAVE 1 RUN 4132021 4 CLASS
TITLE: WAVE 1 MODEL 4-13-2021 with weights added and new tobacco variables : fixing the missing;
DATA: FILE IS newwave4132021editnoheader.csv;
VARIABLE: NAMES ARE CASEID PERSONID weight
acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller
R01R_A_ETHRACECAT7 age education
depressed sleeping anxious ptsd
lied attention listening bully fights
restless answered
weeklyuse timegetting timeusing socialprob reducedact withdraw usetoavoid
sud
SEXMALE_1 SEXFEMALE_2
AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6
RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6
EDU_1
EDU_2 EDU_3 EDU_4 EDU_5
INC_1 INC_2 INC_3 INC_4 INC_5
SOC_1
SOC_2 SOC_3 SOC_4 SOC_5;
USEVARIABLES = acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered;
IDVARIABLE = CASEID;
MISSING ARE ALL (-99999);
CLASSES = c(4);
CATEGORICAL = acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered;
AUXILIARY = SEXMALE_1 (R3STEP)
AGE1824_1 (R3STEP) AGE2534_2 (R3STEP) AGE3544_3 (R3STEP)
AGE4554_4 (R3STEP) AGE5564_5 (R3STEP)
RACEBL_2 (R3STEP) RACEOT_3 (R3STEP) RACEHI_6 (R3STEP)
EDU_1 (R3STEP) EDU_2 (R3STEP) EDU_3(R3STEP)
EDU_4 (R3STEP) INC_1 (R3STEP) INC_2 (R3STEP)
INC_3 (R3STEP) INC_4 (R3STEP)
SOC_2 (R3STEP) SOC_3 (R3STEP) SOC_4 (R3STEP) SOC_5 (R3STEP);
WEIGHT is weight;
ANALYSIS: TYPE = MIXTURE;
STARTS = 100 10;
OPTSEED = 991329;
LRTSTARTS = 0 0 150 40;
SAVEDATA: file is w14class4132021.csv;
save = Cprob;
OUTPUT: TECH1 TECH8 TECH10 TECH11 TECH14;

SAS File name: Wave 1 4 class prediction 4142021
*Prediction Model - Wave 1 4 Class Solution;
*Data into Mplus is from LCA W1 4132021 (newwave4132021editnoheader.csv);
*MPLUS Output = wave 1 run 4132021 4 class;
*CSV = = w14class4132021;
libname pred "U:\CourtneyBlondino\PhD Epidemiology\April Re Run\Wave 1 Prediction 4142021";
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data pred.w14classprob4142021;
input
ACUR_CIG
ACUR_ECI
ACUR_DUA
DEPRESS
SLEEPING
ANXIOUS
LIED
ATTENTIO
LISTENING
SEXMALE_
AGE1824_
AGE2534_
AGE3544_
AGE4554_
AGE5564_
RACEBL_2
RACEOT_3
RACEHI_6
EDU_1
EDU_2
EDU_3
EDU_4
INC_1
INC_2
INC_3
INC_4
SOC_2
SOC_3
SOC_4
SOC_5
CPROB1
CPROB2
CPROB3
CPROB4
C
WEIGHT
CASEID;
datalines;

ACUR_ALC
PTSD
BULLY

ACUR_MAR

ACUR_PAI

FIGHTS

RESTLESS

ANSWERED

******COPY PASTE OUTPUT DATA FROM MPLUS*****
run;

SAS File name: Wave 1 4 class prediction analysis 4142021
*Run analyses;
libname pred "U:\CourtneyBlondino\PhD Epidemiology\April Re Run\Wave 1 Prediction 4142021";
proc contents data=pred.w14classprob4142021;
run;
*check freqs;
proc surveyfreq data=pred.w14classprob4142021;
table ACUR_MAR/row chisq(secondorder);
weight weight;
run;
*the weighted freqs match with the mplus output;
*now need to merge sud into the dataset using idvariable to get sud outcome in same dataset;
proc sort data=pred.w14classprob4142021;
by caseid;
run;
libname LCA "U:\CourtneyBlondino\PhD Epidemiology\LCA\Data Management";
proc sort data=LCA.W1mplusJuly2020weights4132021;
by caseid;
run;
data pred.w14classprobmerge;
merge pred.w14classprob4142021 LCA.W1mplusJuly2020weights4132021;
by caseid;
array change _numeric_;
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do over change;
if change =-99999 then change = .;
end;
run;
proc print data= pred.w14classprobmerge (obs=20);
run;
****confirming data;
proc contents data=pred.w14classprobmerge;
run;
proc surveyfreq data=pred.w14classprobmerge;
table R01R_A_SEX/row chisq(secondorder);
weight weight;
run;
proc freq data=pred.w14classprobmerge;
table acur_cig*acur_cignew;
*acur_alc;
table acur_dua*acur_dualnew;
table acur_eci*acur_ecignew;
table acur_mar*acur_marijuana;
table acur_pai*acur_painkiller;
*table answered*;
*table anxious;
table attentio*attention;
*table bully;
table depress*depressed;
run;
*Just regression;
proc surveylogistic data=pred.w14classprobmerge;
class c (ref='3')/param=ref;
model sud (descending) = c/ link=glogit;
*output predprobs=(I) out=pred.probs72220;
weight weight;
run;
ods pdf;
*Trying ordinal regression;
proc surveylogistic data=pred.w14classprobmerge;
class c (ref='3')/param=ref order=internal;
model sud (descending) = c/lackfit;
*output predprobs=(I) out=pred.probs72220;
weight weight;
run;
*use lackfit to test get pvalue for prop odds assumption;
proc logistic data=pred.w14classprobmerge;
class c (ref='3')/param=ref order=internal;
model sud (descending) = c/lackfit;
*output predprobs=(I) out=pred.probs72220;
weight weight;
run;
ods pdf close;
libname cb "U:\CourtneyBlondino\PhD Epidemiology\LCA\LizHelp";
/* Mode-selective macro wrapper */
%MACRO
cumRoc3(_yOut,_xPred,_vsLbl,_cutFmt,_dsn,_dir00,_dirOut,_dirPng,_dateOut,_libNm=cb,_propOdds=PO,_
yOrd=A,_macMode=1,_macComp=YES,_outCntnts=YES,_outRtf=NO,_debug0=NO) ;
/* Compile supporting macros */
%IF
%UPCASE(&_macComp)= YES %THEN %DO ;
%INCLUDE "U:\CourtneyBlondino\PhD Epidemiology\LCA\LizHelp\words_MAC.sas"
;
%INCLUDE "U:\CourtneyBlondino\PhD Epidemiology\LCA\LizHelp\00_preCheck_MAC.sas"
;
%INCLUDE "U:\CourtneyBlondino\PhD Epidemiology\LCA\LizHelp\01_dataPre_MAC.sas"
;
%INCLUDE "U:\CourtneyBlondino\PhD Epidemiology\LCA\LizHelp\02_cr3_1Logit_MAC.sas" ;
%INCLUDE "U:\CourtneyBlondino\PhD Epidemiology\LCA\LizHelp\03_cr3_2ROC_MAC.sas"
;
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%INCLUDE
%INCLUDE
%INCLUDE
%INCLUDE
%END ;

"U:\CourtneyBlondino\PhD
"U:\CourtneyBlondino\PhD
"U:\CourtneyBlondino\PhD
"U:\CourtneyBlondino\PhD

Epidemiology\LCA\LizHelp\04_cut3Base_MAC.sas"
Epidemiology\LCA\LizHelp\05_cut3Parmx_MAC.sas"
Epidemiology\LCA\LizHelp\06_parmx95_MAC.sas"
Epidemiology\LCA\LizHelp\07_cr3Results_MAC.sas"

;
;
;
;

%GLOBAL _poTitle _fileSfx ;
/* For portrait with 10pt font */
OPTIONS LINESIZE= 95
PAGESIZE= 54
;
OPTIONS FORMCHAR='|----|+|---+=|-/\<>*';
ODS ESCAPECHAR= "^" ;
/* Check ternary ordinal outcome encoding is compatible with macro */
%preCheck ;
%IF &_yOK EQ PASS %THEN %DO ;
%IF
%UPCASE(&_propOdds)= PO %THEN %DO ;
%LET _poTitle= %STR(Proportional Odds) ;
%LET _fileSfx= &_YOUT._&_XPRED._PO ;
%END ;
%ELSE %IF %UPCASE(&_propOdds)= NPO %THEN %DO ;
%LET _poTitle= %STR(Non-Proportional Odds) ;
%LET _fileSfx= &_YOUT._&_XPRED._NPO ;
%END ;
/* Discard previous temporary datasets */
PROC DATASETS LIBRARY= WORK NOLIST NOPRINT ;
DELETE _inDsn _cutParmx _parmx95 ;
RUN ; QUIT ;
/* Discard previous permanent output datasets */
PROC DATASETS LIBRARY= &_LIBNM NOLIST NOPRINT ;
DELETE PARMS4VAR_&_fileSfx
COVB_&_fileSfx
CUMLOGPARM_&_fileSfx
CUMLOGTABLE_&_fileSfx
CUMLOGPRED_&_fileSfx
ASSOC_&_fileSfx
ROC_&_fileSfx
AUC_&_fileSfx
CUTBASE_&_fileSfx
CUTPARMX_&_fileSfx
CUMROC3_&_fileSfx
;
RUN ; QUIT ;
/*

MACRO MODE
1: Complete procedure: analysis, criteria and parametric cutpoint calculation,

reporting

2: Analysis and criteria and parametric cutpoint calculation only
3: Reporting only: requires 1 or 2 to have been run previously */
%IF &_macMode= 1 OR &_macMode= 2 %THEN %DO ;
%dataPre ;
%cr3_1Logit ;
%cr3_2ROC ;
%cut3Base ;
%cut3Parmx ; %parmx95 ;
%END ;
%IF &_macMode= 1 OR &_macMode= 3
%THEN %cr3Results(CUTPARMX CUTBASE) ;
/* Clean up */
%IF %upCase(&_debug0)= NO
AND
(&_macMode= 1 OR &_macMode= 2)
%THEN %DO ;
PROC DATASETS library= WORK NOLIST NOPRINT ;
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DELETE _inDsn _cutParmx _parmx95 ;
RUN ; QUIT ;
%END ;
%END ;
%MEND cumRoc3 ;
*Create dataset for class and SUD to run the cum ROC;
data cb.macrotestclass4142021;
set pred.w14classprobmerge (keep = sud c);
run;
*ODS HTML Close ; *ODS HTML ;
ODS PDF;
/* Macro debugging: ENABLED */
OPTIONS MLOGIC MPRINT SYMBOLGEN ;
%cumRoc3(sud,c,SUD,%STR(BESTD8.3),macrotestclass4142021,
%STR(C:\Users\blondinoct\Documents\LCA),
%STR(C:\Users\blondinoct\Documents\LCA),
%STR(C:\Users\blondinoct\Documents\LCA),
2019_DEMO,_macMode=1,_macComp=YES,
_outCntnts=YES,_outRtf=NO) ;
/* Macro debugging: DISABLED */
OPTIONS noMLOGIC noMPRINT noSYMBOLGEN ;
*ODS HTML Close ; *ODS HTML ;
ODS PDF CLOSE;
*Create internal score;
data pred.internalscore;
set pred.w14classprobmerge;
*create our continuous internalizing "predictive variable";
int_score = sum (depressed, sleeping, anxious, ptsd);
run;
proc freq data=pred.internalscore;
table int_score;
table sud;
run;
*Create dataset for internalizing and SUD to run the cum ROC;
data cb.macrotestintscore4142021;
set pred.internalscore (keep = sud int_score);
run;
proc contents data=cb.macrotestintscore4142021;
run;
*ODS HTML Close ; *ODS HTML ;
ODS PDF;
/* Macro debugging: ENABLED */
OPTIONS MLOGIC MPRINT SYMBOLGEN ;
%cumRoc3(sud,int_score,SUD,%STR(BESTD8.3),macrotestintscore4142021,
%STR(C:\Users\blondinoct\Documents\LCA),
%STR(C:\Users\blondinoct\Documents\LCA),
%STR(C:\Users\blondinoct\Documents\LCA),
2019_DEMO,_macMode=1,_macComp=YES,
_outCntnts=YES,_outRtf=NO) ;
/* Macro debugging: DISABLED */
OPTIONS noMLOGIC noMPRINT noSYMBOLGEN ;
*ODS HTML Close ; *ODS HTML ;
ODS PDF CLOSE;

*Create external score;
data pred.externalscore;
set pred.w14classprobmerge;
*create our continuous "predictive variable";
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ext_score = sum (lied, attention, listening, bully, fights, restless, answered);
run;
proc freq data=pred.externalscore;
table ext_score;
table sud;
run;
*Create dataset for externalizing and SUD to run the cum ROC;
data cb.macrotestextscore4142021;
set pred.externalscore (keep = sud ext_score);
run;
proc contents data=cb.macrotestextscore4142021;
run;
*ODS HTML Close ; *ODS HTML ;
ODS PDF;
/* Macro debugging: ENABLED */
OPTIONS MLOGIC MPRINT SYMBOLGEN ;
%cumRoc3(sud,ext_score,SUD,%STR(BESTD8.3),macrotestextscore4142021,
%STR(C:\Users\blondinoct\Documents\LCA),
%STR(C:\Users\blondinoct\Documents\LCA),
%STR(C:\Users\blondinoct\Documents\LCA),
2019_DEMO,_macMode=1,_macComp=YES,
_outCntnts=YES,_outRtf=NO) ;
/* Macro debugging: DISABLED */
OPTIONS noMLOGIC noMPRINT noSYMBOLGEN ;
*ODS HTML Close ; *ODS HTML ;
ODS PDF CLOSE;
proc freq data=pred.w14classprobmerge;
table acur_marijuana;
run;
*Create substance use score;
data pred.subsscore;
set pred.w14classprobmerge;
*create our continuous "predictive variable";
subs_score = sum (acur_cignew, acur_ecignew, acur_dualnew, acur_alc, acur_marijuana,
acur_painkiller);
run;
proc freq data=pred.subsscore;
table subs_score;
table sud;
run;
*Create dataset for substance use and SUD to run the cum ROC;
data cb.macrotestsubsscore4142021;
set pred.subsscore (keep = sud subs_score);
run;
proc contents data=cb.macrotestsubsscore4142021;
run;
*ODS HTML Close ; *ODS HTML ;
ODS PDF;
/* Macro debugging: ENABLED */
OPTIONS MLOGIC MPRINT SYMBOLGEN ;
%cumRoc3(sud,subs_score,SUD,%STR(BESTD8.3),macrotestsubsscore4142021,
%STR(C:\Users\blondinoct\Documents\LCA),
%STR(C:\Users\blondinoct\Documents\LCA),
%STR(C:\Users\blondinoct\Documents\LCA),
2019_DEMO,_macMode=1,_macComp=YES,
_outCntnts=YES,_outRtf=NO) ;
/* Macro debugging: DISABLED */

307

OPTIONS noMLOGIC noMPRINT noSYMBOLGEN ;
*ODS HTML Close ; *ODS HTML ;
ODS PDF CLOSE;

*Now create datasets for IP_2 IP_1 IP_0 to run in macro from pred.probs72220;
*********************************************IP_2;
data pred.macroip2;
set pred.probs72220 (keep = sud IP_2);
run;
*move the dataset into cb;
*ODS HTML Close ; *ODS HTML ;
ODS PDF;
/* Macro debugging: ENABLED */
OPTIONS MLOGIC MPRINT SYMBOLGEN ;
%cumRoc3(sud,IP_2,SUD,%STR(BESTD8.3),macroip2,
%STR(C:\Users\blondinoct\Documents\LCA),
%STR(C:\Users\blondinoct\Documents\LCA),
%STR(C:\Users\blondinoct\Documents\LCA),
2019_DEMO,_macMode=1,_macComp=YES,
_outCntnts=YES,_outRtf=NO) ;
/* Macro debugging: DISABLED */
OPTIONS noMLOGIC noMPRINT noSYMBOLGEN ;
*ODS HTML Close ; *ODS HTML ;
ODS PDF CLOSE;
*********************************************IP_1;
data pred.macroip1;
set pred.probs72220 (keep = sud IP_1);
run;
*move the dataset into cb;
*ODS HTML Close ; *ODS HTML ;
ODS PDF;
/* Macro debugging: ENABLED */
OPTIONS MLOGIC MPRINT SYMBOLGEN ;
%cumRoc3(sud,IP_1,SUD,%STR(BESTD8.3),macroip1,
%STR(C:\Users\blondinoct\Documents\LCA),
%STR(C:\Users\blondinoct\Documents\LCA),
%STR(C:\Users\blondinoct\Documents\LCA),
2019_DEMO,_macMode=1,_macComp=YES,
_outCntnts=YES,_outRtf=NO) ;
/* Macro debugging: DISABLED */
OPTIONS noMLOGIC noMPRINT noSYMBOLGEN ;
*ODS HTML Close ; *ODS HTML ;
ODS PDF CLOSE;
*********************************************IP_0;
data pred.macroip0;
set pred.probs72220 (keep = sud IP_0);
run;
*move the dataset into cb;
*ODS HTML Close ; *ODS HTML ;
ODS PDF;
/* Macro debugging: ENABLED */
OPTIONS MLOGIC MPRINT SYMBOLGEN ;
%cumRoc3(sud,IP_0,SUD,%STR(BESTD8.3),macroip0,
%STR(C:\Users\blondinoct\Documents\LCA),
%STR(C:\Users\blondinoct\Documents\LCA),
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%STR(C:\Users\blondinoct\Documents\LCA),
2019_DEMO,_macMode=1,_macComp=YES,
_outCntnts=YES,_outRtf=NO) ;
/* Macro debugging: DISABLED */
OPTIONS noMLOGIC noMPRINT noSYMBOLGEN ;
*ODS HTML Close ; *ODS HTML ;
ODS PDF CLOSE;

SAS File name: Network W1 4142021
****SA 2 - Network Analysis
****Making datasets for overall Wave 1 then by sex
****NEW!!!! APRIL 14 2021;
libname LCA "U:\CourtneyBlondino\PhD Epidemiology\LCA\Data Management";
proc contents data=LCA.W1mplusJuly2020weights4132021;
run;
data lca.newwave1fornet442021;
set LCA.W1mplusJuly2020weights4132021 (keep = R01R_A_SEX CASEID PERSONID
acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana
acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered);
array change _numeric_;
do over change;
if change =-99999 then change = .;
end;
run;
proc contents data=lca.newwave1fornet442021;
run;
proc freq data=lca.newwave1fornet442021;
table R01R_A_SEX ;
run;
proc freq data=lca.newwave1fornet442021;
table R01R_A_SEX
acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered;
run;
libname net "U:\CourtneyBlondino\PhD Epidemiology\April Re Run\Network Wave 1 Data Management";
*OVERALL WAVE 1;
data net.overallwave14142021;
set lca.newwave1fornet442021 (keep =
acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana
acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered);
run;
*************
*male wave 1;
data net.malesubset4142021;
set lca.newwave1fornet442021;
if R01R_A_SEX=1 then output;
run;
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proc contents data=net.malesubset4142021;
run;
*use this one;
data net.malewave14142021;
set net.malesubset4142021(keep = acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana
acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered);
run;

**************
*female wave 1;
data net.femalesubset4142021;
set lca.newwave1fornet442021;
if R01R_A_SEX="2" then output;
run;
proc contents data=net.femalesubset4142021;
run;
*use this one;
data net.femalewave14142021;
set net.femalesubset4142021(keep = acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana
acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered);
run;

**correlations;;
proc contents data=net.overallwave14142021;
run;
proc corr data=net.overallwave14142021;
var ACUR_CIGNEW
ACUR_ECIGNEW
ACUR_DUALNEW
ACUR_ALC
ACUR_PAINKILLER
DEPRESSED
SLEEPING
ANXIOUS
PTSD
LIED
ATTENTION
LISTENING
BULLY
FIGHTS RESTLESS
run;

ACUR_MARIJUANA
ANSWERED;

ods pdf;
*overall cc*substances;
proc freq data=net.overallwave14142021;
table
ACUR_CIGNEW*ACUR_ECIGNEW
ACUR_CIGNEW*ACUR_DUALNEW
ACUR_CIGNEW*ACUR_ALC
ACUR_CIGNEW*ACUR_MARIJUANA
ACUR_CIGNEW*ACUR_PAINKILLER
/plcorr chisq;
run;
*overall ec*substances;
proc freq data=net.overallwave14142021;
table
ACUR_ECIGNEW*ACUR_CIGNEW
ACUR_ECIGNEW*ACUR_DUALNEW
ACUR_ECIGNEW*ACUR_ALC
ACUR_ECIGNEW*ACUR_MARIJUANA
ACUR_ECIGNEW*ACUR_PAINKILLER
/plcorr chisq;
run;
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*overall dual*substances;
proc freq data=net.overallwave14142021;
table
ACUR_DUALNEW*ACUR_CIGNEW
ACUR_DUALNEW*ACUR_ECIGNEW
ACUR_DUALNEW*ACUR_ALC
ACUR_DUALNEW*ACUR_MARIJUANA
ACUR_DUALNEW*ACUR_PAINKILLER
/plcorr chisq;
run;
*overall alcohol*substances;
proc freq data=net.overallwave14142021;
table
ACUR_ALC*ACUR_CIGNEW
ACUR_ALC*ACUR_ECIGNEW
ACUR_ALC*ACUR_DUALNEW
ACUR_ALC*ACUR_MARIJUANA
ACUR_ALC*ACUR_PAINKILLER
/plcorr chisq;
run;
*overall marijuana*pain;
proc freq data=net.overallwave14142021;
table
ACUR_MARIJUANA*ACUR_PAINKILLER
/plcorr chisq;
run;
proc freq data=net.overallwave14142021;
table
ACUR_CIGNEW*DEPRESSED
ACUR_ECIGNEW*DEPRESSED
ACUR_DUALNEW*DEPRESSED
ACUR_ALC*DEPRESSED
ACUR_MARIJUANA*DEPRESSED
ACUR_PAINKILLER*DEPRESSED
/plcorr chisq;
run;
proc freq data=net.overallwave14142021;
table
ACUR_CIGNEW*SLEEPING
ACUR_ECIGNEW*SLEEPING
ACUR_DUALNEW*SLEEPING
ACUR_ALC*SLEEPING
ACUR_MARIJUANA*SLEEPING
ACUR_PAINKILLER*SLEEPING
ACUR_CIGNEW*ANXIOUS
ACUR_ECIGNEW*ANXIOUS
ACUR_DUALNEW*ANXIOUS
ACUR_ALC*ANXIOUS
ACUR_MARIJUANA*ANXIOUS
ACUR_PAINKILLER*ANXIOUS
ACUR_CIGNEW*PTSD
ACUR_ECIGNEW*PTSD
ACUR_DUALNEW*PTSD
ACUR_ALC*PTSD
ACUR_MARIJUANA*PTSD
ACUR_PAINKILLER*PTSD
/plcorr chisq;
run;
proc freq data=net.overallwave14142021;
table SLEEPING*DEPRESSED
ANXIOUS*DEPRESSED
ANXIOUS*SLEEPING
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PTSD*DEPRESSED
PTSD*SLEEPING
PTSD*ANXIOUS/plcorr chisq;
run;
proc freq data=net.overallwave14142021;
table
ACUR_CIGNEW*LIED
ACUR_ECIGNEW*LIED
ACUR_DUALNEW*LIED
ACUR_ALC*LIED
ACUR_MARIJUANA*LIED
ACUR_PAINKILLER*LIED
ACUR_CIGNEW*ATTENTION
ACUR_ECIGNEW*ATTENTION
ACUR_DUALNEW*ATTENTION
ACUR_ALC*ATTENTION
ACUR_MARIJUANA*ATTENTION
ACUR_PAINKILLER*ATTENTION
ACUR_CIGNEW*LISTENING
ACUR_ECIGNEW*LISTENING
ACUR_DUALNEW*LISTENING
ACUR_ALC*LISTENING
ACUR_MARIJUANA*LISTENING
ACUR_PAINKILLER*LISTENING
ACUR_CIGNEW*BULLY
ACUR_ECIGNEW*BULLY
ACUR_DUALNEW*BULLY
ACUR_ALC*BULLY
ACUR_MARIJUANA*BULLY
ACUR_PAINKILLER*BULLY
ACUR_CIGNEW*FIGHTS
ACUR_ECIGNEW*FIGHTS
ACUR_DUALNEW*FIGHTS
ACUR_ALC*FIGHTS
ACUR_MARIJUANA*FIGHTS
ACUR_PAINKILLER*FIGHTS
ACUR_CIGMEW*RESTLESS
ACUR_ECIGNEW*RESTLESS
ACUR_DUALNEW*RESTLESS
ACUR_ALC*RESTLESS
ACUR_MARIJUANA*RESTLESS
ACUR_PAINKILLER*RESTLESS
ACUR_CIGNEW*ANSWERED
ACUR_ECIGNEW*ANSWERED
ACUR_DUALNEW*ANSWERED
ACUR_ALC*ANSWERED
ACUR_MARIJUANA*ANSWERED
ACUR_PAINKILLER*ANSWERED
/plcorr chisq;
run;
proc freq data=net.overallwave14142021;
table
LIED*DEPRESSED
LIED*SLEEPING
LIED*ANXIOUS
LIED*PTSD
ATTENTION*DEPRESSED
ATTENTION*SLEEPING
ATTENTION*ANXIOUS
ATTENTION*PTSD
ATTENTION*LIED
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LISTENING*DEPRESSED
LISTENING*SLEEPING
LISTENING*ANXIOUS
LISTENING*PTSD
LISTENING*LIED
LISTENING*ATTENTION
BULLY*DEPRESSED
BULLY*SLEEPING
BULLY*ANXIOUS
BULLY*PTSD
BULLY*LIED
BULLY*ATTENTION
BULLY*LISTENING
FIGHTS*DEPRESSED
FIGHTS*SLEEPING
FIGHTS*ANXIOUS
FIGHTS*PTSD
FIGHTS*LIED
FIGHTS*ATTENTION
FIGHTS*LISTENING
FIGHTS*BULLY
RESTLESS*DEPRESSED
RESTLESS*SLEEPING
RESTLESS*ANXIOUS
RESTLESS*PTSD
RESTLESS*LIED
RESTLESS*ATTENTION
RESTLESS*LISTENING
RESTLESS*BULLY
RESTLESS*FIGHTS
ANSWERED*DEPRESSED
ANSWERED*SLEEPING
ANSWERED*ANXIOUS
ANSWERED*PTSD
ANSWERED*LIED
ANSWERED*ATTENTION
ANSWERED*LISTENING
ANSWERED*BULLY
ANSWERED*FIGHTS
ANSWERED*RESTLESS
/plcorr chisq;
run;
ods pdf close;

**correlations by sex;
ods pdf;
**male - su;
proc freq data=net.malewave14142021;
table
ACUR_CIGNEW*ACUR_ECIGNEW
ACUR_CIGNEW*ACUR_DUALNEW
ACUR_CIGNEW*ACUR_ALC
ACUR_CIGNEW*ACUR_MARIJUANA
ACUR_CIGNEW*ACUR_PAINKILLER
ACUR_ECIGNEW*ACUR_CIGNEW
ACUR_ECIGNEW*ACUR_DUALNEW
ACUR_ECIGNEW*ACUR_ALC
ACUR_ECIGNEW*ACUR_MARIJUANA
ACUR_ECIGNEW*ACUR_PAINKILLER
ACUR_DUALNEW*ACUR_CIGNEW
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ACUR_DUALNEW*ACUR_ECIGNEW
ACUR_DUALNEW*ACUR_ALC
ACUR_DUALNEW*ACUR_MARIJUANA
ACUR_DUALNEW*ACUR_PAINKILLER
ACUR_ALC*ACUR_CIGNEW
ACUR_ALC*ACUR_ECIGNEW
ACUR_ALC*ACUR_DUALNEW
ACUR_ALC*ACUR_MARIJUANA
ACUR_ALC*ACUR_PAINKILLER
ACUR_MARIJUANA*ACUR_PAINKILLER
/plcorr chisq;
run;
**male - su and int;
proc freq data=net.malewave14142021;
table
ACUR_CIGNEW*DEPRESSED
ACUR_ECIGNEW*DEPRESSED
ACUR_DUALNEW*DEPRESSED
ACUR_ALC*DEPRESSED
ACUR_MARIJUANA*DEPRESSED
ACUR_PAINKILLER*DEPRESSED
ACUR_CIGNEW*SLEEPING
ACUR_ECIGNEW*SLEEPING
ACUR_DUALNEW*SLEEPING
ACUR_ALC*SLEEPING
ACUR_MARIJUANA*SLEEPING
ACUR_PAINKILLER*SLEEPING
ACUR_CIGNEW*ANXIOUS
ACUR_ECIGNEW*ANXIOUS
ACUR_DUALNEW*ANXIOUS
ACUR_ALC*ANXIOUS
ACUR_MARIJUANA*ANXIOUS
ACUR_PAINKILLER*ANXIOUS
ACUR_CIGNEW*PTSD
ACUR_ECIGNEW*PTSD
ACUR_DUALNEW*PTSD
ACUR_ALC*PTSD
ACUR_MARIJUANA*PTSD
ACUR_PAINKILLER*PTSD
/plcorr chisq;
run;
*int;
proc freq data=net.malewave14142021;
table SLEEPING*DEPRESSED
ANXIOUS*DEPRESSED
ANXIOUS*SLEEPING
PTSD*DEPRESSED
PTSD*SLEEPING
PTSD*ANXIOUS/plcorr chisq;
run;
**male - su and ext;
proc freq data=net.malewave14142021;
table
ACUR_CIGNEW*LIED
ACUR_ECIGNEW*LIED
ACUR_DUALNEW*LIED
ACUR_ALC*LIED
ACUR_MARIJUANA*LIED
ACUR_PAINKILLER*LIED
ACUR_CIGNEW*ATTENTION
ACUR_ECIGNEW*ATTENTION
ACUR_DUALNEW*ATTENTION
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ACUR_ALC*ATTENTION
ACUR_MARIJUANA*ATTENTION
ACUR_PAINKILLER*ATTENTION
ACUR_CIGNEW*LISTENING
ACUR_ECIGNEW*LISTENING
ACUR_DUALNEW*LISTENING
ACUR_ALC*LISTENING
ACUR_MARIJUANA*LISTENING
ACUR_PAINKILLER*LISTENING
ACUR_CIGNEW*BULLY
ACUR_ECIGNEW*BULLY
ACUR_DUALNEW*BULLY
ACUR_ALC*BULLY
ACUR_MARIJUANA*BULLY
ACUR_PAINKILLER*BULLY
ACUR_CIGNEW*FIGHTS
ACUR_ECIGNEW*FIGHTS
ACUR_DUALNEW*FIGHTS
ACUR_ALC*FIGHTS
ACUR_MARIJUANA*FIGHTS
ACUR_PAINKILLER*FIGHTS
ACUR_CIGNEW*RESTLESS
ACUR_ECIGNEW*RESTLESS
ACUR_DUALNEW*RESTLESS
ACUR_ALC*RESTLESS
ACUR_MARIJUANA*RESTLESS
ACUR_PAINKILLER*RESTLESS
ACUR_CIGNEW*ANSWERED
ACUR_ECIGNEW*ANSWERED
ACUR_DUALNEW*ANSWERED
ACUR_ALC*ANSWERED
ACUR_MARIJUANA*ANSWERED
ACUR_PAINKILLER*ANSWERED
/plcorr chisq;
run;
*male int and ext;
proc freq data=net.malewave14142021;
table
LIED*DEPRESSED
LIED*SLEEPING
LIED*ANXIOUS
LIED*PTSD
ATTENTION*DEPRESSED
ATTENTION*SLEEPING
ATTENTION*ANXIOUS
ATTENTION*PTSD
ATTENTION*LIED
LISTENING*DEPRESSED
LISTENING*SLEEPING
LISTENING*ANXIOUS
LISTENING*PTSD
LISTENING*LIED
LISTENING*ATTENTION
BULLY*DEPRESSED
BULLY*SLEEPING
BULLY*ANXIOUS
BULLY*PTSD
BULLY*LIED
BULLY*ATTENTION
BULLY*LISTENING
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FIGHTS*DEPRESSED
FIGHTS*SLEEPING
FIGHTS*ANXIOUS
FIGHTS*PTSD
FIGHTS*LIED
FIGHTS*ATTENTION
FIGHTS*LISTENING
FIGHTS*BULLY
RESTLESS*DEPRESSED
RESTLESS*SLEEPING
RESTLESS*ANXIOUS
RESTLESS*PTSD
RESTLESS*LIED
RESTLESS*ATTENTION
RESTLESS*LISTENING
RESTLESS*BULLY
RESTLESS*FIGHTS
ANSWERED*DEPRESSED
ANSWERED*SLEEPING
ANSWERED*ANXIOUS
ANSWERED*PTSD
ANSWERED*LIED
ANSWERED*ATTENTION
ANSWERED*LISTENING
ANSWERED*BULLY
ANSWERED*FIGHTS
ANSWERED*RESTLESS
/plcorr chisq;
run;
ods pdf close;
****************Female;
ods pdf;
**female - su;
proc freq data=net.femalewave14142021;
table
ACUR_CIGNEW*ACUR_ECIGNEW
ACUR_CIGNEW*ACUR_DUALNEW
ACUR_CIGNEW*ACUR_ALC
ACUR_CIGNEW*ACUR_MARIJUANA
ACUR_CIGNEW*ACUR_PAINKILLER
ACUR_ECIGNEW*ACUR_CIGNEW
ACUR_ECIGNEW*ACUR_DUALNEW
ACUR_ECIGNEW*ACUR_ALC
ACUR_ECIGNEW*ACUR_MARIJUANA
ACUR_ECIGNEW*ACUR_PAINKILLER
ACUR_DUALNEW*ACUR_CIGNEW
ACUR_DUALNEW*ACUR_ECIGNEW
ACUR_DUALNEW*ACUR_ALC
ACUR_DUALNEW*ACUR_MARIJUANA
ACUR_DUALNEW*ACUR_PAINKILLER
ACUR_ALC*ACUR_CIGNEW
ACUR_ALC*ACUR_ECIGNEW
ACUR_ALC*ACUR_DUALNEW
ACUR_ALC*ACUR_MARIJUANA
ACUR_ALC*ACUR_PAINKILLER
ACUR_MARIJUANA*ACUR_PAINKILLER
/plcorr chisq;
run;
**female - su and int;
proc freq data=net.femalewave14142021;
table
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ACUR_CIGNEW*DEPRESSED
ACUR_ECIGNEW*DEPRESSED
ACUR_DUALNEW*DEPRESSED
ACUR_ALC*DEPRESSED
ACUR_MARIJUANA*DEPRESSED
ACUR_PAINKILLER*DEPRESSED
ACUR_CIGNEW*SLEEPING
ACUR_ECIGNEW*SLEEPING
ACUR_DUALNEW*SLEEPING
ACUR_ALC*SLEEPING
ACUR_MARIJUANA*SLEEPING
ACUR_PAINKILLER*SLEEPING
ACUR_CIGNEW*ANXIOUS
ACUR_ECIGNEW*ANXIOUS
ACUR_DUALNEW*ANXIOUS
ACUR_ALC*ANXIOUS
ACUR_MARIJUANA*ANXIOUS
ACUR_PAINKILLER*ANXIOUS
ACUR_CIGNEW*PTSD
ACUR_ECIGNEW*PTSD
ACUR_DUALNEW*PTSD
ACUR_ALC*PTSD
ACUR_MARIJUANA*PTSD
ACUR_PAINKILLER*PTSD
/plcorr chisq;
run;
*int;
proc freq data=net.femalewave14142021;
table SLEEPING*DEPRESSED
ANXIOUS*DEPRESSED
ANXIOUS*SLEEPING
PTSD*DEPRESSED
PTSD*SLEEPING
PTSD*ANXIOUS/plcorr chisq;
run;
**female - su and ext;
proc freq data=net.femalewave14142021;
table
ACUR_CIGNEW*LIED
ACUR_ECIGNEW*LIED
ACUR_DUALNEW*LIED
ACUR_ALC*LIED
ACUR_MARIJUANA*LIED
ACUR_PAINKILLER*LIED
ACUR_CIGNEW*ATTENTION
ACUR_ECIGNEW*ATTENTION
ACUR_DUALNEW*ATTENTION
ACUR_ALC*ATTENTION
ACUR_MARIJUANA*ATTENTION
ACUR_PAINKILLER*ATTENTION
ACUR_CIGNEW*LISTENING
ACUR_ECIGNEW*LISTENING
ACUR_DUALNEW*LISTENING
ACUR_ALC*LISTENING
ACUR_MARIJUANA*LISTENING
ACUR_PAINKILLER*LISTENING
ACUR_CIGNEW*BULLY
ACUR_ECIGNEW*BULLY
ACUR_DUALNEW*BULLY
ACUR_ALC*BULLY
ACUR_MARIJUANA*BULLY
ACUR_PAINKILLER*BULLY
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ACUR_CIGNEW*FIGHTS
ACUR_ECIGNEW*FIGHTS
ACUR_DUALNEW*FIGHTS
ACUR_ALC*FIGHTS
ACUR_MARIJUANA*FIGHTS
ACUR_PAINKILLER*FIGHTS
ACUR_CIGNEW*RESTLESS
ACUR_ECIGNEW*RESTLESS
ACUR_DUALNEW*RESTLESS
ACUR_ALC*RESTLESS
ACUR_MARIJUANA*RESTLESS
ACUR_PAINKILLER*RESTLESS
ACUR_CIGNEW*ANSWERED
ACUR_ECIGNEW*ANSWERED
ACUR_DUALNEW*ANSWERED
ACUR_ALC*ANSWERED
ACUR_MARIJUANA*ANSWERED
ACUR_PAINKILLER*ANSWERED
/plcorr chisq;
run;
*female int and ext;
proc freq data=net.femalewave14142021;
table
LIED*DEPRESSED
LIED*SLEEPING
LIED*ANXIOUS
LIED*PTSD
ATTENTION*DEPRESSED
ATTENTION*SLEEPING
ATTENTION*ANXIOUS
ATTENTION*PTSD
ATTENTION*LIED
LISTENING*DEPRESSED
LISTENING*SLEEPING
LISTENING*ANXIOUS
LISTENING*PTSD
LISTENING*LIED
LISTENING*ATTENTION
BULLY*DEPRESSED
BULLY*SLEEPING
BULLY*ANXIOUS
BULLY*PTSD
BULLY*LIED
BULLY*ATTENTION
BULLY*LISTENING
FIGHTS*DEPRESSED
FIGHTS*SLEEPING
FIGHTS*ANXIOUS
FIGHTS*PTSD
FIGHTS*LIED
FIGHTS*ATTENTION
FIGHTS*LISTENING
FIGHTS*BULLY
RESTLESS*DEPRESSED
RESTLESS*SLEEPING
RESTLESS*ANXIOUS
RESTLESS*PTSD
RESTLESS*LIED
RESTLESS*ATTENTION
RESTLESS*LISTENING
RESTLESS*BULLY
RESTLESS*FIGHTS
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ANSWERED*DEPRESSED
ANSWERED*SLEEPING
ANSWERED*ANXIOUS
ANSWERED*PTSD
ANSWERED*LIED
ANSWERED*ATTENTION
ANSWERED*LISTENING
ANSWERED*BULLY
ANSWERED*FIGHTS
ANSWERED*RESTLESS
/plcorr chisq;
run;
ods pdf close;
*tobacco;
proc freq data=net.overallwave14142021;
table
ACUR_CIG*ACUR_ECI
ACUR_CIG*ACUR_DUA
ACUR_ECI*ACUR_DUA
/plcorr chisq;
run;
ods pdf close;

R File name: New W1, M, W Network Analysis 4142021
#PATH WAVE 1 - Network Analysis (Specific Aim 2)
########################################
# Starting with Overall Wave 1 Sample #
########################################
#OVERALL WAVE 1#
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation
Files/Network Chapter")
getwd()
overall<-read.csv("/Users/courtneyblondino/Library/Mobile
Documents/com~apple~CloudDocs/Dissertation Files/Network Chapter/OverallWave1-4142021.csv",
header=T, sep=',')
names(overall)
#checking distributions
table(overall$acur_cignew)
table(overall$acur_ecignew)
table(overall$ACUR_DUA)
table(overall$ACUR_ALC)
table(overall$acur_marijuana)
table(overall$ACUR_PAI)
table(overall$DEPRESS)
table(overall$SLEEPING)
table(overall$ANXIOUS)
table(overall$PTSD)
table(overall$LIED)
table(overall$ATTENTIO)
table(overall$LISTENING)
table(overall$BULLY)
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table(overall$FIGHTS)
table(overall$RESTLESS)
table(overall$ANSWERED)
#rename variables so they look nice on the network
names(overall)[names(overall) == "ACUR_CIG"] <- "CIG"
names(overall)[names(overall) == "ACUR_ECI"] <- "ECIG"
names(overall)[names(overall) == "ACUR_DUA"] <- "Dual CIG + ECIG"
names(overall)[names(overall) == "ACUR_ALC"] <- "Alcohol"
names(overall)[names(overall) == "ACUR_MAR"] <- "Marijuana"
names(overall)[names(overall) == "ACUR_PAI"] <- "PDNP"
names(overall)[names(overall) == "DEPRESS"] <- "Depressed"
names(overall)[names(overall) == "SLEEPING"] <- "Sleeping"
names(overall)[names(overall) == "ANXIOUS"] <- "Anxious"
names(overall)[names(overall) == "PTSD"] <- "Distressed/Past"
names(overall)[names(overall) == "LIED"] <- "Lied"
names(overall)[names(overall) == "ATTENTIO"] <- "Attention"
names(overall)[names(overall) == "LISTENING"] <- "Listening"
names(overall)[names(overall) == "BULLY"] <- "Bully"
names(overall)[names(overall) == "FIGHTS"] <- "Fights"
names(overall)[names(overall) == "RESTLESS"] <- "Restless"
names(overall)[names(overall) == "ANSWERED"] <- "Answered"
require(ggplot2)
require(bootnet)
require(IsingFit)
require(IsingSampler)
require(qgraph)
#########
#IsingFit
OverallNetworkIF <-estimateNetwork(overall, default="IsingFit", missing="listwise")
#try a network with spring layout
plot(OverallNetworkIF, layout = "spring", vsize = 10, cex=8)
OverallNetworkIF
#########
OverallNetworkIF$labels
Names<- c("CIG", "ECIG" , "Dual CIG + ECIG", "Alcohol", "Marijuana", "PDNP",
"Depressed", "Sleeping" , "Anxious", "Distressed/Past" , "Lied",
"Attention" , "Listening" , "Bully" ,"Fights" , "Restless",
"Answered")
Traits <- rep(c(
'Substance Use',
'Negative Affect',
'Externalizing'
), times=c(6,4,7))
#BLACK EDGES
#plot(OverallNetworkIF,
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#
#
#
#
#
#
#
#
#

layout="spring",
cut=0,
theme="colorblind",
groups=Traits,
labels=Names,
#nodeNames=Names,
edge.color="black",
label.scale.equal=TRUE,
label.cex= 1.2,
legend.cex = 0.4)

layout(1)
#COLORED EDGES
plot(OverallNetworkIF,
layout="spring",
cut=0,
theme="colorblind",
groups=Traits,
labels=Names,
#nodeNames=Names,
#edge.color="black",
label.scale.equal=TRUE,
label.cex= 3.0,
legend.cex = 0.4)
#title= "Overall Wave 1 Sample")
#edges
OverallEdges <- OverallNetworkIF$graph
print(OverallEdges)
write.csv(OverallEdges, file="Overall_W1_Edges.csv")
View(OverallNetworkIF$graph)
#write(OverallNetworkIF$graph, file="OverallEdges.csv", sep=" ")
#######################################################################
#Accuracy, Stability, and Replicabiity from PNASS PRACTICALS
#
#TRY THIS WITH OVERALL SAMPLE using IsingFit Model (OverallNetworkIF) #
#######################################################################
#First, test accuracy of connections by obtaining confidence interval around
#estimated edge weight using non-parametric bootstrapping (on original sample and in smaller sample)
library(bootnet)
#Perform a non-parametric bootstrap on the estimated network, and
#plot the confidence intervals of the edge-weights
OverallBoot <- bootnet(OverallNetworkIF, nCores=8)
#note that the default is not listed here but in the notes, they are
plot(OverallBoot, order="sample")
plot(OverallBoot, order="sample", plot="interval", split0=TRUE, labels=FALSE)
plot(OverallBoot, order="sample", labels=FALSE)
plot(OverallBoot, order="sample", plot="interval", split0=TRUE)
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OverallBootSummary <- summary(OverallBoot)
write.csv(OverallBootSummary, file="Overall_Boot_Summary.csv")
OverallInclusion<-bootInclude(OverallBoot, verbose=TRUE)
plot(OverallInclusion)
#plot bootstrapped edge CIs
plot(OverallBoot, labels=FALSE, order="sample")
#plot significant differences (alpha=0.05) of edges
plot(OverallBoot, "edge", plot="difference", onlyNonZero = TRUE,
order="sample")
#removing edges (setting them to 0) based on significance alpha=0.05
# Threshold network:
OverallNetwork_thresholded <- bootThreshold(OverallBoot)
# Plot:
plot(OverallNetwork_thresholded)
OverallNetwork_thresholded$results
#print on PDF so you can read which edge and how many times
#make sure dimensions are quite long
#was it included in the bootstrap
Overall_Ising_threshold <- bootThreshold(OverallBoot, alpha=0.01)
Overall_Ising_threshold$results
L<- averageLayout(OverallNetworkIF, Overall_Ising_threshold)
layout(t(1:2))
plot(OverallNetworkIF,
layout=L,
cut=0,
theme="colorblind",
groups=Traits,
#nodeNames=Names,
edge.color="black",
label.scale.equal=TRUE,
label.cex= 1.2,
legend.cex = 0.4,
title="Ising Fit Overall Sample")
plot(Overall_Ising_threshold,
layout=L,
cut=0,
theme="colorblind",
groups=Traits,
#nodeNames=Names,
edge.color="black",
label.scale.equal=TRUE,
label.cex= 1.2,
legend.cex = 0.4,
title= "Ising Threshold")
OverallNetworkIF$results
Overall_Ising_threshold$results
#edges
Edges <- OverallNetworkIF$graph
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print(Edges)
write(Edges, file="OverallEdges.csv", sep=" ")
OverallSigDifEdge <- summary(OverallBoot)
write(OverallSigDifEdge, file="OverallSigDifEdge.csv", sep=" ")
#Second, investigate stability of centrality indices by case-dropping subset bootstrap
#and get the CS-coefficient
#Perform a case-drop bootstrap on the network, and plot the stability
#of centrality indices. Remember that the default values have now changes
#and do not automatically include stability estimates of 'closeness'
#and 'betweenness'. If you do wish to inspect these, you must include
#statistics = c("strength", "closeness", "betweenness")
OverallBoot2 <- bootnet(OverallNetworkIF, nCores=8, type="case",
statistics=c("strength", "closeness", "betweenness"))
plot(OverallBoot2, statistics = c("strength", "closeness", "betweenness"))
plot(OverallBoot2, statistics = c("strength", "closeness"))
plot(OverallBoot2, statistics = c("strength", "closeness", "betweenness"),
CIstyle="quantiles")
differenceTest(OverallBoot2, "ACUR_CIG", "ACUR_ECIG", "strength")
#Give the CS-coefficient of the three centrality indices, and explain how
#this measure can be interpreted
corStability(OverallBoot2)
#CS-coefficient for
#betweenness= 0.206 (below 0.25- not good) - should not interpret betweenness values because CS
coefficient is not stable
#closeness= 0.517 this is ok
#strength= 0.594 this is good, above 0.5
centralityPlot(OverallNetworkIF, include=c("Strength", "Closeness","Betweenness"))
centralityPlot(OverallNetworkIF, include=c("Strength", "Closeness"))
centralityTable(OverallNetworkIF)
summary(OverallNetworkIF)
summary(OverallBoot)
OverallBoot
summary(OverallBoot2)
OverallBoot2$type
#Third, test whether network connections (step1) and centrality metrics (step2)
#for different variables significantly differ from each other using bootstrapped difference test
#can do the edge weight difference test and the centrality difference test
plot(OverallBoot, "edge", plot="difference", onlyNonZero = TRUE, order="sample", labels=FALSE)
differenceTest(OverallBoot, 3, 17, "strength")

323

differenceTest(OverallBoot, 1, 1, "strength")
plot(OverallBoot, "strength")
#plot(OverallBoot, statistics = c("betweenness", "closeness", "strength"), plot =
#
"difference")
# ^ only gave me strength
OverallBoot$bootTable

######################
##WAVE 1 - MALE ONLY##
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation
Files/Network Chapter")
getwd()
male<-read.csv("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation
Files/Network Chapter/MaleWave1-4142021.csv", header=T, sep=',')
dim(male)
names(male)
#rename variables so they look nice on the network
names(male)[names(male) == "ACUR_CIG"] <- "CIG"
names(male)[names(male) == "ACUR_ECI"] <- "ECIG"
names(male)[names(male) == "ACUR_DUA"] <- "Dual CIG + ECIG"
names(male)[names(male) == "ACUR_ALC"] <- "Alcohol"
names(male)[names(male) == "ACUR_MAR"] <- "Marijuana"
names(male)[names(male) == "ACUR_PAI"] <- "PDNP"
names(male)[names(male) == "DEPRESS"] <- "Depressed"
names(male)[names(male) == "SLEEPING"] <- "Sleeping"
names(male)[names(male) == "ANXIOUS"] <- "Anxious"
names(male)[names(male) == "PTSD"] <- "PTSD"
names(male)[names(male) == "LIED"] <- "Lied"
names(male)[names(male) == "ATTENTIO"] <- "Attention"
names(male)[names(male) == "LISTENING"] <- "Listening"
names(male)[names(male) == "BULLY"] <- "Bully"
names(male)[names(male) == "FIGHTS"] <- "Fights"
names(male)[names(male) == "RESTLESS"] <- "Restless"
names(male)[names(male) == "ANSWERED"] <- "Answered"
#########
#IsingFit
MaleNetworkIF <-estimateNetwork(male, default="IsingFit", missing="listwise")
#try a network with spring layout
plot(MaleNetworkIF, layout = "spring", vsize = 10, cex=8)
#########
MaleNetworkIF$labels
Names<- c("CIG", "ECIG" , "Dual CIG + ECIG", "Alcohol", "Marijuana", "PDNP",
"Depressed", "Sleeping" , "Anxious", "Distressed/Past" , "Lied",
"Attention" , "Listening" , "Bully" ,"Fights" , "Restless",
"Answered")
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Traits <- rep(c(
'Substance Use',
'Internalizing',
'Externalizing'
), times=c(6,4,7))
plot(MaleNetworkIF,
layout="spring",
cut=0,
theme="colorblind",
#title="Wave 1 - Men Only",
groups=Traits,
labels=Names,
#nodeNames=Names,
label.scale.equal=TRUE,
label.cex= 4,
legend.cex = 0.4)
View(MaleNetworkIF$graph)
MaleNetworkIF$results
MaleNetworkIF
#edges
MenEdges <- MaleNetworkIF$graph
print(MenEdges)
#######################################################################
#Accuracy, Stability, and Replicabiity from PNASS PRACTICALS
#
#TRY THIS WITH OVERALL SAMPLE using IsingFit Model (MaleNetworkIF) #
#######################################################################
library(bootnet)
#Network <- estimateNetwork(bfiData, default="ggmModSelect",
#
stepwise=FALSE, corMethod="cor")
#plot(Network)
#Perform a non-parametric bootstrap on the estimated network, and
#plot the confidence intervals of the edge-weights
MaleBoot1 <- bootnet(MaleNetworkIF, nCores=8)
#note that the default is not listed here but in the notes, they are
plot(MaleBoot1, order="sample")
plot(MaleBoot1, order="sample", plot="interval", split0=TRUE)
#print on PDF so you can read which edge and how many times
#make sure dimensions are quite long
#was it included in the bootstrap
plot(MaleBoot1, order="sample", labels=FALSE)
#Perform a case-drop bootstrap on the network, and plot the stability
#of centrality indices. Remember that the default values have now changes
#and do not automatically include stability estimates of 'closeness'
#and 'betweenness'. If you do wish to inspect these, you must include
#statistics = c("strength", "closeness", "betweenness")
MaleBoot2 <- bootnet(MaleNetworkIF, nCores=8, type="case",
statistics=c("strength", "closeness", "betweenness"))
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plot(MaleBoot2, statistics = c("strength", "closeness", "betweenness"))
#Give the CS-coefficient of the three centrality indices, and explain how
#this measure can be interpreted
corStability(MaleBoot2)
#CS-coefficient for
#betweenness= 0.128 (below 0.25- not good)
#closeness= 0.361 (don't think this is good but check)
#strength= 0.517 this is good, before 0.5
centralityPlot(MaleNetworkIF)
centralityPlot(MaleNetworkIF, include=c("Strength", "Closeness","Betweenness"))
centralityPlot(MaleNetworkIF, include=c("Strength", "Closeness"))
centralityPlot(MaleNetworkIF, include=c("Strength"))
centralityTable(MaleNetworkIF)
summary(MaleNetworkIF)
#plot significant differences (alpha=0.05) of edges
plot(MaleBoot1, "edge", plot="difference", onlyNonZero = TRUE,
order="sample", labels=FALSE)
#plot node strength difference
plot(MaleBoot1, "strength")

########################
##WAVE 1 - FEMALE ONLY##
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation
Files/Network Chapter")
getwd()
female<-read.csv("/Users/courtneyblondino/Library/Mobile
Documents/com~apple~CloudDocs/Dissertation Files/Network Chapter/FemaleWave1-4142021.csv",
header=T, sep=',')
dim(female)
names(female)
#rename variables so they look nice on the network
names(female)[names(female) == "ACUR_CIG"] <- "CIG"
names(female)[names(female) == "ACUR_ECI"] <- "ECIG"
names(female)[names(female) == "ACUR_DUA"] <- "Dual CIG + ECIG"
names(female)[names(female) == "ACUR_ALC"] <- "Alcohol"
names(female)[names(female) == "ACUR_MAR"] <- "Marijuana"
names(female)[names(female) == "ACUR_PAI"] <- "PDNP"
names(female)[names(female) == "DEPRESS"] <- "Depressed"
names(female)[names(female) == "SLEEPING"] <- "Sleeping"
names(female)[names(female) == "ANXIOUS"] <- "Anxious"
names(female)[names(female) == "PTSD"] <- "PTSD"
names(female)[names(female) == "LIED"] <- "Lied"
names(female)[names(female) == "ATTENTIO"] <- "Attention"
names(female)[names(female) == "LISTENING"] <- "Listening"
names(female)[names(female) == "BULLY"] <- "Bully"
names(female)[names(female) == "FIGHTS"] <- "Fights"
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names(female)[names(female) == "RESTLESS"] <- "Restless"
names(female)[names(female) == "ANSWERED"] <- "Answered"
#########
#IsingFit
FemaleNetworkIF <-estimateNetwork(female, default="IsingFit", missing="listwise")
#try a network with spring layout
plot(FemaleNetworkIF, layout = "spring", vsize = 10, cex=8)
FemaleNetworkIF
#########
FemaleNetworkIF$labels
Names<- c("CIG", "ECIG" , "Dual CIG + ECIG", "Alcohol", "Marijuana", "PDNP",
"Depressed", "Sleeping" , "Anxious", "Distressed/Past" , "Lied",
"Attention" , "Listening" , "Bully" ,"Fights" , "Restless",
"Answered")
Traits <- rep(c(
'Substance Use',
'Internalizing',
'Externalizing'
), times=c(6,4,7))
plot(FemaleNetworkIF,
layout="spring",
cut=0,
theme="colorblind",
#title="Wave 1 - Women Only",
groups=Traits,
labels=Names,
#nodeNames=Names,
label.scale.equal=TRUE,
label.cex= 4,
legend.cex = 0.4)
View(FemaleNetworkIF$graph)
FemaleNetworkIF$results
#edges
WomenEdges <- FemaleNetworkIF$graph
print(WomenEdges)
#######################################################################
#Accuracy, Stability, and Replicabiity from PNASS PRACTICALS
#
#TRY THIS WITH OVERALL SAMPLE using IsingFit Model (FemaleNetworkIF) #
#######################################################################
library(bootnet)
#Network <- estimateNetwork(bfiData, default="ggmModSelect",
#
stepwise=FALSE, corMethod="cor")
#plot(Network)
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#Perform a non-parametric bootstrap on the estimated network, and
#plot the confidence intervals of the edge-weights
FemaleBoot1 <- bootnet(FemaleNetworkIF, nCores=8)
#note that the default is not listed here but in the notes, they are
plot(FemaleBoot1, order="sample", labels=FALSE)
plot(FemaleBoot1, order="sample", plot="interval", split0=TRUE)
#print on PDF so you can read which edge and how many times
#make sure dimensions are quite long
#was it included in the bootstrap
#Perform a case-drop bootstrap on the network, and plot the stability
#of centrality indices. Remember that the default values have now changes
#and do not automatically include stability estimates of 'closeness'
#and 'betweenness'. If you do wish to inspect these, you must include
#statistics = c("strength", "closeness", "betweenness")
FemaleBoot2 <- bootnet(FemaleNetworkIF, nCores=8, type="case",
statistics=c("strength", "closeness", "betweenness"))
plot(FemaleBoot2, statistics = c("strength", "closeness", "betweenness"))
#Give the CS-coefficient of the three centrality indices, and explain how
#this measure can be interpreted
corStability(FemaleBoot2)
#CS-coefficient for
#betweenness= 0.128 (below 0.25- not good)
#closeness= 0.439 (don't think this is good but check)
#strength= 0.361 not good - all below 0.5 so not good
centralityPlot(FemaleNetworkIF)
centralityPlot(FemaleNetworkIF, include=c("Strength", "Closeness","Betweenness"))
centralityPlot(FemaleNetworkIF, include=c("Strength"))
FemaleNetworkIF$graph
centralityTable(FemaleNetworkIF)
summary(FemaleNetworkIF)
#plot significant differences (alpha=0.05) of edges
plot(FemaleBoot1, "edge", plot="difference", onlyNonZero = TRUE,
order="sample", labels=FALSE)
#plot node strength difference
plot(FemaleBoot1, "strength")

#Network Comparisons
library("qgraph")
L<-averageLayout(MaleNetworkIF, FemaleNetworkIF)
Max<- max(abs(c(getWmat(MaleNetworkIF), getWmat(FemaleNetworkIF))))
layout(t(1:2))
plot(MaleNetworkIF, layout=L, title="Men", maximum=Max)
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plot(FemaleNetworkIF, layout=L, title="Women", maximum=Max)
library("qgraph")
L<-averageLayout(MaleNetworkIF, FemaleNetworkIF)
Max<- max(abs(c(getWmat(MaleNetworkIF), getWmat(FemaleNetworkIF))))
layout(t(1:2))
plot(MaleNetworkIF,
layout=L,
cut=0,
theme="colorblind",
labels=Names,
groups=Traits,
#nodeNames=Names,
#edge.color="black",
label.scale.equal=TRUE,
label.cex=4.0,
legend.cex = 0.4,
legend=FALSE,
title= "Men",
maximum=Max)
plot(FemaleNetworkIF,
layout=L,
cut=0,
theme="colorblind",
labels=Names,
groups=Traits,
#nodeNames=Names,
#edge.color="black",
label.scale.equal=TRUE,
label.cex= 4.0,
legend.cex = 0.4,
legend = FALSE,
title= "Women",
maximum=Max)
MaleW1Edges <- MaleNetworkIF$graph
write.csv(MaleW1Edges, file="Male_W1_Edges.csv")
FemaleW1Edges <- FemaleNetworkIF$graph
write.csv(FemaleW1Edges, file="Female_W1_Edges.csv")

library("devtools")
install_github("cvborkulo/NetworkComparisonTest")
library("NetworkComparisonTest")
#perform NCT and interpret results
NCTres<- NCT(MaleNetworkIF, FemaleNetworkIF, test.edges=TRUE,
it=100)
#difference in global strength between the networks of the observed data sets
NCTres$glstrinv.real
#2.478884
#global strength values of individual networks
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NCTres$glstrinv.sep
#53.41989 vs 50.94101
#Difference in global strength p-value
NCTres$glstrinv.pval
#0.4554455 - so not significantly different from one another in regard to global strength
#Value of the max difference in edge weights of observed networks
NCTres$nwinv.real
#1.327559
#Maximum difference in edge weights
NCTres$nwinv.pval
#0.3168317 - so not significantly different from one another in regard to number of edge weights
#Which edges significantly differ?
NCTres$einv.pvals[which(NCTres$einv.pvals[,3]<0.05),]
#
Var1
Var2 p-value
#72
acur_alc acur_marijuana 0.01980198
#123
acur_alc
sleeping 0.00990099
#141 acur_marijuana
anxious 0.02970297
#172 acur_ecignew
lied 0.03960396
#174
acur_alc
lied 0.00990099
#191
acur_alc
attention 0.01980198
#198
lied
attention 0.03960396
#208
acur_alc
listening 0.04950495

#NCTresCen<- NCT(MaleNetworkIF, FemaleNetworkIF, test.centrality=TRUE, centrality=c("strength"),
#
nodes="all",it=20)
#NCTresCen$diffcen.pvals[which(NCTresCen$diffcen.pvals[,3]<0.05),]
centralityTable(OverallNetworkIF)
centralityTable(MaleNetworkIF)
centralityTable(FemaleNetworkIF)

#######################################################################
#Accuracy, Stability, and Replicabiity from PNASS PRACTICALS
#
#TRY THIS WITH OVERALL SAMPLE using IsingFit Model (OverallNetworkIF) #
#######################################################################
#First, test accuracy of connections by obtaining confidence interval around
#estimated edge weight using non-parametric bootstrapping (on original sample and in smaller sample)
library(bootnet)
#Network <- estimateNetwork(bfiData, default="ggmModSelect",
#
stepwise=FALSE, corMethod="cor")
#plot(Network)
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#Perform a non-parametric bootstrap on the estimated network, and
#plot the confidence intervals of the edge-weights
OverallBoot <- bootnet(OverallNetworkIF, nCores=8)
#note that the default is not listed here but in the notes, they are
plot(OverallBoot, order="sample")
plot(OverallBoot, order="sample", plot="interval", split0=TRUE, labels=FALSE)
plot(OverallBoot, order="sample", labels=FALSE)
plot(OverallBoot, order="sample", plot="interval", split0=TRUE)
summary(OverallBoot)
OverallInclusion<-bootInclude(OverallBoot, verbose=TRUE)
plot(OverallInclusion)
#plot bootstrapped edge CIs
plot(OverallBoot, labels=FALSE, order="sample")
#plot significant differences (alpha=0.05) of edges
plot(OverallBoot, "edge", plot="difference", onlyNonZero = TRUE,
order="sample")
#removing edges (setting them to 0) based on significance alpha=0.05
# Threshold network:
OverallNetwork_thresholded <- bootThreshold(OverallBoot)
# Plot:
plot(OverallNetwork_thresholded)
OverallNetwork_thresholded$results
#print on PDF so you can read which edge and how many times
#make sure dimensions are quite long
#was it included in the bootstrap
Overall_Ising_threshold <- bootThreshold(OverallBoot, alpha=0.01)
Overall_Ising_threshold$results
L<- averageLayout(OverallNetworkIF, Overall_Ising_threshold)
layout(t(1:2))
plot(OverallNetworkIF,
layout=L,
cut=0,
theme="colorblind",
groups=Traits,
#nodeNames=Names,
edge.color="black",
label.scale.equal=TRUE,
label.cex= 1.2,
legend.cex = 0.4,
title="Ising Fit Overall Sample")
plot(Overall_Ising_threshold,
layout=L,
cut=0,
theme="colorblind",
groups=Traits,
#nodeNames=Names,
edge.color="black",
label.scale.equal=TRUE,
label.cex= 1.2,
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legend.cex = 0.4,
title= "Ising Threshold")
OverallNetworkIF$results
Overall_Ising_threshold$results

#Second, investigate stability of centrality indices by case-dropping subset bootstrap
#and get the CS-coefficient
#Perform a case-drop bootstrap on the network, and plot the stability
#of centrality indices. Remember that the default values have now changes
#and do not automatically include stability estimates of 'closeness'
#and 'betweenness'. If you do wish to inspect these, you must include
#statistics = c("strength", "closeness", "betweenness")
OverallBoot2 <- bootnet(OverallNetworkIF, nCores=8, type="case",
statistics=c("strength", "closeness", "betweenness"))
plot(OverallBoot2, statistics = c("strength", "closeness", "betweenness"))
plot(OverallBoot2, statistics = c("strength", "closeness"))
plot(OverallBoot2, statistics = c("strength", "closeness", "betweenness"),
CIstyle="quantiles")
differenceTest(OverallBoot2, "ACUR_CIG", "ACUR_ECIG", "strength")
#Give the CS-coefficient of the three centrality indices, and explain how
#this measure can be interpreted
corStability(OverallBoot2)
#CS-coefficient for
#betweenness= 0.128 (below 0.25- not good) - should not interpret betweenness values because CS
coefficient is not stable
#closeness= 0.594 this is ok
#strength= 0.594 this is good, above 0.5
centralityPlot(OverallNetworkIF, include=c("Strength", "Closeness","Betweenness"))
centralityPlot(OverallNetworkIF, include=c("Strength", "Closeness"))
centralityTable(OverallNetworkIF)
summary(OverallNetworkIF)
summary(OverallBoot)
OverallBoot
summary(OverallBoot2)
OverallBoot2$type
#Third, test whether network connections (step1) and centrality metrics (step2)
#for different variables significantly differ from each other using bootstrapped difference test
#can do the edge weight difference test and the centrality difference test
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plot(OverallBoot, "edge", plot="difference", onlyNonZero = TRUE, order="sample", labels=FALSE)
differenceTest(OverallBoot, 3, 17, "strength")
differenceTest(OverallBoot, 1, 1, "strength")
plot(OverallBoot, "strength")
#plot(OverallBoot, statistics = c("betweenness", "closeness", "strength"), plot =
#
"difference")
# ^ only gave me strength

#Fifth, compare networks visually AND using network comparison test (NCT)

#######################################################################
#Accuracy, Stability, and Replicabiity from PNASS PRACTICALS
#
#TRY THIS WITH OVERALL SAMPLE using IsingFit Model (MaleNetworkIF) #
#######################################################################
library(bootnet)
#Network <- estimateNetwork(bfiData, default="ggmModSelect",
#
stepwise=FALSE, corMethod="cor")
#plot(Network)
#Perform a non-parametric bootstrap on the estimated network, and
#plot the confidence intervals of the edge-weights
Boot1 <- bootnet(MaleNetworkIF, nCores=8)
#note that the default is not listed here but in the notes, they are
plot(Boot1, order="sample")
plot(Boot1, order="sample", plot="interval", split0=TRUE)
#print on PDF so you can read which edge and how many times
#make sure dimensions are quite long
#was it included in the bootstrap
plot(Boot1, order="sample", labels=FALSE)
#Perform a case-drop bootstrap on the network, and plot the stability
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#of centrality indices. Remember that the default values have now changes
#and do not automatically include stability estimates of 'closeness'
#and 'betweenness'. If you do wish to inspect these, you must include
#statistics = c("strength", "closeness", "betweenness")
Boot2 <- bootnet(MaleNetworkIF, nCores=8, type="case",
statistics=c("strength", "closeness", "betweenness"))
plot(Boot2, statistics = c("strength", "closeness", "betweenness"))
#Give the CS-coefficient of the three centrality indices, and explain how
#this measure can be interpreted
corStability(Boot2)
#CS-coefficient for
#betweenness= 0.128 (below 0.25- not good)
#closeness= 0.283 (don't think this is good but check)
#strength= 0.517 this is good, before 0.5
centralityPlot(MaleNetworkIF)
centralityPlot(MaleNetworkIF, include=c("Strength", "Closeness","Betweenness"))
centralityPlot(MaleNetworkIF, include=c("Strength", "Closeness"))
centralityTable(MaleNetworkIF)
summary(MaleNetworkIF)
#plot significant differences (alpha=0.05) of edges
plot(Boot1, "edge", plot="difference", onlyNonZero = TRUE,
order="sample", labels=FALSE)
#plot node strength difference
plot(Boot1, "strength")

#######################################################################
#Accuracy, Stability, and Replicabiity from PNASS PRACTICALS
#
#TRY THIS WITH OVERALL SAMPLE using IsingFit Model (FemaleNetworkIF) #
#######################################################################
library(bootnet)
#Network <- estimateNetwork(bfiData, default="ggmModSelect",
#
stepwise=FALSE, corMethod="cor")
#plot(Network)
#Perform a non-parametric bootstrap on the estimated network, and
#plot the confidence intervals of the edge-weights
FemaleBoot1 <- bootnet(FemaleNetworkIF, nCores=8)
#note that the default is not listed here but in the notes, they are
plot(FemaleBoot1, order="sample", labels=FALSE)
plot(FemaleBoot1, order="sample", plot="interval", split0=TRUE)
#print on PDF so you can read which edge and how many times
#make sure dimensions are quite long
#was it included in the bootstrap
#Perform a case-drop bootstrap on the network, and plot the stability
#of centrality indices. Remember that the default values have now changes
#and do not automatically include stability estimates of 'closeness'
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#and 'betweenness'. If you do wish to inspect these, you must include
#statistics = c("strength", "closeness", "betweenness")
FemaleBoot2 <- bootnet(FemaleNetworkIF, nCores=8, type="case",
statistics=c("strength", "closeness", "betweenness"))
plot(FemaleBoot2, statistics = c("strength", "closeness", "betweenness"))
#Give the CS-coefficient of the three centrality indices, and explain how
#this measure can be interpreted
corStability(FemaleBoot2)
#CS-coefficient for
#betweenness= 0.05 (below 0.25- not good)
#closeness= 0.05 (don't think this is good but check)
#strength= 0.439 not good
centralityPlot(FemaleNetworkIF)
centralityPlot(FemaleNetworkIF, include=c("Strength", "Closeness","Betweenness"))
centralityPlot(FemaleNetworkIF, include=c("Strength"))
FemaleNetworkIF$graph
centralityTable(FemaleNetworkIF)
summary(FemaleNetworkIF)
#plot significant differences (alpha=0.05) of edges
plot(FemaleBoot1, "edge", plot="difference", onlyNonZero = TRUE,
order="sample", labels=FALSE)
#plot node strength difference
plot(FemaleBoot1, "strength")
R File name: Nodewise Predictability 4162021
#Nodewise predictability 4162021
#OVERALL WAVE 1#
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation
Files/Network Chapter")
getwd()
overall<-read.csv("/Users/courtneyblondino/Library/Mobile
Documents/com~apple~CloudDocs/Dissertation Files/Network Chapter/OverallWave1-4142021.csv",
header=T, sep=',')
names(overall)
#rename variables so they look nice on the network
names(overall)[names(overall) == "acur_cignew"] <- "CIG"
names(overall)[names(overall) == "acur_ecignew"] <- "ECIG"
names(overall)[names(overall) == "acur_dualnew"] <- "Dual CIG + ECIG"
names(overall)[names(overall) == "acur_alc"] <- "Alcohol"
names(overall)[names(overall) == "acur_marijuana"] <- "Marijuana"
names(overall)[names(overall) == "acur_painkiller"] <- "PDNP"
names(overall)[names(overall) == "depressed"] <- "Depressed"
names(overall)[names(overall) == "sleeping"] <- "Sleeping"
names(overall)[names(overall) == "anxious"] <- "Anxious"
names(overall)[names(overall) == "ptsd"] <- "PTSD"
names(overall)[names(overall) == "lied"] <- "Lied"
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names(overall)[names(overall) == "attention"] <- "Attention"
names(overall)[names(overall) == "listening"] <- "Listening"
names(overall)[names(overall) == "bully"] <- "Bully"
names(overall)[names(overall) == "fights"] <- "Fights"
names(overall)[names(overall) == "restless"] <- "Restless"
names(overall)[names(overall) == "answered"] <- "Answered"
require(ggplot2)
#require(bootnet)
require(IsingFit)
require(IsingSampler)
require(qgraph)
require(mgm)
#delete obs with missing data
overall_complete_cases <- overall[complete.cases(overall),]
#make into matrix
overall_matrix <- data.matrix(overall_complete_cases)
OverallNetworkMGM <- mgm (data = overall_matrix,
type = c("c", "c","c","c","c","c","c","c","c","c",
"c","c","c","c","c","c","c"),
level = c(2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2,
2, 2, 2),
ruleReg = "OR",
k = 2,
binarySign = TRUE)
OverallNetworkMGM$pairwise
#########
Names<- c("CIG", "ECIG" , "Dual CIG + ECIG", "Alcohol", "Marijuana", "PDNP",
"Depressed", "Sleeping" , "Anxious", "Distressed/Past" , "Lied",
"Attention" , "Listening" , "Bully" ,"Fights" , "Restless",
"Answered")
Traits <- rep(c(
'Substance Use',
'Negative Affect',
'Externalizing'
), times=c(6,4,7))
#this won't run...
plot(OverallNetworkMGM,
layout="spring",
cut=0,
theme="colorblind",
groups=Traits,
#nodeNames=Names,
#edge.color="black",
minimum=0,
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label.scale.equal=TRUE,
label.cex= 2.0,
legend.cex = 0.6,
title= "Overall Wave 1 Sample")

###########################################################################
# Step 2: Predict the given node A by its neighbors - "Making Predictions #
###########################################################################
predModel <- predict(OverallNetworkMGM, overall_matrix,
errorCat = c("CC", "nCC", "CCmarg"))
predModel$errors
#created a columb list with CCmarg values
error_list_me <- list ()
for(i in 1:17) error_list_me[[i]] <- predModel$errors[i,4]
error_list_me
#created the beyond marg values
#beyondmarg_me <- predModel$errors[1:17,2]-predModel$errors[1:17,4]
#beyondmarg_me
#need to combine ccmarg values with beyond marg values in 2 columns, 1 list
beyondmarg_list_me <- list ()
for(i in 1:17) beyondmarg_list_me[[i]] <- (predModel$errors[i,2]-predModel$errors[i,4])
beyondmarg_list_me
#for (i in 1:17) error_list_me[[i]] <- c(predModel$errors[4], beyondmarg_me)
#new_error_list_me <- c(error_list_me, beyondmarg_list_me)
#new_error_list_me
new_error_list_me <- Map(c, error_list_me, beyondmarg_list_me)
new_error_list_me
color_list_me <- list ()
for(i in 1:17) color_list_me[[i]] <- c("#ffa500", "#ff4300")
color_list_me
#error_list_CC <- list()
#for (i in 1:17) error_list_CC[[i]] <- predModel$errors[i,2]
#error_list_NCC <- list()
#for (i in 1:17) error_list_NCC[[i]] <- predModel$errors[i,3]
#error_list_CCmarg <- list()
#for (i in 1:17) error_list_CCmarg[[i]] <- predModel$errors[i,4]
#color_list <- list ()
#for (i in 1:17) color_list[[i]] <- "#90B4D4"
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#pieColor <- c(rep("#90B4D4", 17), rep("#EB9446", 1))
#pieColor
####################################################################
# Step 3: Quantify how close predictions are to actual values of A #
####################################################################
OverallNetworkMGM$pairwise
layout(t(1))
library(qgraph)
set.seed(1)
OGpred <- qgraph(OverallNetworkMGM$pairwise$wadj, pie = new_error_list_me,
layout="spring", labels = Names,
theme="colorblind",
groups=Traits,
pieColor = color_list_me,
label.scale.equal=TRUE,
label.cex= 4.0,
legend.cex = 0.4,
edge.color = OverallNetworkMGM$pairwise$edgecolor,
curveAll = TRUE, curveDefault = .6,
cut = 0)

SAS File name: READ in W1 4 CLASS 4142021
*Read in W1;
*MPLUS Output = wave 1 run 4132021 4 class;
*CSV = = w14class4132021;
libname aim3 "U:\CourtneyBlondino\PhD Epidemiology\April Re Run\LCA Wave 2 and 3 - 4 class 4142021";
data aim3.w14classprob4142021;
input
W1_ACUR_CIG
W1_ACUR_ECI
W1_ACUR_PAI
W1_DEPRESS
W1_SLEEPING
W1_LIED
W1_ATTENTIO
W1_RESTLESS
W1_ANSWERED
W1_SEXMALE_
W1_AGE1824_
W1_AGE2534_
W1_AGE3544_
W1_AGE4554_
W1_AGE5564_
W1_RACEBL_2
W1_RACEOT_3
W1_RACEHI_6
W1_EDU_1
W1_EDU_2
W1_EDU_3
W1_EDU_4
W1_INC_1
W1_INC_2
W1_INC_3
W1_INC_4
W1_SOC_2

W1_ACUR_DUA

W1_ACUR_ALC

W1_ACUR_MAR

W1_ANXIOUS
W1_LISTENING

W1_PTSD
W1_BULLY

W1_FIGHTS
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W1_SOC_3
W1_SOC_4
W1_SOC_5
W1_CPROB1
W1_CPROB2
W1_CPROB3
W1_CPROB4
W1_C
W1_WEIGHT
CASEID;
datalines;

*************COPY AND PASTE OUTPUT FROM MPLUS************
RUN;

SAS File name: LCA W2
*In the ICPSR_36498 folder, select DS2001 and open the data file (36498-2001-Data) which is
a SAS Cport Transport file. Once this is open, formats are in, and can begin data management;
libname LCA "U:\CourtneyBlondino\PhD Epidemiology\LCA\Wave 2\Data Management";
*Recoding Missings;
data LCA.W2;
set da36498p2001;
*Current User Cigarette;
*R02_AC1002_12M: In past 12 months, smoked a cigarette, even one or two puffs;
*R02_AC1005: Number of cigarettes smoked in your entire life;
*R02_AC1003: Now smoke cigarettes;
*if R02_AC1002_12M = 1 AND R02_AC1005=6 AND R02_AC1003 in (1 2) then acur_cig = 1;
*else if R02_AC1002_12M = 2 OR R02_AC1003=3 OR (R02_AC1003 in (1,2,.) AND R02_AC1005 in
(1,2,3,4,5)) then acur_cig=0;
*else if R02_AC1002_12M = . OR R02_AC1003=. OR R02_AC1005=. then acur_cig = .;
if R02R_A_CUR_ESTD_CIGS=1 then acur_cig=1;
else if R02R_A_CUR_ESTD_CIGS=2 then acur_cig=0;
else if R02R_A_CUR_ESTD_CIGS=. then acur_cig=.;
*Current E-cigarette user;
*R02_AO9035_01: Ever used the following electronic nicotine product: E-cigarette;
*R02_AE1100: Ever used e-cigarettes fairly regularly;
*R02_AO1003C: Now use e-cigarettes;
*if R02_AO9035_01 = 1 AND R02_AE1100=1 AND R02_AO1003C in (1,2) then acur_ecig = 1;
*else if R02_AO9035_01=2 OR R02_AE1100 = 2 OR R02_AO1003C = 3 OR (R02_AE1100 in (1,2,.)
AND R02_AO1003C = 2) then acur_ecig=0;
*else if R02_AO9035_01 = . OR R02_AE1100=. OR R02_AO1003C = . OR R02_AE1100 = . then
acur_ecig = .;
if R02R_A_CUR_ESTD_ECIG=1 then acur_ecig=1;
else if R02R_A_CUR_ESTD_ECIG=2 then acur_ecig=0;
else if R02R_A_CUR_ESTD_ECIG=. then acur_ecig=.;
***NOT USING FOR LCA************
********************************
*Current Traditional cigar user
if R02_AG9003 = 1 AND R02_AG1100TC=1 AND R02_AG1003TC in (1,2) then acur_cigr = 1
else if R02_AG1001=2 OR R02_AG9002_01 = 2 OR R02_AG9003= 2 OR R02_AG1003TC= 3 OR
(R02_AG1003TC in
(1,2,.) AND R02_AG1100TC = 2) THEN acur_cigr = 0
ELSE IF R02_AG1001 = . OR R02_AG9003 = . OR R02_AG1100TC = . OR R02_AG1003TC = . OR
R02_AG9002_01 = . THEN
acur_cigr = .;
*Current Cigarillo user
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IF R02_AG9004=1 AND (R02_AG9009_01=1 OR R02_AG9009_03=1) AND R02_AG1100CG = 1 AND
R02_AG1003CG in
(1, 2) THEN acur_cigrlo= 1
ELSE IF R02_AG9004= 2 OR R02_AG1001=2 OR R02_AG9002_02 = 2 OR R02_AG1003CG=3 OR
R02_AG1100CG=2 OR (R02_AG9009_01=2 AND R02_AG9009_03=2) OR ((R02_AG9009_01=1
OR R02_AG9009_03=1) AND R02_AG1100CG= 2 AND R02_AG1003CG=.) OR ((R02_AG9009_01=1 OR
R02_AG9009_03=1) AND R02_AG1100CG=. AND R02_AG1003CG= 3) THEN acur_cigrlo= 0
ELSE IF R02_AG1001 = . OR R02_AG9004 = . OR R02_AG9009_03 = . OR R02_AG9009_01 = . OR
R02_AG1100CG = . OR R02_AG1003CG = . OR R02_AG9002_02 = . THEN acur_cigrlo = .;
*Current Filtered Cigar user
IF R02_AG9004=1 AND R02_AG9009_02=1 AND R02_AG1100FC = 1 AND R02_AG1003FC in (1, 2) THEN
acur_filcigr= 1
ELSE IF R02_AG9004= 2 OR R02_AG1001=2 OR R02_AG9002_02 = 2 OR R02_AG1003FC=3 OR
R02_AG1100FC=2 OR R02_AG9009_02=2
OR (R02_AG9009_02=1 AND R02_AG1100FC= 2 AND R02_AG1003FC=.) OR (R02_AG9009_02=1 AND
R02_AG1100FC=. AND
R02_AG1003FC= 3) THEN acur_filcigr=0
ELSE IF R02_AG9004 = . OR R02_AG9009_02 =. OR R02_AG1100FC = . OR R02_AG1003FC = . OR
R02_AG1001 = . OR R02_AG9002_02 = . THEN
acur_filcigr = .;
*Current Use Any Cigar/Cigarillo
IF (acur_cigr = 1 OR acur_cigrlo = 1 OR acur_filcigr = 1) THEN acur_fullcigr = 1
ELSE IF (acur_cigr = 0 AND acur_cigrlo = 0 AND acur_filcigr= 0) THEN acur_fullcigr = 0
ELSE IF acur_cigr = . OR acur_cigrlo = . OR acur_filcigr = . THEN acur_fullcigr = .;
*Current Pipe user
IF R01_AP1002 = 1 AND R01_AP1100=1 AND R01_AP1003 in (1,2) THEN acur_pipe= 1
ELSE IF R01_AP1001=2 OR R01_AP1002= 2 OR R01_AP1003= 3 OR (R01_AP1003 in (1,2,.) AND
R01_AP1100 = 2)
THEN acur_pipe=0
ELSE IF R01_AP1001 = . OR R01_AP1002 = . OR R01_AP1003 = . OR R01_AP1100 = . THEN
acur_pipe= .;
*Current Hookah User
IF R02_AH1002 = 1 AND R02_AH1100=1 AND R02_AH1003 in (1, 2) THEN acur_hook= 1
ELSE IF R02_AH1001=2 OR R02_AH1002= 2 OR R02_AH1003= 3 OR (R02_AH1003 in (1,2,.) AND
R02_AH1100 = 2)
THEN acur_hook=0
ELSE IF R02_AH1002=. OR R02_AH1001=. OR R02_AH1003=. OR R02_AH1100=.
THEN acur_hook=.;
*Current User Smokeless
IF (R02_AS1002_02=1 OR R02_AU1003 in (1,2)) AND R02_AS1100SM = 1 AND R02_AS1003SM in (1,
2) THEN acur_smls= 1
ELSE IF R02_AS1001=2 OR R02_AS1002_03=1 OR (R02_AS1002_02=2 AND R02_AU1003 in
(2,3,.)) OR R02_AS1003SM= 3 OR (R02_AS1003SM in (1,2,.) AND R02_AS1100SM = 2) THEN
acur_smls=0
ELSE IF R02_AS1002_02 = . OR R02_AU1003 = . OR R02_AS1100SM = . OR
R02_AS1003SM = . OR R02_AS1001 = . THEN acur_smls = .;
*Current User Snus
IF R02_AS1002_01=1 AND R02_AU1003 in (2, 3) AND R02_AS1100SU= 1 AND R02_AS1003SU in (1,2)
THEN acur_snus= 1
ELSE IF R02_AS1001=2 OR R02_AS1002_03=1 OR (R02_AS1002_01=2 AND R02_AS1002_02=1)
OR (R02_AS1002_01=1 AND R02_AU1003=1) OR (R02_AU1003 in (2,3) AND R02_AS1003SU= 3) OR
(R02_AU1003 in (2,3) AND
R02_AS1003SU in (1,2,.) AND R02_AS1100SU = 2) THEN acur_snus= 0
ELSE IF R02_AS1002_01 = . OR R02_AS1002_02 = . OR R02_AS1002_03 = . OR R02_AU1003 = . OR
R02_AS1100SU = . OR R02_AS1003SU =.
OR R02_AS1001 = . THEN acur_snus=.;
*Current Use Any Smokeless/Snus
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IF (acur_smls = 1 OR acur_snus = 1) THEN acur_fullsmkls = 1
ELSE IF (acur_smls = 0 AND acur_snus = 0) THEN acur_fullsmkls = 0
ELSE IF acur_smls = . OR acur_snus = . THEN acur_fullsmkls = .;
*Current User Dissolvable
IF R02_AD1002 = 1 AND R02_AD1100=1 AND R02_AD1003 in (1,2) THEN acur_diss= 1
ELSE IF R02_AD1001=2 OR R02_AD1002= 2 OR R02_AD1003= 3 OR (R02_AD1003 in (1,2,.) AND
R02_AD1100 = 2) THEN acur_diss=0
ELSE IF R02_AD1001 = . OR R02_AD1002 = . OR R02_AD1003 = . OR R02_AD1100 = . THEN
acur_diss = .;

*******************************
*******************************
NEW SUBSTANCES ADDED;
*Current Use Alcohol;
*R02_AX0084_12M: In past 12 months, used alcohol, including small tastes or sips
*R02_AX0673: In past 30 days, used alcohol;
if R02_AX0084_12M = 1 AND R02_AX0673 = 1 then acur_alc=1;
else if R02_AX0084_12M = 2 OR R02_AX0673 = 2 then acur_alc=0;
else if R02_AX0084_12M= . OR R02_AX0673= . then acur_alc=.;
*Current User Marijuana;
*R02_AX0085_12M: In past 12 months, used marijuana, hash, THC, grass, pot or weed;
*R02_AX0675: In past 30 days, used marijuana, hash, THC, grass, pot or weed;
if R02_AX0675 = 1 then acur_marijuana=1;
else if R02_AX0675 in (2 -1) then acur_marijuana=0;
else if R02_AX0675= . then acur_marijuana=.;
*Current User Ritalin or Adderall (prescription drugs not prescribed to you);
*R02_AX0089_12M_01: In past 12 months, used prescription drugs not prescribed to you:
Ritalin or Adderall;
*R02_AX0676_01: In past 30 days, used: Ritalin or Adderall;
*if R02_AX0089_12M_01 = 1 AND R02_AX0676_01 = 1 then acur_ritadder=1;
*else if R02_AX0089_12M_01 = 2 OR R02_AX0676_01 = 2 then acur_ritadder=0;
*else if R02_AX0089_12M_01 = . OR R02_AX0676_01= . then acur_ritadder=.;
*Current User Painkillers, Sedatives, or Tranquilizers (prescription drugs not prescribed
to you);
*R02_AX0089_12M_02: In past 12 months, used prescription drugs not prescribed to you:
Painkillers, sedatives or tranquilizers;
*R02_AX0676_02: In past 30 days, used: Painkillers, sedatives or tranquilizers;
if R02_AX0089_12M_02= 1 AND R02_AX0676_02 = 1 then acur_painkiller=1;
else if R02_AX0089_12M_02 = 2 OR R02_AX0676_02 = 2 then acur_painkiller=0;
else if R02_AX0089_12M_02 = . OR R02_AX0676_02= . then acur_painkiller=.;
*Current User Cocaine or Crack
*R02_AX0220_12M_01: In past 12 months, used substance: Cocaine or crack;
*R02_AX0676_03: In past 30 days, used: Cocaine or crack;
*if R02_AX0220_12M_01 = 1 AND R02_AX0676_03 = 1 then acur_cocaine=1;
*else if R02_AX0220_12M_01 = 2 OR R02_AX0676_03 = 2 then acur_cocaine=0;
*else if R02_AX0220_12M_01 = . OR R02_AX0676_03= . then acur_cocaine=.;
*Curent User Meth or Speed
*R02_AX0220_12M_02: In past 12 months, used substance: Stimulants like methamphetamine or
speed;

*R02_AX0676_04: In past 30 days, used Stimulants like methamphetamine or speed;
*if R02_AX0220_12M_02 = 1 AND R02_AX0676_04 = 1 then acur_meth=1;
*else if R02_AX0220_12M_02 = 2 OR R02_AX0676_04= 2 then acur_meth=0;
*else if R02_AX0220_12M_02 = . OR R02_AX0676_04= . then acur_meth=.;

*Current User Heroin, Inhalents, Solvents, Hallucinogens
*R02_AX0220_12M_03: In past 12 months, used substance: Any other drugs like heroin,
inhalants, solvents or hallucinogens;
*R02_AX0676_05: In past 30 days, used: Any other drugs like heroin, inhalants, solvents
or hallucinogens;
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*if R02_AX0220_12M_03 = 1 AND R02_AX0676_05 = 1 then acur_heroinplus=1;
*else if R02_AX0220_12M_03 = 2 OR R02_AX0676_05 = 2 then acur_heroinplus=0;
*else if R02_AX0220_12M_03 = . OR R02_AX0676_05 = . then acur_heroinplus=.;
*Create new variables;
**********************
**********************
NEED TO COME BACK AND
ADD SUBSTANCE USE VARS
AND SUICIDE QUESTIONS
TO NEXT DATASET;
*********************;
*RACE;
*R02R_A_RACECAT3: DERIVED - Race from the interview (3 levels): 1 = white alone, 2 = black alone,
3 = other;
*R02R_A_HISP: DERIVED - Wave 2 Adult Hispanic Origin (2 levels): 1 = hispanic, 2 = not hispanic;
NUMRACES = 0 ;
if R02R_A_RACECAT3 = 1 then NUMRACES = NUMRACES + 1 ;
if R02R_A_RACECAT3 = 2 then NUMRACES= NUMRACES + 1 ;
if R02R_A_RACECAT3 = 3 then NUMRACES = NUMRACES + 1 ;
if R02R_A_HISP = 1 then NUMRACES = NUMRACES + 1;
if (NUMRACES = 1 and R02R_A_RACECAT3 = 1 AND R02R_A_HISP=2) then R02R_A_ETHRACECAT7= 1 ; *NH
White;
if (NUMRACES = 1 and R02R_A_RACECAT3 = 2 AND R02R_A_HISP=2) then R02R_A_ETHRACECAT7= 2 ; *NH AA;
if (NUMRACES = 1 and R02R_A_RACECAT3 = 3 AND R02R_A_HISP=2) then R02R_A_ETHRACECAT7= 3 ; *NH
Other;
if (NUMRACES = 1 and R02R_A_HISP=1) then R02R_A_ETHRACECAT7= 4; *Hispanic Only;
if (NUMRACES > 1 and R02R_A_HISP=2) then R02R_A_ETHRACECAT7= 5; *NH Multiracial;
if (NUMRACES > 1 and R02R_A_HISP=1) then R02R_A_ETHRACECAT7= 6; *Hispanic Multiracial;
ELSE IF R02R_A_HISP=. OR R02R_A_RACECAT3 = . THEN R02R_A_ETHRACECAT7=.;
*AGE;
*R02R_A_AGECAT7: DERIVED - Age range when interviewed (7 levels);
if R02R_A_AGECAT7=1 then age=1; *18-24;
else if R02R_A_AGECAT7=2 then age=2; *25-34;
else if R02R_A_AGECAT7=3 then age=3; *35-44;
else if R02R_A_AGECAT7=4 then age=4; *45-54;
else if R02R_A_AGECAT7=5 then age=5; *55-64;
else if R02R_A_AGECAT7 in (6 7) then age=6; *65 and older;
else age=.;
*EDUCATION;
*R02R_A_AM0018: DERIVED - Highest grade or level of school completed (6 levels);
if R02R_A_AM0018=1 then education=1; *less than high school;
else if R02R_A_AM0018 in (2 3) then education=2; *GED/high school graduate;
else if R02R_A_AM0018=4 then education=3; *Some college (no degree) or associates degree;
else if R02R_A_AM0018=5 then education=4; *Bachelor's degree;
else if R02R_A_AM0018=6 then education=5; *Advanced degree;
else education=.;
*LIMIT ALL MH VARIABLES TO PAST 30 DAYS;
******INTERNALIZING**********;
*R02_AX0161: Last time you had significant problems with: Feeling very trapped, lonely, sad,
blue, depressed or hopeless about the future;
if R02_AX0161 in (2, 3, 4) then depressed=0;
else if R02_AX0161 in (1) then depressed=1;
else if R02_AX0161 = . then depressed= .;
*R02_AX0162: Last time you had significant problems with: Sleep trouble - such as bad
dreams, sleeping restlessly or falling asleep during the day;
if R02_AX0162 in (2, 3, 4) then sleeping=0;
else if R02_AX0162 in (1) then sleeping=1;
else if R02_AX0162 = . then sleeping=.;
*R02_AX0163: Last time you had significant problems with: Feeling very anxious, nervous,
tense, scared, panicked or like something bad was going to happen;
if R02_AX0163 in (2, 3, 4) then anxious=0;
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else if R02_AX0163 in (1) then anxious=1;
else if R02_AX0163 = . then anxious=.;
*R02_AX0164: Last time you had significant problems with: Becoming very distressed and
upset when something reminded you of the past;
if R02_AX0164 in (2, 3, 4) then ptsd=0;
else if R02_AX0164 in (1) then ptsd=1;
else if R02_AX0164 = . then ptsd=.;
******EXTERNALIZING**********;
*R02_AX0165: Last time you did the following two or more times: Lied or conned to get things
you wanted or to avoid having to do something;
if R02_AX0165 in (2, 3, 4) then lied=0;
else if R02_AX0165 in (1) then lied=1;
else if R02_AX0165 = . then lied=.;
*R02_AX0166: Last time you did the following two or more times: Had a hard time paying
attention at school, work or home;
if R02_AX0166 in (2, 3, 4) then attention=0;
else if R02_AX0166 in (1) then attention=1;
else if R02_AX0166 = . then attention=.;
*R02_AX0167: Last time you did the following two or more times: Had a hard time listening to
instructions at school, work or home;
if R02_AX0167 in (2, 3, 4) then listening=0;
else if R02_AX0167 in (1) then listening=1;
else if R02_AX0167 = . then listening= .;
*R02_AX0168: Last time you did the following two or more times: Were a bully or threatened
other people;
if R02_AX0168 in (2, 3, 4) then bully=0;
else if R02_AX0168 in (1) then bully=1;
else if R02_AX0168 = . then bully= .;
*R02_AX0169: Last time you did the following two or more times: Started physical fights with
other people;
if R02_AX0169 in (2, 3, 4) then fights=0;
else if R02_AX0169 in (1) then fights=1;
else if R02_AX0169 = . then fights= .;
*R02_AX0250: Last time you did the following two or more times: Felt restless or the need to
run around or climb on things;
if R02_AX0250 in (2, 3, 4) then restless=0;
if R02_AX0250 in (1) then restless=1;
else if R02_AX0250 = . then restless=.;
*R02_AX0251: Last time you did the following two or more times: Gave answers before the
other person finished asking the question;
if R02_AX0251 in (2, 3, 4) then answered=0;
if R02_AX0251 in (1) then answered=1;
else if R02_AX0251 = . then answered=.;
******SUBSTANCE USE DISORDERS**********;
*R02_AX0170: Last time that you used alcohol or other drugs weekly or more often;
if R02_AX0170 in (2, 3, 4) then weeklyuse=0;
if R02_AX0170 in (1) then weeklyuse=1;
else if R02_AX0170 = . then weeklyuse=.;
*R02_AX0171: Last time that you spent a lot of time getting alcohol or other drugs;
if R02_AX0171 in (2, 3, 4) then timegetting=0;
if R02_AX0171 in (1) then timegetting=1;
else if R02_AX0171 = . then timegetting=.;
*R02_AX0193: Last time you spent a lot of time using or recovering from alcohol or other drugs;
if R02_AX0193 in (2, 3, 4) then timeusing=0;
if R02_AX0193 in (1) then timeusing=1;
else if R02_AX0193 = . then timeusing=.;
*R02_AX0172: Last time that you kept using alcohol or other drugs even though it was causing
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social problems, leading to fights, or getting you into trouble with other people;
if R02_AX0172 in (2, 3, 4) then socialprob=0;
if R02_AX0172 in (1) then socialprob=1;
else if R02_AX0172 = . then socialprob=.;
*R02_AX0173: Last time that your use of alcohol or other drugs reduced your involvement in
activities at work, school, home or social events;
if R02_AX0173 in (2, 3, 4) then reducedact=0;
if R02_AX0173 in (1) then reducedact=1;
else if R02_AX0173 = . then reducedact=.;
*R02_AX0174: Last time that you had withdrawal problems such as shaky hands, throwing up,
having trouble sitting still or sleeping;
if R02_AX0174 in (2, 3, 4) then withdraw=0;
if R02_AX0174 in (1) then withdraw=1;
else if R02_AX0174 = . then withdraw=.;
*R02_AX0194: Last time you used any alcohol or other drugs to stop being sick or avoid
withdrawal problems;
if R02_AX0194 in (2, 3, 4) then usetoavoid=0;
if R02_AX0194 in (1) then usetoavoid=1;
else if R02_AX0194 = . then usetoavoid=.;
*ALL PAST 30 DAY;
sud_score = sum(weeklyuse, timegetting, timeusing, socialprob, reducedact, withdraw, usetoavoid);
*OLD
*SUD is 3 levels- no/low, moderate, and high;
*if sud_score in (0,1) then sud=0;
*if sud_score in (2,3) then sud=1;
*if sud_score in (4,5,6,7) then sud=2;
*if sud_score = . then sud=.;
*NEW = 1/16/20;
*SUD is 3 levels- no/low, moderate, and high;
if sud_score in (0) then sud=0;
if sud_score in (1,2) then sud=1;
if sud_score in (3,4,5,6,7) then sud=2;
if sud_score = . then sud=.;
*Dichotomize by 0 = no/low, 1 = moderate/high;
*if sud in (0) then sudbin1=0;
*if sud in (1, 2) then sudbin1=1;
*if sud = . then sudbin1 = .;
*Dichotomize by 0 = no/low/moderate, 1 = high;
*if sud in (0,1) then sudbin2=0;
*if sud in (2) then sudbin2=1;
*if sud = . then sudbin2 = .;
*****DUMMY CODING FOR THE COVARIATES******;
IF R02R_A_SEX=1 THEN SEXMALE_1=1;
ELSE SEXMALE_1=0;
IF R02R_A_SEX=2 THEN SEXFEMALE_2=1;
ELSE SEXFEMALE_2=0;
IF age=1 THEN AGE1824_1=1;
ELSE AGE1824_1=0;
IF age=2 THEN AGE2534_2=1;
ELSE AGE2534_2=0;
IF age=3 THEN AGE3544_3=1;
ELSE AGE3544_3=0;
IF age=4 THEN AGE4554_4=1;
ELSE AGE4554_4=0;
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IF age=5 THEN AGE5564_5=1;
ELSE AGE5564_5=0;
IF age=6 THEN AGE65_6=1;
ELSE AGE65_6=0;
IF R02R_A_ETHRACECAT7=1 THEN RACEWH_1=1;
ELSE RACEWH_1=0;
IF R02R_A_ETHRACECAT7=2 THEN RACEBL_2=1;
ELSE RACEBL_2=0;
IF R02R_A_ETHRACECAT7=3 THEN RACEOT_3=1;
ELSE RACEOT_3=0;
IF R02R_A_ETHRACECAT7=6 THEN RACEHI_6=1;
ELSE RACEHI_6=0;
IF education=1 THEN EDU_1=1;
ELSE EDU_1=0;
IF education=2 THEN EDU_2=1;
ELSE EDU_2=0;
IF education=3 THEN EDU_3=1;
ELSE EDU_3=0;
IF education=4 THEN EDU_4=1;
ELSE EDU_4=0;
IF education=5 THEN EDU_5=1;
ELSE EDU_5=0;
IF R02R_A_AM0030=1 THEN INC_1=1;
ELSE INC_1=0;
IF R02R_A_AM0030=2 THEN INC_2=1;
ELSE INC_2=0;
IF R02R_A_AM0030=3 THEN INC_3=1;
ELSE INC_3=0;
IF R02R_A_AM0030=4 THEN INC_4=1;
ELSE INC_4=0;
IF R02R_A_AM0030=5 THEN INC_5=1;
ELSE INC_5=0;
*extremely satisfied =1;
IF R02_AX0092=1 THEN SOC_1=1;
ELSE SOC_1=0;
IF R02_AX0092=2 THEN SOC_2=1;
ELSE SOC_2=0;
IF R02_AX0092=3 THEN SOC_3=1;
ELSE SOC_3=0;
IF R02_AX0092=4 THEN SOC_4=1;
ELSE SOC_4=0;
*not at all satisfied =5;
IF R02_AX0092=5 THEN SOC_5=1;
ELSE SOC_5=0;

array change _numeric_;
do over change;
if change=-97777 then change=.;
else if change=-99999 then change=.;
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else
else
else
else
else
else
else
else
else
end;

if
if
if
if
if
if
if
if
if

change=-99988 then change=.;
change=-99977 then change=.;
change=-99955 then change=.;
change=-99911 then change=.;
change=-9 then change=.;
change=-8 then change=.;
change=-7 then change=.;
change=-1 then change=.;
change=-5 then change=.;

run;
*check dummies;
proc freq data=lca.w2;
table acur_cig acur_ecig acur_alc acur_marijuana acur_painkiller;
run;
proc freq data=lca.w2;
table
R02R_A_SEX*SEXMALE_1
R02R_A_SEX*SEXFEMALE_2
age*AGE1824_1
age*AGE2534_2
age*AGE3544_3
age*AGE4554_4
age*AGE5564_5
age*AGE65_6
R02R_A_ETHRACECAT7*RACEWH_1
R02R_A_ETHRACECAT7*RACEBL_2
R02R_A_ETHRACECAT7*RACEOT_3
R02R_A_ETHRACECAT7*RACEHI_6
education*EDU_1
education*EDU_2
education*EDU_3
education*EDU_4
education*EDU_5
R02R_A_AM0030*INC_1
R02R_A_AM0030*INC_2
R02R_A_AM0030*INC_3
R02R_A_AM0030*INC_4
R02R_A_AM0030*INC_5
R02_AX0092*SOC_1
R02_AX0092*SOC_2
R02_AX0092*SOC_3
R02_AX0092*SOC_4
R02_AX0092*SOC_5;
run;
*check cig/ecig;
proc freq data=lca.w2;
table R02R_A_CUR_ESTD_CIGS*acur_cig
R02R_A_CUR_ESTD_ECIG*acur_ecig;
run;
*derived variables have info from wave 1 so use these not the ones I created;
*check other subs;
proc freq data=lca.w2;
table acur_alc acur_marijuana acur_painkiller;;
run;
*marijuana is still weird;
*check sud;
proc freq data=lca.w2;
table sud_score*sud;
run;
*check int/ext/sud;
proc freq data=lca.w2;
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table

depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
weeklyuse timegetting timeusing socialprob reducedact withdraw usetoavoid
sud;

run;
*only select people from wave 1;
proc freq data=lca.w2;
table R02_CONTINUING_ADULT_LD;
run;
data lca.w2contadult;
set lca.w2;
if R02_CONTINUING_ADULT_LD=1;
run;
proc freq data=lca.w2contadult;
table R02_CONTINUING_ADULT_LD;
run;
proc freq data=lca.w2contadult;
table acur_marijuana;
run;
*Identify all variable want to keep;
proc freq data=lca.w2contadult;
table
acur_cig acur_ecig acur_alc acur_marijuana acur_painkiller
R02R_A_SEX age R02R_A_ETHRACECAT7 education R02R_A_AM0030
R02_AX0092
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
weeklyuse timegetting timeusing socialprob reducedact withdraw
usetoavoid
sud;
run;
*Now limit to the main variables that we want to keep;
data LCA.w2mpluscontadult;
set LCA.w2contadult (keep = caseid personid acur_cig acur_ecig acur_alc acur_marijuana
acur_painkiller
R02R_A_SEX age R02R_A_ETHRACECAT7 education R02R_A_AM0030
R02_AX0092
SEXMALE_1 SEXFEMALE_2
AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6
RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6
EDU_1 EDU_2 EDU_3 EDU_4 EDU_5
INC_1 INC_2 INC_3 INC_4 INC_5
SOC_1 SOC_2 SOC_3 SOC_4 SOC_5
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
weeklyuse timegetting timeusing socialprob reducedact withdraw
usetoavoid
sud);
*rename missings;
array change _numeric_;
do over change;
if change =. then change = -99999;
end;
run;
*Check frequencies;
proc contents data=LCA.W2mpluscontadult;
run;

*So far so good, let's pull this datset into MPlus and try LCA;
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***Missing vs nonmissing for W2;
***using contadultc data because it has new tobacco vars;
proc contents data=lca.w2contadultc;
run;
proc freq data=lca.w2contadultc;
table acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller;
run;
data lca.w2missingtest;
set lca.w2contadultc;
if (acur_cignew=.) or (acur_ecignew=.) or (acur_dualnew=.) or (acur_alc=.) or
(acur_marijuana=.) or (acur_painkiller=.) or
(R02R_A_SEX=.) or (age=.) or (R02R_A_ETHRACECAT7=.) or (education=.) or (R02R_A_AM0030=.) or
(R02_AX0092=.) or
(depressed=.) or (sleeping=.) or (anxious=.) or (ptsd=.) or
(lied=.) or (attention=.) or (listening=.) or (bully=.) or (fights=.) or
(restless=.) or (answered=.) or
(sud=.) then compare=0;
else compare=1;
run;
ods pdf;
proc freq data=lca.w2missingtest;
table compare;
run;
*complete data/analytic sample (compare = 1) = 21508;
*missing (compare = 0) = 4936;
********************************
*compare missing and nonmissing;
*look at column percent;
*subs;
proc freq data=lca.w2missingtest;
table acur_cignew*compare
acur_ecignew*compare
acur_dualnew*compare
acur_alc*compare
acur_marijuana*compare
acur_painkiller*compare/chisq;
run;
*sig diff for all: analytic sample has higher endorsement of all subs;
*demos;
proc freq data=lca.w2missingtest;
table R02R_A_SEX*compare
age*compare
R02R_A_ETHRACECAT7*compare
education*compare
R02R_A_AM0030*compare
R02_AX0092*compare/chisq;
run;
*sig difference sex: more males, less women in analytic sample;
*sig difference by age: more in categories 2, 3, 4 (25-54) in analytic sample;
*sig difference by race: more white, less other cats in analytic sample;
*sig difference by edu: higher edu levels in analytic sample;
*sig difference by income: higher income levels in analytic sample;
*sig difference by social: missing had slightly more extremely and very satisfied and also not at
all satisfied;
*internalizing;
proc freq data=lca.w2missingtest;
table depressed*compare
sleeping*compare
anxious*compare
ptsd*compare/chisq;
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run;
*sig diff for all: analytic sample has higher endorsement of all 4 symptoms;
*externalizing;
proc freq data=lca.w2missingtest;
table lied*compare
attention*compare
listening*compare
bully*compare
fights*compare
restless*compare
answered*compare/chisq;
run;
*sig diff for all except bully and fights: all others - analytic sample has higher endorsement of
the other 5 symptoms;
*no sig diff for bully or fights;
*sud;
proc freq data=lca.w2missingtest;
table sud*compare/chisq;
run;
*sig diff: analytic sample has higher endorsement of moderate and high sud severity;
ods pdf close;

MPLUS File name: w2 4 class 4142021
TITLE: WAVE 2 MODEL 4 CLASS -- APRIL 14 2021;
DATA: FILE IS w2dataformplus232021_noheader.csv;
VARIABLE: NAMES ARE CASEID PERSONID weight
acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller
R02R_A_ETHRACECAT7 age education
depressed sleeping anxious ptsd
lied attention listening bully fights
restless answered
weeklyuse timegetting timeusing socialprob reducedact withdraw usetoavoid
sud
SEXMALE_1 SEXFEMALE_2
AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6
RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6
EDU_1
EDU_2 EDU_3 EDU_4 EDU_5
INC_1 INC_2 INC_3 INC_4 INC_5
SOC_1
SOC_2 SOC_3 SOC_4 SOC_5;
USEVARIABLES = acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered;
IDVARIABLE = CASEID;
MISSING ARE ALL (-99999);
CLASSES = c(4);
CATEGORICAL = acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered;
AUXILIARY = SEXMALE_1 (R3STEP)
AGE1824_1 (R3STEP) AGE2534_2 (R3STEP) AGE3544_3 (R3STEP)
AGE4554_4 (R3STEP) AGE5564_5 (R3STEP)
RACEBL_2 (R3STEP) RACEOT_3 (R3STEP) RACEHI_6 (R3STEP)
EDU_1 (R3STEP) EDU_2 (R3STEP) EDU_3(R3STEP)
EDU_4 (R3STEP) INC_1 (R3STEP) INC_2 (R3STEP)
INC_3 (R3STEP) INC_4 (R3STEP)
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SOC_2 (R3STEP) SOC_3 (R3STEP) SOC_4 (R3STEP) SOC_5 (R3STEP);
WEIGHT is weight;
ANALYSIS: TYPE = MIXTURE;
STARTS = 100 10;
OPTSEED = 991329;
LRTSTARTS = 0 0 150 40;
SAVEDATA: file is w24classweight414.csv;
save = Cprob;
OUTPUT: TECH1 TECH8 TECH10 TECH11 TECH14;
SAS File name: Read in W2 4 CLASS 4142021
*WAVE 2 4 CLASS SOLUTION - import to compare with W1 and W3;
*MPLUS OUTPUT = w2 4 class 4142021;
*CSV = w24classweight414;
libname aim3 "U:\CourtneyBlondino\PhD Epidemiology\April Re Run\LCA Wave 2 and 3 - 4 class 4142021";
data aim3.w24classprob4142021;
input
W2_ACUR_CIG
W2_ACUR_ECI
W2_ACUR_DUA
W2_ACUR_ALC
W2_ACUR_MAR
W2_ACUR_PAI
W2_DEPRESS
W2_SLEEPING
W2_ANXIOUS
W2_PTSD
W2_LIED
W2_ATTENTIO
W2_LISTENIN
W2_BULLY
W2_FIGHTS
W2_RESTLESS
W2_ANSWERED
W2_SEXMALE_
W2_AGE1824_
W2_AGE2534_
W2_AGE3544_
W2_AGE4554_
W2_AGE5564_
W2_RACEBL_2
W2_RACEOT_3
W2_RACEHI_6
W2_EDU_1
W2_EDU_2
W2_EDU_3
W2_EDU_4
W2_INC_1
W2_INC_2
W2_INC_3
W2_INC_4
W2_SOC_2
W2_SOC_3
W2_SOC_4
W2_SOC_5
W2_CPROB1
W2_CPROB2
W2_CPROB3
W2_CPROB4
W2_C
W2_WEIGHT
CASEID;
datalines;
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************COPY AND PASTE OUTPUT FROM MPLUS*********
run;

SAS File name: LCA W3
*In the ICPSR_36498 folder, select DS3001 and open the data file (36498-3001-Data) which is
a SAS Cport Transport file. Once this is open, formats are in, and can begin data management;
libname LCA "U:\CourtneyBlondino\PhD Epidemiology\LCA\Wave 3\Data Management";
*Recoding Missings;
data LCA.W3;
set da36498p3001;
*Current User Cigarette;
*R03_AC1002_12M: In past 12 months, smoked a cigarette, even one or two puffs;
*R03_AC1005: Number of cigarettes smoked in your entire life;
*R03_AC1003: Now smoke cigarettes;
*if R03_AC1002_12M = 1 AND R03_AC1005=6 AND R03_AC1003 in (1 2) then acur_cig = 1;
*else if R03_AC1002_12M = 2 OR R03_AC1003=3 OR (R03_AC1003 in (1,2,.) AND R03_AC1005 in
(1,2,3,4,5)) then acur_cig=0;
*else if R03_AC1002_12M = . OR R03_AC1003=. OR R03_AC1005=. then acur_cig = .;
if R03R_A_CUR_ESTD_CIGS=1 then acur_cig=1;
else if R03R_A_CUR_ESTD_CIGS=2 then acur_cig=0;
else if R03R_A_CUR_ESTD_CIGS=. then acur_cig=.;
*Current E-cigarette user;
*R03_AV1002_12M: Ever used the following electronic nicotine product: E-cigarette;
*R03_AV1100: Ever used e-cigarettes fairly regularly;
*R03_AV1003EC: Now use e-cigarettes;
*if R03_AV1002_12M = 1 AND R03_AV1100=1 AND R03_AV1003EC in (1,2) then acur_ecig = 1;
*else if R03_AV1002_12M=2 OR R03_AV1100 = 2 OR R03_AV1003EC = 3 OR (R03_AV1100 in (1,2,.)
AND R03_AV1003EC = 2) then acur_ecig=0;
*else if R03_AV1002_12M= . OR R03_AV1100=. OR R03_AV1003EC = . OR R03_AV1100 = . then
acur_ecig = .;
if R03R_A_CUR_ESTD_EPRODS=1 then acur_ecig=1;
else if R03R_A_CUR_ESTD_EPRODS=2 then acur_ecig=0;
else if R03R_A_CUR_ESTD_EPRODS=. then acur_ecig=.;
*Current Use Alcohol;
*R03_AX0084_12M: In past 12 months, used alcohol, including small tastes or sips
*R03_AX0673: In past 30 days, used alcohol;
if R03_AX0084_12M = 1 AND R03_AX0673 = 1 then acur_alc=1;
else if R03_AX0084_12M = 2 OR R03_AX0673 = 2 then acur_alc=0;
else if R03_AX0084_12M = . OR R03_AX0673 = . then acur_alc=.;
*Current User Marijuana;
*R03_AX0085_12M: In past 12 months, used marijuana, hash, THC, grass, pot or weed;
*R03_AX0675: In past 30 days, used marijuana, hash, THC, grass, pot or weed;
if R03_AX0675 = 1 then acur_marijuana=1;
else if R03_AX0675 in (-1, 2) then acur_marijuana=0;
else if R03_AX0675 = . then acur_marijuana=.;
*Current User Painkillers, Sedatives, or Tranquilizers (prescription drugs not prescribed
to you);
*R03_AX0089_12M_02: In past 12 months, used prescription drugs not prescribed to you:
Painkillers, sedatives or tranquilizers;
*R03_AX0676_02: In past 30 days, used: Painkillers, sedatives or tranquilizers;
if R03_AX0089_12M_02 = 1 AND R03_AX0676_02 = 1 then acur_painkiller=1;
else if R03_AX0089_12M_02 = 2 OR R03_AX0676_02 = 2 then acur_painkiller=0;
else if R03_AX0089_12M_02 = . OR R03_AX0676_02 = . then acur_painkiller=.;
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*RACE;
*R03R_A_RACECAT3: DERIVED - Race from the interview (3 levels): 1 = white alone, 2 = black alone,
3 = other;
*R03R_A_HISP: DERIVED - Wave 2 Adult Hispanic Origin (2 levels): 1 = hispanic, 2 = not hispanic;
NUMRACES = 0 ;
if R03R_A_RACECAT3 = 1 then NUMRACES = NUMRACES + 1 ;
if R03R_A_RACECAT3 = 2 then NUMRACES= NUMRACES + 1 ;
if R03R_A_RACECAT3 = 3 then NUMRACES = NUMRACES + 1 ;
if R03R_A_HISP = 1 then NUMRACES = NUMRACES + 1;
if (NUMRACES = 1 and R03R_A_RACECAT3 = 1 AND R03R_A_HISP=2) then R03R_A_ETHRACECAT7= 1 ; *NH
White;
if (NUMRACES = 1 and R03R_A_RACECAT3 = 2 AND R03R_A_HISP=2) then R03R_A_ETHRACECAT7= 2 ; *NH AA;
if (NUMRACES = 1 and R03R_A_RACECAT3 = 3 AND R03R_A_HISP=2) then R03R_A_ETHRACECAT7= 3 ; *NH
Other;
if (NUMRACES = 1 and R03R_A_HISP=1) then R03R_A_ETHRACECAT7= 4; *Hispanic Only;
if (NUMRACES > 1 and R03R_A_HISP=2) then R03R_A_ETHRACECAT7= 5; *NH Multiracial;
if (NUMRACES > 1 and R03R_A_HISP=1) then R03R_A_ETHRACECAT7= 6; *Hispanic Multiracial;
ELSE IF R03R_A_HISP=. OR R03R_A_RACECAT3 = . THEN R03R_A_ETHRACECAT7=.;
*AGE;
*R03R_A_AGECAT7: DERIVED - Age range when interviewed (7 levels);
if R03R_A_AGECAT7=1 then age=1; *18-24;
else if R03R_A_AGECAT7=2 then age=2; *25-34;
else if R03R_A_AGECAT7=3 then age=3; *35-44;
else if R03R_A_AGECAT7=4 then age=4; *45-54;
else if R03R_A_AGECAT7=5 then age=5; *55-64;
else if R03R_A_AGECAT7 in (6 7) then age=6; *65 and older;
else age=.;
*EDUCATION;
*R03R_A_AM0018: DERIVED - Highest grade or level of school completed (6 levels);
if R03R_A_AM0018=1 then education=1; *less than high school;
else if R03R_A_AM0018 in (2 3) then education=2; *GED/high school graduate;
else if R03R_A_AM0018=4 then education=3; *Some college (no degree) or associates degree;
else if R03R_A_AM0018=5 then education=4; *Bachelor's degree;
else if R03R_A_AM0018=6 then education=5; *Advanced degree;
else education=.;
******INTERNALIZING**********;
*R03_AX0161: Last time you had significant problems with: Feeling very trapped, lonely, sad,
blue, depressed or hopeless about the future;
if R03_AX0161 in (2, 3, 4) then depressed=0;
else if R03_AX0161 in (1) then depressed=1;
else if R03_AX0161 = . then depressed= .;
*R03_AX0162: Last time you had significant problems with: Sleep trouble - such as bad
dreams, sleeping restlessly or falling asleep during the day;
if R03_AX0162 in (2, 3, 4) then sleeping=0;
else if R03_AX0162 in (1) then sleeping=1;
else if R03_AX0162 = . then sleeping=.;
*R03_AX0163: Last time you had significant problems with: Feeling very anxious, nervous,
tense, scared, panicked or like something bad was going to happen;
if R03_AX0163 in (2, 3, 4) then anxious=0;
else if R03_AX0163 in (1) then anxious=1;
else if R03_AX0163 = . then anxious=.;
*R03_AX0164: Last time you had significant problems with: Becoming very distressed and
upset when something reminded you of the past;
if R03_AX0164 in (2, 3, 4) then ptsd=0;
else if R03_AX0164 in (1) then ptsd=1;
else if R03_AX0164 = . then ptsd=.;
******EXTERNALIZING**********;
*R03_AX0165: Last time you did the following two or more times: Lied or conned to get things
you wanted or to avoid having to do something;
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if R03_AX0165 in (2, 3, 4) then lied=0;
else if R03_AX0165 in (1) then lied=1;
else if R03_AX0165 = . then lied=.;
*R03_AX0166: Last time you did the following two or more times: Had a hard time paying
attention at school, work or home;
if R03_AX0166 in (2, 3, 4) then attention=0;
else if R03_AX0166 in (1) then attention=1;
else if R03_AX0166 = . then attention=.;
*R03_AX0167: Last time you did the following two or more times: Had a hard time listening to
instructions at school, work or home;
if R03_AX0167 in (2, 3, 4) then listening=0;
else if R03_AX0167 in (1) then listening=1;
else if R03_AX0167 = . then listening= .;
*R03_AX0168: Last time you did the following two or more times: Were a bully or threatened
other people;
if R03_AX0168 in (2, 3, 4) then bully=0;
else if R03_AX0168 in (1) then bully=1;
else if R03_AX0168 = . then bully= .;
*R03_AX0169: Last time you did the following two or more times: Started physical fights with
other people;
if R03_AX0169 in (2, 3, 4) then fights=0;
else if R03_AX0169 in (1) then fights=1;
else if R03_AX0169 = . then fights= .;
*R03_AX0250: Last time you did the following two or more times: Felt restless or the need to
run around or climb on things;
if R03_AX0250 in (2, 3, 4) then restless=0;
if R03_AX0250 in (1) then restless=1;
else if R03_AX0250 = . then restless=.;
*R03_AX0251: Last time you did the following two or more times: Gave answers before the
other person finished asking the question;
if R03_AX0251 in (2, 3, 4) then answered=0;
if R03_AX0251 in (1) then answered=1;
else if R03_AX0251 = . then answered=.;
******SUBSTANCE USE DISORDERS**********;
*R03_AX0170: Last time that you used alcohol or other drugs weekly or more often;
if R03_AX0170 in (2, 3, 4) then weeklyuse=0;
if R03_AX0170 in (1) then weeklyuse=1;
else if R03_AX0170 = . then weeklyuse=.;
*R03_AX0171: Last time that you spent a lot of time getting alcohol or other drugs;
if R03_AX0171 in (2, 3, 4) then timegetting=0;
if R03_AX0171 in (1) then timegetting=1;
else if R03_AX0171 = . then timegetting=.;
*R03_AX0193: Last time you spent a lot of time using or recovering from alcohol or other drugs;
if R03_AX0193 in (2, 3, 4) then timeusing=0;
if R03_AX0193 in (1) then timeusing=1;
else if R03_AX0193 = . then timeusing=.;
*R03_AX0172: Last time that you kept using alcohol or other drugs even though it was causing
social problems, leading to fights, or getting you into trouble with other people;
if R03_AX0172 in (2, 3, 4) then socialprob=0;
if R03_AX0172 in (1) then socialprob=1;
else if R03_AX0172 = . then socialprob=.;
*R03_AX0173: Last time that your use of alcohol or other drugs reduced your involvement in
activities at work, school, home or social events;
if R03_AX0173 in (2, 3, 4) then reducedact=0;
if R03_AX0173 in (1) then reducedact=1;
else if R03_AX0173 = . then reducedact=.;
*R03_AX0174: Last time that you had withdrawal problems such as shaky hands, throwing up,
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having trouble sitting still or sleeping;
if R03_AX0174 in (2, 3, 4) then withdraw=0;
if R03_AX0174 in (1) then withdraw=1;
else if R03_AX0174 = . then withdraw=.;
*R03_AX0194: Last time you used any alcohol or other drugs to stop being sick or avoid
withdrawal problems;
if R03_AX0194 in (2, 3, 4) then usetoavoid=0;
if R03_AX0194 in (1) then usetoavoid=1;
else if R03_AX0194 = . then usetoavoid=.;
*ALL PAST 30 DAY;
sud_score = sum(weeklyuse, timegetting, timeusing, socialprob, reducedact, withdraw, usetoavoid);
*SUD is 3 levels- no/low, moderate, and high;
if sud_score in (0) then sud=0;
if sud_score in (1,2) then sud=1;
if sud_score in (3,4,5,6,7) then sud=2;
if sud_score = . then sud=.;
*****DUMMY CODING FOR THE COVARIATES******;
IF R03R_A_SEX=1 THEN SEXMALE_1=1;
ELSE SEXMALE_1=0;
IF R03R_A_SEX=2 THEN SEXFEMALE_2=1;
ELSE SEXFEMALE_2=0;
IF age=1 THEN AGE1824_1=1;
ELSE AGE1824_1=0;
IF age=2 THEN AGE2534_2=1;
ELSE AGE2534_2=0;
IF age=3 THEN AGE3544_3=1;
ELSE AGE3544_3=0;
IF age=4 THEN AGE4554_4=1;
ELSE AGE4554_4=0;
IF age=5 THEN AGE5564_5=1;
ELSE AGE5564_5=0;
IF age=6 THEN AGE65_6=1;
ELSE AGE65_6=0;
IF R03R_A_ETHRACECAT7=1 THEN RACEWH_1=1;
ELSE RACEWH_1=0;
IF R03R_A_ETHRACECAT7=2 THEN RACEBL_2=1;
ELSE RACEBL_2=0;
IF R03R_A_ETHRACECAT7=3 THEN RACEOT_3=1;
ELSE RACEOT_3=0;
IF R03R_A_ETHRACECAT7=6 THEN RACEHI_6=1;
ELSE RACEHI_6=0;
IF education=1 THEN EDU_1=1;
ELSE EDU_1=0;
IF education=2 THEN EDU_2=1;
ELSE EDU_2=0;
IF education=3 THEN EDU_3=1;
ELSE EDU_3=0;
IF education=4 THEN EDU_4=1;
ELSE EDU_4=0;
IF education=5 THEN EDU_5=1;
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ELSE EDU_5=0;
IF R03R_A_AM0030=1 THEN INC_1=1;
ELSE INC_1=0;
IF R03R_A_AM0030=2 THEN INC_2=1;
ELSE INC_2=0;
IF R03R_A_AM0030=3 THEN INC_3=1;
ELSE INC_3=0;
IF R03R_A_AM0030=4 THEN INC_4=1;
ELSE INC_4=0;
IF R03R_A_AM0030=5 THEN INC_5=1;
ELSE INC_5=0;
*extremely satisfied =1;
IF R03_AX0092=1 THEN SOC_1=1;
ELSE SOC_1=0;
IF R03_AX0092=2 THEN SOC_2=1;
ELSE SOC_2=0;
IF R03_AX0092=3 THEN SOC_3=1;
ELSE SOC_3=0;
IF R03_AX0092=4 THEN SOC_4=1;
ELSE SOC_4=0;
*not at all satisfied =5;
IF R03_AX0092=5 THEN SOC_5=1;
ELSE SOC_5=0;
array change _numeric_;
do over change;
if change=-97777 then change=.;
else if change=-99999 then change=.;
else if change=-99988 then change=.;
else if change=-99977 then change=.;
else if change=-99955 then change=.;
else if change=-99911 then change=.;
else if change=-9 then change=.;
else if change=-8 then change=.;
else if change=-7 then change=.;
else if change=-1 then change=.;
else if change=-5 then change=.;
end;
run;

*********confirming recodes worked;
*check dummies;
proc freq data=lca.w3;
table
R03R_A_SEX*SEXMALE_1
R03R_A_SEX*SEXFEMALE_2
age*AGE1824_1
age*AGE2534_2
age*AGE3544_3
age*AGE4554_4
age*AGE5564_5
age*AGE65_6
R03R_A_ETHRACECAT7*RACEWH_1
R03R_A_ETHRACECAT7*RACEBL_2
R03R_A_ETHRACECAT7*RACEOT_3
R03R_A_ETHRACECAT7*RACEHI_6
education*EDU_1
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run;

education*EDU_2
education*EDU_3
education*EDU_4
education*EDU_5
R03R_A_AM0030*INC_1
R03R_A_AM0030*INC_2
R03R_A_AM0030*INC_3
R03R_A_AM0030*INC_4
R03R_A_AM0030*INC_5
R03_AX0092*SOC_1
R03_AX0092*SOC_2
R03_AX0092*SOC_3
R03_AX0092*SOC_4
R03_AX0092*SOC_5;

*check sud;
proc freq data=lca.w3;
table sud_score*sud;
run;
*int/ext/sud;
proc freq data=lca.w3;
table
acur_alc acur_marijuana acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
weeklyuse timegetting timeusing socialprob reducedact withdraw usetoavoid
sud;
run;
proc freq data=lca.w3;
table R03R_A_CUR_ESTD_CIGS*acur_cig
R03R_A_CUR_ESTD_EPRODS*acur_ecig;
run;
proc freq data=lca.w3;
table acur_alc acur_marijuana acur_painkiller;
run;
*marijuana is weird again for past 30 day-because R03_AX0675 is either smoked traditional cigar, cigarillo, or filtered cigar with
marijuana in the past 12 months
OR
have you used marijuana in the past 12 months;
*only select people from wave 1 and wave 2;
proc freq data=lca.w3;
table R03_ADULTTYPE;
run;
data lca.w3contadult;
set lca.w3;
if R03_ADULTTYPE=1;
run;
proc freq data=lca.w3contadult;
table R03_ADULTTYPE;
run;
proc freq data=lca.w3contadult;
table acur_cig acur_ecig acur_alc acur_marijuana acur_painkiller
R03R_A_SEX age R03R_A_ETHRACECAT7 education R03R_A_AM0030 R03_AX0092
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
sud;
run;

*Identify all variable want to keep;
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*Now limit to the main variables that we want to keep;
data LCA.W3mpluscontadult;
set LCA.W3contadult (keep = caseid personid acur_cig acur_ecig acur_alc acur_marijuana
acur_painkiller
R03R_A_SEX age R03R_A_ETHRACECAT7 education R03R_A_AM0030
R03_AX0092
SEXMALE_1 SEXFEMALE_2
AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6
RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6
EDU_1 EDU_2 EDU_3 EDU_4 EDU_5
INC_1 INC_2 INC_3 INC_4 INC_5
SOC_1 SOC_2 SOC_3 SOC_4 SOC_5
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
weeklyuse timegetting timeusing socialprob reducedact withdraw
usetoavoid
sud);
*rename missings;
array change _numeric_;
do over change;
if change =. then change = -99999;
end;
run;
*Check frequencies;
proc contents data=LCA.W3mpluscontadult;
run;

***Missing vs nonmissing for W3;
***using contadultc data because it has new tobacco vars;
proc contents data=lca.w3contadultc;
run;
proc freq data=lca.w3contadultc;
table acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller;
run;
data lca.w3missingtest;
set lca.w3contadultc;
if (acur_cignew=.) or (acur_ecignew=.) or (acur_dualnew=.) or (acur_alc=.) or
(acur_marijuana=.) or (acur_painkiller=.) or
(R03R_A_SEX=.) or (age=.) or (R03R_A_ETHRACECAT7=.) or (education=.) or (R03R_A_AM0030=.) or
(R03_AX0092=.) or
(depressed=.) or (sleeping=.) or (anxious=.) or (ptsd=.) or
(lied=.) or (attention=.) or (listening=.) or (bully=.) or (fights=.) or
(restless=.) or (answered=.) or
(sud=.) then compare=0;
else compare=1;
run;
ods pdf;
proc freq data=lca.w3missingtest;
table compare;
run;
*complete data/analytic sample (compare = 1) = 21628;
*missing (compare = 0) = 4611;
********************************
*compare missing and nonmissing;
*look at column percent;
*subs;
proc freq data=lca.w3missingtest;
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table acur_cignew*compare
acur_ecignew*compare
acur_dualnew*compare
acur_alc*compare
acur_marijuana*compare
acur_painkiller*compare/chisq;
run;
*sig diff for all: analytic sample has higher endorsement of all subs;
*demos;
proc freq data=lca.w3missingtest;
table R03R_A_SEX*compare
age*compare
R03R_A_ETHRACECAT7*compare
education*compare
R03R_A_AM0030*compare
R03_AX0092*compare/chisq;
run;
*sig difference sex: more males, less women in analytic sample;
*sig difference by age: more in categories 2, 3, 4 (25-54) in analytic sample;
*sig difference by race: more white, less other cats in analytic sample;
*sig difference by edu: higher edu levels in analytic sample;
*sig difference by income: higher income levels in analytic sample;
*sig difference by social: missing had more extremely and also not at all satisfied;
*internalizing;
proc freq data=lca.w3missingtest;
table depressed*compare
sleeping*compare
anxious*compare
ptsd*compare/chisq;
run;
*sig diff for all: analytic sample has higher endorsement of all 4 symptoms;
*externalizing;
proc freq data=lca.w3missingtest;
table lied*compare
attention*compare
listening*compare
bully*compare
fights*compare
restless*compare
answered*compare/chisq;
run;
*sig diff for all except bully and fights: all others - analytic sample has higher endorsement of
the other 5 symptoms;
*no sig diff for bully or fights;
*sud;
proc freq data=lca.w3missingtest;
table sud*compare/chisq;
run;
*sig diff: analytic sample has higher endorsement of moderate and high sud severity;
ods pdf close;

MPLUS File name: w3 4 class 4142021
TITLE: WAVE 3 MODEL 4 CLASS -- APRIL 14 2021;
DATA: FILE IS w3dataformplus332021_noheader.csv;
VARIABLE: NAMES ARE CASEID PERSONID weight
acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller
R03R_A_ETHRACECAT7 age education
depressed sleeping anxious ptsd
lied attention listening bully fights
restless answered
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weeklyuse timegetting timeusing socialprob reducedact withdraw usetoavoid
sud
SEXMALE_1 SEXFEMALE_2
AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6
RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6
EDU_1
EDU_2 EDU_3 EDU_4 EDU_5
INC_1 INC_2 INC_3 INC_4 INC_5
SOC_1
SOC_2 SOC_3 SOC_4 SOC_5;
USEVARIABLES = acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered;
IDVARIABLE = CASEID;
MISSING ARE ALL (-99999);
CLASSES = c(5);
CATEGORICAL = acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered;
AUXILIARY = SEXMALE_1 (R3STEP)
AGE1824_1 (R3STEP) AGE2534_2 (R3STEP) AGE3544_3 (R3STEP)
AGE4554_4 (R3STEP) AGE5564_5 (R3STEP)
RACEBL_2 (R3STEP) RACEOT_3 (R3STEP) RACEHI_6 (R3STEP)
EDU_1 (R3STEP) EDU_2 (R3STEP) EDU_3(R3STEP)
EDU_4 (R3STEP) INC_1 (R3STEP) INC_2 (R3STEP)
INC_3 (R3STEP) INC_4 (R3STEP)
SOC_2 (R3STEP) SOC_3 (R3STEP) SOC_4 (R3STEP) SOC_5 (R3STEP);
WEIGHT is weight;
ANALYSIS: TYPE = MIXTURE;
STARTS = 100 10;
OPTSEED = 991329;
LRTSTARTS = 0 0 150 40;
SAVEDATA: file is w34classweight414.csv;
save = Cprob;
OUTPUT: TECH1 TECH8 TECH10 TECH11 TECH14;

SAS File name: Read in W3 4 CLASS 4142021
*WAVE 3 4 CLASS SOLUTION - import to compare with W1 and W2;
*MPLUS OUTPUT = w3 4 class 4152021;
*CSV = w34classweight415;
libname aim3 "U:\CourtneyBlondino\PhD Epidemiology\April Re Run\LCA Wave 2 and 3 - 4 class 4142021";
data aim3.w34classprob4152021;
input
W3_ACUR_CIG
W3_ACUR_ECI
W3_ACUR_DUA
W3_ACUR_ALC
W3_ACUR_MAR
W3_ACUR_PAI
W3_DEPRESS
W3_SLEEPING
W3_ANXIOUS

359

W3_PTSD
W3_LIED
W3_ATTENTIO
W3_LISTENIN
W3_BULLY
W3_FIGHTS
W3_RESTLESS
W3_ANSWERED
W3_SEXMALE_
W3_AGE1824_
W3_AGE2534_
W3_AGE3544_
W3_AGE4554_
W3_AGE5564_
W3_RACEBL_2
W3_RACEOT_3
W3_RACEHI_6
W3_EDU_1
W3_EDU_2
W3_EDU_3
W3_EDU_4
W3_INC_1
W3_INC_2
W3_INC_3
W3_INC_4
W3_SOC_2
W3_SOC_3
W3_SOC_4
W3_SOC_5
W3_CPROB1
W3_CPROB2
W3_CPROB3
W3_CPROB4
W3_C
W3_WEIGHT
CASEID;
datalines;

******************COPY AND PASTE OUTPUT FROM MPLUS***********
run;

SAS File name: LCA Comparisons, Transition Tables 4142021
*Merge the datasets to look at transition tables;
libname aim3 "U:\CourtneyBlondino\PhD Epidemiology\April Re Run\LCA Wave 2 and 3 - 4 class 4142021";
*start by checking freqs;
*Wave 1;
proc surveyfreq data=aim3.w14classprob4142021;
table
W1_ACUR_CIG
W1_ACUR_ECI
W1_ACUR_DUA
W1_ACUR_ALC
W1_ACUR_PAI
W1_DEPRESS
W1_SLEEPING
W1_ANXIOUS
W1_PTSD
W1_LIED
W1_ATTENTIO
W1_LISTENING
W1_BULLY
W1_RESTLESS
W1_ANSWERED / row chisq (secondorder);
weight W1_weight;
run;
*Wave 2;
proc surveyfreq data=aim3.w24classprob4142021;
table
W2_ACUR_CIG
W2_ACUR_ECI
W2_ACUR_DUA
W2_ACUR_PAI
W2_DEPRESS
W2_SLEEPING
W2_ANXIOUS
W2_LIED
W2_ATTENTIO
W2_LISTENIN
W2_ANSWERED / row chisq (secondorder);
weight W2_weight;

W2_ACUR_ALC
W2_PTSD
W2_BULLY

W1_ACUR_MAR
W1_FIGHTS

W2_ACUR_MAR
W2_FIGHTS

W2_RESTLESS
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run;
*Wave 3;
proc surveyfreq data=aim3.W34classprob4152021;
table
W3_ACUR_CIG
W3_ACUR_ECI
W3_ACUR_DUA
W3_DEPRESS
W3_SLEEPING
W3_ANXIOUS
W3_LIED
W3_ATTENTIO
W3_LISTENIN
W3_ANSWERED
/ row chisq (secondorder);
weight W3_weight;
run;

W3_ACUR_ALC
W3_PTSD
W3_BULLY

W3_ACUR_MAR
W3_FIGHTS

W3_ACUR_PAI
W3_RESTLESS

proc surveyfreq data=aim3.W34classprob4152021;
table
w3_C
/ row chisq (secondorder);
weight W3_weight;
run;
*then sort by caseid;
proc sort data=aim3.w14classprob4142021;
by caseid;
run;
proc sort data=aim3.w24classprob4142021;
by caseid;
run;
proc sort data=aim3.W34classprob4152021;
by caseid;
run;
********************need to add in R03_A_AWGT to use when running weighted transition tables;
proc contents data=work.Da36498p3101;
*table R03_A_AWGT;
run;
data aim3.w3allweights;
set WORK.DA36498P3101
(keep = caseid R03_A_AWGT);
run;
proc sort data=aim3.w3allweights;
by caseid;
run;

*then merge;
data aim3.master;
merge aim3.w14classprob4142021 aim3.w24classprob4142021 aim3.W34classprob4152021
aim3.w3allweights;
by caseid;
*array change _numeric_;
*do over change;
*if change =-99999 then change = .;
*end;
run;
proc contents data=aim3.master;
run;
proc print data=aim3.master (obs=20);
run;
*make transition tables;
ods pdf;
*W1 vs W2;
proc freq data=aim3.master;
table w1_c*w2_c;
run;
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*W2 vs W3;
proc freq data=aim3.master;
table w2_c*w3_c;
run;
*W1 vs W3;
proc freq data=aim3.master;
table w1_c*w3_c;
run;
ods pdf close;
*make transition tables - with wave 3 all weights;
ods pdf;
*W1 vs W2;
proc surveyfreq data=aim3.master;
table w1_c*w2_c
/ row chisq (secondorder);
weight R03_A_AWGT;
run;
*W2 vs W3;
proc surveyfreq data=aim3.master;
table w2_c*w3_c
/ row chisq (secondorder);
weight R03_A_AWGT;
run;
*W1 vs W3;
proc surveyfreq data=aim3.master;
table w1_c*w3_c
/ row chisq (secondorder);
weight R03_A_AWGT;
run;
ods pdf close;

*Try to get item response pattern for each comorbidity class for each wave;
*Table 3.7 in Nylund dissertation;

*tetrachoric correlations by wave;
*4/28/2021;
ods pdf;
proc contents data=aim3.master;
run;
******W1 VS W2;
proc freq data=aim3.master;
table
W1_ACUR_CIG*W2_ACUR_CIG
W1_ACUR_CIG*W2_ACUR_ECI
W1_ACUR_CIG*W2_ACUR_DUA
W1_ACUR_CIG*W2_ACUR_ALC
W1_ACUR_CIG*W2_ACUR_MAR
W1_ACUR_CIG*W2_ACUR_PAI
W1_ACUR_CIG*W2_DEPRESS
W1_ACUR_CIG*W2_SLEEPING
W1_ACUR_CIG*W2_ANXIOUS
W1_ACUR_CIG*W2_PTSD
W1_ACUR_CIG*W2_LIED
W1_ACUR_CIG*W2_ATTENTIO
W1_ACUR_CIG*W2_LISTENIN
W1_ACUR_CIG*W2_BULLY
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W1_ACUR_CIG*W2_FIGHTS
W1_ACUR_CIG*W2_RESTLESS
W1_ACUR_CIG*W2_ANSWERED
W1_ACUR_ECI*W2_ACUR_CIG
W1_ACUR_ECI*W2_ACUR_ECI
W1_ACUR_ECI*W2_ACUR_DUA
W1_ACUR_ECI*W2_ACUR_ALC
W1_ACUR_ECI*W2_ACUR_MAR
W1_ACUR_ECI*W2_ACUR_PAI
W1_ACUR_ECI*W2_DEPRESS
W1_ACUR_ECI*W2_SLEEPING
W1_ACUR_ECI*W2_ANXIOUS
W1_ACUR_ECI*W2_PTSD
W1_ACUR_ECI*W2_LIED
W1_ACUR_ECI*W2_ATTENTIO
W1_ACUR_ECI*W2_LISTENIN
W1_ACUR_ECI*W2_BULLY
W1_ACUR_ECI*W2_FIGHTS
W1_ACUR_ECI*W2_RESTLESS
W1_ACUR_ECI*W2_ANSWERED
W1_ACUR_DUA*W2_ACUR_CIG
W1_ACUR_DUA*W2_ACUR_ECI
W1_ACUR_DUA*W2_ACUR_DUA
W1_ACUR_DUA*W2_ACUR_ALC
W1_ACUR_DUA*W2_ACUR_MAR
W1_ACUR_DUA*W2_ACUR_PAI
W1_ACUR_DUA*W2_DEPRESS
W1_ACUR_DUA*W2_SLEEPING
W1_ACUR_DUA*W2_ANXIOUS
W1_ACUR_DUA*W2_PTSD
W1_ACUR_DUA*W2_LIED
W1_ACUR_DUA*W2_ATTENTIO
W1_ACUR_DUA*W2_LISTENIN
W1_ACUR_DUA*W2_BULLY
W1_ACUR_DUA*W2_FIGHTS
W1_ACUR_DUA*W2_RESTLESS
W1_ACUR_DUA*W2_ANSWERED
W1_ACUR_ALC*W2_ACUR_CIG
W1_ACUR_ALC*W2_ACUR_ECI
W1_ACUR_ALC*W2_ACUR_DUA
W1_ACUR_ALC*W2_ACUR_ALC
W1_ACUR_ALC*W2_ACUR_MAR
W1_ACUR_ALC*W2_ACUR_PAI
W1_ACUR_ALC*W2_DEPRESS
W1_ACUR_ALC*W2_SLEEPING
W1_ACUR_ALC*W2_ANXIOUS
W1_ACUR_ALC*W2_PTSD
W1_ACUR_ALC*W2_LIED
W1_ACUR_ALC*W2_ATTENTIO
W1_ACUR_ALC*W2_LISTENIN
W1_ACUR_ALC*W2_BULLY
W1_ACUR_ALC*W2_FIGHTS
W1_ACUR_ALC*W2_RESTLESS
W1_ACUR_ALC*W2_ANSWERED
W1_ACUR_MAR*W2_ACUR_CIG
W1_ACUR_MAR*W2_ACUR_ECI
W1_ACUR_MAR*W2_ACUR_DUA
W1_ACUR_MAR*W2_ACUR_ALC
W1_ACUR_MAR*W2_ACUR_MAR
W1_ACUR_MAR*W2_ACUR_PAI
W1_ACUR_MAR*W2_DEPRESS
W1_ACUR_MAR*W2_SLEEPING
W1_ACUR_MAR*W2_ANXIOUS
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W1_ACUR_MAR*W2_PTSD
W1_ACUR_MAR*W2_LIED
W1_ACUR_MAR*W2_ATTENTIO
W1_ACUR_MAR*W2_LISTENIN
W1_ACUR_MAR*W2_BULLY
W1_ACUR_MAR*W2_FIGHTS
W1_ACUR_MAR*W2_RESTLESS
W1_ACUR_MAR*W2_ANSWERED
W1_ACUR_PAI*W2_ACUR_CIG
W1_ACUR_PAI*W2_ACUR_ECI
W1_ACUR_PAI*W2_ACUR_DUA
W1_ACUR_PAI*W2_ACUR_ALC
W1_ACUR_PAI*W2_ACUR_MAR
W1_ACUR_PAI*W2_ACUR_PAI
W1_ACUR_PAI*W2_DEPRESS
W1_ACUR_PAI*W2_SLEEPING
W1_ACUR_PAI*W2_ANXIOUS
W1_ACUR_PAI*W2_PTSD
W1_ACUR_PAI*W2_LIED
W1_ACUR_PAI*W2_ATTENTIO
W1_ACUR_PAI*W2_LISTENIN
W1_ACUR_PAI*W2_BULLY
W1_ACUR_PAI*W2_FIGHTS
W1_ACUR_PAI*W2_RESTLESS
W1_ACUR_PAI*W2_ANSWERED
W1_DEPRESS*W2_ACUR_CIG
W1_DEPRESS*W2_ACUR_ECI
W1_DEPRESS*W2_ACUR_DUA
W1_DEPRESS*W2_ACUR_ALC
W1_DEPRESS*W2_ACUR_MAR
W1_DEPRESS*W2_ACUR_PAI
W1_DEPRESS*W2_DEPRESS
W1_DEPRESS*W2_SLEEPING
W1_DEPRESS*W2_ANXIOUS
W1_DEPRESS*W2_PTSD
W1_DEPRESS*W2_LIED
W1_DEPRESS*W2_ATTENTIO
W1_DEPRESS*W2_LISTENIN
W1_DEPRESS*W2_BULLY
W1_DEPRESS*W2_FIGHTS
W1_DEPRESS*W2_RESTLESS
W1_DEPRESS*W2_ANSWERED
W1_SLEEPING*W2_ACUR_CIG
W1_SLEEPING*W2_ACUR_ECI
W1_SLEEPING*W2_ACUR_DUA
W1_SLEEPING*W2_ACUR_ALC
W1_SLEEPING*W2_ACUR_MAR
W1_SLEEPING*W2_ACUR_PAI
W1_SLEEPING*W2_DEPRESS
W1_SLEEPING*W2_SLEEPING
W1_SLEEPING*W2_ANXIOUS
W1_SLEEPING*W2_PTSD
W1_SLEEPING*W2_LIED
W1_SLEEPING*W2_ATTENTIO
W1_SLEEPING*W2_LISTENIN
W1_SLEEPING*W2_BULLY
W1_SLEEPING*W2_FIGHTS
W1_SLEEPING*W2_RESTLESS
W1_SLEEPING*W2_ANSWERED
W1_ANXIOUS*W2_ACUR_CIG
W1_ANXIOUS*W2_ACUR_ECI
W1_ANXIOUS*W2_ACUR_DUA
W1_ANXIOUS*W2_ACUR_ALC
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W1_ANXIOUS*W2_ACUR_MAR
W1_ANXIOUS*W2_ACUR_PAI
W1_ANXIOUS*W2_DEPRESS
W1_ANXIOUS*W2_SLEEPING
W1_ANXIOUS*W2_ANXIOUS
W1_ANXIOUS*W2_PTSD
W1_ANXIOUS*W2_LIED
W1_ANXIOUS*W2_ATTENTIO
W1_ANXIOUS*W2_LISTENIN
W1_ANXIOUS*W2_BULLY
W1_ANXIOUS*W2_FIGHTS
W1_ANXIOUS*W2_RESTLESS
W1_ANXIOUS*W2_ANSWERED
W1_PTSD*W2_ACUR_CIG
W1_PTSD*W2_ACUR_ECI
W1_PTSD*W2_ACUR_DUA
W1_PTSD*W2_ACUR_ALC
W1_PTSD*W2_ACUR_MAR
W1_PTSD*W2_ACUR_PAI
W1_PTSD*W2_DEPRESS
W1_PTSD*W2_SLEEPING
W1_PTSD*W2_ANXIOUS
W1_PTSD*W2_PTSD
W1_PTSD*W2_LIED
W1_PTSD*W2_ATTENTIO
W1_PTSD*W2_LISTENIN
W1_PTSD*W2_BULLY
W1_PTSD*W2_FIGHTS
W1_PTSD*W2_RESTLESS
W1_PTSD*W2_ANSWERED
W1_LIED*W2_ACUR_CIG
W1_LIED*W2_ACUR_ECI
W1_LIED*W2_ACUR_DUA
W1_LIED*W2_ACUR_ALC
W1_LIED*W2_ACUR_MAR
W1_LIED*W2_ACUR_PAI
W1_LIED*W2_DEPRESS
W1_LIED*W2_SLEEPING
W1_LIED*W2_ANXIOUS
W1_LIED*W2_PTSD
W1_LIED*W2_LIED
W1_LIED*W2_ATTENTIO
W1_LIED*W2_LISTENIN
W1_LIED*W2_BULLY
W1_LIED*W2_FIGHTS
W1_LIED*W2_RESTLESS
W1_LIED*W2_ANSWERED
W1_ATTENTIO*W2_ACUR_CIG
W1_ATTENTIO*W2_ACUR_ECI
W1_ATTENTIO*W2_ACUR_DUA
W1_ATTENTIO*W2_ACUR_ALC
W1_ATTENTIO*W2_ACUR_MAR
W1_ATTENTIO*W2_ACUR_PAI
W1_ATTENTIO*W2_DEPRESS
W1_ATTENTIO*W2_SLEEPING
W1_ATTENTIO*W2_ANXIOUS
W1_ATTENTIO*W2_PTSD
W1_ATTENTIO*W2_LIED
W1_ATTENTIO*W2_ATTENTIO
W1_ATTENTIO*W2_LISTENIN
W1_ATTENTIO*W2_BULLY
W1_ATTENTIO*W2_FIGHTS
W1_ATTENTIO*W2_RESTLESS
W1_ATTENTIO*W2_ANSWERED
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W1_LISTENING*W2_ACUR_CIG
W1_LISTENING*W2_ACUR_ECI
W1_LISTENING*W2_ACUR_DUA
W1_LISTENING*W2_ACUR_ALC
W1_LISTENING*W2_ACUR_MAR
W1_LISTENING*W2_ACUR_PAI
W1_LISTENING*W2_DEPRESS
W1_LISTENING*W2_SLEEPING
W1_LISTENING*W2_ANXIOUS
W1_LISTENING*W2_PTSD
W1_LISTENING*W2_LIED
W1_LISTENING*W2_ATTENTIO
W1_LISTENING*W2_LISTENIN
W1_LISTENING*W2_BULLY
W1_LISTENING*W2_FIGHTS
W1_LISTENING*W2_RESTLESS
W1_LISTENING*W2_ANSWERED
W1_BULLY*W2_ACUR_CIG
W1_BULLY*W2_ACUR_ECI
W1_BULLY*W2_ACUR_DUA
W1_BULLY*W2_ACUR_ALC
W1_BULLY*W2_ACUR_MAR
W1_BULLY*W2_ACUR_PAI
W1_BULLY*W2_DEPRESS
W1_BULLY*W2_SLEEPING
W1_BULLY*W2_ANXIOUS
W1_BULLY*W2_PTSD
W1_BULLY*W2_LIED
W1_BULLY*W2_ATTENTIO
W1_BULLY*W2_LISTENIN
W1_BULLY*W2_BULLY
W1_BULLY*W2_FIGHTS
W1_BULLY*W2_RESTLESS
W1_BULLY*W2_ANSWERED
W1_FIGHTS*W2_ACUR_CIG
W1_FIGHTS*W2_ACUR_ECI
W1_FIGHTS*W2_ACUR_DUA
W1_FIGHTS*W2_ACUR_ALC
W1_FIGHTS*W2_ACUR_MAR
W1_FIGHTS*W2_ACUR_PAI
W1_FIGHTS*W2_DEPRESS
W1_FIGHTS*W2_SLEEPING
W1_FIGHTS*W2_ANXIOUS
W1_FIGHTS*W2_PTSD
W1_FIGHTS*W2_LIED
W1_FIGHTS*W2_ATTENTIO
W1_FIGHTS*W2_LISTENIN
W1_FIGHTS*W2_BULLY
W1_FIGHTS*W2_FIGHTS
W1_FIGHTS*W2_RESTLESS
W1_FIGHTS*W2_ANSWERED
W1_RESTLESS*W2_ACUR_CIG
W1_RESTLESS*W2_ACUR_ECI
W1_RESTLESS*W2_ACUR_DUA
W1_RESTLESS*W2_ACUR_ALC
W1_RESTLESS*W2_ACUR_MAR
W1_RESTLESS*W2_ACUR_PAI
W1_RESTLESS*W2_DEPRESS
W1_RESTLESS*W2_SLEEPING
W1_RESTLESS*W2_ANXIOUS
W1_RESTLESS*W2_PTSD
W1_RESTLESS*W2_LIED
W1_RESTLESS*W2_ATTENTIO
W1_RESTLESS*W2_LISTENIN
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W1_RESTLESS*W2_BULLY
W1_RESTLESS*W2_FIGHTS
W1_RESTLESS*W2_RESTLESS
W1_RESTLESS*W2_ANSWERED
W1_ANSWERED*W2_ACUR_CIG
W1_ANSWERED*W2_ACUR_ECI
W1_ANSWERED*W2_ACUR_DUA
W1_ANSWERED*W2_ACUR_ALC
W1_ANSWERED*W2_ACUR_MAR
W1_ANSWERED*W2_ACUR_PAI
W1_ANSWERED*W2_DEPRESS
W1_ANSWERED*W2_SLEEPING
W1_ANSWERED*W2_ANXIOUS
W1_ANSWERED*W2_PTSD
W1_ANSWERED*W2_LIED
W1_ANSWERED*W2_ATTENTIO
W1_ANSWERED*W2_LISTENIN
W1_ANSWERED*W2_BULLY
W1_ANSWERED*W2_FIGHTS
W1_ANSWERED*W2_RESTLESS
W1_ANSWERED*W2_ANSWERED
/plcorr chisq;
run;
ods pdf close;
ods pdf;
******W1 VS W3;
proc freq data=aim3.master;
table
W1_ACUR_CIG*W3_ACUR_CIG
W1_ACUR_CIG*W3_ACUR_ECI
W1_ACUR_CIG*W3_ACUR_DUA
W1_ACUR_CIG*W3_ACUR_ALC
W1_ACUR_CIG*W3_ACUR_MAR
W1_ACUR_CIG*W3_ACUR_PAI
W1_ACUR_CIG*W3_DEPRESS
W1_ACUR_CIG*W3_SLEEPING
W1_ACUR_CIG*W3_ANXIOUS
W1_ACUR_CIG*W3_PTSD
W1_ACUR_CIG*W3_LIED
W1_ACUR_CIG*W3_ATTENTIO
W1_ACUR_CIG*W3_LISTENIN
W1_ACUR_CIG*W3_BULLY
W1_ACUR_CIG*W3_FIGHTS
W1_ACUR_CIG*W3_RESTLESS
W1_ACUR_CIG*W3_ANSWERED
W1_ACUR_ECI*W3_ACUR_CIG
W1_ACUR_ECI*W3_ACUR_ECI
W1_ACUR_ECI*W3_ACUR_DUA
W1_ACUR_ECI*W3_ACUR_ALC
W1_ACUR_ECI*W3_ACUR_MAR
W1_ACUR_ECI*W3_ACUR_PAI
W1_ACUR_ECI*W3_DEPRESS
W1_ACUR_ECI*W3_SLEEPING
W1_ACUR_ECI*W3_ANXIOUS
W1_ACUR_ECI*W3_PTSD
W1_ACUR_ECI*W3_LIED
W1_ACUR_ECI*W3_ATTENTIO
W1_ACUR_ECI*W3_LISTENIN
W1_ACUR_ECI*W3_BULLY
W1_ACUR_ECI*W3_FIGHTS
W1_ACUR_ECI*W3_RESTLESS
W1_ACUR_ECI*W3_ANSWERED
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W1_ACUR_DUA*W3_ACUR_CIG
W1_ACUR_DUA*W3_ACUR_ECI
W1_ACUR_DUA*W3_ACUR_DUA
W1_ACUR_DUA*W3_ACUR_ALC
W1_ACUR_DUA*W3_ACUR_MAR
W1_ACUR_DUA*W3_ACUR_PAI
W1_ACUR_DUA*W3_DEPRESS
W1_ACUR_DUA*W3_SLEEPING
W1_ACUR_DUA*W3_ANXIOUS
W1_ACUR_DUA*W3_PTSD
W1_ACUR_DUA*W3_LIED
W1_ACUR_DUA*W3_ATTENTIO
W1_ACUR_DUA*W3_LISTENIN
W1_ACUR_DUA*W3_BULLY
W1_ACUR_DUA*W3_FIGHTS
W1_ACUR_DUA*W3_RESTLESS
W1_ACUR_DUA*W3_ANSWERED
W1_ACUR_ALC*W3_ACUR_CIG
W1_ACUR_ALC*W3_ACUR_ECI
W1_ACUR_ALC*W3_ACUR_DUA
W1_ACUR_ALC*W3_ACUR_ALC
W1_ACUR_ALC*W3_ACUR_MAR
W1_ACUR_ALC*W3_ACUR_PAI
W1_ACUR_ALC*W3_DEPRESS
W1_ACUR_ALC*W3_SLEEPING
W1_ACUR_ALC*W3_ANXIOUS
W1_ACUR_ALC*W3_PTSD
W1_ACUR_ALC*W3_LIED
W1_ACUR_ALC*W3_ATTENTIO
W1_ACUR_ALC*W3_LISTENIN
W1_ACUR_ALC*W3_BULLY
W1_ACUR_ALC*W3_FIGHTS
W1_ACUR_ALC*W3_RESTLESS
W1_ACUR_ALC*W3_ANSWERED
W1_ACUR_MAR*W3_ACUR_CIG
W1_ACUR_MAR*W3_ACUR_ECI
W1_ACUR_MAR*W3_ACUR_DUA
W1_ACUR_MAR*W3_ACUR_ALC
W1_ACUR_MAR*W3_ACUR_MAR
W1_ACUR_MAR*W3_ACUR_PAI
W1_ACUR_MAR*W3_DEPRESS
W1_ACUR_MAR*W3_SLEEPING
W1_ACUR_MAR*W3_ANXIOUS
W1_ACUR_MAR*W3_PTSD
W1_ACUR_MAR*W3_LIED
W1_ACUR_MAR*W3_ATTENTIO
W1_ACUR_MAR*W3_LISTENIN
W1_ACUR_MAR*W3_BULLY
W1_ACUR_MAR*W3_FIGHTS
W1_ACUR_MAR*W3_RESTLESS
W1_ACUR_MAR*W3_ANSWERED
W1_ACUR_PAI*W3_ACUR_CIG
W1_ACUR_PAI*W3_ACUR_ECI
W1_ACUR_PAI*W3_ACUR_DUA
W1_ACUR_PAI*W3_ACUR_ALC
W1_ACUR_PAI*W3_ACUR_MAR
W1_ACUR_PAI*W3_ACUR_PAI
W1_ACUR_PAI*W3_DEPRESS
W1_ACUR_PAI*W3_SLEEPING
W1_ACUR_PAI*W3_ANXIOUS
W1_ACUR_PAI*W3_PTSD
W1_ACUR_PAI*W3_LIED
W1_ACUR_PAI*W3_ATTENTIO
W1_ACUR_PAI*W3_LISTENIN
W1_ACUR_PAI*W3_BULLY
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W1_ACUR_PAI*W3_FIGHTS
W1_ACUR_PAI*W3_RESTLESS
W1_ACUR_PAI*W3_ANSWERED
W1_DEPRESS*W3_ACUR_CIG
W1_DEPRESS*W3_ACUR_ECI
W1_DEPRESS*W3_ACUR_DUA
W1_DEPRESS*W3_ACUR_ALC
W1_DEPRESS*W3_ACUR_MAR
W1_DEPRESS*W3_ACUR_PAI
W1_DEPRESS*W3_DEPRESS
W1_DEPRESS*W3_SLEEPING
W1_DEPRESS*W3_ANXIOUS
W1_DEPRESS*W3_PTSD
W1_DEPRESS*W3_LIED
W1_DEPRESS*W3_ATTENTIO
W1_DEPRESS*W3_LISTENIN
W1_DEPRESS*W3_BULLY
W1_DEPRESS*W3_FIGHTS
W1_DEPRESS*W3_RESTLESS
W1_DEPRESS*W3_ANSWERED
W1_SLEEPING*W3_ACUR_CIG
W1_SLEEPING*W3_ACUR_ECI
W1_SLEEPING*W3_ACUR_DUA
W1_SLEEPING*W3_ACUR_ALC
W1_SLEEPING*W3_ACUR_MAR
W1_SLEEPING*W3_ACUR_PAI
W1_SLEEPING*W3_DEPRESS
W1_SLEEPING*W3_SLEEPING
W1_SLEEPING*W3_ANXIOUS
W1_SLEEPING*W3_PTSD
W1_SLEEPING*W3_LIED
W1_SLEEPING*W3_ATTENTIO
W1_SLEEPING*W3_LISTENIN
W1_SLEEPING*W3_BULLY
W1_SLEEPING*W3_FIGHTS
W1_SLEEPING*W3_RESTLESS
W1_SLEEPING*W3_ANSWERED
W1_ANXIOUS*W3_ACUR_CIG
W1_ANXIOUS*W3_ACUR_ECI
W1_ANXIOUS*W3_ACUR_DUA
W1_ANXIOUS*W3_ACUR_ALC
W1_ANXIOUS*W3_ACUR_MAR
W1_ANXIOUS*W3_ACUR_PAI
W1_ANXIOUS*W3_DEPRESS
W1_ANXIOUS*W3_SLEEPING
W1_ANXIOUS*W3_ANXIOUS
W1_ANXIOUS*W3_PTSD
W1_ANXIOUS*W3_LIED
W1_ANXIOUS*W3_ATTENTIO
W1_ANXIOUS*W3_LISTENIN
W1_ANXIOUS*W3_BULLY
W1_ANXIOUS*W3_FIGHTS
W1_ANXIOUS*W3_RESTLESS
W1_ANXIOUS*W3_ANSWERED
W1_PTSD*W3_ACUR_CIG
W1_PTSD*W3_ACUR_ECI
W1_PTSD*W3_ACUR_DUA
W1_PTSD*W3_ACUR_ALC
W1_PTSD*W3_ACUR_MAR
W1_PTSD*W3_ACUR_PAI
W1_PTSD*W3_DEPRESS
W1_PTSD*W3_SLEEPING
W1_PTSD*W3_ANXIOUS
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W1_PTSD*W3_PTSD
W1_PTSD*W3_LIED
W1_PTSD*W3_ATTENTIO
W1_PTSD*W3_LISTENIN
W1_PTSD*W3_BULLY
W1_PTSD*W3_FIGHTS
W1_PTSD*W3_RESTLESS
W1_PTSD*W3_ANSWERED
W1_LIED*W3_ACUR_CIG
W1_LIED*W3_ACUR_ECI
W1_LIED*W3_ACUR_DUA
W1_LIED*W3_ACUR_ALC
W1_LIED*W3_ACUR_MAR
W1_LIED*W3_ACUR_PAI
W1_LIED*W3_DEPRESS
W1_LIED*W3_SLEEPING
W1_LIED*W3_ANXIOUS
W1_LIED*W3_PTSD
W1_LIED*W3_LIED
W1_LIED*W3_ATTENTIO
W1_LIED*W3_LISTENIN
W1_LIED*W3_BULLY
W1_LIED*W3_FIGHTS
W1_LIED*W3_RESTLESS
W1_LIED*W3_ANSWERED
W1_ATTENTIO*W3_ACUR_CIG
W1_ATTENTIO*W3_ACUR_ECI
W1_ATTENTIO*W3_ACUR_DUA
W1_ATTENTIO*W3_ACUR_ALC
W1_ATTENTIO*W3_ACUR_MAR
W1_ATTENTIO*W3_ACUR_PAI
W1_ATTENTIO*W3_DEPRESS
W1_ATTENTIO*W3_SLEEPING
W1_ATTENTIO*W3_ANXIOUS
W1_ATTENTIO*W3_PTSD
W1_ATTENTIO*W3_LIED
W1_ATTENTIO*W3_ATTENTIO
W1_ATTENTIO*W3_LISTENIN
W1_ATTENTIO*W3_BULLY
W1_ATTENTIO*W3_FIGHTS
W1_ATTENTIO*W3_RESTLESS
W1_ATTENTIO*W3_ANSWERED
W1_LISTENING*W3_ACUR_CIG
W1_LISTENING*W3_ACUR_ECI
W1_LISTENING*W3_ACUR_DUA
W1_LISTENING*W3_ACUR_ALC
W1_LISTENING*W3_ACUR_MAR
W1_LISTENING*W3_ACUR_PAI
W1_LISTENING*W3_DEPRESS
W1_LISTENING*W3_SLEEPING
W1_LISTENING*W3_ANXIOUS
W1_LISTENING*W3_PTSD
W1_LISTENING*W3_LIED
W1_LISTENING*W3_ATTENTIO
W1_LISTENING*W3_LISTENIN
W1_LISTENING*W3_BULLY
W1_LISTENING*W3_FIGHTS
W1_LISTENING*W3_RESTLESS
W1_LISTENING*W3_ANSWERED
W1_BULLY*W3_ACUR_CIG
W1_BULLY*W3_ACUR_ECI
W1_BULLY*W3_ACUR_DUA
W1_BULLY*W3_ACUR_ALC
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W1_BULLY*W3_ACUR_MAR
W1_BULLY*W3_ACUR_PAI
W1_BULLY*W3_DEPRESS
W1_BULLY*W3_SLEEPING
W1_BULLY*W3_ANXIOUS
W1_BULLY*W3_PTSD
W1_BULLY*W3_LIED
W1_BULLY*W3_ATTENTIO
W1_BULLY*W3_LISTENIN
W1_BULLY*W3_BULLY
W1_BULLY*W3_FIGHTS
W1_BULLY*W3_RESTLESS
W1_BULLY*W3_ANSWERED
W1_FIGHTS*W3_ACUR_CIG
W1_FIGHTS*W3_ACUR_ECI
W1_FIGHTS*W3_ACUR_DUA
W1_FIGHTS*W3_ACUR_ALC
W1_FIGHTS*W3_ACUR_MAR
W1_FIGHTS*W3_ACUR_PAI
W1_FIGHTS*W3_DEPRESS
W1_FIGHTS*W3_SLEEPING
W1_FIGHTS*W3_ANXIOUS
W1_FIGHTS*W3_PTSD
W1_FIGHTS*W3_LIED
W1_FIGHTS*W3_ATTENTIO
W1_FIGHTS*W3_LISTENIN
W1_FIGHTS*W3_BULLY
W1_FIGHTS*W3_FIGHTS
W1_FIGHTS*W3_RESTLESS
W1_FIGHTS*W3_ANSWERED
W1_RESTLESS*W3_ACUR_CIG
W1_RESTLESS*W3_ACUR_ECI
W1_RESTLESS*W3_ACUR_DUA
W1_RESTLESS*W3_ACUR_ALC
W1_RESTLESS*W3_ACUR_MAR
W1_RESTLESS*W3_ACUR_PAI
W1_RESTLESS*W3_DEPRESS
W1_RESTLESS*W3_SLEEPING
W1_RESTLESS*W3_ANXIOUS
W1_RESTLESS*W3_PTSD
W1_RESTLESS*W3_LIED
W1_RESTLESS*W3_ATTENTIO
W1_RESTLESS*W3_LISTENIN
W1_RESTLESS*W3_BULLY
W1_RESTLESS*W3_FIGHTS
W1_RESTLESS*W3_RESTLESS
W1_RESTLESS*W3_ANSWERED
W1_ANSWERED*W3_ACUR_CIG
W1_ANSWERED*W3_ACUR_ECI
W1_ANSWERED*W3_ACUR_DUA
W1_ANSWERED*W3_ACUR_ALC
W1_ANSWERED*W3_ACUR_MAR
W1_ANSWERED*W3_ACUR_PAI
W1_ANSWERED*W3_DEPRESS
W1_ANSWERED*W3_SLEEPING
W1_ANSWERED*W3_ANXIOUS
W1_ANSWERED*W3_PTSD
W1_ANSWERED*W3_LIED
W1_ANSWERED*W3_ATTENTIO
W1_ANSWERED*W3_LISTENIN
W1_ANSWERED*W3_BULLY
W1_ANSWERED*W3_FIGHTS
W1_ANSWERED*W3_RESTLESS
W1_ANSWERED*W3_ANSWERED
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/plcorr chisq;
run;
ods pdf close;
ods pdf;
******W2 VS W3;
proc freq data=aim3.master;
table
W2_ACUR_CIG*W3_ACUR_CIG
W2_ACUR_CIG*W3_ACUR_ECI
W2_ACUR_CIG*W3_ACUR_DUA
W2_ACUR_CIG*W3_ACUR_ALC
W2_ACUR_CIG*W3_ACUR_MAR
W2_ACUR_CIG*W3_ACUR_PAI
W2_ACUR_CIG*W3_DEPRESS
W2_ACUR_CIG*W3_SLEEPING
W2_ACUR_CIG*W3_ANXIOUS
W2_ACUR_CIG*W3_PTSD
W2_ACUR_CIG*W3_LIED
W2_ACUR_CIG*W3_ATTENTIO
W2_ACUR_CIG*W3_LISTENIN
W2_ACUR_CIG*W3_BULLY
W2_ACUR_CIG*W3_FIGHTS
W2_ACUR_CIG*W3_RESTLESS
W2_ACUR_CIG*W3_ANSWERED
W2_ACUR_ECI*W3_ACUR_CIG
W2_ACUR_ECI*W3_ACUR_ECI
W2_ACUR_ECI*W3_ACUR_DUA
W2_ACUR_ECI*W3_ACUR_ALC
W2_ACUR_ECI*W3_ACUR_MAR
W2_ACUR_ECI*W3_ACUR_PAI
W2_ACUR_ECI*W3_DEPRESS
W2_ACUR_ECI*W3_SLEEPING
W2_ACUR_ECI*W3_ANXIOUS
W2_ACUR_ECI*W3_PTSD
W2_ACUR_ECI*W3_LIED
W2_ACUR_ECI*W3_ATTENTIO
W2_ACUR_ECI*W3_LISTENIN
W2_ACUR_ECI*W3_BULLY
W2_ACUR_ECI*W3_FIGHTS
W2_ACUR_ECI*W3_RESTLESS
W2_ACUR_ECI*W3_ANSWERED
W2_ACUR_DUA*W3_ACUR_CIG
W2_ACUR_DUA*W3_ACUR_ECI
W2_ACUR_DUA*W3_ACUR_DUA
W2_ACUR_DUA*W3_ACUR_ALC
W2_ACUR_DUA*W3_ACUR_MAR
W2_ACUR_DUA*W3_ACUR_PAI
W2_ACUR_DUA*W3_DEPRESS
W2_ACUR_DUA*W3_SLEEPING
W2_ACUR_DUA*W3_ANXIOUS
W2_ACUR_DUA*W3_PTSD
W2_ACUR_DUA*W3_LIED
W2_ACUR_DUA*W3_ATTENTIO
W2_ACUR_DUA*W3_LISTENIN
W2_ACUR_DUA*W3_BULLY
W2_ACUR_DUA*W3_FIGHTS
W2_ACUR_DUA*W3_RESTLESS
W2_ACUR_DUA*W3_ANSWERED
W2_ACUR_ALC*W3_ACUR_CIG
W2_ACUR_ALC*W3_ACUR_ECI
W2_ACUR_ALC*W3_ACUR_DUA
W2_ACUR_ALC*W3_ACUR_ALC
W2_ACUR_ALC*W3_ACUR_MAR

372

W2_ACUR_ALC*W3_ACUR_PAI
W2_ACUR_ALC*W3_DEPRESS
W2_ACUR_ALC*W3_SLEEPING
W2_ACUR_ALC*W3_ANXIOUS
W2_ACUR_ALC*W3_PTSD
W2_ACUR_ALC*W3_LIED
W2_ACUR_ALC*W3_ATTENTIO
W2_ACUR_ALC*W3_LISTENIN
W2_ACUR_ALC*W3_BULLY
W2_ACUR_ALC*W3_FIGHTS
W2_ACUR_ALC*W3_RESTLESS
W2_ACUR_ALC*W3_ANSWERED
W2_ACUR_MAR*W3_ACUR_CIG
W2_ACUR_MAR*W3_ACUR_ECI
W2_ACUR_MAR*W3_ACUR_DUA
W2_ACUR_MAR*W3_ACUR_ALC
W2_ACUR_MAR*W3_ACUR_MAR
W2_ACUR_MAR*W3_ACUR_PAI
W2_ACUR_MAR*W3_DEPRESS
W2_ACUR_MAR*W3_SLEEPING
W2_ACUR_MAR*W3_ANXIOUS
W2_ACUR_MAR*W3_PTSD
W2_ACUR_MAR*W3_LIED
W2_ACUR_MAR*W3_ATTENTIO
W2_ACUR_MAR*W3_LISTENIN
W2_ACUR_MAR*W3_BULLY
W2_ACUR_MAR*W3_FIGHTS
W2_ACUR_MAR*W3_RESTLESS
W2_ACUR_MAR*W3_ANSWERED
W2_ACUR_PAI*W3_ACUR_CIG
W2_ACUR_PAI*W3_ACUR_ECI
W2_ACUR_PAI*W3_ACUR_DUA
W2_ACUR_PAI*W3_ACUR_ALC
W2_ACUR_PAI*W3_ACUR_MAR
W2_ACUR_PAI*W3_ACUR_PAI
W2_ACUR_PAI*W3_DEPRESS
W2_ACUR_PAI*W3_SLEEPING
W2_ACUR_PAI*W3_ANXIOUS
W2_ACUR_PAI*W3_PTSD
W2_ACUR_PAI*W3_LIED
W2_ACUR_PAI*W3_ATTENTIO
W2_ACUR_PAI*W3_LISTENIN
W2_ACUR_PAI*W3_BULLY
W2_ACUR_PAI*W3_FIGHTS
W2_ACUR_PAI*W3_RESTLESS
W2_ACUR_PAI*W3_ANSWERED
W2_DEPRESS*W3_ACUR_CIG
W2_DEPRESS*W3_ACUR_ECI
W2_DEPRESS*W3_ACUR_DUA
W2_DEPRESS*W3_ACUR_ALC
W2_DEPRESS*W3_ACUR_MAR
W2_DEPRESS*W3_ACUR_PAI
W2_DEPRESS*W3_DEPRESS
W2_DEPRESS*W3_SLEEPING
W2_DEPRESS*W3_ANXIOUS
W2_DEPRESS*W3_PTSD
W2_DEPRESS*W3_LIED
W2_DEPRESS*W3_ATTENTIO
W2_DEPRESS*W3_LISTENIN
W2_DEPRESS*W3_BULLY
W2_DEPRESS*W3_FIGHTS
W2_DEPRESS*W3_RESTLESS
W2_DEPRESS*W3_ANSWERED
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W2_SLEEPING*W3_ACUR_CIG
W2_SLEEPING*W3_ACUR_ECI
W2_SLEEPING*W3_ACUR_DUA
W2_SLEEPING*W3_ACUR_ALC
W2_SLEEPING*W3_ACUR_MAR
W2_SLEEPING*W3_ACUR_PAI
W2_SLEEPING*W3_DEPRESS
W2_SLEEPING*W3_SLEEPING
W2_SLEEPING*W3_ANXIOUS
W2_SLEEPING*W3_PTSD
W2_SLEEPING*W3_LIED
W2_SLEEPING*W3_ATTENTIO
W2_SLEEPING*W3_LISTENIN
W2_SLEEPING*W3_BULLY
W2_SLEEPING*W3_FIGHTS
W2_SLEEPING*W3_RESTLESS
W2_SLEEPING*W3_ANSWERED
W2_ANXIOUS*W3_ACUR_CIG
W2_ANXIOUS*W3_ACUR_ECI
W2_ANXIOUS*W3_ACUR_DUA
W2_ANXIOUS*W3_ACUR_ALC
W2_ANXIOUS*W3_ACUR_MAR
W2_ANXIOUS*W3_ACUR_PAI
W2_ANXIOUS*W3_DEPRESS
W2_ANXIOUS*W3_SLEEPING
W2_ANXIOUS*W3_ANXIOUS
W2_ANXIOUS*W3_PTSD
W2_ANXIOUS*W3_LIED
W2_ANXIOUS*W3_ATTENTIO
W2_ANXIOUS*W3_LISTENIN
W2_ANXIOUS*W3_BULLY
W2_ANXIOUS*W3_FIGHTS
W2_ANXIOUS*W3_RESTLESS
W2_ANXIOUS*W3_ANSWERED
W2_PTSD*W3_ACUR_CIG
W2_PTSD*W3_ACUR_ECI
W2_PTSD*W3_ACUR_DUA
W2_PTSD*W3_ACUR_ALC
W2_PTSD*W3_ACUR_MAR
W2_PTSD*W3_ACUR_PAI
W2_PTSD*W3_DEPRESS
W2_PTSD*W3_SLEEPING
W2_PTSD*W3_ANXIOUS
W2_PTSD*W3_PTSD
W2_PTSD*W3_LIED
W2_PTSD*W3_ATTENTIO
W2_PTSD*W3_LISTENIN
W2_PTSD*W3_BULLY
W2_PTSD*W3_FIGHTS
W2_PTSD*W3_RESTLESS
W2_PTSD*W3_ANSWERED
W2_LIED*W3_ACUR_CIG
W2_LIED*W3_ACUR_ECI
W2_LIED*W3_ACUR_DUA
W2_LIED*W3_ACUR_ALC
W2_LIED*W3_ACUR_MAR
W2_LIED*W3_ACUR_PAI
W2_LIED*W3_DEPRESS
W2_LIED*W3_SLEEPING
W2_LIED*W3_ANXIOUS
W2_LIED*W3_PTSD
W2_LIED*W3_LIED
W2_LIED*W3_ATTENTIO
W2_LIED*W3_LISTENIN
W2_LIED*W3_BULLY
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W2_LIED*W3_FIGHTS
W2_LIED*W3_RESTLESS
W2_LIED*W3_ANSWERED
W2_ATTENTIO*W3_ACUR_CIG
W2_ATTENTIO*W3_ACUR_ECI
W2_ATTENTIO*W3_ACUR_DUA
W2_ATTENTIO*W3_ACUR_ALC
W2_ATTENTIO*W3_ACUR_MAR
W2_ATTENTIO*W3_ACUR_PAI
W2_ATTENTIO*W3_DEPRESS
W2_ATTENTIO*W3_SLEEPING
W2_ATTENTIO*W3_ANXIOUS
W2_ATTENTIO*W3_PTSD
W2_ATTENTIO*W3_LIED
W2_ATTENTIO*W3_ATTENTIO
W2_ATTENTIO*W3_LISTENIN
W2_ATTENTIO*W3_BULLY
W2_ATTENTIO*W3_FIGHTS
W2_ATTENTIO*W3_RESTLESS
W2_ATTENTIO*W3_ANSWERED
W2_LISTENIN*W3_ACUR_CIG
W2_LISTENIN*W3_ACUR_ECI
W2_LISTENIN*W3_ACUR_DUA
W2_LISTENIN*W3_ACUR_ALC
W2_LISTENIN*W3_ACUR_MAR
W2_LISTENIN*W3_ACUR_PAI
W2_LISTENIN*W3_DEPRESS
W2_LISTENIN*W3_SLEEPING
W2_LISTENIN*W3_ANXIOUS
W2_LISTENIN*W3_PTSD
W2_LISTENIN*W3_LIED
W2_LISTENIN*W3_ATTENTIO
W2_LISTENIN*W3_LISTENIN
W2_LISTENIN*W3_BULLY
W2_LISTENIN*W3_FIGHTS
W2_LISTENIN*W3_RESTLESS
W2_LISTENIN*W3_ANSWERED
W2_BULLY*W3_ACUR_CIG
W2_BULLY*W3_ACUR_ECI
W2_BULLY*W3_ACUR_DUA
W2_BULLY*W3_ACUR_ALC
W2_BULLY*W3_ACUR_MAR
W2_BULLY*W3_ACUR_PAI
W2_BULLY*W3_DEPRESS
W2_BULLY*W3_SLEEPING
W2_BULLY*W3_ANXIOUS
W2_BULLY*W3_PTSD
W2_BULLY*W3_LIED
W2_BULLY*W3_ATTENTIO
W2_BULLY*W3_LISTENIN
W2_BULLY*W3_BULLY
W2_BULLY*W3_FIGHTS
W2_BULLY*W3_RESTLESS
W2_BULLY*W3_ANSWERED
W2_FIGHTS*W3_ACUR_CIG
W2_FIGHTS*W3_ACUR_ECI
W2_FIGHTS*W3_ACUR_DUA
W2_FIGHTS*W3_ACUR_ALC
W2_FIGHTS*W3_ACUR_MAR
W2_FIGHTS*W3_ACUR_PAI
W2_FIGHTS*W3_DEPRESS
W2_FIGHTS*W3_SLEEPING
W2_FIGHTS*W3_ANXIOUS
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W2_FIGHTS*W3_PTSD
W2_FIGHTS*W3_LIED
W2_FIGHTS*W3_ATTENTIO
W2_FIGHTS*W3_LISTENIN
W2_FIGHTS*W3_BULLY
W2_FIGHTS*W3_FIGHTS
W2_FIGHTS*W3_RESTLESS
W2_FIGHTS*W3_ANSWERED
W2_RESTLESS*W3_ACUR_CIG
W2_RESTLESS*W3_ACUR_ECI
W2_RESTLESS*W3_ACUR_DUA
W2_RESTLESS*W3_ACUR_ALC
W2_RESTLESS*W3_ACUR_MAR
W2_RESTLESS*W3_ACUR_PAI
W2_RESTLESS*W3_DEPRESS
W2_RESTLESS*W3_SLEEPING
W2_RESTLESS*W3_ANXIOUS
W2_RESTLESS*W3_PTSD
W2_RESTLESS*W3_LIED
W2_RESTLESS*W3_ATTENTIO
W2_RESTLESS*W3_LISTENIN
W2_RESTLESS*W3_BULLY
W2_RESTLESS*W3_FIGHTS
W2_RESTLESS*W3_RESTLESS
W2_RESTLESS*W3_ANSWERED
W2_ANSWERED*W3_ACUR_CIG
W2_ANSWERED*W3_ACUR_ECI
W2_ANSWERED*W3_ACUR_DUA
W2_ANSWERED*W3_ACUR_ALC
W2_ANSWERED*W3_ACUR_MAR
W2_ANSWERED*W3_ACUR_PAI
W2_ANSWERED*W3_DEPRESS
W2_ANSWERED*W3_SLEEPING
W2_ANSWERED*W3_ANXIOUS
W2_ANSWERED*W3_PTSD
W2_ANSWERED*W3_LIED
W2_ANSWERED*W3_ATTENTIO
W2_ANSWERED*W3_LISTENIN
W2_ANSWERED*W3_BULLY
W2_ANSWERED*W3_FIGHTS
W2_ANSWERED*W3_RESTLESS
W2_ANSWERED*W3_ANSWERED
/plcorr chisq;
run;
ods pdf close;

SAS File name: Making W2 and W3 for Network Comparisons
****SA 3 - Network Comparisons for W1 vs W2 vs W3
****W1 already generated for SA2 (can be found in PNASS\\Data Management\\CSVs to use in
R\\overallwave1.csv)
****Making datasets for SA3 including overall W2 and W3
Need to make dual CC + EC variables for W2 and W3
Keep only adults who have continued from W1 (contadult datasets)
Change . to -99999
Export as CSV to R
ONLY KEEPING 17 NODES FOR NETWORK COMPARISON SECTION OF SA 3
****February 1, 2021;
*********************
*Starting with Wave 2
*********************
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Pull most recent version of W2 data created in LCA W2 SAS Program (lca.w2contadult)
Need to download formats for W2;
libname LCA "C:\Users\blondinoct\Documents\LCA\Wave 2\Data Management";
proc contents data=lca.w2contadult;
run;
*Making new tobacco vars;
data lca.w2contadultb;
set lca.w2contadult;
*first do multinomial - 4 levels;
if acur_cig=0 and acur_ecig=0 then
else if acur_cig=1 and acur_ecig=0
else if acur_cig=0 and acur_ecig=1
else if acur_cig=1 and acur_ecig=1
else acur_dual=.;
run;

acur_dual=0;
then acur_dual=1;
then acur_dual=2;
then acur_dual=3;

*check;
proc freq data=lca.w2contadultb;
table acur_cig*acur_dual;
table acur_ecig*acur_dual;
run;
*then do the dummies;
data lca.w2contadultc;
set lca.w2contadultb;
if acur_dual = 1 then acur_cignew=1;
else acur_cignew=0;
if acur_dual = 2 then acur_ecignew=1;
else acur_ecignew=0;
if acur_dual = 3 then acur_dualnew=1;
else acur_dualnew=0;
run;
*check;
proc freq data=lca.w2contadultc;
table acur_cignew*acur_dual;
table acur_ecignew*acur_dual;
table acur_dualnew*acur_dual;
run;
*confirm marijuana is good;
proc freq data=lca.w2contadultc;
table acur_marijuana;
run;
***************************
**SUMMARY STATS FOR WAVE 2;
proc surveyfreq data= LCA.w2contadultc varmethod=BRR (fay=0.3);
table acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana acur_painkiller
R02R_A_SEX age R02R_A_ETHRACECAT7 education R02R_A_AM0030 R02_AX0092
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
sud
/row chisq(secondorder);
weight R02_A_PWGT;
repweights R02_A_PWGT1 - R02_A_PWGT100;
run;
quit;
run;
******************************************
**data kept to run LCA again then compare;
data LCA.w2contadultd;
set LCA.w2contadultc (keep = caseid personid R02_A_PWGT
acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller
R02R_A_SEX age R02R_A_ETHRACECAT7 education R02R_A_AM0030
R02_AX0092
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SEXMALE_1 SEXFEMALE_2
AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6
RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6
EDU_1 EDU_2 EDU_3 EDU_4 EDU_5
INC_1 INC_2 INC_3 INC_4 INC_5
SOC_1 SOC_2 SOC_3 SOC_4 SOC_5
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
weeklyuse timegetting timeusing socialprob reducedact withdraw
usetoavoid

sud);
*rename missings;
array change _numeric_;
do over change;
if change =. then change = -99999;
end;
run;
*Check frequencies;
proc contents data=LCA.w2contadultd;
run;
proc freq data=LCA.w2contadultd;
table
acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered;
run;
*These look good:
*Exported to Aim 3 - Comparisons -> Data Sets as w2dataformplus232021;
**data kept for network comparisons;
data LCA.w2contadulte;
set LCA.w2contadultc (keep =
acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana
acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered);
*rename missings;
array change _numeric_;
do over change;
if change =. then change = -99999;
end;
run;
proc contents data=LCA.w2contadulte;
run;
*These look good:
*Exported to Aim 3 - Comparisons -> Data Sets as w2datafornetcomp232021;

***************
*Now to Wave 3
***************
Pull most recent version of W3 data created in LCA W3 SAS Program (lca.w3contadult)
Need to download formats for W3;
libname LCA "U:\CourtneyBlondino\PhD Epidemiology\LCA\Wave 3\Data Management";
*single w3 weights;
proc contents data=work.Da36498p3102;
*table R03_A_SWGT;
run;
*all waves weights;
proc contents data=work.Da36498p3101;
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*table R03_A_AWGT;
run;
proc contents data=lca.w3;
run;
*proc sort data=lca.w3;
*by personid;
*run;
*************************************************************************************
NEED TO MERGE THIS DATASET WITH WEIGHTS DATASET DS3101 (all) and DS3102 BY PERSONID *
************************************************************************************;
*all weights;
data lca.w3allweights;
set WORK.DA36498P3101;
run;
proc sort data=lca.w3allweights;
by personid;
run;
*w3 single weights;
data lca.w3singleweights;
set WORK.DA36498P3102;
run;
proc sort data=lca.w3singleweights;
by personid;
run;
*merge weights;
*data lca.w3newweights;
*merge lca.w3allweights lca.w3singleweights;
*by personid;
*run;
*proc contents data = lca.w3newweights
run;
data lca.w3contadultweights;
merge lca.w3contalladultweights lca.w3singleweights lca.w3allweights;
by personid;
run;
proc contents data = lca.w3contadultweights;
run;
*Then limit the sample to only people from Wave 1;
proc freq data=lca.w3contadultweights;
table R03_ADULTTYPE;
run;
data lca.w3contadult;
set lca.w3contadultweights;
if R03_ADULTTYPE=1;
run;
proc contents data=lca.w3contadult;
run;
proc freq data=lca.w3contadult;
table R03_ADULTTYPE;
run;
*Making new tobacco vars;
data lca.w3contadultb;
set lca.w3contadult;
*first do multinomial - 4 levels;
if acur_cig=0 and acur_ecig=0 then acur_dual=0;
else if acur_cig=1 and acur_ecig=0 then acur_dual=1;
else if acur_cig=0 and acur_ecig=1 then acur_dual=2;
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else if acur_cig=1 and acur_ecig=1 then acur_dual=3;
else acur_dual=.;
run;
*check;
proc freq data=lca.w3contadultb;
table acur_cig*acur_dual;
table acur_ecig*acur_dual;
run;
*then do the dummies;
data lca.w3contadultc;
set lca.w3contadultb;
if acur_dual = 1 then acur_cignew=1;
else acur_cignew=0;
if acur_dual = 2 then acur_ecignew=1;
else acur_ecignew=0;
if acur_dual = 3 then acur_dualnew=1;
else acur_dualnew=0;
run;
*check;
proc freq data=lca.w3contadultc;
table acur_cignew*acur_dual;
table acur_ecignew*acur_dual;
table acur_dualnew*acur_dual;
run;
*confirm marijuana is good;
proc freq data=lca.w3contadultc;
table acur_marijuana;
run;
proc contents data=lca.w3contadultc;
run;
*proc print data=lca.w3contadultc;
*var R03_A_SWGT R03_ADULTTYPE;
*run;
*proc freq data=lca.w3contadultc;
*table R03_A_SWGT;
*run;
***************************
**SUMMARY STATS FOR WAVE 3;
ods pdf;
proc surveyfreq data= LCA.w3contadultc varmethod=BRR (fay=0.3);
table acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana acur_painkiller
R03R_A_SEX age R03R_A_ETHRACECAT7 education R03R_A_AM0030 R03_AX0092
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
sud
/row chisq(secondorder);
weight R03_A_SWGT;
repweights R03_A_SWGT1 - R03_A_SWGT100;
run;
quit;
run;
ods pdf close;
******************************************
**data kept to run LCA again then compare;
data LCA.w3contadultd;
set LCA.w3contadultc (keep = caseid personid R03_A_SWGT
acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller
R03R_A_SEX age R03R_A_ETHRACECAT7 education R03R_A_AM0030
R03_AX0092
SEXMALE_1 SEXFEMALE_2
AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6
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RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6
EDU_1 EDU_2 EDU_3 EDU_4 EDU_5
INC_1 INC_2 INC_3 INC_4 INC_5
SOC_1 SOC_2 SOC_3 SOC_4 SOC_5
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
weeklyuse timegetting timeusing socialprob reducedact withdraw
usetoavoid
sud);
*rename missings;
array change _numeric_;
do over change;
if change =. then change = -99999;
end;
run;
*Check frequencies;
proc contents data=LCA.w3contadultd;
run;
proc freq data=LCA.w3contadultd;
table
acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered;
run;
*These look good:
*Exported to Aim 3 - Comparisons -> Data Sets as w3dataformplus332021;
**data kept for network comparisons;
data LCA.w3contadulte;
set LCA.w3contadultc (keep =
acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana
acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered);
*rename missings;
array change _numeric_;
do over change;
if change =. then change = -99999;
end;
run;
proc contents data=LCA.w3contadulte;
run;
*These look good:
*Exported to Aim 3 - Comparisons -> Data Sets as w3datafornetcomp332021;

*THIS IS THE WRONG ONE;
*LOOK AT LCA W1 4132021;
***************************
**SUMMARY STATS FOR WAVE 1;
*Overall W1 with new exclusive CC and EC, and dual variables for Table 1 Network Paper;
libname LCA "C:\Users\blondinoct\Documents\LCA\Wave 1\Data Management";
proc surveyfreq data= LCA.W1mplusJuly2020weights varmethod=BRR (fay=0.3);
table
R01R_A_SEX age R01R_A_ETHRACECAT7 education R01R_A_AM0030
R01_AX0092
acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
sud
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/row chisq(secondorder);
weight R01_A_PWGT;
repweights R01_A_PWGT1 - R01_A_PWGT100;
run;
quit;
run;

**************************************************************************************
*Wave 3 - merging weights with diff dataset to try to figure out missing on R03_A_AWGT
**************************************************************************************
Pull most recent version of W3 data created in LCA W3 SAS Program (lca.w3contadult)
Need to download formats for W3;
libname LCA "C:\Users\blondinoct\Documents\LCA\Wave 3\Data Management";
proc freq data=work.Da36498p3101;
table R03_A_AWGT;
run;
proc contents data=lca.w3contadult;
run;
*N = 26239;
proc sort data=lca.w3contadult;
by personid;
run;
********************************************************************
NEED TO MERGE THIS DATASET WITH WEIGHTS DATASET DS3101 BY PERSONID *
********************************************************************;
data lca.w3weights;
set WORK.DA36498P3101;
run;
proc sort data=lca.w3weights;
by personid;
run;
data lca.w3contadultweights;
merge lca.w3contadult lca.w3weights;
by personid;
run;
proc contents data = lca.w3contadultweights;
run;
proc print data = lca.w3contadultweights (obs=20);
var R03_A_AWGT R03_ADULTTYPE;
run;
*Then limit the sample to only people from Wave 1 that have weight info;
proc freq data=lca.w3contadultweights;
table R03_ADULTTYPE;
run;
proc freq data=lca.w3contadultweights;
table R03_A_AWGT;
run;
data lca.w3contadult217;
set lca.w3contadultweights;
if R03_ADULTTYPE=1 and R03_A_AWGT^=.;
run;
proc freq data=lca.w3contadult217;
table R03_ADULTTYPE;
run;
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proc freq data=lca.w3contadult217;
table R03_A_AWGT;
run;
*Making new tobacco vars;
data lca.w3contadultb;
set lca.w3contadult217;
*first do multinomial - 4 levels;
if acur_cig=0 and acur_ecig=0 then
else if acur_cig=1 and acur_ecig=0
else if acur_cig=0 and acur_ecig=1
else if acur_cig=1 and acur_ecig=1
else acur_dual=.;
run;

acur_dual=0;
then acur_dual=1;
then acur_dual=2;
then acur_dual=3;

*check;
proc freq data=lca.w3contadultb;
table acur_cig*acur_dual;
table acur_ecig*acur_dual;
run;
*then do the dummies;
data lca.w3contadultc;
set lca.w3contadultb;
if acur_dual = 1 then acur_cignew=1;
else acur_cignew=0;
if acur_dual = 2 then acur_ecignew=1;
else acur_ecignew=0;
if acur_dual = 3 then acur_dualnew=1;
else acur_dualnew=0;
run;
*check;
proc freq data=lca.w3contadultc;
table acur_cignew*acur_dual;
table acur_ecignew*acur_dual;
table acur_dualnew*acur_dual;
run;
*confirm marijuana is good;
proc freq data=lca.w3contadultc;
table acur_marijuana;
run;
proc print data=lca.w3contadultc;
var R03_A_AWGT R03_ADULTTYPE;
run;
proc freq data=lca.w3contadultc;
table R03_A_AWGT;
run;
***************************
**SUMMARY STATS FOR WAVE 3;
proc surveyfreq data= LCA.w3contadultc varmethod=BRR (fay=0.3);
table acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana acur_painkiller
R03R_A_SEX age R03R_A_ETHRACECAT7 education R03R_A_AM0030 R03_AX0092
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
sud
/row chisq(secondorder);
weight R03_A_AWGT;
repweights R03_A_AWGT1 - R03_A_AWGT100;
run;
quit;
run;
******************************************
**data kept to run LCA again then compare;
data LCA.w3contadultd;
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set LCA.w3contadultc (keep = caseid personid R03_A_AWGT
acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller
R03R_A_SEX age R03R_A_ETHRACECAT7 education R03R_A_AM0030
R03_AX0092
SEXMALE_1 SEXFEMALE_2
AGE1824_1 AGE2534_2 AGE3544_3 AGE4554_4 AGE5564_5 AGE65_6
RACEWH_1 RACEBL_2 RACEOT_3 RACEHI_6
EDU_1 EDU_2 EDU_3 EDU_4 EDU_5
INC_1 INC_2 INC_3 INC_4 INC_5
SOC_1 SOC_2 SOC_3 SOC_4 SOC_5
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered
weeklyuse timegetting timeusing socialprob reducedact withdraw
usetoavoid
sud);
*rename missings;
array change _numeric_;
do over change;
if change =. then change = -99999;
end;
run;
*Check frequencies;
proc contents data=LCA.w3contadultd;
run;
proc freq data=LCA.w3contadultd;
table
acur_cignew acur_ecignew acur_dualnew
acur_alc acur_marijuana acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered;
run;
*These look good:
*Exported to Aim 3 - Comparisons -> Data Sets as w3dataformplus2172021;
**data kept for network comparisons;
data LCA.w3contadulte;
set LCA.w3contadultc (keep =
acur_cignew acur_ecignew acur_dualnew acur_alc acur_marijuana
acur_painkiller
depressed sleeping anxious ptsd
lied attention listening bully fights restless answered);
*rename missings;
array change _numeric_;
do over change;
if change =. then change = -99999;
end;
run;
proc contents data=LCA.w3contadulte;
run;
*These look good:
*Exported to Aim 3 - Comparisons -> Data Sets as w3datafornetcomp2172021;

R File name: Aim 3 – Network Comparisons Waves 1, 2, 3 – 4152021
#PATH Waves 1, 2, 3 - Network Comparisons (Specific Aim 3)
########################################
# READ IN WAVE 1 DATA
#
########################################
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setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation
Files/Network Chapter")
getwd()
overall<-read.csv("/Users/courtneyblondino/Library/Mobile
Documents/com~apple~CloudDocs/Dissertation Files/Network Chapter/OverallWave1-4142021.csv",
header=T, sep=',')
names(overall)
dim(overall)
#rename variables so they look nice on the network
names(overall)[names(overall) == "acur_cignew"] <- "CIG"
names(overall)[names(overall) == "acur_ecignew"] <- "ECIG"
names(overall)[names(overall) == "acur_dualnew"] <- "Dual CIG + ECIG"
names(overall)[names(overall) == "acur_alc"] <- "Alcohol"
names(overall)[names(overall) == "acur_marijuana"] <- "Marijuana"
names(overall)[names(overall) == "acur_painkiller"] <- "PDNP"
names(overall)[names(overall) == "depressed"] <- "Depressed"
names(overall)[names(overall) == "sleeping"] <- "Sleeping"
names(overall)[names(overall) == "anxious"] <- "Anxious"
names(overall)[names(overall) == "PTSD"] <- "Distressed/Past"
names(overall)[names(overall) == "lied"] <- "Lied"
names(overall)[names(overall) == "attention"] <- "Attention"
names(overall)[names(overall) == "listening"] <- "Listening"
names(overall)[names(overall) == "bully"] <- "Bully"
names(overall)[names(overall) == "fights"] <- "Fights"
names(overall)[names(overall) == "restless"] <- "Restless"
names(overall)[names(overall) == "answered"] <- "Answered"
names(overall)
require(ggplot2)
require(bootnet)
require(IsingFit)
require(IsingSampler)
require(qgraph)
########################################
# Estimate the Network Model - W1 #
########################################
#########
#IsingFit
Wave1NetworkIF <-estimateNetwork(overall, default="IsingFit", missing="listwise")
Wave1NetworkIF$labels
Names<- c("CIG", "ECIG" , "Dual CIG + ECIG", "Alcohol", "Marijuana", "PDNP",
"Depressed", "Sleeping" , "Anxious", "Distressed/Past" , "Lied",
"Attention" , "Listening" , "Bully" ,"Fights" , "Restless",
"Answered")
Traits <- rep(c(
'Substance Use',
'Negative Affect',
'Externalizing'

385

), times=c(6,4,7))
layout(t(1))
plot(Wave1NetworkIF,
layout="spring",
cut=0,
theme="colorblind",
groups=Traits,
#nodeNames=Names,
#edge.color="black",
minimum=0,
label.scale.equal=TRUE,
label.cex= 4.0,
legend.cex = 0.4,
title= "Wave 1")
#Results
Wave1NetworkIF$results
#Edges
Edges <- Wave1NetworkIF$graph
print(Edges)
write(Edges, file="OverallEdges.csv", sep=" ")
#Centrality (need to run bootstrap to do accuracy/stability)
centralityTable(Wave1NetworkIF)

########################################
# READ IN WAVE 2 DATA
#
########################################
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation
Files/Wave Comparison Chapter")
getwd()
Wave2<-read.csv("/Users/courtneyblondino/Library/Mobile
Documents/com~apple~CloudDocs/Dissertation Files/Wave Comparison
Chapter/w2datafornetcomp232021.csv", header=T, sep=',')
dim(Wave2)
names(Wave2)
#Have to tell R what missing means
Wave2$acur_cignew[Wave2$acur_cignew==-99999] <- NA
Wave2$acur_ecignew[Wave2$acur_ecignew==-99999] <- NA
Wave2$acur_dualnew[Wave2$acur_dualnew==-99999] <- NA
Wave2$acur_alc[Wave2$acur_alc==-99999] <- NA
Wave2$acur_marijuana[Wave2$acur_marijuana==-99999] <- NA
Wave2$acur_painkiller[Wave2$acur_painkiller==-99999] <- NA
Wave2$depressed[Wave2$depressed==-99999] <- NA
Wave2$sleeping[Wave2$sleeping==-99999] <- NA
Wave2$anxious[Wave2$anxious==-99999] <- NA
Wave2$ptsd[Wave2$ptsd==-99999] <- NA
Wave2$lied[Wave2$lied==-99999] <- NA
Wave2$attention[Wave2$attention==-99999] <- NA
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Wave2$listening[Wave2$listening==-99999] <- NA
Wave2$bully[Wave2$bully==-99999] <- NA
Wave2$fights[Wave2$fights==-99999] <- NA
Wave2$restless[Wave2$restless==-99999] <- NA
Wave2$answered[Wave2$answered==-99999] <- NA
#rename variables so they look nice on the network
names(Wave2)[names(Wave2) == "acur_cignew"] <- "CIG"
names(Wave2)[names(Wave2) == "acur_ecignew"] <- "ECIG"
names(Wave2)[names(Wave2) == "acur_dualnew"] <- "Dual CIG + ECIG"
names(Wave2)[names(Wave2) == "acur_alc"] <- "Alcohol"
names(Wave2)[names(Wave2) == "acur_marijuana"] <- "Marijuana"
names(Wave2)[names(Wave2) == "acur_painkiller"] <- "PDNP"
names(Wave2)[names(Wave2) == "depressed"] <- "Depressed"
names(Wave2)[names(Wave2) == "sleeping"] <- "Sleeping"
names(Wave2)[names(Wave2) == "anxious"] <- "Anxious"
names(Wave2)[names(Wave2) == "ptsd"] <- "Distressed/Past"
names(Wave2)[names(Wave2) == "lied"] <- "Lied"
names(Wave2)[names(Wave2) == "attention"] <- "Attention"
names(Wave2)[names(Wave2) == "listening"] <- "Listening"
names(Wave2)[names(Wave2) == "bully"] <- "Bully"
names(Wave2)[names(Wave2) == "fights"] <- "Fights"
names(Wave2)[names(Wave2) == "restless"] <- "Restless"
names(Wave2)[names(Wave2) == "answered"] <- "Answered"
########################################
# Estimate the Network Model - W2 #
########################################
#########
#IsingFit
Wave2NetworkIF <-estimateNetwork(Wave2, default="IsingFit", missing="listwise")
Wave2NetworkIF
Names<- c("CIG", "ECIG" , "Dual CIG + ECIG", "Alcohol", "Marijuana", "PDNP",
"Depressed", "Sleeping" , "Anxious", "Distressed/Past" , "Lied",
"Attention" , "Listening" , "Bully" ,"Fights" , "Restless",
"Answered")
Traits <- rep(c(
'Substance Use',
'Negative Affect',
'Externalizing'
), times=c(6,4,7))
plot(Wave2NetworkIF,
layout="spring",
cut=0,
theme="colorblind",
groups=Traits,
#nodeNames=Names,
#edge.color="black",
minimum=0,
label.scale.equal=TRUE,
label.cex= 4.0,
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legend.cex = 0.4)
#Results
W2Results <- Wave2NetworkIF$results
#write.csv(W2Results, file="W2Results.csv", sep=" ")
#write(Edges, file="OverallEdges.csv", sep=" ")
#Edges
Edges <- Wave2NetworkIF$graph
print(Edges)
#Centrality (need to run bootstrap to do accuracy/stability)
centralityTable(Wave2NetworkIF)
########################################
# READ IN WAVE 3 DATA
#
########################################
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation
Files/Wave Comparison Chapter")
getwd()
#Wave3<-read.csv("C:\\Users\\blondinoct\\Documents\\Aim 3 - Comparisons\\Data
Sets\\w3datafornetcomp232021.csv", header=T, sep=',')
#dim(Wave3)
#names(Wave3)
############NEW WAVE 3 , N = 25382 ################
#Wave3<-read.csv("/Users/courtneyblondino/Library/Mobile
Documents/com~apple~CloudDocs/Dissertation Files/Wave Comparison
Chapter/w3datafornetcomp2172021.csv", header=T, sep=',')
#dim(Wave3)
#names(Wave3)
Wave3<-read.csv("/Users/courtneyblondino/Library/Mobile
Documents/com~apple~CloudDocs/Dissertation Files/Wave Comparison
Chapter/w3datafornetcomp332021.csv", header=T, sep=',')
dim(Wave3)
names(Wave3)
#Have to tell R what missing means
Wave3$acur_cignew[Wave3$acur_cignew==-99999] <- NA
Wave3$acur_ecignew[Wave3$acur_ecignew==-99999] <- NA
Wave3$acur_dualnew[Wave3$acur_dualnew==-99999] <- NA
Wave3$acur_alc[Wave3$acur_alc==-99999] <- NA
Wave3$acur_marijuana[Wave3$acur_marijuana==-99999] <- NA
Wave3$acur_painkiller[Wave3$acur_painkiller==-99999] <- NA
Wave3$depressed[Wave3$depressed==-99999] <- NA
Wave3$sleeping[Wave3$sleeping==-99999] <- NA
Wave3$anxious[Wave3$anxious==-99999] <- NA
Wave3$ptsd[Wave3$ptsd==-99999] <- NA
Wave3$lied[Wave3$lied==-99999] <- NA
Wave3$attention[Wave3$attention==-99999] <- NA
Wave3$listening[Wave3$listening==-99999] <- NA
Wave3$bully[Wave3$bully==-99999] <- NA
Wave3$fights[Wave3$fights==-99999] <- NA
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Wave3$restless[Wave3$restless==-99999] <- NA
Wave3$answered[Wave3$answered==-99999] <- NA
#rename variables so they look nice on the network
names(Wave3)[names(Wave3) == "acur_cignew"] <- "CIG"
names(Wave3)[names(Wave3) == "acur_ecignew"] <- "ECIG"
names(Wave3)[names(Wave3) == "acur_dualnew"] <- "Dual CIG + ECIG"
names(Wave3)[names(Wave3) == "acur_alc"] <- "Alcohol"
names(Wave3)[names(Wave3) == "acur_marijuana"] <- "Marijuana"
names(Wave3)[names(Wave3) == "acur_painkiller"] <- "PDNP"
names(Wave3)[names(Wave3) == "depressed"] <- "Depressed"
names(Wave3)[names(Wave3) == "sleeping"] <- "Sleeping"
names(Wave3)[names(Wave3) == "anxious"] <- "Anxious"
names(Wave3)[names(Wave3) == "ptsd"] <- "Distressed/Past"
names(Wave3)[names(Wave3) == "lied"] <- "Lied"
names(Wave3)[names(Wave3) == "attention"] <- "Attention"
names(Wave3)[names(Wave3) == "listening"] <- "Listening"
names(Wave3)[names(Wave3) == "bully"] <- "Bully"
names(Wave3)[names(Wave3) == "fights"] <- "Fights"
names(Wave3)[names(Wave3) == "restless"] <- "Restless"
names(Wave3)[names(Wave3) == "answered"] <- "Answered"
########################################
# Estimate the Network Model - W3 #
########################################
#########
#IsingFit
Wave3NetworkIF <-estimateNetwork(Wave3, default="IsingFit", missing="listwise")
Wave3NetworkIF
Names<- c("CIG", "ECIG" , "Dual CIG + ECIG", "Alcohol", "Marijuana", "PDNP",
"Depressed", "Sleeping" , "Anxious", "Distressed/Past" , "Lied",
"Attention" , "Listening" , "Bully" ,"Fights" , "Restless",
"Answered")
Traits <- rep(c(
'Substance Use',
'Negative Affect',
'Externalizing'
), times=c(6,4,7))
plot(Wave3NetworkIF,
layout="spring",
cut=0,
theme="colorblind",
groups=Traits,
#nodeNames=Names,
#edge.color="black",
minimum=0,
label.scale.equal=TRUE,
label.cex= 4.0,
legend.cex = 0.4,
title= "Wave 3")
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#Results
Wave3NetworkIF$results
#Edges
Wave3Edges <- Wave3NetworkIF$graph
print(Wave3Edges)
write(Wave3Edges, file="Wave3Edges.csv", sep=" ")
#Centrality (need to run bootstrap to do accuracy/stability)
centralityTable(Wave3NetworkIF)

############################################
# Visually Compare using Average Layout #
############################################
L<-averageLayout(Wave1NetworkIF, Wave2NetworkIF, Wave3NetworkIF)
Max<- max(abs(c(getWmat(Wave1NetworkIF),getWmat(Wave2NetworkIF),
getWmat(Wave3NetworkIF))))
layout(t(1:3))
plot(Wave1NetworkIF,
layout=L,
cut=0,
theme="colorblind",
groups=Traits,
#nodeNames=Names,
#edge.color="black",
#label.scale.equal=TRUE,
legend=FALSE,
label.cex= 2.0,
legend.cex = 0.4,
title= "Wave 1",
maximum=Max)
plot(Wave2NetworkIF,
layout=L,
cut=0,
theme="colorblind",
groups=Traits,
#nodeNames=Names,
#edge.color="black",
#label.scale.equal=TRUE,
label.cex= 2.0,
legend.cex = 0.4,
legend=FALSE,
title= "Wave 2",
maximum=Max)
plot(Wave3NetworkIF,
layout=L,
cut=0,
theme="colorblind",
groups=Traits,
#nodeNames=Names,
#edge.color="black",
#label.scale.equal=TRUE,
label.cex= 2.0,
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legend.cex = 0.4,
title= "Wave 3",
maximum=Max)
############################################
#
Compare W1 AND W2
#
############################################
L<-averageLayout(Wave1NetworkIF, Wave2NetworkIF)
Max<- max(abs(c(getWmat(Wave1NetworkIF),getWmat(Wave2NetworkIF))))
layout(t(1:2))
plot(Wave1NetworkIF,
layout=L,
cut=0,
theme="colorblind",
groups=Traits,
#nodeNames=Names,
#edge.color="black",
label.scale.equal=TRUE,
labels=Names,
legend=FALSE,
label.cex= 4.0,
legend.cex = 0.4,
title= "Wave 1",
maximum=Max)
plot(Wave2NetworkIF,
layout=L,
cut=0,
theme="colorblind",
groups=Traits,
#nodeNames=Names,
#edge.color="black",
label.scale.equal=TRUE,
label.cex= 4.0,
legend.cex = 0.4,
legend=FALSE,
title= "Wave 2",
maximum=Max)
library("devtools")
install_github("cvborkulo/NetworkComparisonTest")
library("NetworkComparisonTest")
#perform NCT and interpret results
NCTW1vsW2<- NCT(Wave1NetworkIF, Wave2NetworkIF, test.edges=TRUE,
it=100)
#difference in global strength between the networks of the observed data sets
NCTW1vsW2$glstrinv.real
#3.307481
#global strength values of individual networks
NCTW1vsW2$glstrinv.sep
#55.99086 VS 59.29835
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NCTW1vsW2$glstrinv.perm
#there's 100 since we did 100 permutations
#Difference in global strength p-value
NCTW1vsW2$glstrinv.pval
#0.2673267- so not significantly different from one another in regard to global strength
#Value of the max difference in edge weights of observed networks
NCTW1vsW2$nwinv.real
#1.563746
NCTW1vsW2$nwinv.perm
#there's 100 since we did 100 permutations
#Maximum difference in edge weights
NCTW1vsW2$nwinv.pval
#0.2277228 - so not significantly different from one another in regard to number of edge weights
#Which edges significantly differ?
NCTW1vsW2$einv.pvals[which(NCTW1vsW2$einv.pvals[,3]<0.05),]
#
Var1
Var2 p-value
#69
CIG Marijuana 0.00990099
#90 Marijuana
PDNP 0.00990099
#120
CIG Sleeping 0.03960396
#155
ECIG
PTSD 0.02970297
#179 Anxious
Lied 0.02970297
#214
PTSD Listening 0.00990099
#216 Attention Listening 0.01980198
#252 Bully Fights 0.03960396
#263 Sleeping Restless 0.00990099
############################################
#
Compare W1 AND W3
#
############################################
L<-averageLayout(Wave1NetworkIF, Wave3NetworkIF)
Max<- max(abs(c(getWmat(Wave1NetworkIF),getWmat(Wave3NetworkIF))))
layout(t(1:2))
plot(Wave1NetworkIF,
layout=L,
cut=0,
theme="colorblind",
groups=Traits,
#nodeNames=Names,
#edge.color="black",
label.scale.equal=TRUE,
labels=Names,
legend=FALSE,
label.cex= 4.0,
legend.cex = 0.4,
title= "Wave 1",
maximum=Max)
plot(Wave3NetworkIF,
layout=L,
cut=0,

392

theme="colorblind",
groups=Traits,
#nodeNames=Names,
#edge.color="black",
label.scale.equal=TRUE,
label.cex= 4.0,
legend.cex = 0.4,
legend=FALSE,
title= "Wave 3",
maximum=Max)
NCTW1vsW3<- NCT(Wave1NetworkIF, Wave3NetworkIF, test.edges=TRUE,
it=100)
#difference in global strength between the networks of the observed data sets
NCTW1vsW3$glstrinv.real
#4.009107
#global strength values of individual networks
NCTW1vsW3$glstrinv.sep
#55.99086 vs 59.99997
NCTW1vsW3$glstrinv.perm
#there's 100 since we did 100 permutations
#Difference in global strength p-value
NCTW1vsW3$glstrinv.pval
#0.2376238 - so not significantly different from one another in regard to global strength
#Value of the max difference in edge weights of observed networks
NCTW1vsW3$nwinv.real
#0.8183753
NCTW1vsW3$nwinv.perm
#there's 100 since we did 100 permutations
#Maximum difference in edge weights
NCTW1vsW3$nwinv.pval
#0.6039604 - so not significantly different from one another in regard to number of edge weights
#Which edges significantly differ?
NCTW1vsW3$einv.pvals[which(NCTW1vsW3$einv.pvals[,3]<0.05),]
#
Var1
Var2 p-value
#52
CIG Alcohol 0.00990099
#69
CIG Marijuana 0.00990099
#90
Marijuana
PDNP 0.00990099
#106
Alcohol Depressed 0.02970297
#120
CIG Sleeping 0.03960396
#121
ECIG Sleeping 0.03960396
#159
PDNP
PTSD 0.03960396
#162
Anxious
PTSD 0.04950495
#174
Alcohol
Lied 0.00990099
#175
Marijuana
Lied 0.01980198
#178
Sleeping
Lied 0.02970297
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#195
Sleeping Attention 0.03960396
#207 Dual CIG + ECIG Listening 0.03960396
#209
Marijuana Listening 0.01980198
#214
PTSD Listening 0.04950495
#216
Attention Listening 0.02970297
#251
Listening Fights 0.02970297
#252
Bully Fights 0.02970297
#256
CIG Restless 0.03960396
#262
Depressed Restless 0.00990099
#263
Sleeping Restless 0.01980198
#285
Listening Answered 0.04950495

############################################
#
Compare W2 AND W3
#
############################################
L<-averageLayout(Wave2NetworkIF, Wave3NetworkIF)
Max<- max(abs(c(getWmat(Wave2NetworkIF),getWmat(Wave3NetworkIF))))
layout(t(1:2))
plot(Wave2NetworkIF,
layout=L,
cut=0,
theme="colorblind",
groups=Traits,
#nodeNames=Names,
#edge.color="black",
label.scale.equal=TRUE,
labels=Names,
legend=FALSE,
label.cex= 4.0,
legend.cex = 0.4,
title= "Wave 2",
maximum=Max)
plot(Wave3NetworkIF,
layout=L,
cut=0,
theme="colorblind",
groups=Traits,
#nodeNames=Names,
#edge.color="black",
label.scale.equal=TRUE,
label.cex= 4.0,
legend.cex = 0.4,
legend=FALSE,
title= "Wave 3",
maximum=Max)
NCTW2vsW3<- NCT(Wave2NetworkIF, Wave3NetworkIF, test.edges=TRUE,
it=100)
#difference in global strength between the networks of the observed data sets
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NCTW2vsW3$glstrinv.real
#0.7016259
#global strength values of individual networks
NCTW2vsW3$glstrinv.sep
#59.29835 vs 59.99997
NCTW2vsW3$glstrinv.perm
#there's 100 since we did 100 permutations
#Difference in global strength p-value
NCTW2vsW3$glstrinv.pval
#0.7524752 - so not significantly different from one another in regard to global strength
#Value of the max difference in edge weights of observed networks
NCTW2vsW3$nwinv.real
#1.322886
NCTW2vsW3$nwinv.perm
#there's 100 since we did 100 permutations
#Maximum difference in edge weights
NCTW2vsW3$nwinv.pval
#0.2277228 - so not significantly different from one another in regard to number of edge weights
#Which edges significantly differ?
NCTW2vsW3$einv.pvals[which(NCTW2vsW3$einv.pvals[,3]<0.05),]
#
Var1
Var2 p-value
#155
ECIG
PTSD 0.02970297
#207 Dual CIG + ECIG Listening 0.01980198
#209
Marijuana Listening 0.01980198
#251
Listening Fights 0.01980198
#256
CIG Restless 0.01980198
#262
Depressed Restless 0.01980198
#265
PTSD Restless 0.03960396
#276
Alcohol Answered 0.02970297
#286
Bully Answered 0.04950495

R File name: W1W2W3 Merged Network
#PATH WAVE 1, WAVE 2, WAVE 3 - SA 3
#Merge all data and develop network
###########################
# Read in merged dataset #
###########################
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation Files")
getwd()
master<-read.csv("/Users/courtneyblondino/Library/Mobile
Documents/com~apple~CloudDocs/Dissertation Files/w1w2w3master.csv", header=T, sep=',')
names(master)
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#how many complete data
master_complete_cases <- master[complete.cases(master),]
## MASTER TOTAL
= 33106
## MASTER COMPLETE CASES = 21353
## MASTER MISSING
= 11753
#select vars to keep for network modeling
myvars <- c("W1_ACUR_CIG" , "W1_ACUR_ECI" , "W1_ACUR_DUA" , "W1_ACUR_ALC" ,
"W1_ACUR_MAR" , "W1_ACUR_PAI" ,
"W1_DEPRESS" , "W1_SLEEPING" , "W1_ANXIOUS" , "W1_PTSD" ,
"W1_LIED" , "W1_ATTENTIO" , "W1_LISTENING" , "W1_BULLY" ,
"W1_FIGHTS" , "W1_RESTLESS" , "W1_ANSWERED",
"W2_ACUR_CIG" , "W2_ACUR_ECI" , "W2_ACUR_DUA" , "W2_ACUR_ALC" ,
"W2_ACUR_MAR" , "W2_ACUR_PAI" ,
"W2_DEPRESS" , "W2_SLEEPING" , "W2_ANXIOUS" , "W2_PTSD" ,
"W2_LIED" , "W2_ATTENTIO" , "W2_LISTENIN" , "W2_BULLY" ,
"W2_FIGHTS" , "W2_RESTLESS", "W2_ANSWERED",
"W3_ACUR_CIG" , "W3_ACUR_ECI" , "W3_ACUR_DUA", "W3_ACUR_ALC" ,
"W3_ACUR_MAR" , "W3_ACUR_PAI" ,
"W3_DEPRESS", "W3_SLEEPING" , "W3_ANXIOUS" , "W3_PTSD",
"W3_LIED" , "W3_ATTENTIO" , "W3_LISTENIN" , "W3_BULLY" ,
"W3_FIGHTS" , "W3_RESTLESS" ,"W3_ANSWERED")
new_master <- master[myvars]
#check distributions
table(new_master$W1_ACUR_PAI)
#rename variables so they look nice on the network
names(new_master)[names(new_master) == "W1_ACUR_CIG"] <- "W1 CIG"
names(new_master)[names(new_master) == "W1_ACUR_ECI"] <- "W1 ECIG"
names(new_master)[names(new_master) == "W1_ACUR_DUA"] <- "W1 Dual CIG + ECIG"
names(new_master)[names(new_master) == "W1_ACUR_ALC"] <- "W1 Alcohol"
names(new_master)[names(new_master) == "W1_ACUR_MAR"] <- "W1 Marijuana"
names(new_master)[names(new_master) == "W1_ACUR_PAI"] <- "W1 PDNP"
names(new_master)[names(new_master) == "W1_DEPRESS"] <- "W1 Depressed"
names(new_master)[names(new_master) == "W1_SLEEPING"] <- "W1 Sleeping"
names(new_master)[names(new_master) == "W1_ANXIOUS"] <- "W1 Anxious"
names(new_master)[names(new_master) == "W1_PTSD"] <- "W1 Distressed/Past"
names(new_master)[names(new_master) == "W1_LIED"] <- "W1 Lied"
names(new_master)[names(new_master) == "W1_ATTENTIO"] <- "W1 Attention"
names(new_master)[names(new_master) == "W1_LISTENING"] <- "W1 Listening"
names(new_master)[names(new_master) == "W1_BULLY"] <- "W1 Bully"
names(new_master)[names(new_master) == "W1_FIGHTS"] <- "W1 Fights"
names(new_master)[names(new_master) == "W1_RESTLESS"] <- "W1 Restless"
names(new_master)[names(new_master) == "W1_ANSWERED"] <- "W1 Answered"
names(new_master)[names(new_master) == "W2_ACUR_CIG"] <- "W2 CIG"
names(new_master)[names(new_master) == "W2_ACUR_ECI"] <- "W2 ECIG"
names(new_master)[names(new_master) == "W2_ACUR_DUA"] <- "W2 Dual CIG + ECIG"
names(new_master)[names(new_master) == "W2_ACUR_ALC"] <- "W2 Alcohol"
names(new_master)[names(new_master) == "W2_ACUR_MAR"] <- "W2 Marijuana"
names(new_master)[names(new_master) == "W2_ACUR_PAI"] <- "W2 PDNP"
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names(new_master)[names(new_master) == "W2_DEPRESS"] <- "W2 Depressed"
names(new_master)[names(new_master) == "W2_SLEEPING"] <- "W2 Sleeping"
names(new_master)[names(new_master) == "W2_ANXIOUS"] <- "W2 Anxious"
names(new_master)[names(new_master) == "W2_PTSD"] <- "W2 Distressed/Past"
names(new_master)[names(new_master) == "W2_LIED"] <- "W2 Lied"
names(new_master)[names(new_master) == "W2_ATTENTIO"] <- "W2 Attention"
names(new_master)[names(new_master) == "W2_LISTENIN"] <- "W2 Listening"
names(new_master)[names(new_master) == "W2_BULLY"] <- "W2 Bully"
names(new_master)[names(new_master) == "W2_FIGHTS"] <- "W2 Fights"
names(new_master)[names(new_master) == "W2_RESTLESS"] <- "W2 Restless"
names(new_master)[names(new_master) == "W2_ANSWERED"] <- "W2 Answered"
names(new_master)[names(new_master) == "W3_ACUR_CIG"] <- "W3 CIG"
names(new_master)[names(new_master) == "W3_ACUR_ECI"] <- "W3 ECIG"
names(new_master)[names(new_master) == "W3_ACUR_DUA"] <- "W3 Dual CIG + ECIG"
names(new_master)[names(new_master) == "W3_ACUR_ALC"] <- "W3 Alcohol"
names(new_master)[names(new_master) == "W3_ACUR_MAR"] <- "W3 Marijuana"
names(new_master)[names(new_master) == "W3_ACUR_PAI"] <- "W3 PDNP"
names(new_master)[names(new_master) == "W3_DEPRESS"] <- "W3 Depressed"
names(new_master)[names(new_master) == "W3_SLEEPING"] <- "W3 Sleeping"
names(new_master)[names(new_master) == "W3_ANXIOUS"] <- "W3 Anxious"
names(new_master)[names(new_master) == "W3_PTSD"] <- "W3 Distressed/Past"
names(new_master)[names(new_master) == "W3_LIED"] <- "W3 Lied"
names(new_master)[names(new_master) == "W3_ATTENTIO"] <- "W3 Attention"
names(new_master)[names(new_master) == "W3_LISTENIN"] <- "W3 Listening"
names(new_master)[names(new_master) == "W3_BULLY"] <- "W3 Bully"
names(new_master)[names(new_master) == "W3_FIGHTS"] <- "W3 Fights"
names(new_master)[names(new_master) == "W3_RESTLESS"] <- "W3 Restless"
names(new_master)[names(new_master) == "W3_ANSWERED"] <- "W3 Answered"
names(new_master)
require(ggplot2)
require(bootnet)
require(IsingFit)
require(IsingSampler)
require(qgraph)
#########
#IsingFit
MasterNetworkIF <-estimateNetwork(new_master, default="IsingFit", missing="listwise")
plot(MasterNetworkIF, layout = "spring", vsize = 10, cex=8)
MasterTraits <- rep(c(
'Substance Use',
'Negative Affect',
'Externalizing',
'Substance Use',
'Negative Affect',
'Externalizing',
'Substance Use',
'Negative Affect',
'Externalizing'
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), times=c(6,4,7,6,4,7,6,4,7))
#COLORED EDGES
layout(t(1))
plot(MasterNetworkIF,
layout="spring",
cut=0,
theme="colorblind",
groups=MasterTraits,
#labels=Names,
#nodeNames=Names,
#edge.color="black",
label.scale.equal=TRUE,
label.cex= 3,
legend.cex = 0.4,
title= "Wave 1, Wave 2, and Wave 3")
MasterNetworkIF
#edges
MasterEdges <- MasterNetworkIF$graph
write.csv(MasterEdges, file="MasterEdges.csv")
#this worked!
#(do this for all other edge matrices)
#Very little overlap across the waves, edges within the waves are weaker
R File name: Checking for missing data from network
## Checking for missing data from network analyses ##
################
#OVERALL WAVE 1#
#setwd("C:\Users\blondinoct\\Documents\\PNASS\\Data Management\\CSVs to use in R")
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation Files")
getwd()
overall<-read.csv("/Users/courtneyblondino/Library/Mobile
Documents/com~apple~CloudDocs/Dissertation Files/overallwave1.csv", header=T, sep=',')
#rename variables so they look nice on the network
names(overall)[names(overall) == "ACUR_CIG"] <- "CC"
names(overall)[names(overall) == "ACUR_ECI"] <- "EC"
names(overall)[names(overall) == "ACUR_DUA"] <- "Dual CC + EC"
names(overall)[names(overall) == "ACUR_ALC"] <- "Alcohol"
names(overall)[names(overall) == "ACUR_MAR"] <- "Marijuana"
names(overall)[names(overall) == "ACUR_PAI"] <- "PDNP"
names(overall)[names(overall) == "DEPRESS"] <- "Depressed"
names(overall)[names(overall) == "SLEEPING"] <- "Sleeping"
names(overall)[names(overall) == "ANXIOUS"] <- "Anxious"
names(overall)[names(overall) == "PTSD"] <- "PTSD"
names(overall)[names(overall) == "LIED"] <- "Lied"
names(overall)[names(overall) == "ATTENTIO"] <- "Attention"
names(overall)[names(overall) == "LISTENING"] <- "Listening"
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names(overall)[names(overall) == "BULLY"] <- "Bully"
names(overall)[names(overall) == "FIGHTS"] <- "Fights"
names(overall)[names(overall) == "RESTLESS"] <- "Restless"
names(overall)[names(overall) == "ANSWERED"] <- "Answered"
#delete obs with missing data
overall_complete_cases <- overall[complete.cases(overall),]
## W1 OVERALL TOTAL = 32,320
## W1 COMPLETE CASES = 15,299
## W1 MISSING
= 17,021
######################
##WAVE 1 - MALE ONLY##
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation Files")
getwd()
male<-read.csv("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation
Files/malewave1.csv", header=T, sep=',')
dim(male)
names(male)
#rename variables so they look nice on the network
names(male)[names(male) == "ACUR_CIG"] <- "CC"
names(male)[names(male) == "ACUR_ECI"] <- "EC"
names(male)[names(male) == "ACUR_DUA"] <- "Dual CC + EC"
names(male)[names(male) == "ACUR_ALC"] <- "Alcohol"
names(male)[names(male) == "ACUR_MAR"] <- "Marijuana"
names(male)[names(male) == "ACUR_PAI"] <- "PDNP"
names(male)[names(male) == "DEPRESS"] <- "Depressed"
names(male)[names(male) == "SLEEPING"] <- "Sleeping"
names(male)[names(male) == "ANXIOUS"] <- "Anxious"
names(male)[names(male) == "PTSD"] <- "PTSD"
names(male)[names(male) == "LIED"] <- "Lied"
names(male)[names(male) == "ATTENTIO"] <- "Attention"
names(male)[names(male) == "LISTENING"] <- "Listening"
names(male)[names(male) == "BULLY"] <- "Bully"
names(male)[names(male) == "FIGHTS"] <- "Fights"
names(male)[names(male) == "RESTLESS"] <- "Restless"
names(male)[names(male) == "ANSWERED"] <- "Answered"
#delete obs with missing data
malew1_complete_cases <- male[complete.cases(male),]
## W1 MALE OVERALL TOTAL = 16,306
## W1 MALE COMPLETE CASES = 8,406
## W1 MALE MISSING
= 7,900
########################
##WAVE 1 - FEMALE ONLY##
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation Files")
getwd()
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female<-read.csv("/Users/courtneyblondino/Library/Mobile
Documents/com~apple~CloudDocs/Dissertation Files/femalewave1.csv", header=T, sep=',')
dim(female)
names(female)
#rename variables so they look nice on the network
names(female)[names(female) == "ACUR_CIG"] <- "CC"
names(female)[names(female) == "ACUR_ECI"] <- "EC"
names(female)[names(female) == "ACUR_DUA"] <- "Dual CC + EC"
names(female)[names(female) == "ACUR_ALC"] <- "Alcohol"
names(female)[names(female) == "ACUR_MAR"] <- "Marijuana"
names(female)[names(female) == "ACUR_PAI"] <- "PDNP"
names(female)[names(female) == "DEPRESS"] <- "Depressed"
names(female)[names(female) == "SLEEPING"] <- "Sleeping"
names(female)[names(female) == "ANXIOUS"] <- "Anxious"
names(female)[names(female) == "PTSD"] <- "PTSD"
names(female)[names(female) == "LIED"] <- "Lied"
names(female)[names(female) == "ATTENTIO"] <- "Attention"
names(female)[names(female) == "LISTENING"] <- "Listening"
names(female)[names(female) == "BULLY"] <- "Bully"
names(female)[names(female) == "FIGHTS"] <- "Fights"
names(female)[names(female) == "RESTLESS"] <- "Restless"
names(female)[names(female) == "ANSWERED"] <- "Answered"
#delete obs with missing data
femalew1_complete_cases <- female[complete.cases(female),]
## W1 FEMALE OVERALL TOTAL = 15,980
## W1 FEMALE COMPLETE CASES = 6,888
## W1 FEMALE MISSING
= 9,092
########
## W2 ##
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation Files")
getwd()
Wave2<-read.csv("/Users/courtneyblondino/Library/Mobile
Documents/com~apple~CloudDocs/Dissertation Files/w2datafornetcomp232021.csv", header=T, sep=',')
dim(Wave2)
names(Wave2)
#Have to tell R what missing means
Wave2$acur_cignew[Wave2$acur_cignew==-99999] <- NA
Wave2$acur_ecignew[Wave2$acur_ecignew==-99999] <- NA
Wave2$acur_dualnew[Wave2$acur_dualnew==-99999] <- NA
Wave2$acur_alc[Wave2$acur_alc==-99999] <- NA
Wave2$acur_marijuana[Wave2$acur_marijuana==-99999] <- NA
Wave2$acur_painkiller[Wave2$acur_painkiller==-99999] <- NA
Wave2$depressed[Wave2$depressed==-99999] <- NA
Wave2$sleeping[Wave2$sleeping==-99999] <- NA
Wave2$anxious[Wave2$anxious==-99999] <- NA
Wave2$ptsd[Wave2$ptsd==-99999] <- NA
Wave2$lied[Wave2$lied==-99999] <- NA
Wave2$attention[Wave2$attention==-99999] <- NA
Wave2$listening[Wave2$listening==-99999] <- NA
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Wave2$bully[Wave2$bully==-99999] <- NA
Wave2$fights[Wave2$fights==-99999] <- NA
Wave2$restless[Wave2$restless==-99999] <- NA
Wave2$answered[Wave2$answered==-99999] <- NA
#rename variables so they look nice on the network
names(Wave2)[names(Wave2) == "acur_cignew"] <- "CC"
names(Wave2)[names(Wave2) == "acur_ecignew"] <- "EC"
names(Wave2)[names(Wave2) == "acur_dualnew"] <- "Dual CC + EC"
names(Wave2)[names(Wave2) == "acur_alc"] <- "Alcohol"
names(Wave2)[names(Wave2) == "acur_marijuana"] <- "Marijuana"
names(Wave2)[names(Wave2) == "acur_painkiller"] <- "PDNP"
names(Wave2)[names(Wave2) == "depressed"] <- "Depressed"
names(Wave2)[names(Wave2) == "sleeping"] <- "Sleeping"
names(Wave2)[names(Wave2) == "anxious"] <- "Anxious"
names(Wave2)[names(Wave2) == "ptsd"] <- "PTSD"
names(Wave2)[names(Wave2) == "lied"] <- "Lied"
names(Wave2)[names(Wave2) == "attention"] <- "Attention"
names(Wave2)[names(Wave2) == "listening"] <- "Listening"
names(Wave2)[names(Wave2) == "bully"] <- "Bully"
names(Wave2)[names(Wave2) == "fights"] <- "Fights"
names(Wave2)[names(Wave2) == "restless"] <- "Restless"
names(Wave2)[names(Wave2) == "answered"] <- "Answered"
#delete obs with missing data
w2_complete_cases <- Wave2[complete.cases(Wave2),]
## W2 TOTAL
= 26,444
## W2 COMPLETE CASES = 25,592
## W2 MISSING
= 852
########
## W3 ##
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation Files")
getwd()
Wave3<-read.csv("/Users/courtneyblondino/Library/Mobile
Documents/com~apple~CloudDocs/Dissertation Files/w3datafornetcomp332021.csv", header=T, sep=',')
dim(Wave3)
names(Wave3)
#Have to tell R what missing means
Wave3$acur_cignew[Wave3$acur_cignew==-99999] <- NA
Wave3$acur_ecignew[Wave3$acur_ecignew==-99999] <- NA
Wave3$acur_dualnew[Wave3$acur_dualnew==-99999] <- NA
Wave3$acur_alc[Wave3$acur_alc==-99999] <- NA
Wave3$acur_marijuana[Wave3$acur_marijuana==-99999] <- NA
Wave3$acur_painkiller[Wave3$acur_painkiller==-99999] <- NA
Wave3$depressed[Wave3$depressed==-99999] <- NA
Wave3$sleeping[Wave3$sleeping==-99999] <- NA
Wave3$anxious[Wave3$anxious==-99999] <- NA
Wave3$ptsd[Wave3$ptsd==-99999] <- NA
Wave3$lied[Wave3$lied==-99999] <- NA
Wave3$attention[Wave3$attention==-99999] <- NA
Wave3$listening[Wave3$listening==-99999] <- NA
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Wave3$bully[Wave3$bully==-99999] <- NA
Wave3$fights[Wave3$fights==-99999] <- NA
Wave3$restless[Wave3$restless==-99999] <- NA
Wave3$answered[Wave3$answered==-99999] <- NA
#rename variables so they look nice on the network
names(Wave3)[names(Wave3) == "acur_cignew"] <- "CC"
names(Wave3)[names(Wave3) == "acur_ecignew"] <- "EC"
names(Wave3)[names(Wave3) == "acur_dualnew"] <- "Dual CC + EC"
names(Wave3)[names(Wave3) == "acur_alc"] <- "Alcohol"
names(Wave3)[names(Wave3) == "acur_marijuana"] <- "Marijuana"
names(Wave3)[names(Wave3) == "acur_painkiller"] <- "PDNP"
names(Wave3)[names(Wave3) == "depressed"] <- "Depressed"
names(Wave3)[names(Wave3) == "sleeping"] <- "Sleeping"
names(Wave3)[names(Wave3) == "anxious"] <- "Anxious"
names(Wave3)[names(Wave3) == "ptsd"] <- "PTSD"
names(Wave3)[names(Wave3) == "lied"] <- "Lied"
names(Wave3)[names(Wave3) == "attention"] <- "Attention"
names(Wave3)[names(Wave3) == "listening"] <- "Listening"
names(Wave3)[names(Wave3) == "bully"] <- "Bully"
names(Wave3)[names(Wave3) == "fights"] <- "Fights"
names(Wave3)[names(Wave3) == "restless"] <- "Restless"
names(Wave3)[names(Wave3) == "answered"] <- "Answered"
#delete obs with missing data
w3_complete_cases <- Wave3[complete.cases(Wave3),]
## W3 TOTAL
= 26,239
## W3 COMPLETE CASES = 25,359
## W3 MISSING
= 880

###NEW DATA
###APRIL 14
################
#OVERALL WAVE 1#
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation
Files/Network Chapter")
getwd()
overall<-read.csv("/Users/courtneyblondino/Library/Mobile
Documents/com~apple~CloudDocs/Dissertation Files/Network Chapter/OverallWave1-4142021.csv",
header=T, sep=',')
#rename variables so they look nice on the network
names(overall)[names(overall) == "ACUR_CIG"] <- "CIG"
names(overall)[names(overall) == "ACUR_ECI"] <- "ECIG"
names(overall)[names(overall) == "ACUR_DUA"] <- "Dual CIG + ECIG"
names(overall)[names(overall) == "ACUR_ALC"] <- "Alcohol"
names(overall)[names(overall) == "ACUR_MAR"] <- "Marijuana"
names(overall)[names(overall) == "ACUR_PAI"] <- "PDNP"
names(overall)[names(overall) == "DEPRESS"] <- "Depressed"
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names(overall)[names(overall) == "SLEEPING"] <- "Sleeping"
names(overall)[names(overall) == "ANXIOUS"] <- "Anxious"
names(overall)[names(overall) == "PTSD"] <- "PTSD"
names(overall)[names(overall) == "LIED"] <- "Lied"
names(overall)[names(overall) == "ATTENTIO"] <- "Attention"
names(overall)[names(overall) == "LISTENING"] <- "Listening"
names(overall)[names(overall) == "BULLY"] <- "Bully"
names(overall)[names(overall) == "FIGHTS"] <- "Fights"
names(overall)[names(overall) == "RESTLESS"] <- "Restless"
names(overall)[names(overall) == "ANSWERED"] <- "Answered"
#delete obs with missing data
overall_complete_cases <- overall[complete.cases(overall),]
## W1 OVERALL TOTAL = 32,320
## W1 COMPLETE CASES = 30,211
## W1 MISSING
= 2,109
######################
##WAVE 1 - MALE ONLY##
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation
Files/Network Chapter")
getwd()
male<-read.csv("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation
Files/Network Chapter/MaleWave1-4142021.csv", header=T, sep=',')
dim(male)
names(male)
#rename variables so they look nice on the network
names(male)[names(male) == "ACUR_CIG"] <- "CIG"
names(male)[names(male) == "ACUR_ECI"] <- "ECIG"
names(male)[names(male) == "ACUR_DUA"] <- "Dual CIG + ECIG"
names(male)[names(male) == "ACUR_ALC"] <- "Alcohol"
names(male)[names(male) == "ACUR_MAR"] <- "Marijuana"
names(male)[names(male) == "ACUR_PAI"] <- "PDNP"
names(male)[names(male) == "DEPRESS"] <- "Depressed"
names(male)[names(male) == "SLEEPING"] <- "Sleeping"
names(male)[names(male) == "ANXIOUS"] <- "Anxious"
names(male)[names(male) == "PTSD"] <- "PTSD"
names(male)[names(male) == "LIED"] <- "Lied"
names(male)[names(male) == "ATTENTIO"] <- "Attention"
names(male)[names(male) == "LISTENING"] <- "Listening"
names(male)[names(male) == "BULLY"] <- "Bully"
names(male)[names(male) == "FIGHTS"] <- "Fights"
names(male)[names(male) == "RESTLESS"] <- "Restless"
names(male)[names(male) == "ANSWERED"] <- "Answered"
#delete obs with missing data
malew1_complete_cases <- male[complete.cases(male),]
## W1 MALE OVERALL TOTAL = 16,306
## W1 MALE COMPLETE CASES = 15,268
## W1 MALE MISSING
= 1,038

403

########################
##WAVE 1 - FEMALE ONLY##
setwd("/Users/courtneyblondino/Library/Mobile Documents/com~apple~CloudDocs/Dissertation
Files/Network Chapter")
getwd()
female<-read.csv("/Users/courtneyblondino/Library/Mobile
Documents/com~apple~CloudDocs/Dissertation Files/Network Chapter/FemaleWave1-4142021.csv",
header=T, sep=',')
dim(female)
names(female)
#rename variables so they look nice on the network
names(female)[names(female) == "ACUR_CIG"] <- "CIG"
names(female)[names(female) == "ACUR_ECI"] <- "ECIG"
names(female)[names(female) == "ACUR_DUA"] <- "Dual CIG + ECIG"
names(female)[names(female) == "ACUR_ALC"] <- "Alcohol"
names(female)[names(female) == "ACUR_MAR"] <- "Marijuana"
names(female)[names(female) == "ACUR_PAI"] <- "PDNP"
names(female)[names(female) == "DEPRESS"] <- "Depressed"
names(female)[names(female) == "SLEEPING"] <- "Sleeping"
names(female)[names(female) == "ANXIOUS"] <- "Anxious"
names(female)[names(female) == "PTSD"] <- "PTSD"
names(female)[names(female) == "LIED"] <- "Lied"
names(female)[names(female) == "ATTENTIO"] <- "Attention"
names(female)[names(female) == "LISTENING"] <- "Listening"
names(female)[names(female) == "BULLY"] <- "Bully"
names(female)[names(female) == "FIGHTS"] <- "Fights"
names(female)[names(female) == "RESTLESS"] <- "Restless"
names(female)[names(female) == "ANSWERED"] <- "Answered"
#delete obs with missing data
femalew1_complete_cases <- female[complete.cases(female),]
## W1 FEMALE OVERALL TOTAL = 15,980
## W1 FEMALE COMPLETE CASES = 14,925
## W1 FEMALE MISSING
= 1,055
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